*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG A 25 ARG.? 9.68 S2 BME A 300 D 219 LYS A 10 LYS~? 16.18 O1 BME A 300 D 376 GLY A 89 GLY~? 6.94 S2 BME A 300 D 399 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 0.59 75.69 110.95 1.51 77.84 112.93 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 1.28 85.37 123.16 0.84 80.41 120.28 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -1.06 80.88 111.45 -0.91 81.65 111.55 6.75 -7.92 2.09 6.22 -8.11 1.54 coo 7.52 81.86 116.81 7.49 81.18 116.34 7.18 -11.38 -5.94 7.80 -10.95 -5.54 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c03 naa= 4 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 1 4 # 1 A 125 ARG A 68 ARG~? -4.35 S2 BME A 300s A 151 SER A 69 SER~? 5.63 S2 BME A 300 A 369 GLY A 88 GLY~? 6.95 O1 BME A 300 A 450 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 48.89 -0.02 20.42 48.11 2.83 21.18 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 43.71 3.15 18.25 42.31 5.11 18.82 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 46.80 10.26 23.98 47.38 10.43 24.45 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 51.72 4.74 17.91 51.63 5.04 21.04 13.39 -11.16 2.90 14.53 -11.26 0.04 2hgs_c00 source 2hgs GLUTATHIONE SYNTHETASE : 1 hits 2hgs_c00 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 60 TYR^? 16.66 S2 BME A 300 B 190 LYS A 2 LYS.? 20.18 S2 BME A 300 B 222 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 7.17 16.59 41.26 8.01 19.20 40.73 9.00 3.02 1.57 7.75 5.45 1.00 coo 13.38 20.00 35.06 11.43 22.49 39.53 2.39 3.95 8.25 5.67 8.88 7.74 coo 9.76 26.58 38.10 11.63 25.78 38.76 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 60 TYR^? 16.66 S2 BME A 300 B 190 LYS A 10 LYS~? 16.18 O1 BME A 300 B 222 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 7.17 16.59 41.26 8.01 19.20 40.73 9.00 3.02 1.57 7.75 5.45 1.00 coo 13.38 20.00 35.06 11.43 22.49 39.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 9.76 26.58 38.10 11.63 25.78 38.76 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR A 60 TYR^? 16.66 S2 BME A 300 B 190 LYS A 12 LYS~? 21.81 S2 BME A 300 B 222 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 7.17 16.59 41.26 8.01 19.20 40.73 9.00 3.02 1.57 7.75 5.45 1.00 coo 13.38 20.00 35.06 11.43 22.49 39.53 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 9.76 26.58 38.10 11.63 25.78 38.76 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 3 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 2 LYS.? 20.18 S2 BME A 300 A 222 ASP A 82 ASP^? 20.57 S2 BME A 300 B 140 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -4.61 20.12 30.34 -2.74 22.65 25.95 2.39 3.95 8.25 5.67 8.88 7.74 coo -1.04 26.60 27.37 -2.94 25.93 26.69 10.12 9.33 8.59 8.15 9.51 7.94 coo 1.51 16.60 24.17 0.82 19.23 24.79 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 10 LYS~? 16.18 O1 BME A 300 A 222 ASP A 7 ASP~? 16.68 O1 BME A 300 B 140 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -4.61 20.12 30.34 -2.74 22.65 25.95 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -1.04 26.60 27.37 -2.94 25.93 26.69 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 1.51 16.60 24.17 0.82 19.23 24.79 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS A 39 LYS^? 20.06 S2 BME A 300 A 222 ASP A 23 ASP^? 9.45 S2 BME A 300 B 140 TYR A 59 TYR^? 18.50 S2 BME A 300 coo -4.61 20.12 30.34 -2.74 22.65 25.95 19.85 -1.20 1.64 21.03 4.07 2.80 coo -1.04 26.60 27.37 -2.94 25.93 26.69 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 1.51 16.60 24.17 0.82 19.23 24.79 14.59 5.14 5.72 16.82 6.86 5.68 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 3 hits 1a05_c01 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 25 ARG.? 9.68 S2 BME A 300 265 HIS A 91 HIS~? 7.63 O1 BME A 300 274 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -15.18 55.46 8.55 -14.82 52.98 10.38 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 0.94 52.26 9.16 1.95 54.78 9.91 9.00 3.02 1.57 7.75 5.45 1.00 1a41_c01 source 1a41 TOPOISOMERASE I : 1 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 74 GLU~? 13.09 S2 BME A 300 A 60 ASP A 82 ASP^? 20.57 S2 BME A 300 A 175 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 46.10 28.27 19.27 45.48 26.99 20.84 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 56.42 28.06 12.93 55.01 27.92 14.50 10.12 9.33 8.59 8.15 9.51 7.94 coo 45.02 22.04 15.38 46.16 24.00 13.76 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 99 GLU.? 20.82 S2 BME A 300 A 60 ASP A 95 ASP.? 15.99 O1 BME A 300 A 175 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 46.10 28.27 19.27 45.48 26.99 20.84 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 56.42 28.06 12.93 55.01 27.92 14.50 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 45.02 22.04 15.38 46.16 24.00 13.76 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 2 hits 1a50_c03 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 23 ASP^? 9.45 S2 BME A 300 187 GLU A 99 GLU.? 20.82 S2 BME A 300 229 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -52.57 56.60 47.75 -51.52 54.87 46.95 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -45.08 48.37 46.81 -46.53 49.74 45.96 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -47.40 44.36 48.48 -50.80 49.18 46.20 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 82 ASP^? 20.57 S2 BME A 300 187 GLU A 74 GLU~? 13.09 S2 BME A 300 229 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -52.57 56.60 47.75 -51.52 54.87 46.95 10.12 9.33 8.59 8.15 9.51 7.94 coo -45.08 48.37 46.81 -46.53 49.74 45.96 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -47.40 44.36 48.48 -50.80 49.18 46.20 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 95 ASP.? 15.99 O1 BME A 300 187 GLU A 99 GLU.? 20.82 S2 BME A 300 229 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -52.57 56.60 47.75 -51.52 54.87 46.95 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -45.08 48.37 46.81 -46.53 49.74 45.96 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -47.40 44.36 48.48 -50.80 49.18 46.20 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 3 hits 1ald_c00 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 27 ASP~? 15.09 S2 BME A 300 204 GLU A 29 GLU~? 6.68 S2 BME A 300 289 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 4.34 62.44 32.05 4.22 64.48 32.53 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.97 -5.82 2.06 15.42 -7.84 1.89 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 44 ASP~? 11.03 S2 BME A 300 227 GLU A 74 GLU~? 13.09 S2 BME A 300 289 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 24.97 -2.58 14.97 24.99 -3.62 16.79 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c06 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 53 PHE~? 16.58 S2 BME A 300 A 223 ASP A 23 ASP^? 9.45 S2 BME A 300 A 265 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.96 4.29 9.15 17.54 1.52 8.86 coo 30.70 47.50 67.53 29.83 49.47 67.39 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 6.34 -0.11 -7.21 5.79 -6.41 -7.72 1ax4_c04 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 53 PHE~? 16.58 S2 BME A 300 B 223 ASP A 23 ASP^? 9.45 S2 BME A 300 B 265 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.96 4.29 9.15 17.54 1.52 8.86 coo 10.43 61.66 91.81 9.80 60.04 90.61 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 6.34 -0.11 -7.21 5.79 -6.41 -7.72 1ax4_c05 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 53 PHE~? 16.58 S2 BME A 300 C 223 ASP A 23 ASP^? 9.45 S2 BME A 300 C 265 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.96 4.29 9.15 17.54 1.52 8.86 coo -9.52 75.74 33.62 -8.85 73.74 33.93 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 6.34 -0.11 -7.21 5.79 -6.41 -7.72 1ax4_c06 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 53 PHE~? 16.58 S2 BME A 300 D 223 ASP A 23 ASP^? 9.45 S2 BME A 300 D 265 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.96 4.29 9.15 17.54 1.52 8.86 coo -29.46 51.67 48.51 -28.63 53.31 49.56 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 6.34 -0.11 -7.21 5.79 -6.41 -7.72 1ax4_c07 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c07 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 7 ASP~? 16.68 O1 BME A 300 B 182 GLU A 87 GLU.? 12.12 O1 BME A 300 B 286 ASN A 11 ASN~? 22.08 O1 BME A 300 coo 13.82 69.26 132.27 11.87 70.14 132.51 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 8.74 63.05 136.42 9.87 62.19 134.79 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 8.26 72.60 129.22 10.14 73.45 129.80 3.09 3.41 -8.04 1.54 2.11 -8.64 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 53 PHE~? 16.58 S2 BME A 300 A 159 ASP A 48 ASP~? 19.85 S2 BME A 300 A 188 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 13.91 34.58 14.67 12.95 36.00 12.47 17.96 4.29 9.15 17.54 1.52 8.86 coo 20.97 28.40 16.26 20.19 30.15 15.34 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 19.85 -1.20 1.64 21.03 4.07 2.80 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 1 hits 1b9h_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 27 ASP~? 15.09 S2 BME A 300 435 GLU A 29 GLU~? 6.68 S2 BME A 300 510 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 88.62 69.90 41.16 89.05 70.67 43.04 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 89.52 76.11 40.17 89.01 75.16 41.97 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 84.89 77.60 46.67 85.63 75.79 46.03 15.97 -5.82 2.06 15.42 -7.84 1.89 1bf2_c00 source 1bf2 ISOAMYLASE : 1 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 77 GLU~? 17.67 S2 BME A 300 A 503 TYR A 75 TYR~? 15.90 S2 BME A 300 A 537 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 24.06 146.21 11.09 22.89 146.18 9.36 7.63 5.18 13.95 5.55 5.01 14.48 coo 15.91 140.69 8.32 15.71 143.39 9.13 14.46 -0.26 16.60 17.11 0.41 17.22 coo 16.65 144.44 13.24 18.34 145.22 12.33 6.36 -0.87 15.92 5.32 -2.36 17.02 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 1 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 74 GLU~? 13.09 S2 BME A 300 B 504 TYR A 75 TYR~? 15.90 S2 BME A 300 B 540 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 84.93 40.21 105.31 85.72 41.45 107.72 14.46 -0.26 16.60 17.11 0.41 17.22 coo 83.38 41.19 112.55 85.47 40.59 112.72 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 77 GLU~? 17.67 S2 BME A 300 B 504 TYR A 75 TYR~? 15.90 S2 BME A 300 B 540 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 7.63 5.18 13.95 5.55 5.01 14.48 coo 84.93 40.21 105.31 85.72 41.45 107.72 14.46 -0.26 16.60 17.11 0.41 17.22 coo 83.38 41.19 112.55 85.47 40.59 112.72 6.36 -0.87 15.92 5.32 -2.36 17.02 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 25 ARG.? 9.68 S2 BME A 300 B 451 GLU A 28 GLU~? 14.38 S2 BME A 300 B 540 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 82.21 41.07 119.14 83.95 40.66 116.59 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 86.52 35.28 112.74 87.08 36.38 110.99 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 83.38 41.19 112.55 85.47 40.59 112.72 15.50 -15.19 4.21 14.37 -14.08 5.62 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c05 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 25 ARG.? 9.68 S2 BME A 300 A 128 GLU A 28 GLU~? 14.38 S2 BME A 300 A 225 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 38.56 19.11 14.83 37.12 21.00 16.76 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 36.48 24.43 22.02 36.86 26.34 21.13 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 40.16 23.71 17.01 38.52 24.96 17.40 15.50 -15.19 4.21 14.37 -14.08 5.62 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 53 PHE~? 16.58 S2 BME A 300 A 205 ASP A 44 ASP~? 11.03 S2 BME A 300 A 236 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 4.14 2.10 36.34 6.69 3.08 36.92 17.96 4.29 9.15 17.54 1.52 8.86 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 8.82 -4.39 14.42 10.42 -10.04 16.23 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 1 hits 1bs0_c01 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 27 ASP~? 15.09 S2 BME A 300 A 354 GLU A 29 GLU~? 6.68 S2 BME A 300 A 421 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 29.07 50.42 58.36 29.02 52.18 59.49 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 30.82 59.76 58.47 31.12 59.02 60.40 15.97 -5.82 2.06 15.42 -7.84 1.89 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 27 ASP~? 15.09 S2 BME A 300 B 354 GLU A 29 GLU~? 6.68 S2 BME A 300 B 421 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 27.87 10.66 47.95 27.82 8.60 48.27 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 26.02 1.87 43.38 25.90 1.97 45.49 15.97 -5.82 2.06 15.42 -7.84 1.89 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c09 naa= 3 ULMN 3 1bzc_c00 PROTEIN-TYROSINE-PHOSPHATASE user 1 3 # 1 A 181 ASP A 23 ASP^? 9.45 S2 BME A 300 A 215 CYH A 63 CYH.? -3.36 S2 BME A 300s A 221 ARG A 25 ARG.? 9.68 S2 BME A 300 coo -20.67 62.35 15.68 -20.16 63.09 17.59 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -17.06 60.65 8.77 -19.43 59.04 8.89 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -21.54 63.29 10.68 -19.32 62.77 12.69 13.39 -11.16 2.90 14.53 -11.26 0.04 1bzc_c00 source 1bzc PROTEIN-TYROSINE-PHOSPHATASE : 1 hits 1bzc_c00 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 68 ARG~? -4.35 S2 BME A 300s 127 ARG A 25 ARG.? 9.68 S2 BME A 300 270 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -0.83 25.63 1.57 0.97 28.05 0.90 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.30 -17.97 5.16 20.86 -18.94 6.97 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 1 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 48 ASP~? 19.85 S2 BME A 300 264 GLU A 74 GLU~? 13.09 S2 BME A 300 328 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 45.39 90.72 40.63 45.07 89.14 41.90 19.36 -9.90 14.44 17.51 -11.01 14.77 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 1 hits 1cdg_c00 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 70 ALA~? 8.30 S2 BME A 300 A 74 ASN A 85 ASN^? 8.15 S2 BME A 300 A 75 GLY A 66 GLY.? -4.48 C1 BME A 300s coo -1.80 62.71 122.76 -1.88 63.70 123.92 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 1.20 66.40 122.20 2.03 64.53 121.46 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 4.68 65.84 125.52 4.11 65.60 126.05 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA A 78 ALA~? 19.15 S2 BME A 300 A 74 ASN A 79 ASN.? 19.89 S2 BME A 300 A 75 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -1.80 62.71 122.76 -1.88 63.70 123.92 11.30 5.32 18.63 11.37 4.04 19.42 coo 1.20 66.40 122.20 2.03 64.53 121.46 15.66 5.60 16.72 16.27 4.24 18.24 coo 4.68 65.84 125.52 4.11 65.60 126.05 13.21 9.55 15.29 13.34 8.86 14.89 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 70 ALA~? 8.30 S2 BME A 300 B 74 ASN A 85 ASN^? 8.15 S2 BME A 300 B 75 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 39.21 14.97 27.55 40.19 16.01 27.08 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 43.06 12.94 25.74 42.26 11.81 27.44 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 46.38 13.54 29.18 46.14 14.29 29.26 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA A 78 ALA~? 19.15 S2 BME A 300 B 74 ASN A 79 ASN.? 19.89 S2 BME A 300 B 75 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 39.21 14.97 27.55 40.19 16.01 27.08 11.30 5.32 18.63 11.37 4.04 19.42 coo 43.06 12.94 25.74 42.26 11.81 27.44 15.66 5.60 16.72 16.27 4.24 18.24 coo 46.38 13.54 29.18 46.14 14.29 29.26 13.21 9.55 15.29 13.34 8.86 14.89 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 70 ALA~? 8.30 S2 BME A 300 C 74 ASN A 85 ASN^? 8.15 S2 BME A 300 C 75 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 16.14 15.08 36.63 15.28 14.65 37.81 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 11.60 16.13 36.70 12.80 17.74 35.96 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 10.99 19.23 40.32 11.50 18.77 40.74 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA A 78 ALA~? 19.15 S2 BME A 300 C 74 ASN A 79 ASN.? 19.89 S2 BME A 300 C 75 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 16.14 15.08 36.63 15.28 14.65 37.81 11.30 5.32 18.63 11.37 4.04 19.42 coo 11.60 16.13 36.70 12.80 17.74 35.96 15.66 5.60 16.72 16.27 4.24 18.24 coo 10.99 19.23 40.32 11.50 18.77 40.74 13.21 9.55 15.29 13.34 8.86 14.89 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 70 ALA~? 8.30 S2 BME A 300 D 74 ASN A 85 ASN^? 8.15 S2 BME A 300 D 75 GLY A 66 GLY.? -4.48 C1 BME A 300s coo -13.31 41.90 116.45 -13.05 40.39 116.25 6.63 -3.94 11.35 5.27 -4.56 11.61 coo -16.85 39.36 115.26 -17.55 40.58 116.90 5.01 -1.60 7.62 5.37 -3.69 7.71 coo -17.65 36.37 119.00 -16.85 36.22 119.00 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA A 78 ALA~? 19.15 S2 BME A 300 D 74 ASN A 79 ASN.? 19.89 S2 BME A 300 D 75 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -13.31 41.90 116.45 -13.05 40.39 116.25 11.30 5.32 18.63 11.37 4.04 19.42 coo -16.85 39.36 115.26 -17.55 40.58 116.90 15.66 5.60 16.72 16.27 4.24 18.24 coo -17.65 36.37 119.00 -16.85 36.22 119.00 13.21 9.55 15.29 13.34 8.86 14.89 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 7 ASP~? 16.68 O1 BME A 300 315 GLU A 8 GLU~? 18.47 O1 BME A 300 390 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 32.46 99.13 19.34 30.94 100.38 20.07 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 32.04 94.22 18.23 30.57 94.75 16.88 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 21.10 94.74 18.36 23.09 96.71 18.59 9.00 3.02 1.57 7.75 5.45 1.00 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 27 ASP~? 15.09 S2 BME A 300 A 56 ILE A 100 ILE.? 19.99 S2 BME A 300 A 82 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 21.53 -12.29 -7.18 21.37 -13.39 -7.89 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 82 ASP^? 20.57 S2 BME A 300 A 56 ILE A 4 ILE^? 15.59 S2 BME A 300 A 82 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 10.12 9.33 8.59 8.15 9.51 7.94 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 3.44 1.75 1.25 4.45 2.06 0.27 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 82 ASP^? 20.57 S2 BME A 300 A 56 ILE A 61 ILE^? 10.29 S2 BME A 300 A 82 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 10.12 9.33 8.59 8.15 9.51 7.94 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 10.84 -1.33 6.84 12.18 -0.95 7.29 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP A 95 ASP.? 15.99 O1 BME A 300 A 56 ILE A 35 ILE.? 14.29 S2 BME A 300 A 82 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 13.89 -4.42 -3.92 12.58 -3.84 -3.70 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP A 95 ASP.? 15.99 O1 BME A 300 A 56 ILE A 100 ILE.? 19.99 S2 BME A 300 A 82 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 21.53 -12.29 -7.18 21.37 -13.39 -7.89 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 5 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 27 ASP~? 15.09 S2 BME A 300 B 56 ILE A 100 ILE.? 19.99 S2 BME A 300 B 82 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 21.53 -12.29 -7.18 21.37 -13.39 -7.89 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 82 ASP^? 20.57 S2 BME A 300 B 56 ILE A 4 ILE^? 15.59 S2 BME A 300 B 82 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 10.12 9.33 8.59 8.15 9.51 7.94 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 3.44 1.75 1.25 4.45 2.06 0.27 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP A 82 ASP^? 20.57 S2 BME A 300 B 56 ILE A 61 ILE^? 10.29 S2 BME A 300 B 82 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 10.12 9.33 8.59 8.15 9.51 7.94 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 10.84 -1.33 6.84 12.18 -0.95 7.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP A 95 ASP.? 15.99 O1 BME A 300 B 56 ILE A 35 ILE.? 14.29 S2 BME A 300 B 82 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 13.89 -4.42 -3.92 12.58 -3.84 -3.70 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP A 95 ASP.? 15.99 O1 BME A 300 B 56 ILE A 100 ILE.? 19.99 S2 BME A 300 B 82 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 21.53 -12.29 -7.18 21.37 -13.39 -7.89 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 5 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 93 TRP~? 14.44 S2 BME A 300 A 243 ASP A 7 ASP~? 16.68 O1 BME A 300 A 272 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 18.21 54.75 18.05 19.91 55.17 21.59 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 16.93 55.67 9.65 17.16 54.23 11.19 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 14.13 45.79 13.40 14.25 49.41 18.30 7.13 5.12 -6.84 5.25 7.73 -2.58 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 1 hits 1d7r_c01 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 10 LYS~? 16.18 O1 BME A 300 A 177 GLU A 15 GLU~? 24.22 S2 BME A 300 A 201 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 10 LYS~? 16.18 O1 BME A 300 A 177 GLU A 15 GLU~? 24.22 S2 BME A 300 A 201 LEU A 14 LEU~? 26.41 S2 BME A 300 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 6.47 5.89 -12.18 5.84 4.27 -13.50 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 10 LYS~? 16.18 O1 BME A 300 B 177 GLU A 15 GLU~? 24.22 S2 BME A 300 B 201 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 27.00 6.35 51.01 26.30 4.53 50.18 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 23.74 1.68 49.50 22.87 -0.24 49.97 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 10 LYS~? 16.18 O1 BME A 300 B 177 GLU A 15 GLU~? 24.22 S2 BME A 300 B 201 LEU A 14 LEU~? 26.41 S2 BME A 300 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 27.00 6.35 51.01 26.30 4.53 50.18 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 23.74 1.68 49.50 22.87 -0.24 49.97 6.47 5.89 -12.18 5.84 4.27 -13.50 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 12 LYS~? 21.81 S2 BME A 300 B 177 GLU A 8 GLU~? 18.47 O1 BME A 300 B 201 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 27.00 6.35 51.01 26.30 4.53 50.18 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 23.74 1.68 49.50 22.87 -0.24 49.97 6.39 0.21 -2.66 8.38 0.58 -1.75 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 3 hits 1daa_c01 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 91 HIS~? 7.63 O1 BME A 300 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 229 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 1.13 77.49 40.64 0.62 75.57 39.98 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 0.84 91.24 49.01 2.91 91.61 49.23 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 10.53 97.56 43.71 9.33 93.71 47.17 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 91 HIS~? 7.63 O1 BME A 300 B 200 ASP A 23 ASP^? 9.45 S2 BME A 300 B 229 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 9.24 94.26 88.22 8.02 94.07 89.92 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 17.54 90.31 75.01 17.17 92.01 73.80 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 22.32 101.61 71.64 17.89 98.63 71.55 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 91 HIS~? 7.63 O1 BME A 300 C 200 ASP A 23 ASP^? 9.45 S2 BME A 300 C 229 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 26.77 65.84 83.49 27.06 67.76 84.27 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 19.52 52.01 79.59 20.28 51.65 77.65 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 28.90 45.91 73.55 25.22 49.72 72.97 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 91 HIS~? 7.63 O1 BME A 300 D 200 ASP A 23 ASP^? 9.45 S2 BME A 300 D 229 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -10.90 48.74 53.41 -12.98 48.90 53.67 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 4.60 52.95 52.50 5.57 51.29 53.40 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 10.05 41.79 49.80 7.94 44.71 53.76 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 5 THR~? 15.55 O1 BME A 300 A 45 THR A 6 THR~? 12.27 O1 BME A 300 A 161 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 26.16 88.25 79.16 25.22 89.47 80.71 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 27.73 89.90 76.08 29.24 91.46 75.95 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 2.39 3.95 8.25 5.67 8.88 7.74 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 5 THR~? 15.55 O1 BME A 300 B 45 THR A 6 THR~? 12.27 O1 BME A 300 B 161 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 7.39 128.28 94.56 8.34 126.36 94.79 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 5.75 129.25 91.25 4.29 128.16 90.07 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 2.39 3.95 8.25 5.67 8.88 7.74 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 59 TYR^? 18.50 S2 BME A 300 150 LYS A 55 LYS.? 25.54 S2 BME A 300 186 ASN A 37 ASN.? 22.15 S2 BME A 300 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.59 5.14 5.72 16.82 6.86 5.68 coo 27.04 52.42 22.30 26.88 49.99 27.00 15.98 12.20 9.88 16.28 11.97 16.11 coo 36.98 50.30 37.29 35.85 50.29 35.50 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 59 TYR^? 18.50 S2 BME A 300 150 LYS A 55 LYS.? 25.54 S2 BME A 300 186 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.59 5.14 5.72 16.82 6.86 5.68 coo 27.04 52.42 22.30 26.88 49.99 27.00 15.98 12.20 9.88 16.28 11.97 16.11 coo 36.98 50.30 37.29 35.85 50.29 35.50 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR A 75 TYR~? 15.90 S2 BME A 300 150 LYS A 71 LYS~? 8.54 S2 BME A 300 186 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.46 -0.26 16.60 17.11 0.41 17.22 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 36.98 50.30 37.29 35.85 50.29 35.50 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR A 75 TYR~? 15.90 S2 BME A 300 150 LYS A 71 LYS~? 8.54 S2 BME A 300 186 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.46 -0.26 16.60 17.11 0.41 17.22 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 36.98 50.30 37.29 35.85 50.29 35.50 19.57 10.98 7.57 19.01 10.99 5.54 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 4 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 60 TYR^? 16.66 S2 BME A 300 A 183 LYS A 12 LYS~? 21.81 S2 BME A 300 A 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 19.43 18.53 42.32 17.66 18.80 40.15 9.00 3.02 1.57 7.75 5.45 1.00 coo 21.92 15.80 36.19 17.64 19.44 36.35 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 15.46 19.03 31.40 15.01 18.25 33.31 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1do8_c00 source 1do8 MALIC ENZYME : 1 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 60 TYR^? 16.66 S2 BME A 300 B 183 LYS A 12 LYS~? 21.81 S2 BME A 300 B 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 58.62 15.99 58.34 60.98 14.60 58.93 9.00 3.02 1.57 7.75 5.45 1.00 coo 60.11 10.60 53.63 62.59 10.74 58.67 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 66.50 7.32 58.45 66.26 9.42 58.23 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1do8_c01 source 1do8 MALIC ENZYME : 1 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 60 TYR^? 16.66 S2 BME A 300 C 183 LYS A 12 LYS~? 21.81 S2 BME A 300 C 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 9.00 3.02 1.57 7.75 5.45 1.00 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1do8_c02 source 1do8 MALIC ENZYME : 1 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 60 TYR^? 16.66 S2 BME A 300 D 183 LYS A 12 LYS~? 21.81 S2 BME A 300 D 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 9.00 3.02 1.57 7.75 5.45 1.00 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1do8_c03 source 1do8 MALIC ENZYME : 1 hits 1do8_c03 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 34 TYR.? 16.37 S2 BME A 300 A 40 ASP A 27 ASP~? 15.09 S2 BME A 300 A 103 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 15.97 -5.82 2.06 15.42 -7.84 1.89 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 34 TYR.? 16.37 S2 BME A 300 B 40 ASP A 27 ASP~? 15.09 S2 BME A 300 B 103 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 15.97 -5.82 2.06 15.42 -7.84 1.89 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 31 ALA~? 16.01 S2 BME A 300 A 136 TYR A 34 TYR.? 16.37 S2 BME A 300 A 140 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 55.90 7.49 23.83 56.71 8.23 22.76 21.12 -13.83 -1.18 21.96 -14.90 -0.48 coo 59.38 10.02 17.51 59.95 9.89 20.21 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 59.52 3.69 18.67 62.31 6.19 22.58 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 1 hits 1e7q_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 10 LYS~? 16.18 O1 BME A 300 A 207 LYS A 12 LYS~? 21.81 S2 BME A 300 A 366 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 10 LYS~? 16.18 O1 BME A 300 B 207 LYS A 12 LYS~? 21.81 S2 BME A 300 B 366 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -11.13 25.71 4.86 -10.82 24.43 3.24 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 10 LYS~? 16.18 O1 BME A 300 C 207 LYS A 12 LYS~? 21.81 S2 BME A 300 C 366 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 10 LYS~? 16.18 O1 BME A 300 D 207 LYS A 12 LYS~? 21.81 S2 BME A 300 D 366 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c07 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 71 LYS~? 8.54 S2 BME A 300 A 193 GLU A 77 GLU~? 17.67 S2 BME A 300 A 217 VAL A 73 VAL~? 12.09 S2 BME A 300 coo 2.10 10.68 61.44 -2.14 13.16 60.61 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -5.33 11.71 69.72 -4.62 11.92 67.73 7.63 5.18 13.95 5.55 5.01 14.48 coo 0.07 12.29 66.53 -0.24 11.95 64.38 9.22 0.35 11.81 7.68 0.85 10.34 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 1 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 5 THR~? 15.55 O1 BME A 300 A 159 LYS A 2 LYS.? 20.18 S2 BME A 300 A 193 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -2.58 16.31 54.79 -4.02 14.93 55.64 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 2.10 10.68 61.44 -2.14 13.16 60.61 2.39 3.95 8.25 5.67 8.88 7.74 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 5 THR~? 15.55 O1 BME A 300 A 159 LYS A 10 LYS~? 16.18 O1 BME A 300 A 193 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -2.58 16.31 54.79 -4.02 14.93 55.64 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 2.10 10.68 61.44 -2.14 13.16 60.61 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 5 THR~? 15.55 O1 BME A 300 A 159 LYS A 10 LYS~? 16.18 O1 BME A 300 A 193 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -2.58 16.31 54.79 -4.02 14.93 55.64 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 2.10 10.68 61.44 -2.14 13.16 60.61 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 3 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 95 ASP.? 15.99 O1 BME A 300 260 GLU A 99 GLU.? 20.82 S2 BME A 300 370 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 99 GLU.? 20.82 S2 BME A 300 A 260 ARG A 25 ARG.? 9.68 S2 BME A 300 A 270 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 50.99 29.43 12.86 52.11 29.45 14.65 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 39.80 27.50 22.98 42.20 26.56 21.34 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 48.83 21.70 19.50 47.44 24.99 15.25 19.85 -1.20 1.64 21.03 4.07 2.80 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 1 hits 1euy_c00 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 75 TYR~? 15.90 S2 BME A 300 C 142 LEU A 50 LEU~? 20.27 S2 BME A 300 C 165 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 14.46 -0.26 16.60 17.11 0.41 17.22 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 21.11 4.23 14.59 19.47 3.75 15.94 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 8.82 -4.39 14.42 10.42 -10.04 16.23 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c02 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 25 ARG.? 9.68 S2 BME A 300 A 136 GLU A 28 GLU~? 14.38 S2 BME A 300 A 246 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 13.48 30.30 107.06 11.75 30.99 109.44 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 9.46 32.37 115.82 8.50 34.20 115.47 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 11.99 34.33 109.92 10.08 34.19 110.77 15.50 -15.19 4.21 14.37 -14.08 5.62 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 1 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 25 ARG.? 9.68 S2 BME A 300 A 136 GLU A 28 GLU~? 14.38 S2 BME A 300 A 246 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 13.94 29.84 106.80 11.67 30.40 108.79 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 9.52 31.97 115.23 8.45 33.74 114.72 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 11.92 33.82 109.35 10.10 33.50 110.39 15.50 -15.19 4.21 14.37 -14.08 5.62 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 1 hits 1fob_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 74 GLU~? 13.09 S2 BME A 300 A 47 ASP A 82 ASP^? 20.57 S2 BME A 300 A 161 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 37.12 18.35 73.76 37.09 16.69 72.44 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 29.81 8.06 73.13 30.21 10.11 72.95 10.12 9.33 8.59 8.15 9.51 7.94 coo 37.29 15.56 67.90 37.37 13.79 70.08 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 99 GLU.? 20.82 S2 BME A 300 A 47 ASP A 27 ASP~? 15.09 S2 BME A 300 A 161 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 37.12 18.35 73.76 37.09 16.69 72.44 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.81 8.06 73.13 30.21 10.11 72.95 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 37.29 15.56 67.90 37.37 13.79 70.08 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU A 99 GLU.? 20.82 S2 BME A 300 A 47 ASP A 95 ASP.? 15.99 O1 BME A 300 A 161 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 37.12 18.35 73.76 37.09 16.69 72.44 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.81 8.06 73.13 30.21 10.11 72.95 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 37.29 15.56 67.90 37.37 13.79 70.08 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 74 GLU~? 13.09 S2 BME A 300 B 47 ASP A 82 ASP^? 20.57 S2 BME A 300 B 161 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 53.87 35.49 53.22 55.44 35.72 54.61 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 63.47 43.65 53.95 61.45 43.07 54.06 10.12 9.33 8.59 8.15 9.51 7.94 coo 56.38 35.81 59.19 58.25 35.77 57.10 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 99 GLU.? 20.82 S2 BME A 300 B 47 ASP A 27 ASP~? 15.09 S2 BME A 300 B 161 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 53.87 35.49 53.22 55.44 35.72 54.61 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 63.47 43.65 53.95 61.45 43.07 54.06 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 56.38 35.81 59.19 58.25 35.77 57.10 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU A 99 GLU.? 20.82 S2 BME A 300 B 47 ASP A 95 ASP.? 15.99 O1 BME A 300 B 161 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 53.87 35.49 53.22 55.44 35.72 54.61 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 63.47 43.65 53.95 61.45 43.07 54.06 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 56.38 35.81 59.19 58.25 35.77 57.10 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 2 LYS.? 20.18 S2 BME A 300 210 ARG A 25 ARG.? 9.68 S2 BME A 300 225 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 17.51 28.50 73.42 17.24 23.02 75.86 2.39 3.95 8.25 5.67 8.88 7.74 coo 24.74 11.56 73.05 25.29 14.32 71.80 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 27.81 15.44 77.10 25.66 16.50 75.19 12.31 -11.28 10.33 12.92 -12.61 7.64 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 1 hits 1gsa_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 19 VAL.? 20.13 S2 BME A 300 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 226 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.85 5.85 -2.74 11.03 5.09 -3.64 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 19 VAL.? 20.13 S2 BME A 300 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 226 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.85 5.85 -2.74 11.03 5.09 -3.64 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 19 VAL.? 20.13 S2 BME A 300 A 200 ASP A 82 ASP^? 20.57 S2 BME A 300 A 226 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.85 5.85 -2.74 11.03 5.09 -3.64 coo 24.51 43.28 11.18 25.17 44.50 9.58 10.12 9.33 8.59 8.15 9.51 7.94 coo 34.47 51.09 7.19 28.58 51.18 7.53 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 67 VAL~? -3.24 C1 BME A 300s A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 226 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.93 -9.15 10.02 5.29 -10.97 11.03 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 72 VAL~? 9.85 S2 BME A 300 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 226 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 19.13 38.05 1.41 19.72 38.80 -0.53 11.63 -2.55 12.61 13.22 -3.01 11.19 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 73 VAL~? 12.09 S2 BME A 300 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 226 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 19.13 38.05 1.41 19.72 38.80 -0.53 9.22 0.35 11.81 7.68 0.85 10.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL A 86 VAL^? 10.46 S2 BME A 300 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 226 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.69 -2.55 3.15 7.10 -2.56 1.49 coo 24.51 43.28 11.18 25.17 44.50 9.58 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 34.47 51.09 7.19 28.58 51.18 7.53 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1i29_c03 source 1i29 CSDB : 7 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 10 LYS~? 16.18 O1 BME A 300 A 165 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 0.17 -4.11 3.03 -1.78 -3.73 3.87 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 1 hits 1idt_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 23 ASP^? 9.45 S2 BME A 300 158 THR A 30 THR~? 11.99 S2 BME A 300 317 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -2.63 8.40 35.07 -3.66 9.81 36.17 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -5.30 12.75 41.86 -4.34 13.05 39.99 18.48 -11.65 0.55 19.28 -10.22 2.01 coo -12.63 17.64 33.66 -10.65 17.90 34.40 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 1 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 7 ASP~? 16.68 O1 BME A 300 A 204 GLU A 8 GLU~? 18.47 O1 BME A 300 A 279 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 5.85 5.60 30.32 5.00 7.49 29.88 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 7.79 1.83 27.81 9.08 3.25 26.92 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 8.22 7.77 18.64 7.58 8.47 21.28 9.00 3.02 1.57 7.75 5.45 1.00 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 1 hits 1itx_c00 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 29 GLU~? 6.68 S2 BME A 300 A 163 ARG A 25 ARG.? 9.68 S2 BME A 300 A 222 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 51.27 81.34 48.31 51.67 80.79 50.28 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 48.06 78.22 50.94 48.51 78.27 53.98 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 54.85 84.16 52.60 54.26 81.23 53.34 12.31 -11.28 10.33 12.92 -12.61 7.64 1kim_c00 source 1kim THYMIDINE KINASE : 1 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 12 LYS~? 21.81 S2 BME A 300 C 74 LYS A 10 LYS~? 16.18 O1 BME A 300 C 165 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 17.59 37.25 25.80 19.64 34.15 21.60 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 12.29 34.52 28.11 16.84 32.47 25.43 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 12.06 27.10 15.56 13.23 27.02 13.80 0.17 -4.11 3.03 -1.78 -3.73 3.87 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_c02 naa= 3 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 60 GLU A 74 GLU~? 13.09 S2 BME A 300 198 CYH A 63 CYH.? -3.36 S2 BME A 300s 229 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 5.01 -1.60 7.62 5.37 -3.69 7.71 1lcb_c02 source 1lcb THYMIDYLATE SYNTHASE : 1 hits 1lcb_c02 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 27 ASP~? 15.09 S2 BME A 300 A 295 GLU A 29 GLU~? 6.68 S2 BME A 300 A 369 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 16.11 33.72 80.99 14.10 33.54 81.63 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.97 -5.82 2.06 15.42 -7.84 1.89 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 44 ASP~? 11.03 S2 BME A 300 A 265 GLU A 74 GLU~? 13.09 S2 BME A 300 A 369 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 12.19 31.08 87.29 11.13 32.66 86.38 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 44 ASP~? 11.03 S2 BME A 300 A 265 GLU A 77 GLU~? 17.67 S2 BME A 300 A 369 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 7.63 5.18 13.95 5.55 5.01 14.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 48 ASP~? 19.85 S2 BME A 300 A 265 GLU A 74 GLU~? 13.09 S2 BME A 300 A 369 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 48 ASP~? 19.85 S2 BME A 300 A 265 GLU A 77 GLU~? 17.67 S2 BME A 300 A 369 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 7.63 5.18 13.95 5.55 5.01 14.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 19.36 -9.90 14.44 17.51 -11.01 14.77 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 23 ASP^? 9.45 S2 BME A 300 A 279 GLU A 8 GLU~? 18.47 O1 BME A 300 A 369 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 16.54 46.37 63.94 14.77 45.79 62.95 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 23.07 -12.79 5.06 23.81 -10.95 5.75 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c06 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 12 LYS~? 21.81 S2 BME A 300 166 LYS A 10 LYS~? 16.18 O1 BME A 300 324 SER A 52 SER~? 19.64 S2 BME A 300 coo 25.93 8.11 25.51 26.40 7.80 19.66 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 27.27 1.43 25.09 29.18 5.25 22.89 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 46.32 14.55 19.93 45.95 12.72 21.27 22.49 4.36 7.95 23.43 2.12 7.73 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 1 hits 1mdr_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 82 ASP^? 20.57 S2 BME A 300 A 55 TYR A 60 TYR^? 16.66 S2 BME A 300 A 84 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 11.09 42.89 24.44 11.32 42.06 22.49 10.12 9.33 8.59 8.15 9.51 7.94 coo 4.60 40.33 20.42 7.25 39.50 20.05 9.00 3.02 1.57 7.75 5.45 1.00 coo 9.71 44.83 15.47 10.13 41.43 19.93 2.39 3.95 8.25 5.67 8.88 7.74 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 1 hits 1mrq_c02 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 69 SER~? 5.63 S2 BME A 300 A 154 ASP A 44 ASP~? 11.03 S2 BME A 300 A 261 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 16.10 74.10 3.11 17.18 73.52 5.20 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 16.07 84.71 8.14 15.20 82.81 8.14 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 10.59 77.85 4.81 13.09 76.36 5.76 12.31 -11.28 10.33 12.92 -12.61 7.64 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 1 hits 1o98_c00 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 27 ASP~? 15.09 S2 BME A 300 A 146 TYR A 34 TYR.? 16.37 S2 BME A 300 A 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -3.50 124.89 25.05 -2.25 124.77 23.26 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 1.87 119.38 16.45 1.41 122.11 16.84 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -2.59 124.07 12.67 -0.91 126.17 18.42 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 27 ASP~? 15.09 S2 BME A 300 A 146 TYR A 34 TYR.? 16.37 S2 BME A 300 A 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -3.50 124.89 25.05 -2.25 124.77 23.26 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 1.87 119.38 16.45 1.41 122.11 16.84 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -2.59 124.07 12.67 -0.91 126.17 18.42 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP A 44 ASP~? 11.03 S2 BME A 300 A 146 TYR A 75 TYR~? 15.90 S2 BME A 300 A 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -3.50 124.89 25.05 -2.25 124.77 23.26 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 1.87 119.38 16.45 1.41 122.11 16.84 14.46 -0.26 16.60 17.11 0.41 17.22 coo -2.59 124.07 12.67 -0.91 126.17 18.42 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 27 ASP~? 15.09 S2 BME A 300 B 146 TYR A 34 TYR.? 16.37 S2 BME A 300 B 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -7.43 109.06 51.23 -5.84 110.54 50.86 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 0.22 114.56 44.62 -0.76 115.18 47.18 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -4.18 120.17 46.85 -4.02 115.31 51.00 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 27 ASP~? 15.09 S2 BME A 300 B 146 TYR A 34 TYR.? 16.37 S2 BME A 300 B 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -7.43 109.06 51.23 -5.84 110.54 50.86 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 0.22 114.56 44.62 -0.76 115.18 47.18 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -4.18 120.17 46.85 -4.02 115.31 51.00 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP A 44 ASP~? 11.03 S2 BME A 300 B 146 TYR A 75 TYR~? 15.90 S2 BME A 300 B 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -7.43 109.06 51.23 -5.84 110.54 50.86 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 0.22 114.56 44.62 -0.76 115.18 47.18 14.46 -0.26 16.60 17.11 0.41 17.22 coo -4.18 120.17 46.85 -4.02 115.31 51.00 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 27 ASP~? 15.09 S2 BME A 300 C 146 TYR A 34 TYR.? 16.37 S2 BME A 300 C 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -13.49 79.65 43.90 -12.13 80.29 45.45 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -5.65 86.78 48.49 -7.16 84.72 49.65 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -11.22 87.18 53.49 -10.94 81.64 50.31 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 27 ASP~? 15.09 S2 BME A 300 C 146 TYR A 34 TYR.? 16.37 S2 BME A 300 C 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -13.49 79.65 43.90 -12.13 80.29 45.45 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -5.65 86.78 48.49 -7.16 84.72 49.65 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -11.22 87.18 53.49 -10.94 81.64 50.31 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP A 44 ASP~? 11.03 S2 BME A 300 C 146 TYR A 75 TYR~? 15.90 S2 BME A 300 C 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -13.49 79.65 43.90 -12.13 80.29 45.45 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -5.65 86.78 48.49 -7.16 84.72 49.65 14.46 -0.26 16.60 17.11 0.41 17.22 coo -11.22 87.18 53.49 -10.94 81.64 50.31 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 27 ASP~? 15.09 S2 BME A 300 D 146 TYR A 34 TYR.? 16.37 S2 BME A 300 D 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -13.44 77.36 13.12 -12.53 75.97 14.48 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -7.85 74.44 22.75 -9.22 72.86 20.89 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -14.24 70.61 23.48 -12.55 71.73 17.42 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 27 ASP~? 15.09 S2 BME A 300 D 146 TYR A 34 TYR.? 16.37 S2 BME A 300 D 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -13.44 77.36 13.12 -12.53 75.97 14.48 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -7.85 74.44 22.75 -9.22 72.86 20.89 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -14.24 70.61 23.48 -12.55 71.73 17.42 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP A 44 ASP~? 11.03 S2 BME A 300 D 146 TYR A 75 TYR~? 15.90 S2 BME A 300 D 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -13.44 77.36 13.12 -12.53 75.97 14.48 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -7.85 74.44 22.75 -9.22 72.86 20.89 14.46 -0.26 16.60 17.11 0.41 17.22 coo -14.24 70.61 23.48 -12.55 71.73 17.42 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 27 ASP~? 15.09 S2 BME A 300 E 146 TYR A 34 TYR.? 16.37 S2 BME A 300 E 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -7.12 105.25 1.43 -6.30 103.34 0.77 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -3.11 94.55 3.01 -3.83 95.92 0.66 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 27 ASP~? 15.09 S2 BME A 300 E 146 TYR A 34 TYR.? 16.37 S2 BME A 300 E 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -7.12 105.25 1.43 -6.30 103.34 0.77 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -3.11 94.55 3.01 -3.83 95.92 0.66 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP A 44 ASP~? 11.03 S2 BME A 300 E 146 TYR A 75 TYR~? 15.90 S2 BME A 300 E 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -7.12 105.25 1.43 -6.30 103.34 0.77 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -3.11 94.55 3.01 -3.83 95.92 0.66 14.46 -0.26 16.60 17.11 0.41 17.22 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 27 ASP~? 15.09 S2 BME A 300 F 146 TYR A 34 TYR.? 16.37 S2 BME A 300 F 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -44.75 128.15 10.28 -45.68 129.67 11.55 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -50.43 131.90 19.60 -49.04 133.31 17.60 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -44.10 135.86 19.99 -45.67 134.21 14.07 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 27 ASP~? 15.09 S2 BME A 300 F 146 TYR A 34 TYR.? 16.37 S2 BME A 300 F 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -44.75 128.15 10.28 -45.68 129.67 11.55 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -50.43 131.90 19.60 -49.04 133.31 17.60 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -44.10 135.86 19.99 -45.67 134.21 14.07 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP A 44 ASP~? 11.03 S2 BME A 300 F 146 TYR A 75 TYR~? 15.90 S2 BME A 300 F 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -44.75 128.15 10.28 -45.68 129.67 11.55 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -50.43 131.90 19.60 -49.04 133.31 17.60 14.46 -0.26 16.60 17.11 0.41 17.22 coo -44.10 135.86 19.99 -45.67 134.21 14.07 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 27 ASP~? 15.09 S2 BME A 300 G 146 TYR A 34 TYR.? 16.37 S2 BME A 300 G 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -44.97 128.78 41.20 -46.32 128.26 42.83 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -52.83 122.13 46.42 -51.31 124.30 47.39 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -47.30 122.24 51.49 -47.46 127.44 47.81 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 27 ASP~? 15.09 S2 BME A 300 G 146 TYR A 34 TYR.? 16.37 S2 BME A 300 G 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -44.97 128.78 41.20 -46.32 128.26 42.83 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -52.83 122.13 46.42 -51.31 124.30 47.39 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -47.30 122.24 51.49 -47.46 127.44 47.81 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP A 44 ASP~? 11.03 S2 BME A 300 G 146 TYR A 75 TYR~? 15.90 S2 BME A 300 G 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -44.97 128.78 41.20 -46.32 128.26 42.83 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -52.83 122.13 46.42 -51.31 124.30 47.39 14.46 -0.26 16.60 17.11 0.41 17.22 coo -47.30 122.24 51.49 -47.46 127.44 47.81 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 27 ASP~? 15.09 S2 BME A 300 H 146 TYR A 34 TYR.? 16.37 S2 BME A 300 H 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -51.11 100.30 51.41 -52.67 98.82 51.12 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -58.70 94.17 45.32 -57.76 93.82 47.92 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -54.32 88.79 48.13 -54.61 94.04 51.74 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 27 ASP~? 15.09 S2 BME A 300 H 146 TYR A 34 TYR.? 16.37 S2 BME A 300 H 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -51.11 100.30 51.41 -52.67 98.82 51.12 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -58.70 94.17 45.32 -57.76 93.82 47.92 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -54.32 88.79 48.13 -54.61 94.04 51.74 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP A 44 ASP~? 11.03 S2 BME A 300 H 146 TYR A 75 TYR~? 15.90 S2 BME A 300 H 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -51.11 100.30 51.41 -52.67 98.82 51.12 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -58.70 94.17 45.32 -57.76 93.82 47.92 14.46 -0.26 16.60 17.11 0.41 17.22 coo -54.32 88.79 48.13 -54.61 94.04 51.74 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 27 ASP~? 15.09 S2 BME A 300 I 146 TYR A 34 TYR.? 16.37 S2 BME A 300 I 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -54.65 81.97 26.87 -55.88 81.89 25.07 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -59.92 86.62 17.74 -59.42 83.94 18.40 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -55.38 81.61 14.50 -57.11 80.05 20.41 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 27 ASP~? 15.09 S2 BME A 300 I 146 TYR A 34 TYR.? 16.37 S2 BME A 300 I 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -54.65 81.97 26.87 -55.88 81.89 25.07 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -59.92 86.62 17.74 -59.42 83.94 18.40 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -55.38 81.61 14.50 -57.11 80.05 20.41 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP A 44 ASP~? 11.03 S2 BME A 300 I 146 TYR A 75 TYR~? 15.90 S2 BME A 300 I 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -54.65 81.97 26.87 -55.88 81.89 25.07 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -59.92 86.62 17.74 -59.42 83.94 18.40 14.46 -0.26 16.60 17.11 0.41 17.22 coo -55.38 81.61 14.50 -57.11 80.05 20.41 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 27 ASP~? 15.09 S2 BME A 300 J 146 TYR A 34 TYR.? 16.37 S2 BME A 300 J 177 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -50.64 99.08 1.52 -51.52 100.83 0.67 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 27 ASP~? 15.09 S2 BME A 300 J 146 TYR A 34 TYR.? 16.37 S2 BME A 300 J 177 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -50.64 99.08 1.52 -51.52 100.83 0.67 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP A 44 ASP~? 11.03 S2 BME A 300 J 146 TYR A 75 TYR~? 15.90 S2 BME A 300 J 177 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -50.64 99.08 1.52 -51.52 100.83 0.67 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 14.46 -0.26 16.60 17.11 0.41 17.22 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 8.82 -4.39 14.42 10.42 -10.04 16.23 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 23 ASP^? 9.45 S2 BME A 300 A 96 GLU A 99 GLU.? 20.82 S2 BME A 300 A 132 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 31.23 12.29 16.44 30.82 11.56 18.39 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 26.82 3.20 24.36 27.99 4.86 24.98 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.99 0.62 22.18 30.38 6.69 20.81 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 27 ASP~? 15.09 S2 BME A 300 A 96 GLU A 99 GLU.? 20.82 S2 BME A 300 A 132 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 31.23 12.29 16.44 30.82 11.56 18.39 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 26.82 3.20 24.36 27.99 4.86 24.98 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.99 0.62 22.18 30.38 6.69 20.81 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 82 ASP^? 20.57 S2 BME A 300 A 96 GLU A 74 GLU~? 13.09 S2 BME A 300 A 132 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 31.23 12.29 16.44 30.82 11.56 18.39 10.12 9.33 8.59 8.15 9.51 7.94 coo 26.82 3.20 24.36 27.99 4.86 24.98 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 29.99 0.62 22.18 30.38 6.69 20.81 8.82 -4.39 14.42 10.42 -10.04 16.23 1onr_c00 source 1onr TRANSALDOLASE B : 3 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 23 ASP^? 9.45 S2 BME A 300 B 96 GLU A 99 GLU.? 20.82 S2 BME A 300 B 132 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 31.16 57.31 -0.94 30.73 56.64 1.01 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 26.69 48.45 7.18 27.85 50.13 7.74 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.82 45.80 5.07 30.26 51.81 3.56 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 27 ASP~? 15.09 S2 BME A 300 B 96 GLU A 99 GLU.? 20.82 S2 BME A 300 B 132 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 31.16 57.31 -0.94 30.73 56.64 1.01 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 26.69 48.45 7.18 27.85 50.13 7.74 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.82 45.80 5.07 30.26 51.81 3.56 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 82 ASP^? 20.57 S2 BME A 300 B 96 GLU A 74 GLU~? 13.09 S2 BME A 300 B 132 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 31.16 57.31 -0.94 30.73 56.64 1.01 10.12 9.33 8.59 8.15 9.51 7.94 coo 26.69 48.45 7.18 27.85 50.13 7.74 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 29.82 45.80 5.07 30.26 51.81 3.56 8.82 -4.39 14.42 10.42 -10.04 16.23 1onr_c01 source 1onr TRANSALDOLASE B : 3 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 3 SER^? 13.09 C1 BME A 300 A 239 VAL A 84 VAL^? 14.84 S2 BME A 300 A 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 80.14 40.76 52.28 77.73 40.59 51.94 2.01 1.27 5.67 0.61 -0.61 5.33 coo 75.67 35.37 52.30 76.00 35.96 50.23 6.77 2.80 6.54 5.77 4.01 5.02 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 3 SER^? 13.09 C1 BME A 300 A 239 VAL A 86 VAL^? 10.46 S2 BME A 300 A 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 80.14 40.76 52.28 77.73 40.59 51.94 2.01 1.27 5.67 0.61 -0.61 5.33 coo 75.67 35.37 52.30 76.00 35.96 50.23 5.69 -2.55 3.15 7.10 -2.56 1.49 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER A 69 SER~? 5.63 S2 BME A 300 A 239 VAL A 62 VAL^? 8.11 S2 BME A 300 A 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 80.14 40.76 52.28 77.73 40.59 51.94 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 75.67 35.37 52.30 76.00 35.96 50.23 10.52 -4.83 3.69 10.95 -5.47 1.63 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER A 69 SER~? 5.63 S2 BME A 300 A 239 VAL A 67 VAL~? -3.24 C1 BME A 300s A 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 80.14 40.76 52.28 77.73 40.59 51.94 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 75.67 35.37 52.30 76.00 35.96 50.23 5.93 -9.15 10.02 5.29 -10.97 11.03 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER A 69 SER~? 5.63 S2 BME A 300 A 239 VAL A 73 VAL~? 12.09 S2 BME A 300 A 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 80.14 40.76 52.28 77.73 40.59 51.94 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 75.67 35.37 52.30 76.00 35.96 50.23 9.22 0.35 11.81 7.68 0.85 10.34 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER A 69 SER~? 5.63 S2 BME A 300 A 239 VAL A 84 VAL^? 14.84 S2 BME A 300 A 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 80.14 40.76 52.28 77.73 40.59 51.94 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 75.67 35.37 52.30 76.00 35.96 50.23 6.77 2.80 6.54 5.77 4.01 5.02 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 7 3 # 7 A 170 SER A 69 SER~? 5.63 S2 BME A 300 A 239 VAL A 86 VAL^? 10.46 S2 BME A 300 A 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 80.14 40.76 52.28 77.73 40.59 51.94 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 75.67 35.37 52.30 76.00 35.96 50.23 5.69 -2.55 3.15 7.10 -2.56 1.49 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.01 -1.60 7.62 5.37 -3.69 7.71 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 7 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 3 SER^? 13.09 C1 BME A 300 B 239 VAL A 84 VAL^? 14.84 S2 BME A 300 B 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 25.22 6.41 2.90 27.67 6.33 3.11 2.01 1.27 5.67 0.61 -0.61 5.33 coo 29.71 1.00 2.66 29.43 1.57 4.74 6.77 2.80 6.54 5.77 4.01 5.02 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER A 3 SER^? 13.09 C1 BME A 300 B 239 VAL A 86 VAL^? 10.46 S2 BME A 300 B 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 25.22 6.41 2.90 27.67 6.33 3.11 2.01 1.27 5.67 0.61 -0.61 5.33 coo 29.71 1.00 2.66 29.43 1.57 4.74 5.69 -2.55 3.15 7.10 -2.56 1.49 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER A 69 SER~? 5.63 S2 BME A 300 B 239 VAL A 62 VAL^? 8.11 S2 BME A 300 B 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 25.22 6.41 2.90 27.67 6.33 3.11 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 29.71 1.00 2.66 29.43 1.57 4.74 10.52 -4.83 3.69 10.95 -5.47 1.63 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER A 69 SER~? 5.63 S2 BME A 300 B 239 VAL A 67 VAL~? -3.24 C1 BME A 300s B 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 25.22 6.41 2.90 27.67 6.33 3.11 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 29.71 1.00 2.66 29.43 1.57 4.74 5.93 -9.15 10.02 5.29 -10.97 11.03 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER A 69 SER~? 5.63 S2 BME A 300 B 239 VAL A 73 VAL~? 12.09 S2 BME A 300 B 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 25.22 6.41 2.90 27.67 6.33 3.11 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 29.71 1.00 2.66 29.43 1.57 4.74 9.22 0.35 11.81 7.68 0.85 10.34 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER A 69 SER~? 5.63 S2 BME A 300 B 239 VAL A 84 VAL^? 14.84 S2 BME A 300 B 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 25.22 6.41 2.90 27.67 6.33 3.11 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 29.71 1.00 2.66 29.43 1.57 4.74 6.77 2.80 6.54 5.77 4.01 5.02 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 7 3 # 7 B 170 SER A 69 SER~? 5.63 S2 BME A 300 B 239 VAL A 86 VAL^? 10.46 S2 BME A 300 B 413 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 25.22 6.41 2.90 27.67 6.33 3.11 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 29.71 1.00 2.66 29.43 1.57 4.74 5.69 -2.55 3.15 7.10 -2.56 1.49 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.01 -1.60 7.62 5.37 -3.69 7.71 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 7 hits 1oqz_c01 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 7 ASP~? 16.68 O1 BME A 300 A 167 LYS A 10 LYS~? 16.18 O1 BME A 300 A 201 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 26.53 8.31 20.37 28.45 8.41 19.40 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 24.92 6.08 13.38 27.75 4.33 18.83 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 29.08 5.53 11.69 30.46 5.61 17.93 7.13 5.12 -6.84 5.25 7.73 -2.58 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 7 ASP~? 16.68 O1 BME A 300 B1167 LYS A 10 LYS~? 16.18 O1 BME A 300 B1201 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 26.10 12.11 49.61 24.19 12.48 50.51 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 27.70 11.69 56.92 24.82 8.55 52.12 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 23.50 11.64 58.67 22.19 10.19 52.59 7.13 5.12 -6.84 5.25 7.73 -2.58 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c01 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 3 SER^? 13.09 C1 BME A 300 B 69 ALA A 83 ALA^? 14.63 S2 BME A 300 B 241 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 13.24 41.94 33.13 13.08 39.54 33.17 2.01 1.27 5.67 0.61 -0.61 5.33 coo 9.15 37.89 36.69 10.55 37.76 37.22 9.58 4.45 8.44 10.26 3.43 9.36 coo 10.91 43.03 38.47 11.81 41.82 36.93 5.01 -1.60 7.62 5.37 -3.69 7.71 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 1 hits 1pnl_c00 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 82 ASP^? 20.57 S2 BME A 300 A 68 ALA A 83 ALA^? 14.63 S2 BME A 300 A 72 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 46.76 7.59 18.65 45.27 6.01 18.52 10.12 9.33 8.59 8.15 9.51 7.94 coo 48.88 4.35 16.59 48.73 5.09 15.20 9.58 4.45 8.44 10.26 3.43 9.36 coo 53.89 6.25 15.09 52.88 7.92 14.14 13.01 3.14 12.38 14.61 2.09 11.22 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 1 hits 1q6l_c05 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 23 ASP^? 9.45 S2 BME A 300 A 147 THR A 30 THR~? 11.99 S2 BME A 300 A 294 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 1 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 23 ASP^? 9.45 S2 BME A 300 A 260 ASP A 48 ASP~? 19.85 S2 BME A 300 A 329 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 30.73 81.29 37.61 31.23 82.07 35.69 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 27 ASP~? 15.09 S2 BME A 300 A 260 ASP A 48 ASP~? 19.85 S2 BME A 300 A 329 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 27 ASP~? 15.09 S2 BME A 300 A 260 ASP A 95 ASP.? 15.99 O1 BME A 300 A 329 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 48 ASP~? 19.85 S2 BME A 300 A 260 ASP A 23 ASP^? 9.45 S2 BME A 300 A 329 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 30.73 81.29 37.61 31.23 82.07 35.69 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 37.87 70.12 31.80 36.61 69.74 30.15 19.36 -9.90 14.44 17.51 -11.01 14.77 1qho_c07 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c07 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 53 PHE~? 16.58 S2 BME A 300 A 201 ASP A 82 ASP^? 20.57 S2 BME A 300 A 227 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.96 4.29 9.15 17.54 1.52 8.86 coo 25.52 45.12 37.98 23.98 46.65 37.85 10.12 9.33 8.59 8.15 9.51 7.94 coo 12.68 46.83 36.69 18.26 48.67 34.51 8.82 -4.39 14.42 10.42 -10.04 16.23 1qz9_c02 source 1qz9 KYNURENINASE : 1 hits 1qz9_c02 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 95 ASP.? 15.99 O1 BME A 300 595 GLU A 99 GLU.? 20.82 S2 BME A 300 713 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 5.64 2.82 38.49 4.59 4.19 37.25 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 4.35 13.73 37.63 3.39 12.18 36.55 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 3.76 10.25 31.38 3.16 9.87 34.10 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 7 ASP~? 16.68 O1 BME A 300 E 168 LYS A 10 LYS~? 16.18 O1 BME A 300 E 171 ASN A 11 ASN~? 22.08 O1 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 5.06 22.32 18.11 1.02 22.08 22.74 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 6.68 21.78 22.39 5.28 20.74 23.60 3.09 3.41 -8.04 1.54 2.11 -8.64 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 1 hits 1stc_c03 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 74 GLU~? 13.09 S2 BME A 300 A 126 LYS A 2 LYS.? 20.18 S2 BME A 300 A 171 ALA A 70 ALA~? 8.30 S2 BME A 300 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 2.39 3.95 8.25 5.67 8.88 7.74 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 6.63 -3.94 11.35 5.27 -4.56 11.61 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 77 GLU~? 17.67 S2 BME A 300 A 126 LYS A 2 LYS.? 20.18 S2 BME A 300 A 171 ALA A 83 ALA^? 14.63 S2 BME A 300 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 7.63 5.18 13.95 5.55 5.01 14.48 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 2.39 3.95 8.25 5.67 8.88 7.74 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 9.58 4.45 8.44 10.26 3.43 9.36 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 74 GLU~? 13.09 S2 BME A 300 B 126 LYS A 2 LYS.? 20.18 S2 BME A 300 B 171 ALA A 70 ALA~? 8.30 S2 BME A 300 coo 20.47 87.42 16.54 20.16 87.17 14.45 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 24.73 94.37 14.59 21.08 89.84 11.98 2.39 3.95 8.25 5.67 8.88 7.74 coo 24.38 86.32 12.71 22.88 86.54 12.71 6.63 -3.94 11.35 5.27 -4.56 11.61 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 77 GLU~? 17.67 S2 BME A 300 B 126 LYS A 2 LYS.? 20.18 S2 BME A 300 B 171 ALA A 83 ALA^? 14.63 S2 BME A 300 coo 20.47 87.42 16.54 20.16 87.17 14.45 7.63 5.18 13.95 5.55 5.01 14.48 coo 24.73 94.37 14.59 21.08 89.84 11.98 2.39 3.95 8.25 5.67 8.88 7.74 coo 24.38 86.32 12.71 22.88 86.54 12.71 9.58 4.45 8.44 10.26 3.43 9.36 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 44 ASP~? 11.03 S2 BME A 300 218 GLU A 15 GLU~? 24.22 S2 BME A 300 329 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 70.09 11.71 8.46 70.56 12.89 6.77 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 48 ASP~? 19.85 S2 BME A 300 218 GLU A 8 GLU~? 18.47 O1 BME A 300 329 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 59.16 37.82 13.95 57.63 37.03 15.12 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 48 ASP~? 19.85 S2 BME A 300 218 GLU A 96 GLU.? 20.00 O1 BME A 300 329 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 19.36 -9.90 14.44 17.51 -11.01 14.77 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 23 ASP^? 9.45 S2 BME A 300 242 GLU A 15 GLU~? 24.22 S2 BME A 300 329 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 23.07 -12.79 5.06 23.81 -10.95 5.75 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c05 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 34 TYR.? 16.37 S2 BME A 300 A 40 ASP A 27 ASP~? 15.09 S2 BME A 300 A 103 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 12.09 16.13 10.57 11.28 18.80 10.73 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 7.55 25.51 14.34 9.65 25.73 14.24 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 60 TYR^? 16.66 S2 BME A 300 A 40 ASP A 7 ASP~? 16.68 O1 BME A 300 A 103 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 12.09 16.13 10.57 11.28 18.80 10.73 9.00 3.02 1.57 7.75 5.45 1.00 coo 7.55 25.51 14.34 9.65 25.73 14.24 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 11.83 18.73 16.99 10.99 19.71 15.26 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 75 TYR~? 15.90 S2 BME A 300 A 40 ASP A 48 ASP~? 19.85 S2 BME A 300 A 103 LEU A 50 LEU~? 20.27 S2 BME A 300 coo 12.09 16.13 10.57 11.28 18.80 10.73 14.46 -0.26 16.60 17.11 0.41 17.22 coo 7.55 25.51 14.34 9.65 25.73 14.24 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.11 4.23 14.59 19.47 3.75 15.94 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 3 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 34 TYR.? 16.37 S2 BME A 300 B 40 ASP A 27 ASP~? 15.09 S2 BME A 300 B 103 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 14.25 20.09 37.35 13.48 17.40 37.38 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 9.39 10.77 34.53 11.50 10.63 34.41 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 60 TYR^? 16.66 S2 BME A 300 B 40 ASP A 7 ASP~? 16.68 O1 BME A 300 B 103 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 14.25 20.09 37.35 13.48 17.40 37.38 9.00 3.02 1.57 7.75 5.45 1.00 coo 9.39 10.77 34.53 11.50 10.63 34.41 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 12.89 17.60 31.13 12.34 16.51 32.90 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 75 TYR~? 15.90 S2 BME A 300 B 40 ASP A 48 ASP~? 19.85 S2 BME A 300 B 103 LEU A 50 LEU~? 20.27 S2 BME A 300 coo 14.25 20.09 37.35 13.48 17.40 37.38 14.46 -0.26 16.60 17.11 0.41 17.22 coo 9.39 10.77 34.53 11.50 10.63 34.41 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.11 4.23 14.59 19.47 3.75 15.94 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 3 hits 1vzz_c01 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 65 GLY.? -2.84 O1 BME A 300s B 419 GLY A 88 GLY~? 6.95 O1 BME A 300 B 420 ALA A 92 ALA~? 9.87 O1 BME A 300 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 6.04 -11.31 4.77 6.43 -10.68 5.09 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 3.61 -9.63 -2.13 2.90 -8.54 -1.35 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 65 GLY.? -2.84 O1 BME A 300s B 419 GLY A 89 GLY~? 6.94 S2 BME A 300 B 420 ALA A 92 ALA~? 9.87 O1 BME A 300 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 6.04 -11.31 4.77 6.43 -10.68 5.09 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.75 -7.92 2.09 6.22 -8.11 1.54 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 3.61 -9.63 -2.13 2.90 -8.54 -1.35 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY A 66 GLY.? -4.48 C1 BME A 300s B 419 GLY A 65 GLY.? -2.84 O1 BME A 300s B 420 ALA A 64 ALA.? -4.27 S2 BME A 300s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 5.61 -7.93 6.44 5.80 -8.57 6.93 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.04 -11.31 4.77 6.43 -10.68 5.09 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 9.64 -11.83 3.81 9.95 -13.24 4.40 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY A 66 GLY.? -4.48 C1 BME A 300s B 419 GLY A 88 GLY~? 6.95 O1 BME A 300 B 420 ALA A 92 ALA~? 9.87 O1 BME A 300 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 5.61 -7.93 6.44 5.80 -8.57 6.93 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 3.61 -9.63 -2.13 2.90 -8.54 -1.35 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY A 66 GLY.? -4.48 C1 BME A 300s B 419 GLY A 89 GLY~? 6.94 S2 BME A 300 B 420 ALA A 64 ALA.? -4.27 S2 BME A 300s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 5.61 -7.93 6.44 5.80 -8.57 6.93 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.75 -7.92 2.09 6.22 -8.11 1.54 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 9.64 -11.83 3.81 9.95 -13.24 4.40 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY A 66 GLY.? -4.48 C1 BME A 300s B 419 GLY A 89 GLY~? 6.94 S2 BME A 300 B 420 ALA A 92 ALA~? 9.87 O1 BME A 300 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 5.61 -7.93 6.44 5.80 -8.57 6.93 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.75 -7.92 2.09 6.22 -8.11 1.54 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 3.61 -9.63 -2.13 2.90 -8.54 -1.35 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 183 GLY A 88 GLY~? 6.95 O1 BME A 300 B 419 GLY A 65 GLY.? -2.84 O1 BME A 300s B 420 ALA A 64 ALA.? -4.27 S2 BME A 300s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.04 -11.31 4.77 6.43 -10.68 5.09 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 9.64 -11.83 3.81 9.95 -13.24 4.40 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 183 GLY A 88 GLY~? 6.95 O1 BME A 300 B 419 GLY A 89 GLY~? 6.94 S2 BME A 300 B 420 ALA A 64 ALA.? -4.27 S2 BME A 300s coo 26.12 -67.67-130.71 26.18 -67.32-131.45 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 6.75 -7.92 2.09 6.22 -8.11 1.54 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 9.64 -11.83 3.81 9.95 -13.24 4.40 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 183 GLY A 89 GLY~? 6.94 S2 BME A 300 B 419 GLY A 88 GLY~? 6.95 O1 BME A 300 B 420 ALA A 92 ALA~? 9.87 O1 BME A 300 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 6.75 -7.92 2.09 6.22 -8.11 1.54 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 3.61 -9.63 -2.13 2.90 -8.54 -1.35 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 9 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 64 ALA.? -4.27 S2 BME A 300s B 182 GLY A 88 GLY~? 6.95 O1 BME A 300 B 183 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 38.36-101.47-135.52 39.62-101.29-136.35 9.64 -11.83 3.81 9.95 -13.24 4.40 coo 41.93-102.35-126.87 41.52-101.89-126.30 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 38.37-101.99-128.11 38.63-102.24-127.37 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 70 ALA~? 8.30 S2 BME A 300 B 182 GLY A 65 GLY.? -2.84 O1 BME A 300s B 183 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 38.36-101.47-135.52 39.62-101.29-136.35 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 41.93-102.35-126.87 41.52-101.89-126.30 6.04 -11.31 4.77 6.43 -10.68 5.09 coo 38.37-101.99-128.11 38.63-102.24-127.37 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 70 ALA~? 8.30 S2 BME A 300 B 182 GLY A 88 GLY~? 6.95 O1 BME A 300 B 183 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 38.36-101.47-135.52 39.62-101.29-136.35 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 41.93-102.35-126.87 41.52-101.89-126.30 2.96 -8.32 2.51 3.58 -7.86 2.69 coo 38.37-101.99-128.11 38.63-102.24-127.37 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA A 70 ALA~? 8.30 S2 BME A 300 B 182 GLY A 89 GLY~? 6.94 S2 BME A 300 B 183 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 38.36-101.47-135.52 39.62-101.29-136.35 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 41.93-102.35-126.87 41.52-101.89-126.30 6.75 -7.92 2.09 6.22 -8.11 1.54 coo 38.37-101.99-128.11 38.63-102.24-127.37 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA A 92 ALA~? 9.87 O1 BME A 300 B 182 GLY A 65 GLY.? -2.84 O1 BME A 300s B 183 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 38.36-101.47-135.52 39.62-101.29-136.35 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo 41.93-102.35-126.87 41.52-101.89-126.30 6.04 -11.31 4.77 6.43 -10.68 5.09 coo 38.37-101.99-128.11 38.63-102.24-127.37 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA A 92 ALA~? 9.87 O1 BME A 300 B 182 GLY A 65 GLY.? -2.84 O1 BME A 300s B 183 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 38.36-101.47-135.52 39.62-101.29-136.35 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo 41.93-102.35-126.87 41.52-101.89-126.30 6.04 -11.31 4.77 6.43 -10.68 5.09 coo 38.37-101.99-128.11 38.63-102.24-127.37 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA A 92 ALA~? 9.87 O1 BME A 300 B 182 GLY A 66 GLY.? -4.48 C1 BME A 300s B 183 GLY A 65 GLY.? -2.84 O1 BME A 300s coo 38.36-101.47-135.52 39.62-101.29-136.35 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo 41.93-102.35-126.87 41.52-101.89-126.30 5.61 -7.93 6.44 5.80 -8.57 6.93 coo 38.37-101.99-128.11 38.63-102.24-127.37 6.04 -11.31 4.77 6.43 -10.68 5.09 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA A 92 ALA~? 9.87 O1 BME A 300 B 182 GLY A 66 GLY.? -4.48 C1 BME A 300s B 183 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 38.36-101.47-135.52 39.62-101.29-136.35 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo 41.93-102.35-126.87 41.52-101.89-126.30 5.61 -7.93 6.44 5.80 -8.57 6.93 coo 38.37-101.99-128.11 38.63-102.24-127.37 6.75 -7.92 2.09 6.22 -8.11 1.54 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 8 hits 1xny_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 70 ALA~? 8.30 S2 BME A 300 B 126 ARG A 68 ARG~? -4.35 S2 BME A 300s B 138 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 2.11 4.00 19.31 3.14 4.86 19.99 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 2.45 5.53 11.28 3.59 7.56 13.29 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 6.10 2.00 25.24 6.12 1.84 23.13 6.36 -0.87 15.92 5.32 -2.36 17.02 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 70 ALA~? 8.30 S2 BME A 300 C 126 ARG A 68 ARG~? -4.35 S2 BME A 300s C 138 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 6.63 -3.94 11.35 5.27 -4.56 11.61 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 6.36 -0.87 15.92 5.32 -2.36 17.02 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 70 ALA~? 8.30 S2 BME A 300 D 126 ARG A 68 ARG~? -4.35 S2 BME A 300s D 138 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 6.23 0.50 57.10 5.93 0.72 59.19 6.36 -0.87 15.92 5.32 -2.36 17.02 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 70 ALA~? 8.30 S2 BME A 300 E 126 ARG A 68 ARG~? -4.35 S2 BME A 300s E 138 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -4.56 10.03 62.36 -4.38 11.31 61.55 6.63 -3.94 11.35 5.27 -4.56 11.61 coo -3.02 12.00 70.07 -1.94 13.84 67.82 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -8.67 12.22 56.54 -8.68 12.09 58.65 6.36 -0.87 15.92 5.32 -2.36 17.02 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 70 ALA~? 8.30 S2 BME A 300 F 126 ARG A 68 ARG~? -4.35 S2 BME A 300s F 138 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 6.63 -3.94 11.35 5.27 -4.56 11.61 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 6.36 -0.87 15.92 5.32 -2.36 17.02 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 94 GLY~? 13.27 O1 BME A 300 B 175 ARG A 25 ARG.? 9.68 S2 BME A 300 B 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 99.45 58.28 3.33 99.57 58.61 4.10 7.18 -11.38 -5.94 7.80 -10.95 -5.54 coo 106.37 63.53 0.89 108.02 63.40 -1.62 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 1 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 10 LYS~? 16.18 O1 BME A 300 A 165 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 18.28 7.83 36.39 22.82 8.75 39.52 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 14.16 13.09 37.03 20.00 12.44 37.49 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 22.22 16.06 48.76 23.94 15.33 49.78 0.17 -4.11 3.03 -1.78 -3.73 3.87 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 12 LYS~? 21.81 S2 BME A 300 B 74 LYS A 10 LYS~? 16.18 O1 BME A 300 B 165 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 13.51 0.92 76.10 12.98 6.13 74.68 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 19.89 -0.55 76.51 17.10 4.32 77.43 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 21.39 11.56 68.52 20.24 13.13 67.73 0.17 -4.11 3.03 -1.78 -3.73 3.87 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 7 ASP~? 16.68 O1 BME A 300 A 371 LYS A 10 LYS~? 16.18 O1 BME A 300 A 407 THR A 5 THR~? 15.55 O1 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -4.43 30.92 22.89 -6.61 31.91 19.71 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -8.38 36.02 19.06 -8.83 34.10 19.89 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 7 ASP~? 16.68 O1 BME A 300 A 371 LYS A 10 LYS~? 16.18 O1 BME A 300 A 407 THR A 6 THR~? 12.27 O1 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -4.43 30.92 22.89 -6.61 31.91 19.71 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -8.38 36.02 19.06 -8.83 34.10 19.89 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 7 ASP~? 16.68 O1 BME A 300 A 371 LYS A 10 LYS~? 16.18 O1 BME A 300 A 374 ASN A 11 ASN~? 22.08 O1 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -4.43 30.92 22.89 -6.61 31.91 19.71 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -4.84 27.04 20.49 -6.40 27.76 19.26 3.09 3.41 -8.04 1.54 2.11 -8.64 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 1 hits 1zrz_c03 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 37 ASN.? 22.15 S2 BME A 300 A 106 PRO A 36 PRO.? 18.77 S2 BME A 300 A 108 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 34.91 38.94 20.48 33.53 38.20 19.00 18.58 0.66 -5.47 19.39 1.00 -7.43 coo 36.18 33.51 20.99 37.11 35.33 20.14 16.36 -4.28 -8.75 16.89 -3.72 -6.60 coo 33.01 33.46 15.68 31.96 34.97 17.80 18.83 -7.61 -2.88 21.31 -7.06 -4.03 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 37 ASN.? 22.15 S2 BME A 300 B 106 PRO A 36 PRO.? 18.77 S2 BME A 300 B 108 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 5.98 38.14 46.94 7.30 38.92 45.46 18.58 0.66 -5.47 19.39 1.00 -7.43 coo 4.66 43.53 47.47 3.74 41.73 46.59 16.36 -4.28 -8.75 16.89 -3.72 -6.60 coo 7.86 43.80 42.15 8.87 42.26 44.27 18.83 -7.61 -2.88 21.31 -7.06 -4.03 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c01 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 44 ASP~? 11.03 S2 BME A 300 231 ASP A 82 ASP^? 20.57 S2 BME A 300 294 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 10.12 9.33 8.59 8.15 9.51 7.94 coo 33.16 106.80 7.72 33.34 104.87 6.92 23.07 -12.79 5.06 23.81 -10.95 5.75 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c06 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 82 ASP^? 20.57 S2 BME A 300 A 233 GLU A 77 GLU~? 17.67 S2 BME A 300 A 300 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 10.12 9.33 8.59 8.15 9.51 7.94 coo 6.52 19.14 48.16 7.77 18.42 46.61 7.63 5.18 13.95 5.55 5.01 14.48 coo 9.30 22.40 41.76 10.10 20.96 40.36 15.66 5.60 16.72 16.27 4.24 18.24 2cpu_c01 source 2cpu ALPHA-AMYLASE : 1 hits 2cpu_c01 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 10 LYS~? 16.18 O1 BME A 300 B 184 LYS A 12 LYS~? 21.81 S2 BME A 300 B 345 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 38.76 2.27 4.00 34.00 5.99 4.37 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 40.63 7.13 9.06 35.85 7.36 8.95 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 17 LYS.? 25.68 S2 BME A 300 B 184 LYS A 12 LYS~? 21.81 S2 BME A 300 B 345 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 38.76 2.27 4.00 34.00 5.99 4.37 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 40.63 7.13 9.06 35.85 7.36 8.95 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 10.12 9.33 8.59 8.15 9.51 7.94 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 10 LYS~? 16.18 O1 BME A 300 J 184 LYS A 12 LYS~? 21.81 S2 BME A 300 J 345 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 25.22 70.55 14.03 27.64 73.07 18.65 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 31.73 69.87 11.50 32.73 70.19 16.40 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 25.87 58.42 18.79 23.95 58.54 17.90 15.97 -5.82 2.06 15.42 -7.84 1.89 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 10 LYS~? 16.18 O1 BME A 300 L 184 LYS A 12 LYS~? 21.81 S2 BME A 300 L 345 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 17 LYS.? 25.68 S2 BME A 300 L 184 LYS A 12 LYS~? 21.81 S2 BME A 300 L 345 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 10.12 9.33 8.59 8.15 9.51 7.94 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 10 LYS~? 16.18 O1 BME A 300 M 184 LYS A 12 LYS~? 21.81 S2 BME A 300 M 345 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 17 LYS.? 25.68 S2 BME A 300 M 184 LYS A 12 LYS~? 21.81 S2 BME A 300 M 345 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 13.04 11.19 -6.33 8.80 12.60 -2.10 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 10.12 9.33 8.59 8.15 9.51 7.94 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 10 LYS~? 16.18 O1 BME A 300 P 184 LYS A 12 LYS~? 21.81 S2 BME A 300 P 345 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 17 LYS.? 25.68 S2 BME A 300 P 184 LYS A 12 LYS~? 21.81 S2 BME A 300 P 345 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 10.12 9.33 8.59 8.15 9.51 7.94 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c47 naa= 3 ULMN 3 2esd_c00 1.02.01.0009 user 1 3 # 1 A 154 ASN A 85 ASN^? 8.15 S2 BME A 300 A 250 ALA A 92 ALA~? 9.87 O1 BME A 300 A 284 CYH A 63 CYH.? -3.36 S2 BME A 300s coo -98.31 19.25 26.95 -99.27 21.10 26.57 5.01 -1.60 7.62 5.37 -3.69 7.71 coo -102.90 29.72 23.02 -103.69 28.50 23.43 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo -98.59 26.45 29.50 -99.24 25.73 26.84 10.91 -8.39 4.98 11.88 -9.73 7.18 2esd_c00 source 2esd 1.02.01.0009 : 1 hits 2esd_c00 naa= 3 ULMN 3 2esd_c01 1.02.01.0009 user 1 3 # 1 B 154 ASN A 85 ASN^? 8.15 S2 BME A 300 B 250 ALA A 92 ALA~? 9.87 O1 BME A 300 B 284 CYH A 63 CYH.? -3.36 S2 BME A 300s coo -116.62 58.12 2.11 -116.17 56.24 3.01 5.01 -1.60 7.62 5.37 -3.69 7.71 coo -114.20 47.61 7.65 -114.88 48.80 8.33 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo -118.73 50.90 1.30 -116.61 51.76 2.87 10.91 -8.39 4.98 11.88 -9.73 7.18 2esd_c01 source 2esd 1.02.01.0009 : 1 hits 2esd_c01 naa= 3 ULMN 3 2esd_c02 1.02.01.0009 user 1 3 # 1 C 154 ASN A 85 ASN^? 8.15 S2 BME A 300 C 250 ALA A 92 ALA~? 9.87 O1 BME A 300 C 284 CYH A 63 CYH.? -3.36 S2 BME A 300s coo -155.36 18.42 28.93 -154.49 20.30 29.39 5.01 -1.60 7.62 5.37 -3.69 7.71 coo -150.95 29.02 32.87 -150.10 27.86 32.40 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo -155.22 25.64 26.33 -154.78 25.20 29.09 10.91 -8.39 4.98 11.88 -9.73 7.18 2esd_c02 source 2esd 1.02.01.0009 : 1 hits 2esd_c02 naa= 3 ULMN 3 2esd_c03 1.02.01.0009 user 1 3 # 1 D 154 ASN A 85 ASN^? 8.15 S2 BME A 300 D 250 ALA A 92 ALA~? 9.87 O1 BME A 300 D 284 CYH A 63 CYH.? -3.36 S2 BME A 300s coo -138.05 57.23 54.59 -137.96 55.47 53.43 5.01 -1.60 7.62 5.37 -3.69 7.71 coo -139.97 46.71 48.80 -139.25 47.90 48.19 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo -135.22 50.13 55.22 -137.25 50.94 53.65 10.91 -8.39 4.98 11.88 -9.73 7.18 2esd_c03 source 2esd 1.02.01.0009 : 1 hits 2esd_c03 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 7 ASP~? 16.68 O1 BME A 300 A 151 LYS A 10 LYS~? 16.18 O1 BME A 300 A 186 THR A 5 THR~? 15.55 O1 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 45.75 16.58 39.61 47.43 18.26 45.54 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 45.88 23.02 44.72 46.99 21.16 44.68 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 2phk_c02 source 2phk MC-PEPTIDE : 1 hits 2phk_c02 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 7 ASP~? 16.68 O1 BME A 300 A 151 LYS A 10 LYS~? 16.18 O1 BME A 300 A 154 ASN A 11 ASN~? 22.08 O1 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 45.75 16.58 39.61 47.43 18.26 45.54 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 44.77 13.10 43.25 45.01 14.21 45.03 3.09 3.41 -8.04 1.54 2.11 -8.64 2phk_c03 source 2phk MC-PEPTIDE : 1 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 27 ASP~? 15.09 S2 BME A 300 166 GLY A 65 GLY.? -2.84 O1 BME A 300s 169 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 8.28 6.87 1.62 10.08 5.77 1.34 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.04 -11.31 4.77 6.43 -10.68 5.09 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 44 ASP~? 11.03 S2 BME A 300 166 GLY A 65 GLY.? -2.84 O1 BME A 300s 169 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.04 -11.31 4.77 6.43 -10.68 5.09 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 82 ASP^? 20.57 S2 BME A 300 166 GLY A 89 GLY~? 6.94 S2 BME A 300 169 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 8.28 6.87 1.62 10.08 5.77 1.34 10.12 9.33 8.59 8.15 9.51 7.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 6.75 -7.92 2.09 6.22 -8.11 1.54 coo -16.67 7.89 2.78 -17.65 6.56 1.49 15.50 -15.19 4.21 14.37 -14.08 5.62 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 3 hits 2tdt_c00 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 25 ARG.? 9.68 S2 BME A 300 127 ARG A 68 ARG~? -4.35 S2 BME A 300s 270 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -1.14 25.72 1.64 0.76 28.10 1.50 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 68 ARG~? -4.35 S2 BME A 300s 127 ARG A 25 ARG.? 9.68 S2 BME A 300 270 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -1.14 25.72 1.64 0.76 28.10 1.50 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.30 -17.97 5.16 20.86 -18.94 6.97 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 2 hits 5cpa_c01 naa= 3 ULMN 2 132l_c00 LYSOZYME user 1 2 # 1 A 35 GLU A 29 GLU~? 6.68 S2 BME A 300 A 52 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 0.57 10.10 59.04 0.13 9.60 61.00 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -3.95 14.26 64.11 -2.90 13.35 65.69 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 132l_c00 LYSOZYME user 2 2 # 2 A 35 GLU A 29 GLU~? 6.68 S2 BME A 300 A 52 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 0.57 10.10 59.04 0.13 9.60 61.00 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -3.95 14.26 64.11 -2.90 13.35 65.69 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 132l_c00 LYSOZYME user 3 2 # 3 A 35 GLU A 57 GLU.? 23.43 S2 BME A 300 A 52 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 0.57 10.10 59.04 0.13 9.60 61.00 16.30 10.78 3.24 16.87 9.97 1.36 coo -3.95 14.26 64.11 -2.90 13.35 65.69 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 132l_c00 LYSOZYME user 4 2 # 4 A 35 GLU A 77 GLU~? 17.67 S2 BME A 300 A 52 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 0.57 10.10 59.04 0.13 9.60 61.00 7.63 5.18 13.95 5.55 5.01 14.48 coo -3.95 14.26 64.11 -2.90 13.35 65.69 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 132l_c00 LYSOZYME user 5 2 # 5 A 35 GLU A 87 GLU.? 12.12 O1 BME A 300 A 52 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 0.57 10.10 59.04 0.13 9.60 61.00 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -3.95 14.26 64.11 -2.90 13.35 65.69 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 132l_c00 source 132l LYSOZYME : 5 hits 132l_c00 naa= 2 ULMN 2 135l_c00 LYSOZYME user 1 2 # 1 35 GLU A 29 GLU~? 6.68 S2 BME A 300 52 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 11.73 12.37 28.72 9.72 13.02 28.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 9.54 19.42 32.23 7.70 18.49 32.58 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 135l_c00 LYSOZYME user 2 2 # 2 35 GLU A 29 GLU~? 6.68 S2 BME A 300 52 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 11.73 12.37 28.72 9.72 13.02 28.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 9.54 19.42 32.23 7.70 18.49 32.58 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 135l_c00 LYSOZYME user 3 2 # 3 35 GLU A 57 GLU.? 23.43 S2 BME A 300 52 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 11.73 12.37 28.72 9.72 13.02 28.94 16.30 10.78 3.24 16.87 9.97 1.36 coo 9.54 19.42 32.23 7.70 18.49 32.58 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 135l_c00 LYSOZYME user 4 2 # 4 35 GLU A 77 GLU~? 17.67 S2 BME A 300 52 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 11.73 12.37 28.72 9.72 13.02 28.94 7.63 5.18 13.95 5.55 5.01 14.48 coo 9.54 19.42 32.23 7.70 18.49 32.58 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 135l_c00 LYSOZYME user 5 2 # 5 35 GLU A 87 GLU.? 12.12 O1 BME A 300 52 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 11.73 12.37 28.72 9.72 13.02 28.94 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 9.54 19.42 32.23 7.70 18.49 32.58 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 135l_c00 source 135l LYSOZYME : 5 hits 135l_c00 naa= 2 ULMN 2 1a16_c00 AMINOPEPTIDASE P user 1 2 # 1 361 HIS A 91 HIS~? 7.63 O1 BME A 300 383 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 59.75 55.06 51.09 59.96 53.47 52.44 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 62.63 46.38 48.62 62.87 47.86 50.20 0.17 -4.11 3.03 -1.78 -3.73 3.87 1a16_c00 source 1a16 AMINOPEPTIDASE P : 1 hits 1a16_c00 naa= 2 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 1 2 # 1 907 TYR A 34 TYR.? 16.37 S2 BME A 300 988 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 38.29 21.82 26.74 37.66 20.24 25.49 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 2 2 # 2 907 TYR A 59 TYR^? 18.50 S2 BME A 300 988 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 14.59 5.14 5.72 16.82 6.86 5.68 coo 38.29 21.82 26.74 37.66 20.24 25.49 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 3 2 # 3 907 TYR A 60 TYR^? 16.66 S2 BME A 300 988 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 9.00 3.02 1.57 7.75 5.45 1.00 coo 38.29 21.82 26.74 37.66 20.24 25.49 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 4 2 # 4 907 TYR A 60 TYR^? 16.66 S2 BME A 300 988 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 9.00 3.02 1.57 7.75 5.45 1.00 coo 38.29 21.82 26.74 37.66 20.24 25.49 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 5 2 # 5 907 TYR A 60 TYR^? 16.66 S2 BME A 300 988 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 9.00 3.02 1.57 7.75 5.45 1.00 coo 38.29 21.82 26.74 37.66 20.24 25.49 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 6 2 # 6 907 TYR A 60 TYR^? 16.66 S2 BME A 300 988 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 9.00 3.02 1.57 7.75 5.45 1.00 coo 38.29 21.82 26.74 37.66 20.24 25.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 7 2 # 7 907 TYR A 75 TYR~? 15.90 S2 BME A 300 988 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 14.46 -0.26 16.60 17.11 0.41 17.22 coo 38.29 21.82 26.74 37.66 20.24 25.49 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1a26_c00 POLY (ADP-RIBOSE) POLYMERASE user 8 2 # 8 907 TYR A 75 TYR~? 15.90 S2 BME A 300 988 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 42.62 20.46 18.03 40.71 19.08 19.58 14.46 -0.26 16.60 17.11 0.41 17.22 coo 38.29 21.82 26.74 37.66 20.24 25.49 7.63 5.18 13.95 5.55 5.01 14.48 1a26_c00 source 1a26 POLY (ADP-RIBOSE) POLYMERASE : 8 hits 1a26_c00 naa= 2 ULMN 2 1a30_c01 HIV-1 PROTEASE user 1 2 # 1 A 25 ASP A 44 ASP~? 11.03 S2 BME A 300 B 25 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 16.19 28.53 6.78 15.21 26.90 5.90 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 15.69 25.44 0.11 15.17 25.11 2.13 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1a30_c01 HIV-1 PROTEASE user 2 2 # 2 A 25 ASP A 48 ASP~? 19.85 S2 BME A 300 B 25 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 16.19 28.53 6.78 15.21 26.90 5.90 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 15.69 25.44 0.11 15.17 25.11 2.13 19.36 -9.90 14.44 17.51 -11.01 14.77 1a30_c01 source 1a30 HIV-1 PROTEASE : 2 hits 1a30_c01 naa= 2 ULMN 2 1a41_c00 TOPOISOMERASE I user 1 2 # 1 223 ARG A 25 ARG.? 9.68 S2 BME A 300 265 HIS A 91 HIS~? 7.63 O1 BME A 300 coo -15.18 55.46 8.55 -14.82 52.98 10.38 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 3.84 -13.89 0.30 2.26 -15.26 0.08 1a41_c00 source 1a41 TOPOISOMERASE I : 1 hits 1a41_c00 naa= 2 ULMN 2 1a4g_c00 NEURAMINIDASE user 1 2 # 1 A 148 ASP A 7 ASP~? 16.68 O1 BME A 300 A 275 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1a4g_c00 NEURAMINIDASE user 2 2 # 2 A 148 ASP A 23 ASP^? 9.45 S2 BME A 300 A 275 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1a4g_c00 NEURAMINIDASE user 3 2 # 3 A 148 ASP A 23 ASP^? 9.45 S2 BME A 300 A 275 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1a4g_c00 NEURAMINIDASE user 4 2 # 4 A 148 ASP A 44 ASP~? 11.03 S2 BME A 300 A 275 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1a4g_c00 NEURAMINIDASE user 5 2 # 5 A 148 ASP A 44 ASP~? 11.03 S2 BME A 300 A 275 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1a4g_c00 NEURAMINIDASE user 6 2 # 6 A 148 ASP A 95 ASP.? 15.99 O1 BME A 300 A 275 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1a4g_c00 NEURAMINIDASE user 7 2 # 7 A 148 ASP A 95 ASP.? 15.99 O1 BME A 300 A 275 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1a4g_c00 source 1a4g NEURAMINIDASE : 7 hits 1a4g_c00 naa= 2 ULMN 2 1a4g_c01 NEURAMINIDASE user 1 2 # 1 B 148 ASP A 7 ASP~? 16.68 O1 BME A 300 B 275 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1a4g_c01 NEURAMINIDASE user 2 2 # 2 B 148 ASP A 23 ASP^? 9.45 S2 BME A 300 B 275 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1a4g_c01 NEURAMINIDASE user 3 2 # 3 B 148 ASP A 23 ASP^? 9.45 S2 BME A 300 B 275 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1a4g_c01 NEURAMINIDASE user 4 2 # 4 B 148 ASP A 44 ASP~? 11.03 S2 BME A 300 B 275 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1a4g_c01 NEURAMINIDASE user 5 2 # 5 B 148 ASP A 44 ASP~? 11.03 S2 BME A 300 B 275 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1a4g_c01 NEURAMINIDASE user 6 2 # 6 B 148 ASP A 95 ASP.? 15.99 O1 BME A 300 B 275 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1a4g_c01 NEURAMINIDASE user 7 2 # 7 B 148 ASP A 95 ASP.? 15.99 O1 BME A 300 B 275 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1a4g_c01 source 1a4g NEURAMINIDASE : 7 hits 1a4g_c01 naa= 2 ULMN 2 1a50_c02 TRYPTOPHAN SYNTHASE user 1 2 # 1 B 87 LYS A 12 LYS~? 21.81 S2 BME A 300 B 377 SER A 16 SER.? 30.21 S2 BME A 300 coo 79.96 10.34 6.36 80.68 15.13 9.07 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 87.05 10.11 10.96 86.59 11.97 12.49 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1a50_c02 TRYPTOPHAN SYNTHASE user 2 2 # 2 B 87 LYS A 39 LYS^? 20.06 S2 BME A 300 B 377 SER A 52 SER~? 19.64 S2 BME A 300 coo 79.96 10.34 6.36 80.68 15.13 9.07 19.85 -1.20 1.64 21.03 4.07 2.80 coo 87.05 10.11 10.96 86.59 11.97 12.49 22.49 4.36 7.95 23.43 2.12 7.73 ULMN 2 1a50_c02 TRYPTOPHAN SYNTHASE user 3 2 # 3 B 87 LYS A 55 LYS.? 25.54 S2 BME A 300 B 377 SER A 52 SER~? 19.64 S2 BME A 300 coo 79.96 10.34 6.36 80.68 15.13 9.07 15.98 12.20 9.88 16.28 11.97 16.11 coo 87.05 10.11 10.96 86.59 11.97 12.49 22.49 4.36 7.95 23.43 2.12 7.73 1a50_c02 source 1a50 TRYPTOPHAN SYNTHASE : 3 hits 1a50_c02 naa= 2 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 1 2 # 1 A 204 ASP A 23 ASP^? 9.45 S2 BME A 300 A 217 ARG A 25 ARG.? 9.68 S2 BME A 300 coo -24.32 68.31 63.50 -22.74 69.45 64.25 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -24.22 66.54 70.62 -24.40 68.56 68.30 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1a69_c00 PURINE NUCLEOSIDE PHOSPHORYLASE user 2 2 # 2 A 204 ASP A 44 ASP~? 11.03 S2 BME A 300 A 217 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -24.32 68.31 63.50 -22.74 69.45 64.25 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -24.22 66.54 70.62 -24.40 68.56 68.30 12.31 -11.28 10.33 12.92 -12.61 7.64 1a69_c00 source 1a69 PURINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1a69_c00 naa= 2 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 1 2 # 1 C 204 ASP A 27 ASP~? 15.09 S2 BME A 300 C 217 ARG A 25 ARG.? 9.68 S2 BME A 300 coo -3.24 84.82 92.39 -3.67 84.32 90.40 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -8.68 83.28 98.52 -7.90 81.07 100.50 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1a69_c02 PURINE NUCLEOSIDE PHOSPHORYLASE user 2 2 # 2 C 204 ASP A 44 ASP~? 11.03 S2 BME A 300 C 217 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -3.24 84.82 92.39 -3.67 84.32 90.40 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -8.68 83.28 98.52 -7.90 81.07 100.50 12.31 -11.28 10.33 12.92 -12.61 7.64 1a69_c02 source 1a69 PURINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1a69_c02 naa= 2 ULMN 2 1a8h_c00 METHIONYL-TRNA SYNTHETASE user 1 2 # 1 297 LYS A 12 LYS~? 21.81 S2 BME A 300 300 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 36.67 38.37 51.36 37.08 40.44 45.80 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 44.84 42.05 56.18 49.73 42.07 58.38 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1a8h_c00 METHIONYL-TRNA SYNTHETASE user 2 2 # 2 297 LYS A 17 LYS.? 25.68 S2 BME A 300 300 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 36.67 38.37 51.36 37.08 40.44 45.80 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 44.84 42.05 56.18 49.73 42.07 58.38 7.13 5.12 -6.84 5.25 7.73 -2.58 1a8h_c00 source 1a8h METHIONYL-TRNA SYNTHETASE : 2 hits 1a8h_c00 naa= 2 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 1 2 # 1 142 TRP A 93 TRP~? 14.44 S2 BME A 300 223 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 127.19 33.46 26.14 126.78 36.79 28.15 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 126.95 41.66 23.38 128.48 40.72 24.51 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 2 2 # 2 142 TRP A 93 TRP~? 14.44 S2 BME A 300 223 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 127.19 33.46 26.14 126.78 36.79 28.15 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 126.95 41.66 23.38 128.48 40.72 24.51 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1aam_c00 ASPARTATE AMINOTRANSFERASE user 3 2 # 3 142 TRP A 93 TRP~? 14.44 S2 BME A 300 223 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 127.19 33.46 26.14 126.78 36.79 28.15 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 126.95 41.66 23.38 128.48 40.72 24.51 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1aam_c00 source 1aam ASPARTATE AMINOTRANSFERASE : 3 hits 1aam_c00 naa= 2 ULMN 2 1abr_c00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 1 2 # 1 A 164 GLU A 29 GLU~? 6.68 S2 BME A 300 A 167 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 62.73 6.07 37.74 64.13 7.43 36.88 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 64.19 10.87 39.90 66.62 8.97 39.90 13.39 -11.16 2.90 14.53 -11.26 0.04 1abr_c00 source 1abr ABRIN-A COMPLEXED WITH TWO SUGAR CHAINS : 1 hits 1abr_c00 naa= 2 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 1 2 # 1 98 ARG A 25 ARG.? 9.68 S2 BME A 300 154 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 30.46 16.14 41.59 29.16 15.67 44.34 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 29.87 29.36 46.86 29.51 27.55 47.90 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1af7_c00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 2 2 # 2 98 ARG A 68 ARG~? -4.35 S2 BME A 300s 154 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 30.46 16.14 41.59 29.16 15.67 44.34 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 29.87 29.36 46.86 29.51 27.55 47.90 24.97 -2.58 14.97 24.99 -3.62 16.79 1af7_c00 source 1af7 CHEMOTAXIS RECEPTOR METHYLTRANSFERASE CHER : 2 hits 1af7_c00 naa= 2 ULMN 2 1afw_c02 3-KETOACETYL-COA THIOLASE user 1 2 # 1 A 375 HIS A 91 HIS~? 7.63 O1 BME A 300 A 403 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 64.06 3.38 87.94 62.07 2.70 87.91 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 58.48 -3.82 90.81 60.44 -2.47 92.32 10.91 -8.39 4.98 11.88 -9.73 7.18 1afw_c02 source 1afw 3-KETOACETYL-COA THIOLASE : 1 hits 1afw_c02 naa= 2 ULMN 2 1afw_c03 3-KETOACETYL-COA THIOLASE user 1 2 # 1 B 375 HIS A 91 HIS~? 7.63 O1 BME A 300 B 403 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 33.63 16.39 76.29 35.22 15.29 75.46 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 36.85 13.36 67.74 35.71 15.87 68.44 10.91 -8.39 4.98 11.88 -9.73 7.18 1afw_c03 source 1afw 3-KETOACETYL-COA THIOLASE : 1 hits 1afw_c03 naa= 2 ULMN 2 1agm_c00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 1 2 # 1 179 GLU A 8 GLU~? 18.47 O1 BME A 300 400 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 32.98 15.63 8.99 31.06 16.43 9.08 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 34.51 26.41 7.72 33.50 24.94 6.68 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1agm_c00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 2 2 # 2 179 GLU A 15 GLU~? 24.22 S2 BME A 300 400 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 32.98 15.63 8.99 31.06 16.43 9.08 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 34.51 26.41 7.72 33.50 24.94 6.68 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1agm_c00 source 1agm GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-GLUCOSIDASE: 2 hits 1agm_c00 naa= 2 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 1 2 # 1 251 ASP A 7 ASP~? 16.68 O1 BME A 300 252 THR A 5 THR~? 15.55 O1 BME A 300 coo 22.35 20.89 12.77 23.04 22.54 13.90 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 17.85 20.47 14.62 16.85 19.84 12.80 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 2 2 # 2 251 ASP A 7 ASP~? 16.68 O1 BME A 300 252 THR A 6 THR~? 12.27 O1 BME A 300 coo 22.35 20.89 12.77 23.04 22.54 13.90 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 17.85 20.47 14.62 16.85 19.84 12.80 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 3 2 # 3 251 ASP A 23 ASP^? 9.45 S2 BME A 300 252 THR A 30 THR~? 11.99 S2 BME A 300 coo 22.35 20.89 12.77 23.04 22.54 13.90 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 17.85 20.47 14.62 16.85 19.84 12.80 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 4 2 # 4 251 ASP A 27 ASP~? 15.09 S2 BME A 300 252 THR A 26 THR~? 9.55 S2 BME A 300 coo 22.35 20.89 12.77 23.04 22.54 13.90 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 17.85 20.47 14.62 16.85 19.84 12.80 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 5 2 # 5 251 ASP A 27 ASP~? 15.09 S2 BME A 300 252 THR A 30 THR~? 11.99 S2 BME A 300 coo 22.35 20.89 12.77 23.04 22.54 13.90 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 17.85 20.47 14.62 16.85 19.84 12.80 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 6 2 # 6 251 ASP A 44 ASP~? 11.03 S2 BME A 300 252 THR A 45 THR~? 14.85 S2 BME A 300 coo 22.35 20.89 12.77 23.04 22.54 13.90 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.85 20.47 14.62 16.85 19.84 12.80 21.81 -5.88 13.03 22.64 -6.51 11.11 ULMN 2 1akd_c00 CYTOCHROME P450CAM user 7 2 # 7 251 ASP A 48 ASP~? 19.85 S2 BME A 300 252 THR A 45 THR~? 14.85 S2 BME A 300 coo 22.35 20.89 12.77 23.04 22.54 13.90 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 17.85 20.47 14.62 16.85 19.84 12.80 21.81 -5.88 13.03 22.64 -6.51 11.11 1akd_c00 source 1akd CYTOCHROME P450CAM : 7 hits 1akd_c00 naa= 2 ULMN 2 1alk_c00 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 1 2 # 1 A 102 SER A 69 SER~? 5.63 S2 BME A 300 A 166 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 77.14 38.59 40.00 75.03 39.65 40.47 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 80.16 39.46 45.79 77.49 39.97 44.40 12.31 -11.28 10.33 12.92 -12.61 7.64 1alk_c00 source 1alk ALKALINE PHOSPHATASE (E.C.3.1.3.1) : 1 hits 1alk_c00 naa= 2 ULMN 2 1alk_c01 ALKALINE PHOSPHATASE (E.C.3.1.3.1) user 1 2 # 1 B 102 SER A 69 SER~? 5.63 S2 BME A 300 B 166 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 49.65 19.46 28.35 51.43 18.07 29.31 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 44.56 16.48 30.76 47.68 16.19 30.95 12.31 -11.28 10.33 12.92 -12.61 7.64 1alk_c01 source 1alk ALKALINE PHOSPHATASE (E.C.3.1.3.1) : 1 hits 1alk_c01 naa= 2 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 2 # 1 179 ASP A 7 ASP~? 16.68 O1 BME A 300 204 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 4.34 62.44 32.05 4.22 64.48 32.53 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 2 # 2 179 ASP A 27 ASP~? 15.09 S2 BME A 300 204 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 4.34 62.44 32.05 4.22 64.48 32.53 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 2 # 3 179 ASP A 27 ASP~? 15.09 S2 BME A 300 204 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 4.34 62.44 32.05 4.22 64.48 32.53 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 2 # 4 179 ASP A 82 ASP^? 20.57 S2 BME A 300 204 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.12 9.33 8.59 8.15 9.51 7.94 coo 4.34 62.44 32.05 4.22 64.48 32.53 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 2 # 5 179 ASP A 82 ASP^? 20.57 S2 BME A 300 204 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.12 9.33 8.59 8.15 9.51 7.94 coo 4.34 62.44 32.05 4.22 64.48 32.53 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1amy_c00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 2 # 6 179 ASP A 95 ASP.? 15.99 O1 BME A 300 204 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 4.34 62.44 32.05 4.22 64.48 32.53 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1amy_c00 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c00 naa= 2 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 1 2 # 1 A 232 GLU A 8 GLU~? 18.47 O1 BME A 300 A 288 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 5.76 85.47 37.35 6.76 85.56 39.24 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 13.49 92.75 43.16 12.39 91.15 42.33 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 2 2 # 2 A 232 GLU A 15 GLU~? 24.22 S2 BME A 300 A 288 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 5.76 85.47 37.35 6.76 85.56 39.24 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 13.49 92.75 43.16 12.39 91.15 42.33 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 3 2 # 3 A 232 GLU A 96 GLU.? 20.00 O1 BME A 300 A 288 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 5.76 85.47 37.35 6.76 85.56 39.24 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 13.49 92.75 43.16 12.39 91.15 42.33 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1aq0_c02 1,3-1,4-BETA-GLUCANASE user 4 2 # 4 A 232 GLU A 99 GLU.? 20.82 S2 BME A 300 A 288 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 5.76 85.47 37.35 6.76 85.56 39.24 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 13.49 92.75 43.16 12.39 91.15 42.33 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1aq0_c02 source 1aq0 1,3-1,4-BETA-GLUCANASE : 4 hits 1aq0_c02 naa= 2 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 1 2 # 1 B 232 GLU A 8 GLU~? 18.47 O1 BME A 300 B 288 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 2 2 # 2 B 232 GLU A 15 GLU~? 24.22 S2 BME A 300 B 288 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -0.96 61.87 2.24 -2.27 63.48 2.70 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 3 2 # 3 B 232 GLU A 96 GLU.? 20.00 O1 BME A 300 B 288 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -0.96 61.87 2.24 -2.27 63.48 2.70 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1aq0_c03 1,3-1,4-BETA-GLUCANASE user 4 2 # 4 B 232 GLU A 99 GLU.? 20.82 S2 BME A 300 B 288 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -0.96 61.87 2.24 -2.27 63.48 2.70 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1aq0_c03 source 1aq0 1,3-1,4-BETA-GLUCANASE : 4 hits 1aq0_c03 naa= 2 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 1 2 # 1 A 278 GLU A 8 GLU~? 18.47 O1 BME A 300 A 354 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 2 2 # 2 A 278 GLU A 8 GLU~? 18.47 O1 BME A 300 A 354 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 3 2 # 3 A 278 GLU A 15 GLU~? 24.22 S2 BME A 300 A 354 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 4 2 # 4 A 278 GLU A 15 GLU~? 24.22 S2 BME A 300 A 354 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 5 2 # 5 A 278 GLU A 28 GLU~? 14.38 S2 BME A 300 A 354 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 6 2 # 6 A 278 GLU A 29 GLU~? 6.68 S2 BME A 300 A 354 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 7 2 # 7 A 278 GLU A 57 GLU.? 23.43 S2 BME A 300 A 354 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 16.30 10.78 3.24 16.87 9.97 1.36 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 8 2 # 8 A 278 GLU A 74 GLU~? 13.09 S2 BME A 300 A 354 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 9 2 # 9 A 278 GLU A 77 GLU~? 17.67 S2 BME A 300 A 354 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 7.63 5.18 13.95 5.55 5.01 14.48 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 10 2 # 10 A 278 GLU A 77 GLU~? 17.67 S2 BME A 300 A 354 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 7.63 5.18 13.95 5.55 5.01 14.48 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 11 2 # 11 A 278 GLU A 77 GLU~? 17.67 S2 BME A 300 A 354 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 7.63 5.18 13.95 5.55 5.01 14.48 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 12 2 # 12 A 278 GLU A 87 GLU.? 12.12 O1 BME A 300 A 354 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 13 2 # 13 A 278 GLU A 87 GLU.? 12.12 O1 BME A 300 A 354 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 14 2 # 14 A 278 GLU A 96 GLU.? 20.00 O1 BME A 300 A 354 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ar1_c01 CYTOCHROME C OXIDASE user 15 2 # 15 A 278 GLU A 99 GLU.? 20.82 S2 BME A 300 A 354 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 10.31 15.79 49.32 9.85 15.75 51.40 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 13.04 11.19 -6.33 8.80 12.60 -2.10 1ar1_c01 source 1ar1 CYTOCHROME C OXIDASE : 15 hits 1ar1_c01 naa= 2 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 1 2 # 1 93 GLU A 8 GLU~? 18.47 O1 BME A 300 149 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 15.94 26.98 26.92 17.27 26.11 25.50 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 21.50 28.85 18.49 20.74 27.28 20.66 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 2 2 # 2 93 GLU A 15 GLU~? 24.22 S2 BME A 300 149 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 15.94 26.98 26.92 17.27 26.11 25.50 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 21.50 28.85 18.49 20.74 27.28 20.66 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 3 2 # 3 93 GLU A 29 GLU~? 6.68 S2 BME A 300 149 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 15.94 26.98 26.92 17.27 26.11 25.50 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 21.50 28.85 18.49 20.74 27.28 20.66 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 4 2 # 4 93 GLU A 57 GLU.? 23.43 S2 BME A 300 149 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 15.94 26.98 26.92 17.27 26.11 25.50 16.30 10.78 3.24 16.87 9.97 1.36 coo 21.50 28.85 18.49 20.74 27.28 20.66 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 5 2 # 5 93 GLU A 77 GLU~? 17.67 S2 BME A 300 149 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 15.94 26.98 26.92 17.27 26.11 25.50 7.63 5.18 13.95 5.55 5.01 14.48 coo 21.50 28.85 18.49 20.74 27.28 20.66 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 6 2 # 6 93 GLU A 77 GLU~? 17.67 S2 BME A 300 149 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 15.94 26.98 26.92 17.27 26.11 25.50 7.63 5.18 13.95 5.55 5.01 14.48 coo 21.50 28.85 18.49 20.74 27.28 20.66 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ast_c00 ASTACIN (E.C.3.4.24.21) user 7 2 # 7 93 GLU A 87 GLU.? 12.12 O1 BME A 300 149 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 15.94 26.98 26.92 17.27 26.11 25.50 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 21.50 28.85 18.49 20.74 27.28 20.66 9.00 3.02 1.57 7.75 5.45 1.00 1ast_c00 source 1ast ASTACIN (E.C.3.4.24.21) : 7 hits 1ast_c00 naa= 2 ULMN 2 1avf_c09 GASTRICSIN user 1 2 # 1 A 32 ASP A 44 ASP~? 11.03 S2 BME A 300 A 217 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -10.06 2.54 49.69 -8.83 3.73 50.96 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -5.22 1.43 56.08 -5.36 2.84 54.49 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1avf_c09 GASTRICSIN user 2 2 # 2 A 32 ASP A 48 ASP~? 19.85 S2 BME A 300 A 217 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -10.06 2.54 49.69 -8.83 3.73 50.96 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -5.22 1.43 56.08 -5.36 2.84 54.49 19.36 -9.90 14.44 17.51 -11.01 14.77 1avf_c09 source 1avf GASTRICSIN : 2 hits 1avf_c09 naa= 2 ULMN 2 1avf_c10 GASTRICSIN user 1 2 # 1 J 32 ASP A 44 ASP~? 11.03 S2 BME A 300 J 217 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1avf_c10 GASTRICSIN user 2 2 # 2 J 32 ASP A 48 ASP~? 19.85 S2 BME A 300 J 217 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 19.36 -9.90 14.44 17.51 -11.01 14.77 1avf_c10 source 1avf GASTRICSIN : 2 hits 1avf_c10 naa= 2 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 1 2 # 1 A 9 LYS A 2 LYS.? 20.18 S2 BME A 300 B 58 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 2.39 3.95 8.25 5.67 8.88 7.74 coo 60.69 34.67 32.44 62.26 33.65 34.50 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 2 2 # 2 A 9 LYS A 10 LYS~? 16.18 O1 BME A 300 B 58 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 60.69 34.67 32.44 62.26 33.65 34.50 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 3 2 # 3 A 9 LYS A 10 LYS~? 16.18 O1 BME A 300 B 58 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 60.69 34.67 32.44 62.26 33.65 34.50 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 4 2 # 4 A 9 LYS A 12 LYS~? 21.81 S2 BME A 300 B 58 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 60.69 34.67 32.44 62.26 33.65 34.50 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 5 2 # 5 A 9 LYS A 12 LYS~? 21.81 S2 BME A 300 B 58 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 60.69 34.67 32.44 62.26 33.65 34.50 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 6 2 # 6 A 9 LYS A 39 LYS^? 20.06 S2 BME A 300 B 58 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 19.85 -1.20 1.64 21.03 4.07 2.80 coo 60.69 34.67 32.44 62.26 33.65 34.50 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 7 2 # 7 A 9 LYS A 55 LYS.? 25.54 S2 BME A 300 B 58 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 15.98 12.20 9.88 16.28 11.97 16.11 coo 60.69 34.67 32.44 62.26 33.65 34.50 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 8 2 # 8 A 9 LYS A 55 LYS.? 25.54 S2 BME A 300 B 58 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 15.98 12.20 9.88 16.28 11.97 16.11 coo 60.69 34.67 32.44 62.26 33.65 34.50 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 9 2 # 9 A 9 LYS A 71 LYS~? 8.54 S2 BME A 300 B 58 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 60.69 34.67 32.44 62.26 33.65 34.50 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1aw8_c00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 10 2 # 10 A 9 LYS A 71 LYS~? 8.54 S2 BME A 300 B 58 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 52.74 47.41 27.36 54.00 51.99 23.19 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 60.69 34.67 32.44 62.26 33.65 34.50 9.00 3.02 1.57 7.75 5.45 1.00 1aw8_c00 source 1aw8 L-ASPARTATE-ALPHA-DECARBOXYLASE : 10 hits 1aw8_c00 naa= 2 ULMN 2 1ax4_c00 TRYPTOPHANASE user 1 2 # 1 A 132 PHE A 53 PHE~? 16.58 S2 BME A 300 A 223 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 31.56 54.91 67.81 30.07 57.23 67.43 17.96 4.29 9.15 17.54 1.52 8.86 coo 30.70 47.50 67.53 29.83 49.47 67.39 10.12 9.33 8.59 8.15 9.51 7.94 1ax4_c00 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c00 naa= 2 ULMN 2 1ax4_c01 TRYPTOPHANASE user 1 2 # 1 B 132 PHE A 53 PHE~? 16.58 S2 BME A 300 B 223 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 8.96 54.33 91.07 8.09 52.55 89.13 17.96 4.29 9.15 17.54 1.52 8.86 coo 10.43 61.66 91.81 9.80 60.04 90.61 10.12 9.33 8.59 8.15 9.51 7.94 1ax4_c01 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c01 naa= 2 ULMN 2 1ax4_c02 TRYPTOPHANASE user 1 2 # 1 C 132 PHE A 53 PHE~? 16.58 S2 BME A 300 C 223 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -7.99 68.93 30.87 -7.11 66.46 31.77 17.96 4.29 9.15 17.54 1.52 8.86 coo -9.52 75.74 33.62 -8.85 73.74 33.93 10.12 9.33 8.59 8.15 9.51 7.94 1ax4_c02 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c02 naa= 2 ULMN 2 1ax4_c03 TRYPTOPHANASE user 1 2 # 1 D 132 PHE A 53 PHE~? 16.58 S2 BME A 300 D 223 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -30.45 58.28 51.78 -28.99 60.20 53.18 17.96 4.29 9.15 17.54 1.52 8.86 coo -29.46 51.67 48.51 -28.63 53.31 49.56 10.12 9.33 8.59 8.15 9.51 7.94 1ax4_c03 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c03 naa= 2 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 2 # 1 A 140 TRP A 93 TRP~? 14.44 S2 BME A 300 A 222 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 89.83 15.40 0.01 90.61 18.86 1.71 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 82.92 20.43 2.47 84.82 20.45 1.55 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 2 # 2 A 140 TRP A 93 TRP~? 14.44 S2 BME A 300 A 222 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 89.83 15.40 0.01 90.61 18.86 1.71 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 82.92 20.43 2.47 84.82 20.45 1.55 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1ay4_c00 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 2 # 3 A 140 TRP A 93 TRP~? 14.44 S2 BME A 300 A 222 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 89.83 15.40 0.01 90.61 18.86 1.71 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 82.92 20.43 2.47 84.82 20.45 1.55 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1ay4_c00 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 3 hits 1ay4_c00 naa= 2 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 2 # 1 B 140 TRP A 93 TRP~? 14.44 S2 BME A 300 B 222 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 103.45 44.39 16.20 102.66 41.02 14.32 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 110.10 38.66 15.58 108.40 39.41 14.53 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 2 # 2 B 140 TRP A 93 TRP~? 14.44 S2 BME A 300 B 222 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 103.45 44.39 16.20 102.66 41.02 14.32 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 110.10 38.66 15.58 108.40 39.41 14.53 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1ay4_c01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 2 # 3 B 140 TRP A 93 TRP~? 14.44 S2 BME A 300 B 222 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 103.45 44.39 16.20 102.66 41.02 14.32 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 110.10 38.66 15.58 108.40 39.41 14.53 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1ay4_c01 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 3 hits 1ay4_c01 naa= 2 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 1 2 # 1 A 80 SER A 3 SER^? 13.09 C1 BME A 300 A 301 ALA A 70 ALA~? 8.30 S2 BME A 300 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 2.01 1.27 5.67 0.61 -0.61 5.33 coo -22.54 45.09 5.28 -22.99 46.36 4.56 6.63 -3.94 11.35 5.27 -4.56 11.61 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 2 2 # 2 A 80 SER A 3 SER^? 13.09 C1 BME A 300 A 301 ALA A 83 ALA^? 14.63 S2 BME A 300 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 2.01 1.27 5.67 0.61 -0.61 5.33 coo -22.54 45.09 5.28 -22.99 46.36 4.56 9.58 4.45 8.44 10.26 3.43 9.36 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 3 2 # 3 A 80 SER A 69 SER~? 5.63 S2 BME A 300 A 301 ALA A 64 ALA.? -4.27 S2 BME A 300s coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -22.54 45.09 5.28 -22.99 46.36 4.56 9.64 -11.83 3.81 9.95 -13.24 4.40 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 4 2 # 4 A 80 SER A 69 SER~? 5.63 S2 BME A 300 A 301 ALA A 83 ALA^? 14.63 S2 BME A 300 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -22.54 45.09 5.28 -22.99 46.36 4.56 9.58 4.45 8.44 10.26 3.43 9.36 ULMN 2 1b2r_c01 FERREDOXIN-NADP+ REDUCTASE user 5 2 # 5 A 80 SER A 102 SER.? -26.95 S2 BME A 300s A 301 ALA A 31 ALA~? 16.01 S2 BME A 300 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 28.10 -11.09 -8.44 28.33 -11.90 -10.72 coo -22.54 45.09 5.28 -22.99 46.36 4.56 21.12 -13.83 -1.18 21.96 -14.90 -0.48 1b2r_c01 source 1b2r FERREDOXIN-NADP+ REDUCTASE : 5 hits 1b2r_c01 naa= 2 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 A 28 GLU A 15 GLU~? 24.22 S2 BME A 300 A 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -19.49 15.64 24.83 -18.39 16.64 23.30 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 2 2 # 2 A 28 GLU A 28 GLU~? 14.38 S2 BME A 300 A 120 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -19.49 15.64 24.83 -18.39 16.64 23.30 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 3 2 # 3 A 28 GLU A 28 GLU~? 14.38 S2 BME A 300 A 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -19.49 15.64 24.83 -18.39 16.64 23.30 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 4 2 # 4 A 28 GLU A 29 GLU~? 6.68 S2 BME A 300 A 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -19.49 15.64 24.83 -18.39 16.64 23.30 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 5 2 # 5 A 28 GLU A 29 GLU~? 6.68 S2 BME A 300 A 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -19.49 15.64 24.83 -18.39 16.64 23.30 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 6 2 # 6 A 28 GLU A 74 GLU~? 13.09 S2 BME A 300 A 120 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -19.49 15.64 24.83 -18.39 16.64 23.30 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 7 2 # 7 A 28 GLU A 96 GLU.? 20.00 O1 BME A 300 A 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -19.49 15.64 24.83 -18.39 16.64 23.30 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 8 2 # 8 A 28 GLU A 99 GLU.? 20.82 S2 BME A 300 A 120 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -19.49 15.64 24.83 -18.39 16.64 23.30 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1b5t_c00 METHYLENETETRAHYDROFOLATE REDUCTASE user 9 2 # 9 A 28 GLU A 99 GLU.? 20.82 S2 BME A 300 A 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -6.26 14.85 21.66 -7.83 16.24 21.69 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -19.49 15.64 24.83 -18.39 16.64 23.30 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1b5t_c00 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 9 hits 1b5t_c00 naa= 2 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 B 28 GLU A 15 GLU~? 24.22 S2 BME A 300 B 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 19.27 43.87 32.88 18.74 43.97 30.83 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 2 2 # 2 B 28 GLU A 28 GLU~? 14.38 S2 BME A 300 B 120 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 19.27 43.87 32.88 18.74 43.97 30.83 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 3 2 # 3 B 28 GLU A 28 GLU~? 14.38 S2 BME A 300 B 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 19.27 43.87 32.88 18.74 43.97 30.83 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 4 2 # 4 B 28 GLU A 29 GLU~? 6.68 S2 BME A 300 B 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 19.27 43.87 32.88 18.74 43.97 30.83 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 5 2 # 5 B 28 GLU A 29 GLU~? 6.68 S2 BME A 300 B 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 19.27 43.87 32.88 18.74 43.97 30.83 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 6 2 # 6 B 28 GLU A 74 GLU~? 13.09 S2 BME A 300 B 120 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 19.27 43.87 32.88 18.74 43.97 30.83 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 7 2 # 7 B 28 GLU A 96 GLU.? 20.00 O1 BME A 300 B 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 19.27 43.87 32.88 18.74 43.97 30.83 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 8 2 # 8 B 28 GLU A 99 GLU.? 20.82 S2 BME A 300 B 120 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 19.27 43.87 32.88 18.74 43.97 30.83 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1b5t_c01 METHYLENETETRAHYDROFOLATE REDUCTASE user 9 2 # 9 B 28 GLU A 99 GLU.? 20.82 S2 BME A 300 B 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 19.99 54.72 24.39 18.91 52.94 24.71 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 19.27 43.87 32.88 18.74 43.97 30.83 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1b5t_c01 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 9 hits 1b5t_c01 naa= 2 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 C 28 GLU A 15 GLU~? 24.22 S2 BME A 300 C 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -15.26 61.78 57.87 -16.19 60.59 59.37 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 2 2 # 2 C 28 GLU A 28 GLU~? 14.38 S2 BME A 300 C 120 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -15.26 61.78 57.87 -16.19 60.59 59.37 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 3 2 # 3 C 28 GLU A 28 GLU~? 14.38 S2 BME A 300 C 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -15.26 61.78 57.87 -16.19 60.59 59.37 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 4 2 # 4 C 28 GLU A 74 GLU~? 13.09 S2 BME A 300 C 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -15.26 61.78 57.87 -16.19 60.59 59.37 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 5 2 # 5 C 28 GLU A 74 GLU~? 13.09 S2 BME A 300 C 120 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -15.26 61.78 57.87 -16.19 60.59 59.37 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 6 2 # 6 C 28 GLU A 87 GLU.? 12.12 O1 BME A 300 C 120 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -15.26 61.78 57.87 -16.19 60.59 59.37 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 7 2 # 7 C 28 GLU A 96 GLU.? 20.00 O1 BME A 300 C 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -15.26 61.78 57.87 -16.19 60.59 59.37 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 8 2 # 8 C 28 GLU A 99 GLU.? 20.82 S2 BME A 300 C 120 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -15.26 61.78 57.87 -16.19 60.59 59.37 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1b5t_c02 METHYLENETETRAHYDROFOLATE REDUCTASE user 9 2 # 9 C 28 GLU A 99 GLU.? 20.82 S2 BME A 300 C 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -14.39 50.83 66.85 -15.79 51.94 65.73 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -15.26 61.78 57.87 -16.19 60.59 59.37 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1b5t_c02 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 9 hits 1b5t_c02 naa= 2 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 1 2 # 1 A 204 ARG A 25 ARG.? 9.68 S2 BME A 300 A 314 ALA A 83 ALA^? 14.63 S2 BME A 300 coo 11.90 60.00 22.81 13.91 61.27 20.88 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 27.03 64.92 14.26 27.11 64.46 15.71 9.58 4.45 8.44 10.26 3.43 9.36 ULMN 2 1b7y_c00 PHENYLALANYL-TRNA SYNTHETASE user 2 2 # 2 A 204 ARG A 68 ARG~? -4.35 S2 BME A 300s A 314 ALA A 78 ALA~? 19.15 S2 BME A 300 coo 11.90 60.00 22.81 13.91 61.27 20.88 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 27.03 64.92 14.26 27.11 64.46 15.71 11.30 5.32 18.63 11.37 4.04 19.42 1b7y_c00 source 1b7y PHENYLALANYL-TRNA SYNTHETASE : 2 hits 1b7y_c00 naa= 2 ULMN 2 1b8g_c00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 A 145 TYR A 34 TYR.? 16.37 S2 BME A 300 A 230 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 9.23 21.44 106.88 10.18 19.34 105.31 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 1.45 22.80 104.16 2.58 21.02 104.01 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1b8g_c00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 A 145 TYR A 59 TYR^? 18.50 S2 BME A 300 A 230 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 9.23 21.44 106.88 10.18 19.34 105.31 14.59 5.14 5.72 16.82 6.86 5.68 coo 1.45 22.80 104.16 2.58 21.02 104.01 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1b8g_c00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 2 # 3 A 145 TYR A 60 TYR^? 16.66 S2 BME A 300 A 230 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 9.23 21.44 106.88 10.18 19.34 105.31 9.00 3.02 1.57 7.75 5.45 1.00 coo 1.45 22.80 104.16 2.58 21.02 104.01 10.12 9.33 8.59 8.15 9.51 7.94 1b8g_c00 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 3 hits 1b8g_c00 naa= 2 ULMN 2 1b8g_c02 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 B 145 TYR A 59 TYR^? 18.50 S2 BME A 300 B 230 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 11.81 13.41 73.03 10.00 13.03 75.12 14.59 5.14 5.72 16.82 6.86 5.68 coo 19.17 11.01 76.14 17.26 10.42 76.77 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1b8g_c02 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 B 145 TYR A 60 TYR^? 16.66 S2 BME A 300 B 230 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 11.81 13.41 73.03 10.00 13.03 75.12 9.00 3.02 1.57 7.75 5.45 1.00 coo 19.17 11.01 76.14 17.26 10.42 76.77 10.12 9.33 8.59 8.15 9.51 7.94 1b8g_c02 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c02 naa= 2 ULMN 2 1b8g_c06 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 A 273 LYS A 12 LYS~? 21.81 S2 BME A 300 A 398 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 2.97 11.64 107.87 6.59 15.13 107.03 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 13.10 26.17 112.42 12.37 23.74 113.49 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 2 1b8g_c06 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 A 273 LYS A 101 LYS.? -19.93 S2 BME A 300s A 398 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 2.97 11.64 107.87 6.59 15.13 107.03 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 13.10 26.17 112.42 12.37 23.74 113.49 10.91 -8.39 4.98 11.88 -9.73 7.18 1b8g_c06 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c06 naa= 2 ULMN 2 1b8g_c07 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 B 273 LYS A 12 LYS~? 21.81 S2 BME A 300 B 398 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 11.10 2.31 76.60 10.24 7.24 75.62 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 10.80 16.99 65.65 9.83 14.36 65.68 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 2 1b8g_c07 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 B 273 LYS A 101 LYS.? -19.93 S2 BME A 300s B 398 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 11.10 2.31 76.60 10.24 7.24 75.62 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 10.80 16.99 65.65 9.83 14.36 65.68 10.91 -8.39 4.98 11.88 -9.73 7.18 1b8g_c07 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c07 naa= 2 ULMN 2 1b9h_c00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 2 # 1 A 88 PHE A 53 PHE~? 16.58 S2 BME A 300 A 159 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 13.91 34.58 14.67 12.95 36.00 12.47 17.96 4.29 9.15 17.54 1.52 8.86 coo 20.97 28.40 16.26 20.19 30.15 15.34 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1b9h_c00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 2 # 2 A 88 PHE A 53 PHE~? 16.58 S2 BME A 300 A 159 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 13.91 34.58 14.67 12.95 36.00 12.47 17.96 4.29 9.15 17.54 1.52 8.86 coo 20.97 28.40 16.26 20.19 30.15 15.34 10.12 9.33 8.59 8.15 9.51 7.94 1b9h_c00 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 2 hits 1b9h_c00 naa= 2 ULMN 2 1bf2_c02 ISOAMYLASE user 1 2 # 1 375 ASP A 7 ASP~? 16.68 O1 BME A 300 435 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 88.62 69.90 41.16 89.05 70.67 43.04 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 89.52 76.11 40.17 89.01 75.16 41.97 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bf2_c02 ISOAMYLASE user 2 2 # 2 375 ASP A 27 ASP~? 15.09 S2 BME A 300 435 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 88.62 69.90 41.16 89.05 70.67 43.04 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 89.52 76.11 40.17 89.01 75.16 41.97 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bf2_c02 ISOAMYLASE user 3 2 # 3 375 ASP A 27 ASP~? 15.09 S2 BME A 300 435 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 88.62 69.90 41.16 89.05 70.67 43.04 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 89.52 76.11 40.17 89.01 75.16 41.97 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bf2_c02 ISOAMYLASE user 4 2 # 4 375 ASP A 82 ASP^? 20.57 S2 BME A 300 435 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.12 9.33 8.59 8.15 9.51 7.94 coo 89.52 76.11 40.17 89.01 75.16 41.97 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1bf2_c02 ISOAMYLASE user 5 2 # 5 375 ASP A 82 ASP^? 20.57 S2 BME A 300 435 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.12 9.33 8.59 8.15 9.51 7.94 coo 89.52 76.11 40.17 89.01 75.16 41.97 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bf2_c02 ISOAMYLASE user 6 2 # 6 375 ASP A 95 ASP.? 15.99 O1 BME A 300 435 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 89.52 76.11 40.17 89.01 75.16 41.97 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1bf2_c02 source 1bf2 ISOAMYLASE : 6 hits 1bf2_c02 naa= 2 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 1 2 # 1 A 461 GLU A 8 GLU~? 18.47 O1 BME A 300 A 537 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 24.06 146.21 11.09 22.89 146.18 9.36 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 16.65 144.44 13.24 18.34 145.22 12.33 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 2 2 # 2 A 461 GLU A 28 GLU~? 14.38 S2 BME A 300 A 537 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 24.06 146.21 11.09 22.89 146.18 9.36 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 16.65 144.44 13.24 18.34 145.22 12.33 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 3 2 # 3 A 461 GLU A 29 GLU~? 6.68 S2 BME A 300 A 537 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 24.06 146.21 11.09 22.89 146.18 9.36 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 16.65 144.44 13.24 18.34 145.22 12.33 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 4 2 # 4 A 461 GLU A 74 GLU~? 13.09 S2 BME A 300 A 537 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 24.06 146.21 11.09 22.89 146.18 9.36 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 16.65 144.44 13.24 18.34 145.22 12.33 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 5 2 # 5 A 461 GLU A 77 GLU~? 17.67 S2 BME A 300 A 537 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 24.06 146.21 11.09 22.89 146.18 9.36 7.63 5.18 13.95 5.55 5.01 14.48 coo 16.65 144.44 13.24 18.34 145.22 12.33 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1bgl_c00 BETA-GALACTOSIDASE user 6 2 # 6 A 461 GLU A 87 GLU.? 12.12 O1 BME A 300 A 537 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 24.06 146.21 11.09 22.89 146.18 9.36 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 16.65 144.44 13.24 18.34 145.22 12.33 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1bgl_c00 source 1bgl BETA-GALACTOSIDASE : 6 hits 1bgl_c00 naa= 2 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 1 2 # 1 A 451 GLU A 8 GLU~? 18.47 O1 BME A 300 A 540 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 81.34 87.29 87.22 82.36 86.09 88.61 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 79.94 80.46 88.84 81.11 81.36 87.27 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 2 2 # 2 A 451 GLU A 28 GLU~? 14.38 S2 BME A 300 A 540 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 81.34 87.29 87.22 82.36 86.09 88.61 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 79.94 80.46 88.84 81.11 81.36 87.27 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 3 2 # 3 A 451 GLU A 29 GLU~? 6.68 S2 BME A 300 A 540 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 81.34 87.29 87.22 82.36 86.09 88.61 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 79.94 80.46 88.84 81.11 81.36 87.27 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 4 2 # 4 A 451 GLU A 74 GLU~? 13.09 S2 BME A 300 A 540 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 81.34 87.29 87.22 82.36 86.09 88.61 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 79.94 80.46 88.84 81.11 81.36 87.27 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 5 2 # 5 A 451 GLU A 77 GLU~? 17.67 S2 BME A 300 A 540 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 81.34 87.29 87.22 82.36 86.09 88.61 7.63 5.18 13.95 5.55 5.01 14.48 coo 79.94 80.46 88.84 81.11 81.36 87.27 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1bhg_c00 BETA-GLUCURONIDASE user 6 2 # 6 A 451 GLU A 87 GLU.? 12.12 O1 BME A 300 A 540 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 81.34 87.29 87.22 82.36 86.09 88.61 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 79.94 80.46 88.84 81.11 81.36 87.27 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1bhg_c00 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c00 naa= 2 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 1 2 # 1 B 451 GLU A 8 GLU~? 18.47 O1 BME A 300 B 540 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 83.38 41.19 112.55 85.47 40.59 112.72 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 2 2 # 2 B 451 GLU A 28 GLU~? 14.38 S2 BME A 300 B 540 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 83.38 41.19 112.55 85.47 40.59 112.72 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 3 2 # 3 B 451 GLU A 29 GLU~? 6.68 S2 BME A 300 B 540 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 83.38 41.19 112.55 85.47 40.59 112.72 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 4 2 # 4 B 451 GLU A 74 GLU~? 13.09 S2 BME A 300 B 540 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 83.38 41.19 112.55 85.47 40.59 112.72 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 5 2 # 5 B 451 GLU A 77 GLU~? 17.67 S2 BME A 300 B 540 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 7.63 5.18 13.95 5.55 5.01 14.48 coo 83.38 41.19 112.55 85.47 40.59 112.72 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1bhg_c01 BETA-GLUCURONIDASE user 6 2 # 6 B 451 GLU A 87 GLU.? 12.12 O1 BME A 300 B 540 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 86.52 35.28 112.74 87.08 36.38 110.99 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 83.38 41.19 112.55 85.47 40.59 112.72 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1bhg_c01 source 1bhg BETA-GLUCURONIDASE : 6 hits 1bhg_c01 naa= 2 ULMN 2 1bjo_c01 PHOSPHOSERINE AMINOTRANSFERASE user 1 2 # 1 B 102 TRP A 93 TRP~? 14.44 S2 BME A 300 B 174 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 4.77 55.75 65.93 6.30 59.02 64.41 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 2.21 52.73 59.53 3.97 53.77 60.07 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1bjo_c01 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 1 hits 1bjo_c01 naa= 2 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 1 2 # 1 A 150 LYS A 2 LYS.? 20.18 S2 BME A 300 A 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 2.39 3.95 8.25 5.67 8.88 7.74 coo 55.33 66.46 41.57 56.47 67.38 40.06 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 2 2 # 2 A 150 LYS A 2 LYS.? 20.18 S2 BME A 300 A 278 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 2.39 3.95 8.25 5.67 8.88 7.74 coo 55.33 66.46 41.57 56.47 67.38 40.06 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 3 2 # 3 A 150 LYS A 10 LYS~? 16.18 O1 BME A 300 A 278 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 55.33 66.46 41.57 56.47 67.38 40.06 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 4 2 # 4 A 150 LYS A 12 LYS~? 21.81 S2 BME A 300 A 278 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 55.33 66.46 41.57 56.47 67.38 40.06 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 5 2 # 5 A 150 LYS A 12 LYS~? 21.81 S2 BME A 300 A 278 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 55.33 66.46 41.57 56.47 67.38 40.06 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 6 2 # 6 A 150 LYS A 17 LYS.? 25.68 S2 BME A 300 A 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 55.33 66.46 41.57 56.47 67.38 40.06 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 7 2 # 7 A 150 LYS A 17 LYS.? 25.68 S2 BME A 300 A 278 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 55.33 66.46 41.57 56.47 67.38 40.06 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 8 2 # 8 A 150 LYS A 39 LYS^? 20.06 S2 BME A 300 A 278 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 19.85 -1.20 1.64 21.03 4.07 2.80 coo 55.33 66.46 41.57 56.47 67.38 40.06 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 9 2 # 9 A 150 LYS A 39 LYS^? 20.06 S2 BME A 300 A 278 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 19.85 -1.20 1.64 21.03 4.07 2.80 coo 55.33 66.46 41.57 56.47 67.38 40.06 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 10 2 # 10 A 150 LYS A 39 LYS^? 20.06 S2 BME A 300 A 278 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 19.85 -1.20 1.64 21.03 4.07 2.80 coo 55.33 66.46 41.57 56.47 67.38 40.06 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 11 2 # 11 A 150 LYS A 55 LYS.? 25.54 S2 BME A 300 A 278 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 15.98 12.20 9.88 16.28 11.97 16.11 coo 55.33 66.46 41.57 56.47 67.38 40.06 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 12 2 # 12 A 150 LYS A 71 LYS~? 8.54 S2 BME A 300 A 278 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 55.33 66.46 41.57 56.47 67.38 40.06 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 13 2 # 13 A 150 LYS A 71 LYS~? 8.54 S2 BME A 300 A 278 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 55.33 66.46 41.57 56.47 67.38 40.06 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1bo1_c00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 14 2 # 14 A 150 LYS A 101 LYS.? -19.93 S2 BME A 300s A 278 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 43.46 54.32 43.90 48.56 57.30 46.35 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 55.33 66.46 41.57 56.47 67.38 40.06 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1bo1_c00 source 1bo1 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE IIBETA : 14 hits 1bo1_c00 naa= 2 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 1 2 # 1 B 150 LYS A 2 LYS.? 20.18 S2 BME A 300 B 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 2.39 3.95 8.25 5.67 8.88 7.74 coo 23.28 1.35 20.09 22.28 1.00 18.22 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 2 2 # 2 B 150 LYS A 2 LYS.? 20.18 S2 BME A 300 B 278 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 2.39 3.95 8.25 5.67 8.88 7.74 coo 23.28 1.35 20.09 22.28 1.00 18.22 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 3 2 # 3 B 150 LYS A 10 LYS~? 16.18 O1 BME A 300 B 278 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 23.28 1.35 20.09 22.28 1.00 18.22 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 4 2 # 4 B 150 LYS A 12 LYS~? 21.81 S2 BME A 300 B 278 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 23.28 1.35 20.09 22.28 1.00 18.22 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 5 2 # 5 B 150 LYS A 12 LYS~? 21.81 S2 BME A 300 B 278 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 23.28 1.35 20.09 22.28 1.00 18.22 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 6 2 # 6 B 150 LYS A 17 LYS.? 25.68 S2 BME A 300 B 278 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 23.28 1.35 20.09 22.28 1.00 18.22 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 7 2 # 7 B 150 LYS A 17 LYS.? 25.68 S2 BME A 300 B 278 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 23.28 1.35 20.09 22.28 1.00 18.22 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 8 2 # 8 B 150 LYS A 39 LYS^? 20.06 S2 BME A 300 B 278 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 19.85 -1.20 1.64 21.03 4.07 2.80 coo 23.28 1.35 20.09 22.28 1.00 18.22 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 9 2 # 9 B 150 LYS A 39 LYS^? 20.06 S2 BME A 300 B 278 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 19.85 -1.20 1.64 21.03 4.07 2.80 coo 23.28 1.35 20.09 22.28 1.00 18.22 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 10 2 # 10 B 150 LYS A 55 LYS.? 25.54 S2 BME A 300 B 278 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 15.98 12.20 9.88 16.28 11.97 16.11 coo 23.28 1.35 20.09 22.28 1.00 18.22 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 11 2 # 11 B 150 LYS A 71 LYS~? 8.54 S2 BME A 300 B 278 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 23.28 1.35 20.09 22.28 1.00 18.22 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1bo1_c01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 12 2 # 12 B 150 LYS A 71 LYS~? 8.54 S2 BME A 300 B 278 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 35.25 10.18 29.50 33.26 8.54 24.76 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 23.28 1.35 20.09 22.28 1.00 18.22 24.97 -2.58 14.97 24.99 -3.62 16.79 1bo1_c01 source 1bo1 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE IIBETA : 12 hits 1bo1_c01 naa= 2 ULMN 2 1bqc_c02 BETA-MANNANASE user 1 2 # 1 A 128 GLU A 28 GLU~? 14.38 S2 BME A 300 A 225 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 36.48 24.43 22.02 36.86 26.34 21.13 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 40.16 23.71 17.01 38.52 24.96 17.40 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bqc_c02 BETA-MANNANASE user 2 2 # 2 A 128 GLU A 29 GLU~? 6.68 S2 BME A 300 A 225 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 36.48 24.43 22.02 36.86 26.34 21.13 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 40.16 23.71 17.01 38.52 24.96 17.40 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bqc_c02 BETA-MANNANASE user 3 2 # 3 A 128 GLU A 74 GLU~? 13.09 S2 BME A 300 A 225 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 36.48 24.43 22.02 36.86 26.34 21.13 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 40.16 23.71 17.01 38.52 24.96 17.40 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bqc_c02 BETA-MANNANASE user 4 2 # 4 A 128 GLU A 77 GLU~? 17.67 S2 BME A 300 A 225 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 36.48 24.43 22.02 36.86 26.34 21.13 7.63 5.18 13.95 5.55 5.01 14.48 coo 40.16 23.71 17.01 38.52 24.96 17.40 6.36 -0.87 15.92 5.32 -2.36 17.02 1bqc_c02 source 1bqc BETA-MANNANASE : 4 hits 1bqc_c02 naa= 2 ULMN 2 1bu7_c00 CYTOCHROME P450 user 1 2 # 1 A 267 GLU A 8 GLU~? 18.47 O1 BME A 300 A 268 THR A 5 THR~? 15.55 O1 BME A 300 coo 45.43 74.80 39.41 46.09 75.11 37.45 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 45.81 71.19 43.26 47.70 70.19 43.25 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1bu7_c00 CYTOCHROME P450 user 2 2 # 2 A 267 GLU A 8 GLU~? 18.47 O1 BME A 300 A 268 THR A 6 THR~? 12.27 O1 BME A 300 coo 45.43 74.80 39.41 46.09 75.11 37.45 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 45.81 71.19 43.26 47.70 70.19 43.25 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1bu7_c00 CYTOCHROME P450 user 3 2 # 3 A 267 GLU A 28 GLU~? 14.38 S2 BME A 300 A 268 THR A 26 THR~? 9.55 S2 BME A 300 coo 45.43 74.80 39.41 46.09 75.11 37.45 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 45.81 71.19 43.26 47.70 70.19 43.25 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1bu7_c00 CYTOCHROME P450 user 4 2 # 4 A 267 GLU A 29 GLU~? 6.68 S2 BME A 300 A 268 THR A 26 THR~? 9.55 S2 BME A 300 coo 45.43 74.80 39.41 46.09 75.11 37.45 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 45.81 71.19 43.26 47.70 70.19 43.25 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1bu7_c00 CYTOCHROME P450 user 5 2 # 5 A 267 GLU A 29 GLU~? 6.68 S2 BME A 300 A 268 THR A 30 THR~? 11.99 S2 BME A 300 coo 45.43 74.80 39.41 46.09 75.11 37.45 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 45.81 71.19 43.26 47.70 70.19 43.25 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1bu7_c00 CYTOCHROME P450 user 6 2 # 6 A 267 GLU A 87 GLU.? 12.12 O1 BME A 300 A 268 THR A 5 THR~? 15.55 O1 BME A 300 coo 45.43 74.80 39.41 46.09 75.11 37.45 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 45.81 71.19 43.26 47.70 70.19 43.25 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1bu7_c00 CYTOCHROME P450 user 7 2 # 7 A 267 GLU A 87 GLU.? 12.12 O1 BME A 300 A 268 THR A 6 THR~? 12.27 O1 BME A 300 coo 45.43 74.80 39.41 46.09 75.11 37.45 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 45.81 71.19 43.26 47.70 70.19 43.25 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1bu7_c00 source 1bu7 CYTOCHROME P450 : 7 hits 1bu7_c00 naa= 2 ULMN 2 1bu7_c01 CYTOCHROME P450 user 1 2 # 1 B 267 GLU A 8 GLU~? 18.47 O1 BME A 300 B 268 THR A 5 THR~? 15.55 O1 BME A 300 coo 37.51 113.26 46.73 39.45 112.75 46.09 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 37.20 116.32 52.00 35.18 117.07 52.13 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1bu7_c01 CYTOCHROME P450 user 2 2 # 2 B 267 GLU A 8 GLU~? 18.47 O1 BME A 300 B 268 THR A 6 THR~? 12.27 O1 BME A 300 coo 37.51 113.26 46.73 39.45 112.75 46.09 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 37.20 116.32 52.00 35.18 117.07 52.13 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1bu7_c01 CYTOCHROME P450 user 3 2 # 3 B 267 GLU A 28 GLU~? 14.38 S2 BME A 300 B 268 THR A 26 THR~? 9.55 S2 BME A 300 coo 37.51 113.26 46.73 39.45 112.75 46.09 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 37.20 116.32 52.00 35.18 117.07 52.13 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1bu7_c01 CYTOCHROME P450 user 4 2 # 4 B 267 GLU A 29 GLU~? 6.68 S2 BME A 300 B 268 THR A 26 THR~? 9.55 S2 BME A 300 coo 37.51 113.26 46.73 39.45 112.75 46.09 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 37.20 116.32 52.00 35.18 117.07 52.13 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1bu7_c01 CYTOCHROME P450 user 5 2 # 5 B 267 GLU A 29 GLU~? 6.68 S2 BME A 300 B 268 THR A 30 THR~? 11.99 S2 BME A 300 coo 37.51 113.26 46.73 39.45 112.75 46.09 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 37.20 116.32 52.00 35.18 117.07 52.13 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1bu7_c01 CYTOCHROME P450 user 6 2 # 6 B 267 GLU A 87 GLU.? 12.12 O1 BME A 300 B 268 THR A 5 THR~? 15.55 O1 BME A 300 coo 37.51 113.26 46.73 39.45 112.75 46.09 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 37.20 116.32 52.00 35.18 117.07 52.13 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1bu7_c01 CYTOCHROME P450 user 7 2 # 7 B 267 GLU A 87 GLU.? 12.12 O1 BME A 300 B 268 THR A 6 THR~? 12.27 O1 BME A 300 coo 37.51 113.26 46.73 39.45 112.75 46.09 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 37.20 116.32 52.00 35.18 117.07 52.13 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1bu7_c01 source 1bu7 CYTOCHROME P450 : 7 hits 1bu7_c01 naa= 2 ULMN 2 1bu7_c04 CYTOCHROME P450 user 1 2 # 1 A 269 THR A 6 THR~? 12.27 O1 BME A 300 A 409 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 44.86 72.34 46.76 46.06 72.57 48.57 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 45.56 75.42 52.98 46.85 76.54 51.76 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bu7_c04 CYTOCHROME P450 user 2 2 # 2 A 269 THR A 6 THR~? 12.27 O1 BME A 300 A 409 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 44.86 72.34 46.76 46.06 72.57 48.57 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 45.56 75.42 52.98 46.85 76.54 51.76 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1bu7_c04 CYTOCHROME P450 user 3 2 # 3 A 269 THR A 26 THR~? 9.55 S2 BME A 300 A 409 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 44.86 72.34 46.76 46.06 72.57 48.57 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 45.56 75.42 52.98 46.85 76.54 51.76 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bu7_c04 CYTOCHROME P450 user 4 2 # 4 A 269 THR A 30 THR~? 11.99 S2 BME A 300 A 409 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 44.86 72.34 46.76 46.06 72.57 48.57 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 45.56 75.42 52.98 46.85 76.54 51.76 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bu7_c04 CYTOCHROME P450 user 5 2 # 5 A 269 THR A 30 THR~? 11.99 S2 BME A 300 A 409 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 44.86 72.34 46.76 46.06 72.57 48.57 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 45.56 75.42 52.98 46.85 76.54 51.76 15.50 -15.19 4.21 14.37 -14.08 5.62 1bu7_c04 source 1bu7 CYTOCHROME P450 : 5 hits 1bu7_c04 naa= 2 ULMN 2 1bu7_c05 CYTOCHROME P450 user 1 2 # 1 B 269 THR A 5 THR~? 15.55 O1 BME A 300 B 409 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 37.77 113.78 54.79 36.33 112.76 56.05 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 36.78 108.70 59.19 35.94 108.22 57.32 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bu7_c05 CYTOCHROME P450 user 2 2 # 2 B 269 THR A 6 THR~? 12.27 O1 BME A 300 B 409 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 37.77 113.78 54.79 36.33 112.76 56.05 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 36.78 108.70 59.19 35.94 108.22 57.32 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bu7_c05 CYTOCHROME P450 user 3 2 # 3 B 269 THR A 6 THR~? 12.27 O1 BME A 300 B 409 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 37.77 113.78 54.79 36.33 112.76 56.05 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 36.78 108.70 59.19 35.94 108.22 57.32 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1bu7_c05 CYTOCHROME P450 user 4 2 # 4 B 269 THR A 26 THR~? 9.55 S2 BME A 300 B 409 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 37.77 113.78 54.79 36.33 112.76 56.05 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 36.78 108.70 59.19 35.94 108.22 57.32 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bu7_c05 CYTOCHROME P450 user 5 2 # 5 B 269 THR A 26 THR~? 9.55 S2 BME A 300 B 409 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 37.77 113.78 54.79 36.33 112.76 56.05 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 36.78 108.70 59.19 35.94 108.22 57.32 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bu7_c05 CYTOCHROME P450 user 6 2 # 6 B 269 THR A 30 THR~? 11.99 S2 BME A 300 B 409 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 37.77 113.78 54.79 36.33 112.76 56.05 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 36.78 108.70 59.19 35.94 108.22 57.32 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bu7_c05 CYTOCHROME P450 user 7 2 # 7 B 269 THR A 30 THR~? 11.99 S2 BME A 300 B 409 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 37.77 113.78 54.79 36.33 112.76 56.05 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 36.78 108.70 59.19 35.94 108.22 57.32 15.50 -15.19 4.21 14.37 -14.08 5.62 1bu7_c05 source 1bu7 CYTOCHROME P450 : 7 hits 1bu7_c05 naa= 2 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 1 2 # 1 78 GLU A 8 GLU~? 18.47 O1 BME A 300 172 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 29.78 23.72 34.61 31.02 22.02 34.93 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 36.89 20.40 30.23 35.07 20.37 31.31 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1bvv_c00 ENDO-1,4-BETA-XYLANASE user 2 2 # 2 78 GLU A 87 GLU.? 12.12 O1 BME A 300 172 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 29.78 23.72 34.61 31.02 22.02 34.93 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 36.89 20.40 30.23 35.07 20.37 31.31 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1bvv_c00 source 1bvv ENDO-1,4-BETA-XYLANASE : 2 hits 1bvv_c00 naa= 2 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 1 2 # 1 A 325 ASP A 7 ASP~? 16.68 O1 BME A 300 A 350 LEU A 98 LEU.? 15.58 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 17.08 44.76 64.40 16.58 45.38 62.42 14.96 -9.92 -7.39 13.27 -9.83 -6.06 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 2 2 # 2 A 325 ASP A 23 ASP^? 9.45 S2 BME A 300 A 350 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 17.08 44.76 64.40 16.58 45.38 62.42 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 3 2 # 3 A 325 ASP A 23 ASP^? 9.45 S2 BME A 300 A 350 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 17.08 44.76 64.40 16.58 45.38 62.42 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 4 2 # 4 A 325 ASP A 27 ASP~? 15.09 S2 BME A 300 A 350 LEU A 98 LEU.? 15.58 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 17.08 44.76 64.40 16.58 45.38 62.42 14.96 -9.92 -7.39 13.27 -9.83 -6.06 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 5 2 # 5 A 325 ASP A 44 ASP~? 11.03 S2 BME A 300 A 350 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.08 44.76 64.40 16.58 45.38 62.42 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 6 2 # 6 A 325 ASP A 44 ASP~? 11.03 S2 BME A 300 A 350 LEU A 50 LEU~? 20.27 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.08 44.76 64.40 16.58 45.38 62.42 21.11 4.23 14.59 19.47 3.75 15.94 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 7 2 # 7 A 325 ASP A 44 ASP~? 11.03 S2 BME A 300 A 350 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.08 44.76 64.40 16.58 45.38 62.42 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 8 2 # 8 A 325 ASP A 48 ASP~? 19.85 S2 BME A 300 A 350 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 17.08 44.76 64.40 16.58 45.38 62.42 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 9 2 # 9 A 325 ASP A 48 ASP~? 19.85 S2 BME A 300 A 350 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 17.08 44.76 64.40 16.58 45.38 62.42 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 10 2 # 10 A 325 ASP A 82 ASP^? 20.57 S2 BME A 300 A 350 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.12 9.33 8.59 8.15 9.51 7.94 coo 17.08 44.76 64.40 16.58 45.38 62.42 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 11 2 # 11 A 325 ASP A 82 ASP^? 20.57 S2 BME A 300 A 350 LEU A 50 LEU~? 20.27 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.12 9.33 8.59 8.15 9.51 7.94 coo 17.08 44.76 64.40 16.58 45.38 62.42 21.11 4.23 14.59 19.47 3.75 15.94 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 12 2 # 12 A 325 ASP A 95 ASP.? 15.99 O1 BME A 300 A 350 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 17.08 44.76 64.40 16.58 45.38 62.42 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 2 1bvz_c00 ALPHA-AMYLASE II user 13 2 # 13 A 325 ASP A 95 ASP.? 15.99 O1 BME A 300 A 350 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 17.08 44.76 64.40 16.58 45.38 62.42 21.19 -5.80 2.30 20.52 -6.59 0.34 1bvz_c00 source 1bvz ALPHA-AMYLASE II : 13 hits 1bvz_c00 naa= 2 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 1 2 # 1 B 325 ASP A 7 ASP~? 16.68 O1 BME A 300 B 350 LEU A 98 LEU.? 15.58 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 39.81 12.72 56.17 40.30 13.16 54.11 14.96 -9.92 -7.39 13.27 -9.83 -6.06 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 2 2 # 2 B 325 ASP A 23 ASP^? 9.45 S2 BME A 300 B 350 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 39.81 12.72 56.17 40.30 13.16 54.11 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 3 2 # 3 B 325 ASP A 23 ASP^? 9.45 S2 BME A 300 B 350 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 39.81 12.72 56.17 40.30 13.16 54.11 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 4 2 # 4 B 325 ASP A 27 ASP~? 15.09 S2 BME A 300 B 350 LEU A 98 LEU.? 15.58 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 39.81 12.72 56.17 40.30 13.16 54.11 14.96 -9.92 -7.39 13.27 -9.83 -6.06 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 5 2 # 5 B 325 ASP A 44 ASP~? 11.03 S2 BME A 300 B 350 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 39.81 12.72 56.17 40.30 13.16 54.11 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 6 2 # 6 B 325 ASP A 44 ASP~? 11.03 S2 BME A 300 B 350 LEU A 50 LEU~? 20.27 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 39.81 12.72 56.17 40.30 13.16 54.11 21.11 4.23 14.59 19.47 3.75 15.94 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 7 2 # 7 B 325 ASP A 44 ASP~? 11.03 S2 BME A 300 B 350 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 39.81 12.72 56.17 40.30 13.16 54.11 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 8 2 # 8 B 325 ASP A 48 ASP~? 19.85 S2 BME A 300 B 350 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 39.81 12.72 56.17 40.30 13.16 54.11 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 9 2 # 9 B 325 ASP A 48 ASP~? 19.85 S2 BME A 300 B 350 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 39.81 12.72 56.17 40.30 13.16 54.11 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 10 2 # 10 B 325 ASP A 82 ASP^? 20.57 S2 BME A 300 B 350 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.12 9.33 8.59 8.15 9.51 7.94 coo 39.81 12.72 56.17 40.30 13.16 54.11 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 11 2 # 11 B 325 ASP A 82 ASP^? 20.57 S2 BME A 300 B 350 LEU A 50 LEU~? 20.27 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.12 9.33 8.59 8.15 9.51 7.94 coo 39.81 12.72 56.17 40.30 13.16 54.11 21.11 4.23 14.59 19.47 3.75 15.94 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 12 2 # 12 B 325 ASP A 95 ASP.? 15.99 O1 BME A 300 B 350 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 39.81 12.72 56.17 40.30 13.16 54.11 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 13 2 # 13 B 325 ASP A 95 ASP.? 15.99 O1 BME A 300 B 350 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 39.81 12.72 56.17 40.30 13.16 54.11 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 2 1bvz_c01 ALPHA-AMYLASE II user 14 2 # 14 B 325 ASP A 95 ASP.? 15.99 O1 BME A 300 B 350 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 39.81 12.72 56.17 40.30 13.16 54.11 21.19 -5.80 2.30 20.52 -6.59 0.34 1bvz_c01 source 1bvz ALPHA-AMYLASE II : 14 hits 1bvz_c01 naa= 2 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 1 2 # 1 A 325 ASP A 7 ASP~? 16.68 O1 BME A 300 A 354 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 29.07 50.42 58.36 29.02 52.18 59.49 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 2 2 # 2 A 325 ASP A 27 ASP~? 15.09 S2 BME A 300 A 354 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 29.07 50.42 58.36 29.02 52.18 59.49 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 3 2 # 3 A 325 ASP A 27 ASP~? 15.09 S2 BME A 300 A 354 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 29.07 50.42 58.36 29.02 52.18 59.49 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 4 2 # 4 A 325 ASP A 82 ASP^? 20.57 S2 BME A 300 A 354 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.12 9.33 8.59 8.15 9.51 7.94 coo 29.07 50.42 58.36 29.02 52.18 59.49 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 5 2 # 5 A 325 ASP A 82 ASP^? 20.57 S2 BME A 300 A 354 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.12 9.33 8.59 8.15 9.51 7.94 coo 29.07 50.42 58.36 29.02 52.18 59.49 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bvz_c04 ALPHA-AMYLASE II user 6 2 # 6 A 325 ASP A 95 ASP.? 15.99 O1 BME A 300 A 354 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 29.07 50.42 58.36 29.02 52.18 59.49 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1bvz_c04 source 1bvz ALPHA-AMYLASE II : 6 hits 1bvz_c04 naa= 2 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 1 2 # 1 B 325 ASP A 7 ASP~? 16.68 O1 BME A 300 B 354 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 27.87 10.66 47.95 27.82 8.60 48.27 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 2 2 # 2 B 325 ASP A 27 ASP~? 15.09 S2 BME A 300 B 354 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 27.87 10.66 47.95 27.82 8.60 48.27 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 3 2 # 3 B 325 ASP A 27 ASP~? 15.09 S2 BME A 300 B 354 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 27.87 10.66 47.95 27.82 8.60 48.27 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 4 2 # 4 B 325 ASP A 82 ASP^? 20.57 S2 BME A 300 B 354 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.12 9.33 8.59 8.15 9.51 7.94 coo 27.87 10.66 47.95 27.82 8.60 48.27 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 5 2 # 5 B 325 ASP A 82 ASP^? 20.57 S2 BME A 300 B 354 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.12 9.33 8.59 8.15 9.51 7.94 coo 27.87 10.66 47.95 27.82 8.60 48.27 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bvz_c05 ALPHA-AMYLASE II user 6 2 # 6 B 325 ASP A 95 ASP.? 15.99 O1 BME A 300 B 354 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 27.87 10.66 47.95 27.82 8.60 48.27 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1bvz_c05 source 1bvz ALPHA-AMYLASE II : 6 hits 1bvz_c05 naa= 2 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 1 2 # 1 101 ASP A 23 ASP^? 9.45 S2 BME A 300 186 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.70 33.61 26.27 5.12 32.50 27.11 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 2 2 # 2 101 ASP A 23 ASP^? 9.45 S2 BME A 300 186 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.70 33.61 26.27 5.12 32.50 27.11 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 3 2 # 3 101 ASP A 23 ASP^? 9.45 S2 BME A 300 186 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.70 33.61 26.27 5.12 32.50 27.11 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 4 2 # 4 101 ASP A 23 ASP^? 9.45 S2 BME A 300 186 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.70 33.61 26.27 5.12 32.50 27.11 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 5 2 # 5 101 ASP A 23 ASP^? 9.45 S2 BME A 300 186 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.70 33.61 26.27 5.12 32.50 27.11 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 6 2 # 6 101 ASP A 44 ASP~? 11.03 S2 BME A 300 186 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 6.70 33.61 26.27 5.12 32.50 27.11 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 7 2 # 7 101 ASP A 48 ASP~? 19.85 S2 BME A 300 186 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 6.70 33.61 26.27 5.12 32.50 27.11 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 8 2 # 8 101 ASP A 48 ASP~? 19.85 S2 BME A 300 186 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 6.70 33.61 26.27 5.12 32.50 27.11 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 9 2 # 9 101 ASP A 48 ASP~? 19.85 S2 BME A 300 186 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 6.70 33.61 26.27 5.12 32.50 27.11 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 10 2 # 10 101 ASP A 48 ASP~? 19.85 S2 BME A 300 186 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 6.70 33.61 26.27 5.12 32.50 27.11 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 11 2 # 11 101 ASP A 48 ASP~? 19.85 S2 BME A 300 186 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 6.70 33.61 26.27 5.12 32.50 27.11 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 12 2 # 12 101 ASP A 82 ASP^? 20.57 S2 BME A 300 186 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 10.12 9.33 8.59 8.15 9.51 7.94 coo 6.70 33.61 26.27 5.12 32.50 27.11 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 13 2 # 13 101 ASP A 82 ASP^? 20.57 S2 BME A 300 186 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 10.12 9.33 8.59 8.15 9.51 7.94 coo 6.70 33.61 26.27 5.12 32.50 27.11 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 14 2 # 14 101 ASP A 82 ASP^? 20.57 S2 BME A 300 186 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 10.12 9.33 8.59 8.15 9.51 7.94 coo 6.70 33.61 26.27 5.12 32.50 27.11 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 15 2 # 15 101 ASP A 95 ASP.? 15.99 O1 BME A 300 186 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 6.70 33.61 26.27 5.12 32.50 27.11 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 16 2 # 16 101 ASP A 95 ASP.? 15.99 O1 BME A 300 186 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 6.70 33.61 26.27 5.12 32.50 27.11 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1bya_c00 BETA-AMYLASE (E.C.3.2.1.2) user 17 2 # 17 101 ASP A 95 ASP.? 15.99 O1 BME A 300 186 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -0.56 17.74 21.75 0.00 19.22 23.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 6.70 33.61 26.27 5.12 32.50 27.11 0.17 -4.11 3.03 -1.78 -3.73 3.87 1bya_c00 source 1bya BETA-AMYLASE (E.C.3.2.1.2) : 17 hits 1bya_c00 naa= 2 ULMN 2 1bzy_c12 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 105 CYH A 63 CYH.? -3.36 S2 BME A 300s A 137 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 1.51 81.58 37.40 -0.24 80.35 35.63 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 11.51 80.72 44.41 10.38 78.98 44.80 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1bzy_c12 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 A 105 CYH A 63 CYH.? -3.36 S2 BME A 300s A 137 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 1.51 81.58 37.40 -0.24 80.35 35.63 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 11.51 80.72 44.41 10.38 78.98 44.80 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1bzy_c12 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 A 105 CYH A 63 CYH.? -3.36 S2 BME A 300s A 137 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 1.51 81.58 37.40 -0.24 80.35 35.63 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 11.51 80.72 44.41 10.38 78.98 44.80 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1bzy_c12 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1bzy_c12 naa= 2 ULMN 2 1bzy_c13 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 B 105 CYH A 63 CYH.? -3.36 S2 BME A 300s B 137 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 12.29 118.86 36.37 14.58 119.51 34.93 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 1.33 120.54 41.38 2.37 122.32 41.83 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1bzy_c13 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 B 105 CYH A 63 CYH.? -3.36 S2 BME A 300s B 137 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 12.29 118.86 36.37 14.58 119.51 34.93 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 1.33 120.54 41.38 2.37 122.32 41.83 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1bzy_c13 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 B 105 CYH A 63 CYH.? -3.36 S2 BME A 300s B 137 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 12.29 118.86 36.37 14.58 119.51 34.93 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 1.33 120.54 41.38 2.37 122.32 41.83 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1bzy_c13 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1bzy_c13 naa= 2 ULMN 2 1bzy_c14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 105 CYH A 63 CYH.? -3.36 S2 BME A 300s C 137 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 13.83 89.09 94.43 15.92 89.35 96.30 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 5.10 82.97 88.07 6.79 81.71 87.85 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1bzy_c14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 105 CYH A 63 CYH.? -3.36 S2 BME A 300s C 137 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 13.83 89.09 94.43 15.92 89.35 96.30 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 5.10 82.97 88.07 6.79 81.71 87.85 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1bzy_c14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 C 105 CYH A 63 CYH.? -3.36 S2 BME A 300s C 137 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 13.83 89.09 94.43 15.92 89.35 96.30 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 5.10 82.97 88.07 6.79 81.71 87.85 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1bzy_c14 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1bzy_c14 naa= 2 ULMN 2 1bzy_c15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 D 105 CYH A 63 CYH.? -3.36 S2 BME A 300s D 137 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -10.58 118.36 90.34 -12.93 118.38 91.82 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -0.72 123.60 84.94 -2.32 124.82 84.32 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1bzy_c15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 D 105 CYH A 63 CYH.? -3.36 S2 BME A 300s D 137 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -10.58 118.36 90.34 -12.93 118.38 91.82 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -0.72 123.60 84.94 -2.32 124.82 84.32 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1bzy_c15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 D 105 CYH A 63 CYH.? -3.36 S2 BME A 300s D 137 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -10.58 118.36 90.34 -12.93 118.38 91.82 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -0.72 123.60 84.94 -2.32 124.82 84.32 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1bzy_c15 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1bzy_c15 naa= 2 ULMN 2 1bzy_c16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 104 TYR A 34 TYR.? 16.37 S2 BME A 300 A 137 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 6.06 82.60 40.26 8.21 81.19 41.35 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 11.51 80.72 44.41 10.38 78.98 44.80 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bzy_c16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 A 104 TYR A 59 TYR^? 18.50 S2 BME A 300 A 137 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 6.06 82.60 40.26 8.21 81.19 41.35 14.59 5.14 5.72 16.82 6.86 5.68 coo 11.51 80.72 44.41 10.38 78.98 44.80 10.12 9.33 8.59 8.15 9.51 7.94 1bzy_c16 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c16 naa= 2 ULMN 2 1bzy_c17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 B 104 TYR A 34 TYR.? 16.37 S2 BME A 300 B 137 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 7.21 118.18 38.45 4.99 119.76 39.04 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 1.33 120.54 41.38 2.37 122.32 41.83 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bzy_c17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 B 104 TYR A 59 TYR^? 18.50 S2 BME A 300 B 137 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 7.21 118.18 38.45 4.99 119.76 39.04 14.59 5.14 5.72 16.82 6.86 5.68 coo 1.33 120.54 41.38 2.37 122.32 41.83 10.12 9.33 8.59 8.15 9.51 7.94 1bzy_c17 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c17 naa= 2 ULMN 2 1bzy_c18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 104 TYR A 34 TYR.? 16.37 S2 BME A 300 C 137 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 9.22 87.61 91.72 7.84 85.28 91.02 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 5.10 82.97 88.07 6.79 81.71 87.85 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bzy_c18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 104 TYR A 59 TYR^? 18.50 S2 BME A 300 C 137 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 9.22 87.61 91.72 7.84 85.28 91.02 14.59 5.14 5.72 16.82 6.86 5.68 coo 5.10 82.97 88.07 6.79 81.71 87.85 10.12 9.33 8.59 8.15 9.51 7.94 1bzy_c18 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c18 naa= 2 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 D 104 TYR A 34 TYR.? 16.37 S2 BME A 300 D 137 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -5.64 119.47 88.35 -4.20 121.69 87.46 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -0.72 123.60 84.94 -2.32 124.82 84.32 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1bzy_c19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 D 104 TYR A 59 TYR^? 18.50 S2 BME A 300 D 137 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -5.64 119.47 88.35 -4.20 121.69 87.46 14.59 5.14 5.72 16.82 6.86 5.68 coo -0.72 123.60 84.94 -2.32 124.82 84.32 10.12 9.33 8.59 8.15 9.51 7.94 1bzy_c19 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1bzy_c19 naa= 2 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 1 2 # 1 A 22 GLU A 29 GLU~? 6.68 S2 BME A 300 A 100 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 2 2 # 2 A 22 GLU A 29 GLU~? 6.68 S2 BME A 300 A 100 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 3 2 # 3 A 22 GLU A 57 GLU.? 23.43 S2 BME A 300 A 100 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 16.30 10.78 3.24 16.87 9.97 1.36 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 4 2 # 4 A 22 GLU A 87 GLU.? 12.12 O1 BME A 300 A 100 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1c3j_c00 BETA-GLUCOSYLTRANSFERASE user 5 2 # 5 A 22 GLU A 99 GLU.? 20.82 S2 BME A 300 A 100 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 15.97 -5.82 2.06 15.42 -7.84 1.89 1c3j_c00 source 1c3j BETA-GLUCOSYLTRANSFERASE : 5 hits 1c3j_c00 naa= 2 ULMN 2 1c4t_c00 DIHYDROLIPOAMIDE SUCCINYLTRANSFERASEuser 1 2 # 1 A 375 HIS A 91 HIS~? 7.63 O1 BME A 300 C 323 THR A 5 THR~? 15.55 O1 BME A 300 coo 17.15 114.64 90.83 16.04 113.80 92.40 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 9.83 104.32 92.97 10.90 105.81 91.83 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1c4t_c00 DIHYDROLIPOAMIDE SUCCINYLTRANSFERASEuser 2 2 # 2 A 375 HIS A 91 HIS~? 7.63 O1 BME A 300 C 323 THR A 6 THR~? 12.27 O1 BME A 300 coo 17.15 114.64 90.83 16.04 113.80 92.40 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 9.83 104.32 92.97 10.90 105.81 91.83 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1c4t_c00 source 1c4t DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE : 2 hits 1c4t_c00 naa= 2 ULMN 2 1c4t_c03 DIHYDROLIPOAMIDE SUCCINYLTRANSFERASEuser 1 2 # 1 A 375 HIS A 91 HIS~? 7.63 O1 BME A 300 C 323 THR A 5 THR~? 15.55 O1 BME A 300 coo 17.15 114.64 90.83 16.04 113.80 92.40 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 9.83 104.32 92.97 10.90 105.81 91.83 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1c4t_c03 DIHYDROLIPOAMIDE SUCCINYLTRANSFERASEuser 2 2 # 2 A 375 HIS A 91 HIS~? 7.63 O1 BME A 300 C 323 THR A 6 THR~? 12.27 O1 BME A 300 coo 17.15 114.64 90.83 16.04 113.80 92.40 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 9.83 104.32 92.97 10.90 105.81 91.83 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1c4t_c03 source 1c4t DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE : 2 hits 1c4t_c03 naa= 2 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 106 GLU A 8 GLU~? 18.47 O1 BME A 300 199 THR A 5 THR~? 15.55 O1 BME A 300 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 2 2 # 2 106 GLU A 8 GLU~? 18.47 O1 BME A 300 199 THR A 6 THR~? 12.27 O1 BME A 300 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 3 2 # 3 106 GLU A 28 GLU~? 14.38 S2 BME A 300 199 THR A 26 THR~? 9.55 S2 BME A 300 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 4 2 # 4 106 GLU A 28 GLU~? 14.38 S2 BME A 300 199 THR A 30 THR~? 11.99 S2 BME A 300 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 5 2 # 5 106 GLU A 29 GLU~? 6.68 S2 BME A 300 199 THR A 26 THR~? 9.55 S2 BME A 300 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 6 2 # 6 106 GLU A 29 GLU~? 6.68 S2 BME A 300 199 THR A 30 THR~? 11.99 S2 BME A 300 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1ca2_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 7 2 # 7 106 GLU A 87 GLU.? 12.12 O1 BME A 300 199 THR A 6 THR~? 12.27 O1 BME A 300 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1ca2_c00 source 1ca2 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 7 hits 1ca2_c00 naa= 2 ULMN 2 1ca2_c01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 64 HIS A 91 HIS~? 7.63 O1 BME A 300 199 THR A 6 THR~? 12.27 O1 BME A 300 coo -0.75 -0.87 9.12 -1.30 1.12 9.42 3.84 -13.89 0.30 2.26 -15.26 0.08 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1ca2_c01 source 1ca2 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 1 hits 1ca2_c01 naa= 2 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 A 106 GLU A 8 GLU~? 18.47 O1 BME A 300 A 199 THR A 5 THR~? 15.55 O1 BME A 300 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 2 2 # 2 A 106 GLU A 8 GLU~? 18.47 O1 BME A 300 A 199 THR A 6 THR~? 12.27 O1 BME A 300 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 3 2 # 3 A 106 GLU A 28 GLU~? 14.38 S2 BME A 300 A 199 THR A 26 THR~? 9.55 S2 BME A 300 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 4 2 # 4 A 106 GLU A 29 GLU~? 6.68 S2 BME A 300 A 199 THR A 26 THR~? 9.55 S2 BME A 300 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 5 2 # 5 A 106 GLU A 29 GLU~? 6.68 S2 BME A 300 A 199 THR A 30 THR~? 11.99 S2 BME A 300 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1ca3_c00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 6 2 # 6 A 106 GLU A 87 GLU.? 12.12 O1 BME A 300 A 199 THR A 6 THR~? 12.27 O1 BME A 300 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1ca3_c00 source 1ca3 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 6 hits 1ca3_c00 naa= 2 ULMN 2 1ca3_c01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 A 64 HIS A 91 HIS~? 7.63 O1 BME A 300 A 199 THR A 5 THR~? 15.55 O1 BME A 300 coo 0.41 -0.63 8.41 1.49 1.00 7.81 3.84 -13.89 0.30 2.26 -15.26 0.08 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1ca3_c01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 2 2 # 2 A 64 HIS A 91 HIS~? 7.63 O1 BME A 300 A 199 THR A 6 THR~? 12.27 O1 BME A 300 coo 0.41 -0.63 8.41 1.49 1.00 7.81 3.84 -13.89 0.30 2.26 -15.26 0.08 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1ca3_c01 source 1ca3 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 2 hits 1ca3_c01 naa= 2 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 1 2 # 1 183 GLU A 8 GLU~? 18.47 O1 BME A 300 397 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 39.31 34.78 85.95 38.51 34.50 84.04 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 42.23 29.47 82.87 40.46 30.21 83.67 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 2 2 # 2 183 GLU A 28 GLU~? 14.38 S2 BME A 300 397 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 39.31 34.78 85.95 38.51 34.50 84.04 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 42.23 29.47 82.87 40.46 30.21 83.67 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 3 2 # 3 183 GLU A 29 GLU~? 6.68 S2 BME A 300 397 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 39.31 34.78 85.95 38.51 34.50 84.04 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 42.23 29.47 82.87 40.46 30.21 83.67 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 4 2 # 4 183 GLU A 74 GLU~? 13.09 S2 BME A 300 397 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 39.31 34.78 85.95 38.51 34.50 84.04 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 42.23 29.47 82.87 40.46 30.21 83.67 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 5 2 # 5 183 GLU A 77 GLU~? 17.67 S2 BME A 300 397 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 39.31 34.78 85.95 38.51 34.50 84.04 7.63 5.18 13.95 5.55 5.01 14.48 coo 42.23 29.47 82.87 40.46 30.21 83.67 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1cbg_c01 CYANOGENIC BETA-GLUCOSIDASE user 6 2 # 6 183 GLU A 87 GLU.? 12.12 O1 BME A 300 397 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 39.31 34.78 85.95 38.51 34.50 84.04 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 42.23 29.47 82.87 40.46 30.21 83.67 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1cbg_c01 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 6 hits 1cbg_c01 naa= 2 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 2 # 1 127 ARG A 25 ARG.? 9.68 S2 BME A 300 270 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 2 # 2 127 ARG A 25 ARG.? 9.68 S2 BME A 300 270 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 2 # 3 127 ARG A 68 ARG~? -4.35 S2 BME A 300s 270 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1cbx_c00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 2 # 4 127 ARG A 68 ARG~? -4.35 S2 BME A 300s 270 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 6.36 -0.87 15.92 5.32 -2.36 17.02 1cbx_c00 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 4 hits 1cbx_c00 naa= 2 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 1 2 # 1 S 19 THR A 5 THR~? 15.55 O1 BME A 300 L 23 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 39.82 19.80 46.49 40.70 18.87 48.29 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 39.80 15.56 49.54 37.67 16.01 49.64 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 2 2 # 2 S 19 THR A 5 THR~? 15.55 O1 BME A 300 L 23 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 39.82 19.80 46.49 40.70 18.87 48.29 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 39.80 15.56 49.54 37.67 16.01 49.64 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 3 2 # 3 S 19 THR A 6 THR~? 12.27 O1 BME A 300 L 23 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 39.82 19.80 46.49 40.70 18.87 48.29 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 39.80 15.56 49.54 37.67 16.01 49.64 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 4 2 # 4 S 19 THR A 6 THR~? 12.27 O1 BME A 300 L 23 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 39.82 19.80 46.49 40.70 18.87 48.29 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 39.80 15.56 49.54 37.67 16.01 49.64 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 5 2 # 5 S 19 THR A 26 THR~? 9.55 S2 BME A 300 L 23 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 39.82 19.80 46.49 40.70 18.87 48.29 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 39.80 15.56 49.54 37.67 16.01 49.64 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 6 2 # 6 S 19 THR A 26 THR~? 9.55 S2 BME A 300 L 23 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 39.82 19.80 46.49 40.70 18.87 48.29 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 39.80 15.56 49.54 37.67 16.01 49.64 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cc1_c00 HYDROGENASE (LARGE SUBUNIT) user 7 2 # 7 S 19 THR A 30 THR~? 11.99 S2 BME A 300 L 23 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 39.82 19.80 46.49 40.70 18.87 48.29 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 39.80 15.56 49.54 37.67 16.01 49.64 15.50 -15.19 4.21 14.37 -14.08 5.62 1cc1_c00 source 1cc1 HYDROGENASE (LARGE SUBUNIT) : 7 hits 1cc1_c00 naa= 2 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 2 # 1 229 ASP A 7 ASP~? 16.68 O1 BME A 300 257 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 48.97 85.16 40.39 47.18 86.25 40.47 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 2 # 2 229 ASP A 27 ASP~? 15.09 S2 BME A 300 257 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 48.97 85.16 40.39 47.18 86.25 40.47 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 2 # 3 229 ASP A 27 ASP~? 15.09 S2 BME A 300 257 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 48.97 85.16 40.39 47.18 86.25 40.47 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 2 # 4 229 ASP A 82 ASP^? 20.57 S2 BME A 300 257 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.12 9.33 8.59 8.15 9.51 7.94 coo 48.97 85.16 40.39 47.18 86.25 40.47 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 2 # 5 229 ASP A 82 ASP^? 20.57 S2 BME A 300 257 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.12 9.33 8.59 8.15 9.51 7.94 coo 48.97 85.16 40.39 47.18 86.25 40.47 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1cdg_c02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 2 # 6 229 ASP A 95 ASP.? 15.99 O1 BME A 300 257 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 48.97 85.16 40.39 47.18 86.25 40.47 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1cdg_c02 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c02 naa= 2 ULMN 2 1cev_c00 ARGINASE user 1 2 # 1 A 126 ASP A 7 ASP~? 16.68 O1 BME A 300 A 271 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cev_c00 ARGINASE user 2 2 # 2 A 126 ASP A 23 ASP^? 9.45 S2 BME A 300 A 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c00 ARGINASE user 3 2 # 3 A 126 ASP A 27 ASP~? 15.09 S2 BME A 300 A 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c00 ARGINASE user 4 2 # 4 A 126 ASP A 82 ASP^? 20.57 S2 BME A 300 A 271 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 10.12 9.33 8.59 8.15 9.51 7.94 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1cev_c00 ARGINASE user 5 2 # 5 A 126 ASP A 82 ASP^? 20.57 S2 BME A 300 A 271 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 10.12 9.33 8.59 8.15 9.51 7.94 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 7.63 5.18 13.95 5.55 5.01 14.48 1cev_c00 source 1cev ARGINASE : 5 hits 1cev_c00 naa= 2 ULMN 2 1cev_c01 ARGINASE user 1 2 # 1 B 126 ASP A 7 ASP~? 16.68 O1 BME A 300 B 271 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 88.66 4.10 42.84 87.11 4.00 41.44 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 82.56 6.85 36.70 83.82 5.71 35.47 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cev_c01 ARGINASE user 2 2 # 2 B 126 ASP A 23 ASP^? 9.45 S2 BME A 300 B 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 88.66 4.10 42.84 87.11 4.00 41.44 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 82.56 6.85 36.70 83.82 5.71 35.47 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c01 ARGINASE user 3 2 # 3 B 126 ASP A 27 ASP~? 15.09 S2 BME A 300 B 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 88.66 4.10 42.84 87.11 4.00 41.44 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 82.56 6.85 36.70 83.82 5.71 35.47 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c01 ARGINASE user 4 2 # 4 B 126 ASP A 82 ASP^? 20.57 S2 BME A 300 B 271 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 88.66 4.10 42.84 87.11 4.00 41.44 10.12 9.33 8.59 8.15 9.51 7.94 coo 82.56 6.85 36.70 83.82 5.71 35.47 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1cev_c01 ARGINASE user 5 2 # 5 B 126 ASP A 82 ASP^? 20.57 S2 BME A 300 B 271 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 88.66 4.10 42.84 87.11 4.00 41.44 10.12 9.33 8.59 8.15 9.51 7.94 coo 82.56 6.85 36.70 83.82 5.71 35.47 7.63 5.18 13.95 5.55 5.01 14.48 1cev_c01 source 1cev ARGINASE : 5 hits 1cev_c01 naa= 2 ULMN 2 1cev_c02 ARGINASE user 1 2 # 1 C 126 ASP A 7 ASP~? 16.68 O1 BME A 300 C 271 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 45.89 16.49 45.35 46.56 15.26 43.82 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 45.78 10.17 38.80 46.02 11.92 37.61 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cev_c02 ARGINASE user 2 2 # 2 C 126 ASP A 23 ASP^? 9.45 S2 BME A 300 C 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 45.89 16.49 45.35 46.56 15.26 43.82 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 45.78 10.17 38.80 46.02 11.92 37.61 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c02 ARGINASE user 3 2 # 3 C 126 ASP A 27 ASP~? 15.09 S2 BME A 300 C 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 45.89 16.49 45.35 46.56 15.26 43.82 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 45.78 10.17 38.80 46.02 11.92 37.61 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c02 ARGINASE user 4 2 # 4 C 126 ASP A 82 ASP^? 20.57 S2 BME A 300 C 271 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 45.89 16.49 45.35 46.56 15.26 43.82 10.12 9.33 8.59 8.15 9.51 7.94 coo 45.78 10.17 38.80 46.02 11.92 37.61 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1cev_c02 ARGINASE user 5 2 # 5 C 126 ASP A 82 ASP^? 20.57 S2 BME A 300 C 271 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 45.89 16.49 45.35 46.56 15.26 43.82 10.12 9.33 8.59 8.15 9.51 7.94 coo 45.78 10.17 38.80 46.02 11.92 37.61 7.63 5.18 13.95 5.55 5.01 14.48 1cev_c02 source 1cev ARGINASE : 5 hits 1cev_c02 naa= 2 ULMN 2 1cev_c03 ARGINASE user 1 2 # 1 D 126 ASP A 7 ASP~? 16.68 O1 BME A 300 D 271 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cev_c03 ARGINASE user 2 2 # 2 D 126 ASP A 23 ASP^? 9.45 S2 BME A 300 D 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c03 ARGINASE user 3 2 # 3 D 126 ASP A 27 ASP~? 15.09 S2 BME A 300 D 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c03 ARGINASE user 4 2 # 4 D 126 ASP A 82 ASP^? 20.57 S2 BME A 300 D 271 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 10.12 9.33 8.59 8.15 9.51 7.94 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1cev_c03 ARGINASE user 5 2 # 5 D 126 ASP A 82 ASP^? 20.57 S2 BME A 300 D 271 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 10.12 9.33 8.59 8.15 9.51 7.94 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 7.63 5.18 13.95 5.55 5.01 14.48 1cev_c03 source 1cev ARGINASE : 5 hits 1cev_c03 naa= 2 ULMN 2 1cev_c04 ARGINASE user 1 2 # 1 E 126 ASP A 7 ASP~? 16.68 O1 BME A 300 E 271 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 45.56 20.87 83.32 46.70 20.05 84.89 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 51.57 20.36 90.15 49.76 20.10 91.22 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cev_c04 ARGINASE user 2 2 # 2 E 126 ASP A 23 ASP^? 9.45 S2 BME A 300 E 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 45.56 20.87 83.32 46.70 20.05 84.89 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 51.57 20.36 90.15 49.76 20.10 91.22 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c04 ARGINASE user 3 2 # 3 E 126 ASP A 27 ASP~? 15.09 S2 BME A 300 E 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 45.56 20.87 83.32 46.70 20.05 84.89 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 51.57 20.36 90.15 49.76 20.10 91.22 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c04 ARGINASE user 4 2 # 4 E 126 ASP A 82 ASP^? 20.57 S2 BME A 300 E 271 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 45.56 20.87 83.32 46.70 20.05 84.89 10.12 9.33 8.59 8.15 9.51 7.94 coo 51.57 20.36 90.15 49.76 20.10 91.22 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1cev_c04 ARGINASE user 5 2 # 5 E 126 ASP A 82 ASP^? 20.57 S2 BME A 300 E 271 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 45.56 20.87 83.32 46.70 20.05 84.89 10.12 9.33 8.59 8.15 9.51 7.94 coo 51.57 20.36 90.15 49.76 20.10 91.22 7.63 5.18 13.95 5.55 5.01 14.48 1cev_c04 source 1cev ARGINASE : 5 hits 1cev_c04 naa= 2 ULMN 2 1cev_c05 ARGINASE user 1 2 # 1 F 126 ASP A 7 ASP~? 16.68 O1 BME A 300 F 271 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 88.43 8.76 85.43 87.07 8.09 86.86 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 84.65 3.46 91.79 85.25 5.11 93.00 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cev_c05 ARGINASE user 2 2 # 2 F 126 ASP A 23 ASP^? 9.45 S2 BME A 300 F 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 88.43 8.76 85.43 87.07 8.09 86.86 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 84.65 3.46 91.79 85.25 5.11 93.00 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c05 ARGINASE user 3 2 # 3 F 126 ASP A 27 ASP~? 15.09 S2 BME A 300 F 271 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 88.43 8.76 85.43 87.07 8.09 86.86 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 84.65 3.46 91.79 85.25 5.11 93.00 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cev_c05 ARGINASE user 4 2 # 4 F 126 ASP A 82 ASP^? 20.57 S2 BME A 300 F 271 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 88.43 8.76 85.43 87.07 8.09 86.86 10.12 9.33 8.59 8.15 9.51 7.94 coo 84.65 3.46 91.79 85.25 5.11 93.00 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1cev_c05 ARGINASE user 5 2 # 5 F 126 ASP A 82 ASP^? 20.57 S2 BME A 300 F 271 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 88.43 8.76 85.43 87.07 8.09 86.86 10.12 9.33 8.59 8.15 9.51 7.94 coo 84.65 3.46 91.79 85.25 5.11 93.00 7.63 5.18 13.95 5.55 5.01 14.48 1cev_c05 source 1cev ARGINASE : 5 hits 1cev_c05 naa= 2 ULMN 2 1chk_c00 CHITOSANASE user 1 2 # 1 B 22 GLU A 15 GLU~? 24.22 S2 BME A 300 B 40 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1chk_c00 CHITOSANASE user 2 2 # 2 B 22 GLU A 28 GLU~? 14.38 S2 BME A 300 B 40 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1chk_c00 CHITOSANASE user 3 2 # 3 B 22 GLU A 28 GLU~? 14.38 S2 BME A 300 B 40 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1chk_c00 CHITOSANASE user 4 2 # 4 B 22 GLU A 74 GLU~? 13.09 S2 BME A 300 B 40 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1chk_c00 CHITOSANASE user 5 2 # 5 B 22 GLU A 74 GLU~? 13.09 S2 BME A 300 B 40 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1chk_c00 CHITOSANASE user 6 2 # 6 B 22 GLU A 87 GLU.? 12.12 O1 BME A 300 B 40 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1chk_c00 CHITOSANASE user 7 2 # 7 B 22 GLU A 96 GLU.? 20.00 O1 BME A 300 B 40 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1chk_c00 CHITOSANASE user 8 2 # 8 B 22 GLU A 99 GLU.? 20.82 S2 BME A 300 B 40 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1chk_c00 CHITOSANASE user 9 2 # 9 B 22 GLU A 99 GLU.? 20.82 S2 BME A 300 B 40 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 8.24 11.09 5.99 6.67 9.69 5.66 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1chk_c00 source 1chk CHITOSANASE : 9 hits 1chk_c00 naa= 2 ULMN 2 1chk_c01 CHITOSANASE user 1 2 # 1 A 22 GLU A 15 GLU~? 24.22 S2 BME A 300 A 40 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 57.72 22.56 24.95 56.25 21.01 24.85 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1chk_c01 CHITOSANASE user 2 2 # 2 A 22 GLU A 15 GLU~? 24.22 S2 BME A 300 A 40 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 57.72 22.56 24.95 56.25 21.01 24.85 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1chk_c01 CHITOSANASE user 3 2 # 3 A 22 GLU A 28 GLU~? 14.38 S2 BME A 300 A 40 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 57.72 22.56 24.95 56.25 21.01 24.85 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1chk_c01 CHITOSANASE user 4 2 # 4 A 22 GLU A 28 GLU~? 14.38 S2 BME A 300 A 40 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 57.72 22.56 24.95 56.25 21.01 24.85 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1chk_c01 CHITOSANASE user 5 2 # 5 A 22 GLU A 57 GLU.? 23.43 S2 BME A 300 A 40 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 16.30 10.78 3.24 16.87 9.97 1.36 coo 57.72 22.56 24.95 56.25 21.01 24.85 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1chk_c01 CHITOSANASE user 6 2 # 6 A 22 GLU A 74 GLU~? 13.09 S2 BME A 300 A 40 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 57.72 22.56 24.95 56.25 21.01 24.85 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1chk_c01 CHITOSANASE user 7 2 # 7 A 22 GLU A 74 GLU~? 13.09 S2 BME A 300 A 40 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 57.72 22.56 24.95 56.25 21.01 24.85 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1chk_c01 CHITOSANASE user 8 2 # 8 A 22 GLU A 87 GLU.? 12.12 O1 BME A 300 A 40 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 57.72 22.56 24.95 56.25 21.01 24.85 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1chk_c01 CHITOSANASE user 9 2 # 9 A 22 GLU A 96 GLU.? 20.00 O1 BME A 300 A 40 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 57.72 22.56 24.95 56.25 21.01 24.85 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1chk_c01 CHITOSANASE user 10 2 # 10 A 22 GLU A 96 GLU.? 20.00 O1 BME A 300 A 40 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 57.72 22.56 24.95 56.25 21.01 24.85 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1chk_c01 CHITOSANASE user 11 2 # 11 A 22 GLU A 99 GLU.? 20.82 S2 BME A 300 A 40 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 44.97 21.98 32.76 46.32 21.69 34.45 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 57.72 22.56 24.95 56.25 21.01 24.85 23.07 -12.79 5.06 23.81 -10.95 5.75 1chk_c01 source 1chk CHITOSANASE : 11 hits 1chk_c01 naa= 2 ULMN 2 1chm_c04 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 2 # 1 A 331 HIS A 91 HIS~? 7.63 O1 BME A 300 A 358 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 32.65 64.88 45.53 33.25 66.88 46.21 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 27.06 50.43 44.36 27.99 52.27 44.74 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1chm_c04 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 1 hits 1chm_c04 naa= 2 ULMN 2 1chm_c05 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 2 # 1 B 331 HIS A 91 HIS~? 7.63 O1 BME A 300 B 358 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 38.59 73.13 46.90 37.84 71.22 47.24 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 44.05 87.61 48.73 43.15 85.67 48.52 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1chm_c05 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 1 hits 1chm_c05 naa= 2 ULMN 2 1ck7_c00 GELATINASE A user 1 2 # 1 A 404 ALA A 70 ALA~? 8.30 S2 BME A 300 A 421 MET A 1 MET?? 11.79 S2 BME A 300 coo 51.38 82.26 144.01 50.56 83.14 143.08 6.63 -3.94 11.35 5.27 -4.56 11.61 coo 56.67 81.44 150.10 55.06 79.66 147.53 1.73 2.69 11.74 3.89 -0.91 11.26 ULMN 2 1ck7_c00 GELATINASE A user 2 2 # 2 A 404 ALA A 83 ALA^? 14.63 S2 BME A 300 A 421 MET A 1 MET?? 11.79 S2 BME A 300 coo 51.38 82.26 144.01 50.56 83.14 143.08 9.58 4.45 8.44 10.26 3.43 9.36 coo 56.67 81.44 150.10 55.06 79.66 147.53 1.73 2.69 11.74 3.89 -0.91 11.26 1ck7_c00 source 1ck7 GELATINASE A : 2 hits 1ck7_c00 naa= 2 ULMN 2 1cl1_c00 CYSTATHIONINE BETA-LYASE user 1 2 # 1 A 111 TYR A 34 TYR.? 16.37 S2 BME A 300 A 185 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -6.99 5.69 52.91 -8.09 7.69 51.31 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -0.22 4.86 55.08 -1.23 6.48 54.18 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1cl1_c00 CYSTATHIONINE BETA-LYASE user 2 2 # 2 A 111 TYR A 59 TYR^? 18.50 S2 BME A 300 A 185 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -6.99 5.69 52.91 -8.09 7.69 51.31 14.59 5.14 5.72 16.82 6.86 5.68 coo -0.22 4.86 55.08 -1.23 6.48 54.18 10.12 9.33 8.59 8.15 9.51 7.94 1cl1_c00 source 1cl1 CYSTATHIONINE BETA-LYASE : 2 hits 1cl1_c00 naa= 2 ULMN 2 1cl1_c02 CYSTATHIONINE BETA-LYASE user 1 2 # 1 B 111 TYR A 34 TYR.? 16.37 S2 BME A 300 B 185 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -8.78 52.08 24.38 -9.63 50.05 26.11 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -2.31 52.89 21.38 -3.20 51.27 22.38 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1cl1_c02 CYSTATHIONINE BETA-LYASE user 2 2 # 2 B 111 TYR A 59 TYR^? 18.50 S2 BME A 300 B 185 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -8.78 52.08 24.38 -9.63 50.05 26.11 14.59 5.14 5.72 16.82 6.86 5.68 coo -2.31 52.89 21.38 -3.20 51.27 22.38 10.12 9.33 8.59 8.15 9.51 7.94 1cl1_c02 source 1cl1 CYSTATHIONINE BETA-LYASE : 2 hits 1cl1_c02 naa= 2 ULMN 2 1cqg_c00 REF-1 PEPTIDE user 1 2 # 1 A 32 CYH A 63 CYH.? -3.36 S2 BME A 300s A 35 ALA A 64 ALA.? -4.27 S2 BME A 300s coo 10.88 10.50 2.65 10.80 11.19 -0.01 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 5.86 10.20 0.80 6.89 9.09 0.56 9.64 -11.83 3.81 9.95 -13.24 4.40 1cqg_c00 source 1cqg REF-1 PEPTIDE : 1 hits 1cqg_c00 naa= 2 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 A 87 PHE A 53 PHE~? 16.58 S2 BME A 300 A 173 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 17.25 11.19 35.89 19.13 13.25 35.57 17.96 4.29 9.15 17.54 1.52 8.86 coo 24.35 4.55 25.11 25.94 3.23 25.53 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1cs1_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 A 87 PHE A 53 PHE~? 16.58 S2 BME A 300 A 173 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 17.25 11.19 35.89 19.13 13.25 35.57 17.96 4.29 9.15 17.54 1.52 8.86 coo 24.35 4.55 25.11 25.94 3.23 25.53 19.36 -9.90 14.44 17.51 -11.01 14.77 1cs1_c04 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c04 naa= 2 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 B 87 PHE A 53 PHE~? 16.58 S2 BME A 300 B 173 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 84.13 3.94 45.72 82.40 5.78 46.90 17.96 4.29 9.15 17.54 1.52 8.86 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1cs1_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 B 87 PHE A 53 PHE~? 16.58 S2 BME A 300 B 173 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 84.13 3.94 45.72 82.40 5.78 46.90 17.96 4.29 9.15 17.54 1.52 8.86 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 19.36 -9.90 14.44 17.51 -11.01 14.77 1cs1_c05 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c05 naa= 2 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 C 87 PHE A 53 PHE~? 16.58 S2 BME A 300 C 173 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 17.96 4.29 9.15 17.54 1.52 8.86 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1cs1_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 C 87 PHE A 53 PHE~? 16.58 S2 BME A 300 C 173 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 17.96 4.29 9.15 17.54 1.52 8.86 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 19.36 -9.90 14.44 17.51 -11.01 14.77 1cs1_c06 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c06 naa= 2 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 D 87 PHE A 53 PHE~? 16.58 S2 BME A 300 D 173 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 17.96 4.29 9.15 17.54 1.52 8.86 coo 71.60 6.14 19.25 70.26 6.87 20.69 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1cs1_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 D 87 PHE A 53 PHE~? 16.58 S2 BME A 300 D 173 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 17.96 4.29 9.15 17.54 1.52 8.86 coo 71.60 6.14 19.25 70.26 6.87 20.69 19.36 -9.90 14.44 17.51 -11.01 14.77 1cs1_c07 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c07 naa= 2 ULMN 2 1ctn_c01 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 2 # 1 313 ASP A 7 ASP~? 16.68 O1 BME A 300 315 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 32.46 99.13 19.34 30.94 100.38 20.07 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 32.04 94.22 18.23 30.57 94.75 16.88 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1ctn_c01 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 2 # 2 313 ASP A 27 ASP~? 15.09 S2 BME A 300 315 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 32.46 99.13 19.34 30.94 100.38 20.07 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 32.04 94.22 18.23 30.57 94.75 16.88 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1ctn_c01 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 2 # 3 313 ASP A 95 ASP.? 15.99 O1 BME A 300 315 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 32.46 99.13 19.34 30.94 100.38 20.07 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 32.04 94.22 18.23 30.57 94.75 16.88 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1ctn_c01 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 3 hits 1ctn_c01 naa= 2 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 2 # 1 311 ASP A 7 ASP~? 16.68 O1 BME A 300 315 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 32.04 94.22 18.23 30.57 94.75 16.88 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 2 # 2 311 ASP A 23 ASP^? 9.45 S2 BME A 300 315 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 32.04 94.22 18.23 30.57 94.75 16.88 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 2 # 3 311 ASP A 23 ASP^? 9.45 S2 BME A 300 315 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 32.04 94.22 18.23 30.57 94.75 16.88 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 2 # 4 311 ASP A 44 ASP~? 11.03 S2 BME A 300 315 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 32.04 94.22 18.23 30.57 94.75 16.88 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 2 # 5 311 ASP A 44 ASP~? 11.03 S2 BME A 300 315 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 32.04 94.22 18.23 30.57 94.75 16.88 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 2 # 6 311 ASP A 82 ASP^? 20.57 S2 BME A 300 315 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 10.12 9.33 8.59 8.15 9.51 7.94 coo 32.04 94.22 18.23 30.57 94.75 16.88 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 2 # 7 311 ASP A 95 ASP.? 15.99 O1 BME A 300 315 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 32.04 94.22 18.23 30.57 94.75 16.88 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1ctn_c02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 2 # 8 311 ASP A 95 ASP.? 15.99 O1 BME A 300 315 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 31.76 104.69 22.47 30.78 102.79 22.26 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 32.04 94.22 18.23 30.57 94.75 16.88 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1ctn_c02 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 8 hits 1ctn_c02 naa= 2 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 1 2 # 1 A 192 GLU A 8 GLU~? 18.47 O1 BME A 300 A 292 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 29.26 36.42 59.28 31.05 37.29 58.52 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 34.58 32.58 59.98 33.75 33.73 58.43 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 2 2 # 2 A 192 GLU A 28 GLU~? 14.38 S2 BME A 300 A 292 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 29.26 36.42 59.28 31.05 37.29 58.52 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 34.58 32.58 59.98 33.75 33.73 58.43 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 3 2 # 3 A 192 GLU A 29 GLU~? 6.68 S2 BME A 300 A 292 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 29.26 36.42 59.28 31.05 37.29 58.52 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 34.58 32.58 59.98 33.75 33.73 58.43 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 4 2 # 4 A 192 GLU A 74 GLU~? 13.09 S2 BME A 300 A 292 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 29.26 36.42 59.28 31.05 37.29 58.52 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 34.58 32.58 59.98 33.75 33.73 58.43 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 5 2 # 5 A 192 GLU A 77 GLU~? 17.67 S2 BME A 300 A 292 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 29.26 36.42 59.28 31.05 37.29 58.52 7.63 5.18 13.95 5.55 5.01 14.48 coo 34.58 32.58 59.98 33.75 33.73 58.43 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1cz1_c01 EXO-B-(1,3)-GLUCANASE user 6 2 # 6 A 192 GLU A 87 GLU.? 12.12 O1 BME A 300 A 292 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 29.26 36.42 59.28 31.05 37.29 58.52 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 34.58 32.58 59.98 33.75 33.73 58.43 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1cz1_c01 source 1cz1 EXO-B-(1,3)-GLUCANASE : 6 hits 1cz1_c01 naa= 2 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 A 175 LYS A 2 LYS.? 20.18 S2 BME A 300 A 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 2.39 3.95 8.25 5.67 8.88 7.74 coo 26.11 16.88 17.98 23.54 16.14 17.25 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 A 175 LYS A 10 LYS~? 16.18 O1 BME A 300 A 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 26.11 16.88 17.98 23.54 16.14 17.25 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 3 2 # 3 A 175 LYS A 12 LYS~? 21.81 S2 BME A 300 A 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 26.11 16.88 17.98 23.54 16.14 17.25 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 4 2 # 4 A 175 LYS A 39 LYS^? 20.06 S2 BME A 300 A 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 19.85 -1.20 1.64 21.03 4.07 2.80 coo 26.11 16.88 17.98 23.54 16.14 17.25 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 5 2 # 5 A 175 LYS A 39 LYS^? 20.06 S2 BME A 300 A 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 19.85 -1.20 1.64 21.03 4.07 2.80 coo 26.11 16.88 17.98 23.54 16.14 17.25 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 6 2 # 6 A 175 LYS A 55 LYS.? 25.54 S2 BME A 300 A 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 15.98 12.20 9.88 16.28 11.97 16.11 coo 26.11 16.88 17.98 23.54 16.14 17.25 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 7 2 # 7 A 175 LYS A 71 LYS~? 8.54 S2 BME A 300 A 242 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 26.11 16.88 17.98 23.54 16.14 17.25 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1d2h_c00 GLYCINE N-METHYLTRANSFERASE user 8 2 # 8 A 175 LYS A 101 LYS.? -19.93 S2 BME A 300s A 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 23.70 20.51 24.87 21.77 17.06 21.36 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 26.11 16.88 17.98 23.54 16.14 17.25 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1d2h_c00 source 1d2h GLYCINE N-METHYLTRANSFERASE : 8 hits 1d2h_c00 naa= 2 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 B 175 LYS A 2 LYS.? 20.18 S2 BME A 300 B 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 2.39 3.95 8.25 5.67 8.88 7.74 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 B 175 LYS A 10 LYS~? 16.18 O1 BME A 300 B 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 3 2 # 3 B 175 LYS A 12 LYS~? 21.81 S2 BME A 300 B 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 4 2 # 4 B 175 LYS A 39 LYS^? 20.06 S2 BME A 300 B 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 19.85 -1.20 1.64 21.03 4.07 2.80 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 5 2 # 5 B 175 LYS A 39 LYS^? 20.06 S2 BME A 300 B 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 19.85 -1.20 1.64 21.03 4.07 2.80 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 6 2 # 6 B 175 LYS A 55 LYS.? 25.54 S2 BME A 300 B 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 15.98 12.20 9.88 16.28 11.97 16.11 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 7 2 # 7 B 175 LYS A 71 LYS~? 8.54 S2 BME A 300 B 242 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1d2h_c01 GLYCINE N-METHYLTRANSFERASE user 8 2 # 8 B 175 LYS A 101 LYS.? -19.93 S2 BME A 300s B 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 50.50 -2.72 26.10 51.99 -1.50 20.85 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 46.69 -1.22 18.53 48.92 -0.08 17.33 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1d2h_c01 source 1d2h GLYCINE N-METHYLTRANSFERASE : 8 hits 1d2h_c01 naa= 2 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 C 175 LYS A 2 LYS.? 20.18 S2 BME A 300 C 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 2.39 3.95 8.25 5.67 8.88 7.74 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 C 175 LYS A 10 LYS~? 16.18 O1 BME A 300 C 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 3 2 # 3 C 175 LYS A 12 LYS~? 21.81 S2 BME A 300 C 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 4 2 # 4 C 175 LYS A 39 LYS^? 20.06 S2 BME A 300 C 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 19.85 -1.20 1.64 21.03 4.07 2.80 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 5 2 # 5 C 175 LYS A 39 LYS^? 20.06 S2 BME A 300 C 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 19.85 -1.20 1.64 21.03 4.07 2.80 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 6 2 # 6 C 175 LYS A 55 LYS.? 25.54 S2 BME A 300 C 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 15.98 12.20 9.88 16.28 11.97 16.11 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 7 2 # 7 C 175 LYS A 71 LYS~? 8.54 S2 BME A 300 C 242 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1d2h_c02 GLYCINE N-METHYLTRANSFERASE user 8 2 # 8 C 175 LYS A 101 LYS.? -19.93 S2 BME A 300s C 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 16.58 10.43 -27.83 19.37 14.23 -25.91 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 20.83 9.05 -20.50 21.86 11.62 -20.51 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1d2h_c02 source 1d2h GLYCINE N-METHYLTRANSFERASE : 8 hits 1d2h_c02 naa= 2 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 D 175 LYS A 2 LYS.? 20.18 S2 BME A 300 D 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 2.39 3.95 8.25 5.67 8.88 7.74 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 D 175 LYS A 10 LYS~? 16.18 O1 BME A 300 D 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 3 2 # 3 D 175 LYS A 12 LYS~? 21.81 S2 BME A 300 D 242 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 4 2 # 4 D 175 LYS A 39 LYS^? 20.06 S2 BME A 300 D 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 19.85 -1.20 1.64 21.03 4.07 2.80 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 5 2 # 5 D 175 LYS A 39 LYS^? 20.06 S2 BME A 300 D 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 19.85 -1.20 1.64 21.03 4.07 2.80 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 6 2 # 6 D 175 LYS A 55 LYS.? 25.54 S2 BME A 300 D 242 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 15.98 12.20 9.88 16.28 11.97 16.11 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 7 2 # 7 D 175 LYS A 71 LYS~? 8.54 S2 BME A 300 D 242 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1d2h_c03 GLYCINE N-METHYLTRANSFERASE user 8 2 # 8 D 175 LYS A 101 LYS.? -19.93 S2 BME A 300s D 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1d2h_c03 source 1d2h GLYCINE N-METHYLTRANSFERASE : 8 hits 1d2h_c03 naa= 2 ULMN 2 1d2r_c00 TRYPTOPHANYL TRNA SYNTHETASE user 1 2 # 1 A 192 LYS A 12 LYS~? 21.81 S2 BME A 300 A 195 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 36.55 -11.14 59.08 36.44 -7.57 54.88 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 29.94 -4.97 55.49 34.63 -5.71 53.34 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1d2r_c00 TRYPTOPHANYL TRNA SYNTHETASE user 2 2 # 2 A 192 LYS A 17 LYS.? 25.68 S2 BME A 300 A 195 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 36.55 -11.14 59.08 36.44 -7.57 54.88 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 29.94 -4.97 55.49 34.63 -5.71 53.34 7.13 5.12 -6.84 5.25 7.73 -2.58 1d2r_c00 source 1d2r TRYPTOPHANYL TRNA SYNTHETASE : 2 hits 1d2r_c00 naa= 2 ULMN 2 1d2r_c01 TRYPTOPHANYL TRNA SYNTHETASE user 1 2 # 1 B 192 LYS A 12 LYS~? 21.81 S2 BME A 300 B 195 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 103.52 75.13 70.43 102.44 70.84 67.08 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 102.53 74.06 60.83 101.89 70.14 64.23 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1d2r_c01 TRYPTOPHANYL TRNA SYNTHETASE user 2 2 # 2 B 192 LYS A 17 LYS.? 25.68 S2 BME A 300 B 195 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 103.52 75.13 70.43 102.44 70.84 67.08 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 102.53 74.06 60.83 101.89 70.14 64.23 7.13 5.12 -6.84 5.25 7.73 -2.58 1d2r_c01 source 1d2r TRYPTOPHANYL TRNA SYNTHETASE : 2 hits 1d2r_c01 naa= 2 ULMN 2 1d2r_c02 TRYPTOPHANYL TRNA SYNTHETASE user 1 2 # 1 C 192 LYS A 12 LYS~? 21.81 S2 BME A 300 C 195 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 120.98 -3.63 9.59 115.75 -2.87 11.31 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 112.71 -8.66 8.74 112.96 -4.00 11.10 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1d2r_c02 TRYPTOPHANYL TRNA SYNTHETASE user 2 2 # 2 C 192 LYS A 17 LYS.? 25.68 S2 BME A 300 C 195 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 120.98 -3.63 9.59 115.75 -2.87 11.31 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 112.71 -8.66 8.74 112.96 -4.00 11.10 7.13 5.12 -6.84 5.25 7.73 -2.58 1d2r_c02 source 1d2r TRYPTOPHANYL TRNA SYNTHETASE : 2 hits 1d2r_c02 naa= 2 ULMN 2 1d2r_c03 TRYPTOPHANYL TRNA SYNTHETASE user 1 2 # 1 D 192 LYS A 12 LYS~? 21.81 S2 BME A 300 D 195 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 23.03 -10.82 -3.91 23.61 -7.28 0.26 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 30.16 -5.00 -0.79 25.57 -5.46 1.71 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1d2r_c03 TRYPTOPHANYL TRNA SYNTHETASE user 2 2 # 2 D 192 LYS A 17 LYS.? 25.68 S2 BME A 300 D 195 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 23.03 -10.82 -3.91 23.61 -7.28 0.26 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 30.16 -5.00 -0.79 25.57 -5.46 1.71 7.13 5.12 -6.84 5.25 7.73 -2.58 1d2r_c03 source 1d2r TRYPTOPHANYL TRNA SYNTHETASE : 2 hits 1d2r_c03 naa= 2 ULMN 2 1d2r_c04 TRYPTOPHANYL TRNA SYNTHETASE user 1 2 # 1 E 192 LYS A 12 LYS~? 21.81 S2 BME A 300 E 195 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 53.78 41.50 47.30 59.15 42.24 46.21 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 61.86 36.38 48.98 61.90 41.09 46.68 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1d2r_c04 TRYPTOPHANYL TRNA SYNTHETASE user 2 2 # 2 E 192 LYS A 17 LYS.? 25.68 S2 BME A 300 E 195 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 53.78 41.50 47.30 59.15 42.24 46.21 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 61.86 36.38 48.98 61.90 41.09 46.68 7.13 5.12 -6.84 5.25 7.73 -2.58 1d2r_c04 source 1d2r TRYPTOPHANYL TRNA SYNTHETASE : 2 hits 1d2r_c04 naa= 2 ULMN 2 1d2r_c05 TRYPTOPHANYL TRNA SYNTHETASE user 1 2 # 1 F 192 LYS A 12 LYS~? 21.81 S2 BME A 300 F 195 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 70.25 29.12 -8.70 71.47 24.97 -5.20 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 71.79 28.47 0.86 72.17 24.38 -2.36 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1d2r_c05 TRYPTOPHANYL TRNA SYNTHETASE user 2 2 # 2 F 192 LYS A 17 LYS.? 25.68 S2 BME A 300 F 195 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 70.25 29.12 -8.70 71.47 24.97 -5.20 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 71.79 28.47 0.86 72.17 24.38 -2.36 7.13 5.12 -6.84 5.25 7.73 -2.58 1d2r_c05 source 1d2r TRYPTOPHANYL TRNA SYNTHETASE : 2 hits 1d2r_c05 naa= 2 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 2 # 1 A 138 TRP A 93 TRP~? 14.44 S2 BME A 300 A 243 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 18.21 54.75 18.05 19.91 55.17 21.59 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 16.93 55.67 9.65 17.16 54.23 11.19 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 2 # 2 A 138 TRP A 93 TRP~? 14.44 S2 BME A 300 A 243 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 18.21 54.75 18.05 19.91 55.17 21.59 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 16.93 55.67 9.65 17.16 54.23 11.19 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1d7r_c00 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 2 # 3 A 138 TRP A 93 TRP~? 14.44 S2 BME A 300 A 243 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 18.21 54.75 18.05 19.91 55.17 21.59 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 16.93 55.67 9.65 17.16 54.23 11.19 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1d7r_c00 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 3 hits 1d7r_c00 naa= 2 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 1 2 # 1 A 164 LYS A 2 LYS.? 20.18 S2 BME A 300 B 300 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 2.39 3.95 8.25 5.67 8.88 7.74 coo 105.72 27.43 24.98 106.58 26.09 27.30 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 2 2 # 2 A 164 LYS A 10 LYS~? 16.18 O1 BME A 300 B 300 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 105.72 27.43 24.98 106.58 26.09 27.30 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 3 2 # 3 A 164 LYS A 10 LYS~? 16.18 O1 BME A 300 B 300 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 105.72 27.43 24.98 106.58 26.09 27.30 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 4 2 # 4 A 164 LYS A 12 LYS~? 21.81 S2 BME A 300 B 300 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 105.72 27.43 24.98 106.58 26.09 27.30 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 5 2 # 5 A 164 LYS A 12 LYS~? 21.81 S2 BME A 300 B 300 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 105.72 27.43 24.98 106.58 26.09 27.30 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 6 2 # 6 A 164 LYS A 39 LYS^? 20.06 S2 BME A 300 B 300 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 19.85 -1.20 1.64 21.03 4.07 2.80 coo 105.72 27.43 24.98 106.58 26.09 27.30 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 7 2 # 7 A 164 LYS A 55 LYS.? 25.54 S2 BME A 300 B 300 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 15.98 12.20 9.88 16.28 11.97 16.11 coo 105.72 27.43 24.98 106.58 26.09 27.30 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 8 2 # 8 A 164 LYS A 55 LYS.? 25.54 S2 BME A 300 B 300 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 15.98 12.20 9.88 16.28 11.97 16.11 coo 105.72 27.43 24.98 106.58 26.09 27.30 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 9 2 # 9 A 164 LYS A 71 LYS~? 8.54 S2 BME A 300 B 300 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 105.72 27.43 24.98 106.58 26.09 27.30 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1d8d_c00 FARNESYLTRANSFERASE (BETA SUBUNIT) user 10 2 # 10 A 164 LYS A 71 LYS~? 8.54 S2 BME A 300 B 300 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 108.75 18.12 37.36 108.87 18.77 31.55 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 105.72 27.43 24.98 106.58 26.09 27.30 9.00 3.02 1.57 7.75 5.45 1.00 1d8d_c00 source 1d8d FARNESYLTRANSFERASE (BETA SUBUNIT) : 10 hits 1d8d_c00 naa= 2 ULMN 2 1db3_c02 GDP-MANNOSE 4,6-DEHYDRATASE user 1 2 # 1 A 153 ARG A 25 ARG.? 9.68 S2 BME A 300 A 160 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 11.64 53.62 31.80 11.17 52.00 34.34 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 5.78 61.30 21.65 8.04 62.89 17.54 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1db3_c02 GDP-MANNOSE 4,6-DEHYDRATASE user 2 2 # 2 A 153 ARG A 25 ARG.? 9.68 S2 BME A 300 A 160 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 11.64 53.62 31.80 11.17 52.00 34.34 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 5.78 61.30 21.65 8.04 62.89 17.54 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1db3_c02 GDP-MANNOSE 4,6-DEHYDRATASE user 3 2 # 3 A 153 ARG A 68 ARG~? -4.35 S2 BME A 300s A 160 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 11.64 53.62 31.80 11.17 52.00 34.34 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 5.78 61.30 21.65 8.04 62.89 17.54 19.85 -1.20 1.64 21.03 4.07 2.80 1db3_c02 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 3 hits 1db3_c02 naa= 2 ULMN 2 1db3_c03 GDP-MANNOSE 4,6-DEHYDRATASE user 1 2 # 1 A 156 TYR A 34 TYR.? 16.37 S2 BME A 300 A 160 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 11.64 63.07 23.95 11.76 62.47 21.20 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 5.78 61.30 21.65 8.04 62.89 17.54 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1db3_c03 GDP-MANNOSE 4,6-DEHYDRATASE user 2 2 # 2 A 156 TYR A 34 TYR.? 16.37 S2 BME A 300 A 160 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 11.64 63.07 23.95 11.76 62.47 21.20 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 5.78 61.30 21.65 8.04 62.89 17.54 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1db3_c03 GDP-MANNOSE 4,6-DEHYDRATASE user 3 2 # 3 A 156 TYR A 59 TYR^? 18.50 S2 BME A 300 A 160 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 11.64 63.07 23.95 11.76 62.47 21.20 14.59 5.14 5.72 16.82 6.86 5.68 coo 5.78 61.30 21.65 8.04 62.89 17.54 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1db3_c03 GDP-MANNOSE 4,6-DEHYDRATASE user 4 2 # 4 A 156 TYR A 75 TYR~? 15.90 S2 BME A 300 A 160 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 11.64 63.07 23.95 11.76 62.47 21.20 14.46 -0.26 16.60 17.11 0.41 17.22 coo 5.78 61.30 21.65 8.04 62.89 17.54 8.82 -4.39 14.42 10.42 -10.04 16.23 1db3_c03 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 4 hits 1db3_c03 naa= 2 ULMN 2 1dbt_c00 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 2 # 1 B 60 ASP A 7 ASP~? 16.68 O1 BME A 300 B 62 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 58.78 69.55 10.14 57.19 68.14 10.07 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 57.51 66.37 15.65 56.43 65.69 10.35 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1dbt_c00 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 2 # 2 B 60 ASP A 23 ASP^? 9.45 S2 BME A 300 B 62 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 58.78 69.55 10.14 57.19 68.14 10.07 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 57.51 66.37 15.65 56.43 65.69 10.35 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1dbt_c00 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 3 2 # 3 B 60 ASP A 82 ASP^? 20.57 S2 BME A 300 B 62 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 58.78 69.55 10.14 57.19 68.14 10.07 10.12 9.33 8.59 8.15 9.51 7.94 coo 57.51 66.37 15.65 56.43 65.69 10.35 15.98 12.20 9.88 16.28 11.97 16.11 1dbt_c00 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 3 hits 1dbt_c00 naa= 2 ULMN 2 1dbt_c01 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 2 # 1 C 60 ASP A 7 ASP~? 16.68 O1 BME A 300 C 62 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 46.15 51.25 57.34 45.59 51.66 59.34 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 43.68 46.22 60.72 43.55 51.70 60.99 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1dbt_c01 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 2 # 2 C 60 ASP A 23 ASP^? 9.45 S2 BME A 300 C 62 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 46.15 51.25 57.34 45.59 51.66 59.34 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 43.68 46.22 60.72 43.55 51.70 60.99 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1dbt_c01 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 3 2 # 3 C 60 ASP A 82 ASP^? 20.57 S2 BME A 300 C 62 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 46.15 51.25 57.34 45.59 51.66 59.34 10.12 9.33 8.59 8.15 9.51 7.94 coo 43.68 46.22 60.72 43.55 51.70 60.99 15.98 12.20 9.88 16.28 11.97 16.11 1dbt_c01 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 3 hits 1dbt_c01 naa= 2 ULMN 2 1dbt_c05 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 2 # 1 A 60 ASP A 7 ASP~? 16.68 O1 BME A 300 A 62 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 66.44 58.31 23.16 64.45 58.00 23.81 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 61.71 58.67 18.68 62.06 59.06 24.07 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1dbt_c05 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 2 # 2 A 60 ASP A 23 ASP^? 9.45 S2 BME A 300 A 62 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 66.44 58.31 23.16 64.45 58.00 23.81 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 61.71 58.67 18.68 62.06 59.06 24.07 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1dbt_c05 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 3 2 # 3 A 60 ASP A 82 ASP^? 20.57 S2 BME A 300 A 62 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 66.44 58.31 23.16 64.45 58.00 23.81 10.12 9.33 8.59 8.15 9.51 7.94 coo 61.71 58.67 18.68 62.06 59.06 24.07 15.98 12.20 9.88 16.28 11.97 16.11 1dbt_c05 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 3 hits 1dbt_c05 naa= 2 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 1 2 # 1 A 196 GLU A 28 GLU~? 14.38 S2 BME A 300 A 204 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 91.55 34.15 2.80 89.93 32.93 2.11 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 2 2 # 2 A 196 GLU A 29 GLU~? 6.68 S2 BME A 300 A 204 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 91.55 34.15 2.80 89.93 32.93 2.11 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 3 2 # 3 A 196 GLU A 57 GLU.? 23.43 S2 BME A 300 A 204 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 16.30 10.78 3.24 16.87 9.97 1.36 coo 91.55 34.15 2.80 89.93 32.93 2.11 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 4 2 # 4 A 196 GLU A 77 GLU~? 17.67 S2 BME A 300 A 204 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 7.63 5.18 13.95 5.55 5.01 14.48 coo 91.55 34.15 2.80 89.93 32.93 2.11 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1dci_c00 DIENOYL-COA ISOMERASE user 5 2 # 5 A 196 GLU A 96 GLU.? 20.00 O1 BME A 300 A 204 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 91.55 34.15 2.80 89.93 32.93 2.11 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1dci_c00 source 1dci DIENOYL-COA ISOMERASE : 5 hits 1dci_c00 naa= 2 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 1 2 # 1 B 196 GLU A 28 GLU~? 14.38 S2 BME A 300 B 204 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 117.17 62.16 2.87 115.86 61.14 1.55 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 114.89 59.78 9.34 114.72 61.90 9.19 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 2 2 # 2 B 196 GLU A 29 GLU~? 6.68 S2 BME A 300 B 204 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 117.17 62.16 2.87 115.86 61.14 1.55 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 114.89 59.78 9.34 114.72 61.90 9.19 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 3 2 # 3 B 196 GLU A 57 GLU.? 23.43 S2 BME A 300 B 204 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 117.17 62.16 2.87 115.86 61.14 1.55 16.30 10.78 3.24 16.87 9.97 1.36 coo 114.89 59.78 9.34 114.72 61.90 9.19 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 4 2 # 4 B 196 GLU A 77 GLU~? 17.67 S2 BME A 300 B 204 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 117.17 62.16 2.87 115.86 61.14 1.55 7.63 5.18 13.95 5.55 5.01 14.48 coo 114.89 59.78 9.34 114.72 61.90 9.19 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1dci_c01 DIENOYL-COA ISOMERASE user 5 2 # 5 B 196 GLU A 96 GLU.? 20.00 O1 BME A 300 B 204 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 117.17 62.16 2.87 115.86 61.14 1.55 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 114.89 59.78 9.34 114.72 61.90 9.19 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1dci_c01 source 1dci DIENOYL-COA ISOMERASE : 5 hits 1dci_c01 naa= 2 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 1 2 # 1 C 196 GLU A 28 GLU~? 14.38 S2 BME A 300 C 204 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 127.57 24.91 0.86 127.56 26.90 0.05 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 125.57 26.17 7.79 127.49 25.34 7.72 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 2 2 # 2 C 196 GLU A 29 GLU~? 6.68 S2 BME A 300 C 204 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 127.57 24.91 0.86 127.56 26.90 0.05 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 125.57 26.17 7.79 127.49 25.34 7.72 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 3 2 # 3 C 196 GLU A 57 GLU.? 23.43 S2 BME A 300 C 204 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 127.57 24.91 0.86 127.56 26.90 0.05 16.30 10.78 3.24 16.87 9.97 1.36 coo 125.57 26.17 7.79 127.49 25.34 7.72 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 4 2 # 4 C 196 GLU A 77 GLU~? 17.67 S2 BME A 300 C 204 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 127.57 24.91 0.86 127.56 26.90 0.05 7.63 5.18 13.95 5.55 5.01 14.48 coo 125.57 26.17 7.79 127.49 25.34 7.72 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1dci_c02 DIENOYL-COA ISOMERASE user 5 2 # 5 C 196 GLU A 96 GLU.? 20.00 O1 BME A 300 C 204 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 127.57 24.91 0.86 127.56 26.90 0.05 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 125.57 26.17 7.79 127.49 25.34 7.72 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1dci_c02 source 1dci DIENOYL-COA ISOMERASE : 5 hits 1dci_c02 naa= 2 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 1 2 # 1 A 176 ASP A 7 ASP~? 16.68 O1 BME A 300 A 196 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 2 2 # 2 A 176 ASP A 27 ASP~? 15.09 S2 BME A 300 A 196 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 3 2 # 3 A 176 ASP A 27 ASP~? 15.09 S2 BME A 300 A 196 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 4 2 # 4 A 176 ASP A 82 ASP^? 20.57 S2 BME A 300 A 196 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 10.12 9.33 8.59 8.15 9.51 7.94 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 5 2 # 5 A 176 ASP A 82 ASP^? 20.57 S2 BME A 300 A 196 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 10.12 9.33 8.59 8.15 9.51 7.94 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1dci_c03 DIENOYL-COA ISOMERASE user 6 2 # 6 A 176 ASP A 95 ASP.? 15.99 O1 BME A 300 A 196 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1dci_c03 source 1dci DIENOYL-COA ISOMERASE : 6 hits 1dci_c03 naa= 2 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 1 2 # 1 B 176 ASP A 7 ASP~? 16.68 O1 BME A 300 B 196 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 110.25 59.26 2.17 112.32 59.63 2.53 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 117.17 62.16 2.87 115.86 61.14 1.55 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 2 2 # 2 B 176 ASP A 27 ASP~? 15.09 S2 BME A 300 B 196 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 110.25 59.26 2.17 112.32 59.63 2.53 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 117.17 62.16 2.87 115.86 61.14 1.55 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 3 2 # 3 B 176 ASP A 82 ASP^? 20.57 S2 BME A 300 B 196 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 110.25 59.26 2.17 112.32 59.63 2.53 10.12 9.33 8.59 8.15 9.51 7.94 coo 117.17 62.16 2.87 115.86 61.14 1.55 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 4 2 # 4 B 176 ASP A 82 ASP^? 20.57 S2 BME A 300 B 196 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 110.25 59.26 2.17 112.32 59.63 2.53 10.12 9.33 8.59 8.15 9.51 7.94 coo 117.17 62.16 2.87 115.86 61.14 1.55 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1dci_c04 DIENOYL-COA ISOMERASE user 5 2 # 5 B 176 ASP A 95 ASP.? 15.99 O1 BME A 300 B 196 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 110.25 59.26 2.17 112.32 59.63 2.53 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 117.17 62.16 2.87 115.86 61.14 1.55 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1dci_c04 source 1dci DIENOYL-COA ISOMERASE : 5 hits 1dci_c04 naa= 2 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 1 2 # 1 C 176 ASP A 7 ASP~? 16.68 O1 BME A 300 C 196 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 128.37 32.38 2.45 127.70 30.37 2.17 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 127.57 24.91 0.86 127.56 26.90 0.05 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 2 2 # 2 C 176 ASP A 23 ASP^? 9.45 S2 BME A 300 C 196 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 128.37 32.38 2.45 127.70 30.37 2.17 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 127.57 24.91 0.86 127.56 26.90 0.05 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 3 2 # 3 C 176 ASP A 27 ASP~? 15.09 S2 BME A 300 C 196 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 128.37 32.38 2.45 127.70 30.37 2.17 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 127.57 24.91 0.86 127.56 26.90 0.05 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 4 2 # 4 C 176 ASP A 82 ASP^? 20.57 S2 BME A 300 C 196 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 128.37 32.38 2.45 127.70 30.37 2.17 10.12 9.33 8.59 8.15 9.51 7.94 coo 127.57 24.91 0.86 127.56 26.90 0.05 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1dci_c05 DIENOYL-COA ISOMERASE user 5 2 # 5 C 176 ASP A 82 ASP^? 20.57 S2 BME A 300 C 196 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 128.37 32.38 2.45 127.70 30.37 2.17 10.12 9.33 8.59 8.15 9.51 7.94 coo 127.57 24.91 0.86 127.56 26.90 0.05 7.63 5.18 13.95 5.55 5.01 14.48 1dci_c05 source 1dci DIENOYL-COA ISOMERASE : 5 hits 1dci_c05 naa= 2 ULMN 2 1dek_c00 DEOXYNUCLEOSIDE MONOPHOSPHATE KINASEuser 1 2 # 1 A 68 ARG A 68 ARG~? -4.35 S2 BME A 300s A 206 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 43.62 6.34 2.39 44.53 4.47 4.58 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 54.10 -0.86 -3.09 55.51 0.68 -2.87 3.84 -13.89 0.30 2.26 -15.26 0.08 1dek_c00 source 1dek DEOXYNUCLEOSIDE MONOPHOSPHATE KINASE : 1 hits 1dek_c00 naa= 2 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 1 2 # 1 A 22 LEU A 9 LEU~? 15.34 S2 BME A 300 A 30 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 30.17 24.15 15.83 30.23 26.01 16.90 6.39 0.21 -2.66 8.38 0.58 -1.75 coo 32.29 33.65 17.58 30.85 33.19 19.08 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 2 2 # 2 A 22 LEU A 9 LEU~? 15.34 S2 BME A 300 A 30 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 30.17 24.15 15.83 30.23 26.01 16.90 6.39 0.21 -2.66 8.38 0.58 -1.75 coo 32.29 33.65 17.58 30.85 33.19 19.08 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 3 2 # 3 A 22 LEU A 40 LEU^? 14.51 S2 BME A 300 A 30 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 30.17 24.15 15.83 30.23 26.01 16.90 21.19 -5.80 2.30 20.52 -6.59 0.34 coo 32.29 33.65 17.58 30.85 33.19 19.08 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 4 2 # 4 A 22 LEU A 40 LEU^? 14.51 S2 BME A 300 A 30 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 30.17 24.15 15.83 30.23 26.01 16.90 21.19 -5.80 2.30 20.52 -6.59 0.34 coo 32.29 33.65 17.58 30.85 33.19 19.08 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1dhf_c00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 5 2 # 5 A 22 LEU A 76 LEU~? 15.04 S2 BME A 300 A 30 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 30.17 24.15 15.83 30.23 26.01 16.90 13.01 3.14 12.38 14.61 2.09 11.22 coo 32.29 33.65 17.58 30.85 33.19 19.08 6.36 -0.87 15.92 5.32 -2.36 17.02 1dhf_c00 source 1dhf DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) ( DHFR ): 5 hits 1dhf_c00 naa= 2 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 1 2 # 1 B 22 LEU A 9 LEU~? 15.34 S2 BME A 300 B 30 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 3.16 26.59 72.60 5.24 26.56 72.94 6.39 0.21 -2.66 8.38 0.58 -1.75 coo 10.81 21.08 75.40 10.64 21.05 73.28 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 2 2 # 2 B 22 LEU A 9 LEU~? 15.34 S2 BME A 300 B 30 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 3.16 26.59 72.60 5.24 26.56 72.94 6.39 0.21 -2.66 8.38 0.58 -1.75 coo 10.81 21.08 75.40 10.64 21.05 73.28 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 3 2 # 3 B 22 LEU A 40 LEU^? 14.51 S2 BME A 300 B 30 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 3.16 26.59 72.60 5.24 26.56 72.94 21.19 -5.80 2.30 20.52 -6.59 0.34 coo 10.81 21.08 75.40 10.64 21.05 73.28 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 4 2 # 4 B 22 LEU A 40 LEU^? 14.51 S2 BME A 300 B 30 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 3.16 26.59 72.60 5.24 26.56 72.94 21.19 -5.80 2.30 20.52 -6.59 0.34 coo 10.81 21.08 75.40 10.64 21.05 73.28 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 5 2 # 5 B 22 LEU A 76 LEU~? 15.04 S2 BME A 300 B 30 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 3.16 26.59 72.60 5.24 26.56 72.94 13.01 3.14 12.38 14.61 2.09 11.22 coo 10.81 21.08 75.40 10.64 21.05 73.28 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1dhf_c01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 6 2 # 6 B 22 LEU A 98 LEU.? 15.58 S2 BME A 300 B 30 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 3.16 26.59 72.60 5.24 26.56 72.94 14.96 -9.92 -7.39 13.27 -9.83 -6.06 coo 10.81 21.08 75.40 10.64 21.05 73.28 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1dhf_c01 source 1dhf DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) ( DHFR ): 6 hits 1dhf_c01 naa= 2 ULMN 2 1dhr_c01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 2 # 1 143 MET A 1 MET?? 11.79 S2 BME A 300 150 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 37.65 50.92 20.81 37.17 52.95 24.29 1.73 2.69 11.74 3.89 -0.91 11.26 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1dhr_c01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 2 # 2 143 MET A 32 MET?? 16.29 S2 BME A 300 150 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 37.65 50.92 20.81 37.17 52.95 24.29 18.33 -15.35 -3.27 19.07 -18.39 -2.47 coo 27.04 52.42 22.30 26.88 49.99 27.00 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1dhr_c01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 2 # 3 143 MET A 43 MET?? 7.50 S2 BME A 300 150 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 37.65 50.92 20.81 37.17 52.95 24.29 16.84 -7.02 11.44 13.26 -8.32 13.33 coo 27.04 52.42 22.30 26.88 49.99 27.00 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1dhr_c01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 2 # 4 143 MET A 43 MET?? 7.50 S2 BME A 300 150 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 37.65 50.92 20.81 37.17 52.95 24.29 16.84 -7.02 11.44 13.26 -8.32 13.33 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1dhr_c01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 2 # 5 143 MET A 90 MET?? 10.03 S2 BME A 300 150 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 37.65 50.92 20.81 37.17 52.95 24.29 8.61 -9.96 -0.54 11.23 -8.07 -1.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 6.34 -0.11 -7.21 5.79 -6.41 -7.72 1dhr_c01 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 5 hits 1dhr_c01 naa= 2 ULMN 2 1dhr_c02 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 2 # 1 146 TYR A 34 TYR.? 16.37 S2 BME A 300 150 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 32.88 50.55 24.33 31.89 51.78 26.65 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1dhr_c02 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 2 # 2 146 TYR A 34 TYR.? 16.37 S2 BME A 300 150 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 32.88 50.55 24.33 31.89 51.78 26.65 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 27.04 52.42 22.30 26.88 49.99 27.00 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1dhr_c02 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 2 # 3 146 TYR A 59 TYR^? 18.50 S2 BME A 300 150 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.59 5.14 5.72 16.82 6.86 5.68 coo 27.04 52.42 22.30 26.88 49.99 27.00 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1dhr_c02 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 2 # 4 146 TYR A 75 TYR~? 15.90 S2 BME A 300 150 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.46 -0.26 16.60 17.11 0.41 17.22 coo 27.04 52.42 22.30 26.88 49.99 27.00 8.82 -4.39 14.42 10.42 -10.04 16.23 1dhr_c02 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 4 hits 1dhr_c02 naa= 2 ULMN 2 1do6_c00 SUPEROXIDE REDUCTASE user 1 2 # 1 A 14 GLU A 15 GLU~? 24.22 S2 BME A 300 A 15 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 15.56 66.39 46.83 16.55 67.03 48.58 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 13.82 63.46 43.85 10.37 63.35 40.79 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1do6_c00 SUPEROXIDE REDUCTASE user 2 2 # 2 A 14 GLU A 74 GLU~? 13.09 S2 BME A 300 A 15 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 15.56 66.39 46.83 16.55 67.03 48.58 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 13.82 63.46 43.85 10.37 63.35 40.79 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1do6_c00 SUPEROXIDE REDUCTASE user 3 2 # 3 A 14 GLU A 99 GLU.? 20.82 S2 BME A 300 A 15 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 15.56 66.39 46.83 16.55 67.03 48.58 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 13.82 63.46 43.85 10.37 63.35 40.79 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1do6_c00 source 1do6 SUPEROXIDE REDUCTASE : 3 hits 1do6_c00 naa= 2 ULMN 2 1do6_c01 SUPEROXIDE REDUCTASE user 1 2 # 1 B 14 GLU A 15 GLU~? 24.22 S2 BME A 300 B 15 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 3.80 36.92 67.05 5.24 35.66 66.06 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 8.60 35.79 69.51 9.86 31.93 65.43 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1do6_c01 SUPEROXIDE REDUCTASE user 2 2 # 2 B 14 GLU A 15 GLU~? 24.22 S2 BME A 300 B 15 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 3.80 36.92 67.05 5.24 35.66 66.06 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 8.60 35.79 69.51 9.86 31.93 65.43 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1do6_c01 SUPEROXIDE REDUCTASE user 3 2 # 3 B 14 GLU A 57 GLU.? 23.43 S2 BME A 300 B 15 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 3.80 36.92 67.05 5.24 35.66 66.06 16.30 10.78 3.24 16.87 9.97 1.36 coo 8.60 35.79 69.51 9.86 31.93 65.43 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1do6_c01 SUPEROXIDE REDUCTASE user 4 2 # 4 B 14 GLU A 74 GLU~? 13.09 S2 BME A 300 B 15 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 3.80 36.92 67.05 5.24 35.66 66.06 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 8.60 35.79 69.51 9.86 31.93 65.43 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1do6_c01 SUPEROXIDE REDUCTASE user 5 2 # 5 B 14 GLU A 99 GLU.? 20.82 S2 BME A 300 B 15 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 3.80 36.92 67.05 5.24 35.66 66.06 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 8.60 35.79 69.51 9.86 31.93 65.43 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1do6_c01 source 1do6 SUPEROXIDE REDUCTASE : 5 hits 1do6_c01 naa= 2 ULMN 2 1dod_c00 P-HYDROXYBENZOATE HYDROXYLASE COMPLEuser 1 2 # 1 A 201 TYR A 59 TYR^? 18.50 S2 BME A 300 A 385 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 16.27 89.04 39.98 15.61 89.81 42.57 14.59 5.14 5.72 16.82 6.86 5.68 coo 10.94 86.81 45.90 12.21 89.21 45.28 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1dod_c00 P-HYDROXYBENZOATE HYDROXYLASE COMPLEuser 2 2 # 2 A 201 TYR A 60 TYR^? 16.66 S2 BME A 300 A 385 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 16.27 89.04 39.98 15.61 89.81 42.57 9.00 3.02 1.57 7.75 5.45 1.00 coo 10.94 86.81 45.90 12.21 89.21 45.28 14.59 5.14 5.72 16.82 6.86 5.68 1dod_c00 source 1dod P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 2: 2 hits 1dod_c00 naa= 2 ULMN 2 1dtw_c00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 A 291 HIS A 91 HIS~? 7.63 O1 BME A 300 B 76 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 72.33 2.23 1.35 73.00 2.99 3.18 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 77.60 2.15 30.40 76.57 1.77 32.21 16.30 10.78 3.24 16.87 9.97 1.36 1dtw_c00 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 1 hits 1dtw_c00 naa= 2 ULMN 2 1dtw_c01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 A 291 HIS A 91 HIS~? 7.63 O1 BME A 300 B 76 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 72.33 2.23 1.35 73.00 2.99 3.18 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 77.60 2.15 30.40 76.57 1.77 32.21 16.30 10.78 3.24 16.87 9.97 1.36 1dtw_c01 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 1 hits 1dtw_c01 naa= 2 ULMN 2 1dtw_c02 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 B 76 GLU A 29 GLU~? 6.68 S2 BME A 300 B 146 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 77.60 2.15 30.40 76.57 1.77 32.21 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 83.37 -3.72 40.67 81.39 -4.21 40.17 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1dtw_c02 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 2 2 # 2 B 76 GLU A 96 GLU.? 20.00 O1 BME A 300 B 146 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 77.60 2.15 30.40 76.57 1.77 32.21 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 83.37 -3.72 40.67 81.39 -4.21 40.17 3.84 -13.89 0.30 2.26 -15.26 0.08 1dtw_c02 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 2 hits 1dtw_c02 naa= 2 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 1 2 # 1 A 164 GLU A 77 GLU~? 17.67 S2 BME A 300 A 172 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 65.46 104.88 175.81 64.47 105.72 174.12 7.63 5.18 13.95 5.55 5.01 14.48 coo 65.25 99.24 172.80 64.76 99.68 172.43 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 2 2 # 2 A 164 GLU A 87 GLU.? 12.12 O1 BME A 300 A 172 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 65.46 104.88 175.81 64.47 105.72 174.12 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 65.25 99.24 172.80 64.76 99.68 172.43 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 3 2 # 3 A 164 GLU A 87 GLU.? 12.12 O1 BME A 300 A 172 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 65.46 104.88 175.81 64.47 105.72 174.12 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 65.25 99.24 172.80 64.76 99.68 172.43 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 4 2 # 4 A 164 GLU A 87 GLU.? 12.12 O1 BME A 300 A 172 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 65.46 104.88 175.81 64.47 105.72 174.12 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 65.25 99.24 172.80 64.76 99.68 172.43 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 5 2 # 5 A 164 GLU A 96 GLU.? 20.00 O1 BME A 300 A 172 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 65.46 104.88 175.81 64.47 105.72 174.12 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 65.25 99.24 172.80 64.76 99.68 172.43 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 6 2 # 6 A 164 GLU A 96 GLU.? 20.00 O1 BME A 300 A 172 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 65.46 104.88 175.81 64.47 105.72 174.12 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 65.25 99.24 172.80 64.76 99.68 172.43 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1dub_c06 2-ENOYL-COA HYDRATASE user 7 2 # 7 A 164 GLU A 99 GLU.? 20.82 S2 BME A 300 A 172 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 65.46 104.88 175.81 64.47 105.72 174.12 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 65.25 99.24 172.80 64.76 99.68 172.43 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1dub_c06 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c06 naa= 2 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 1 2 # 1 B 164 GLU A 77 GLU~? 17.67 S2 BME A 300 B 172 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 88.14 113.46 145.73 86.79 113.92 147.30 7.63 5.18 13.95 5.55 5.01 14.48 coo 88.37 107.75 148.54 88.01 108.21 149.05 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 2 2 # 2 B 164 GLU A 87 GLU.? 12.12 O1 BME A 300 B 172 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 88.14 113.46 145.73 86.79 113.92 147.30 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 88.37 107.75 148.54 88.01 108.21 149.05 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 3 2 # 3 B 164 GLU A 87 GLU.? 12.12 O1 BME A 300 B 172 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 88.14 113.46 145.73 86.79 113.92 147.30 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 88.37 107.75 148.54 88.01 108.21 149.05 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 4 2 # 4 B 164 GLU A 87 GLU.? 12.12 O1 BME A 300 B 172 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 88.14 113.46 145.73 86.79 113.92 147.30 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 88.37 107.75 148.54 88.01 108.21 149.05 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 5 2 # 5 B 164 GLU A 96 GLU.? 20.00 O1 BME A 300 B 172 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 88.14 113.46 145.73 86.79 113.92 147.30 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 88.37 107.75 148.54 88.01 108.21 149.05 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 6 2 # 6 B 164 GLU A 96 GLU.? 20.00 O1 BME A 300 B 172 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 88.14 113.46 145.73 86.79 113.92 147.30 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 88.37 107.75 148.54 88.01 108.21 149.05 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1dub_c07 2-ENOYL-COA HYDRATASE user 7 2 # 7 B 164 GLU A 99 GLU.? 20.82 S2 BME A 300 B 172 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 88.14 113.46 145.73 86.79 113.92 147.30 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 88.37 107.75 148.54 88.01 108.21 149.05 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1dub_c07 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c07 naa= 2 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 1 2 # 1 C 164 GLU A 77 GLU~? 17.67 S2 BME A 300 C 172 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 51.71 102.03 140.09 53.02 103.62 140.54 7.63 5.18 13.95 5.55 5.01 14.48 coo 56.53 97.84 139.65 56.86 98.55 139.57 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 2 2 # 2 C 164 GLU A 87 GLU.? 12.12 O1 BME A 300 C 172 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 51.71 102.03 140.09 53.02 103.62 140.54 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 56.53 97.84 139.65 56.86 98.55 139.57 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 3 2 # 3 C 164 GLU A 87 GLU.? 12.12 O1 BME A 300 C 172 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 51.71 102.03 140.09 53.02 103.62 140.54 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 56.53 97.84 139.65 56.86 98.55 139.57 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 4 2 # 4 C 164 GLU A 87 GLU.? 12.12 O1 BME A 300 C 172 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 51.71 102.03 140.09 53.02 103.62 140.54 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 56.53 97.84 139.65 56.86 98.55 139.57 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 5 2 # 5 C 164 GLU A 96 GLU.? 20.00 O1 BME A 300 C 172 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 51.71 102.03 140.09 53.02 103.62 140.54 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 56.53 97.84 139.65 56.86 98.55 139.57 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 6 2 # 6 C 164 GLU A 96 GLU.? 20.00 O1 BME A 300 C 172 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 51.71 102.03 140.09 53.02 103.62 140.54 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 56.53 97.84 139.65 56.86 98.55 139.57 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1dub_c08 2-ENOYL-COA HYDRATASE user 7 2 # 7 C 164 GLU A 99 GLU.? 20.82 S2 BME A 300 C 172 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 51.71 102.03 140.09 53.02 103.62 140.54 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 56.53 97.84 139.65 56.86 98.55 139.57 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1dub_c08 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c08 naa= 2 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 1 2 # 1 D 164 GLU A 77 GLU~? 17.67 S2 BME A 300 D 172 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 91.47 83.05 136.24 90.35 81.38 136.84 7.63 5.18 13.95 5.55 5.01 14.48 coo 86.64 87.31 136.66 86.30 86.60 136.64 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 2 2 # 2 D 164 GLU A 87 GLU.? 12.12 O1 BME A 300 D 172 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 91.47 83.05 136.24 90.35 81.38 136.84 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 86.64 87.31 136.66 86.30 86.60 136.64 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 3 2 # 3 D 164 GLU A 87 GLU.? 12.12 O1 BME A 300 D 172 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 91.47 83.05 136.24 90.35 81.38 136.84 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 86.64 87.31 136.66 86.30 86.60 136.64 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 4 2 # 4 D 164 GLU A 87 GLU.? 12.12 O1 BME A 300 D 172 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 91.47 83.05 136.24 90.35 81.38 136.84 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 86.64 87.31 136.66 86.30 86.60 136.64 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 5 2 # 5 D 164 GLU A 96 GLU.? 20.00 O1 BME A 300 D 172 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 91.47 83.05 136.24 90.35 81.38 136.84 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 86.64 87.31 136.66 86.30 86.60 136.64 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 6 2 # 6 D 164 GLU A 96 GLU.? 20.00 O1 BME A 300 D 172 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 91.47 83.05 136.24 90.35 81.38 136.84 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 86.64 87.31 136.66 86.30 86.60 136.64 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1dub_c09 2-ENOYL-COA HYDRATASE user 7 2 # 7 D 164 GLU A 99 GLU.? 20.82 S2 BME A 300 D 172 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 91.47 83.05 136.24 90.35 81.38 136.84 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 86.64 87.31 136.66 86.30 86.60 136.64 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1dub_c09 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c09 naa= 2 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 1 2 # 1 E 164 GLU A 77 GLU~? 17.67 S2 BME A 300 E 172 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 84.40 80.02 173.80 85.08 79.06 172.03 7.63 5.18 13.95 5.55 5.01 14.48 coo 84.01 85.71 170.92 84.43 85.28 170.44 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 2 2 # 2 E 164 GLU A 87 GLU.? 12.12 O1 BME A 300 E 172 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 84.40 80.02 173.80 85.08 79.06 172.03 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 84.01 85.71 170.92 84.43 85.28 170.44 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 3 2 # 3 E 164 GLU A 87 GLU.? 12.12 O1 BME A 300 E 172 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 84.40 80.02 173.80 85.08 79.06 172.03 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 84.01 85.71 170.92 84.43 85.28 170.44 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 4 2 # 4 E 164 GLU A 87 GLU.? 12.12 O1 BME A 300 E 172 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 84.40 80.02 173.80 85.08 79.06 172.03 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 84.01 85.71 170.92 84.43 85.28 170.44 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 5 2 # 5 E 164 GLU A 96 GLU.? 20.00 O1 BME A 300 E 172 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 84.40 80.02 173.80 85.08 79.06 172.03 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 84.01 85.71 170.92 84.43 85.28 170.44 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 6 2 # 6 E 164 GLU A 96 GLU.? 20.00 O1 BME A 300 E 172 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 84.40 80.02 173.80 85.08 79.06 172.03 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 84.01 85.71 170.92 84.43 85.28 170.44 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1dub_c10 2-ENOYL-COA HYDRATASE user 7 2 # 7 E 164 GLU A 99 GLU.? 20.82 S2 BME A 300 E 172 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 84.40 80.02 173.80 85.08 79.06 172.03 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 84.01 85.71 170.92 84.43 85.28 170.44 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1dub_c10 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c10 naa= 2 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 1 2 # 1 F 164 GLU A 77 GLU~? 17.67 S2 BME A 300 F 172 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 56.75 71.71 148.46 58.44 71.01 149.54 7.63 5.18 13.95 5.55 5.01 14.48 coo 57.02 77.49 151.32 57.42 77.01 151.76 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 2 2 # 2 F 164 GLU A 87 GLU.? 12.12 O1 BME A 300 F 172 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 56.75 71.71 148.46 58.44 71.01 149.54 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 57.02 77.49 151.32 57.42 77.01 151.76 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 3 2 # 3 F 164 GLU A 87 GLU.? 12.12 O1 BME A 300 F 172 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 56.75 71.71 148.46 58.44 71.01 149.54 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 57.02 77.49 151.32 57.42 77.01 151.76 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 4 2 # 4 F 164 GLU A 87 GLU.? 12.12 O1 BME A 300 F 172 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 56.75 71.71 148.46 58.44 71.01 149.54 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 57.02 77.49 151.32 57.42 77.01 151.76 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 5 2 # 5 F 164 GLU A 96 GLU.? 20.00 O1 BME A 300 F 172 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 56.75 71.71 148.46 58.44 71.01 149.54 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 57.02 77.49 151.32 57.42 77.01 151.76 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 6 2 # 6 F 164 GLU A 96 GLU.? 20.00 O1 BME A 300 F 172 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 56.75 71.71 148.46 58.44 71.01 149.54 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 57.02 77.49 151.32 57.42 77.01 151.76 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1dub_c11 2-ENOYL-COA HYDRATASE user 7 2 # 7 F 164 GLU A 99 GLU.? 20.82 S2 BME A 300 F 172 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 56.75 71.71 148.46 58.44 71.01 149.54 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 57.02 77.49 151.32 57.42 77.01 151.76 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1dub_c11 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c11 naa= 2 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 1 2 # 1 A 144 GLU A 8 GLU~? 18.47 O1 BME A 300 A 164 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 61.78 103.61 169.93 62.63 102.26 171.29 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 65.46 104.88 175.81 64.47 105.72 174.12 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 2 2 # 2 A 144 GLU A 28 GLU~? 14.38 S2 BME A 300 A 164 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 61.78 103.61 169.93 62.63 102.26 171.29 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 65.46 104.88 175.81 64.47 105.72 174.12 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 3 2 # 3 A 144 GLU A 29 GLU~? 6.68 S2 BME A 300 A 164 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 61.78 103.61 169.93 62.63 102.26 171.29 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 65.46 104.88 175.81 64.47 105.72 174.12 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 4 2 # 4 A 144 GLU A 74 GLU~? 13.09 S2 BME A 300 A 164 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 61.78 103.61 169.93 62.63 102.26 171.29 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 65.46 104.88 175.81 64.47 105.72 174.12 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 5 2 # 5 A 144 GLU A 77 GLU~? 17.67 S2 BME A 300 A 164 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 61.78 103.61 169.93 62.63 102.26 171.29 7.63 5.18 13.95 5.55 5.01 14.48 coo 65.46 104.88 175.81 64.47 105.72 174.12 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1dub_c12 2-ENOYL-COA HYDRATASE user 6 2 # 6 A 144 GLU A 87 GLU.? 12.12 O1 BME A 300 A 164 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 61.78 103.61 169.93 62.63 102.26 171.29 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 65.46 104.88 175.81 64.47 105.72 174.12 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1dub_c12 source 1dub 2-ENOYL-COA HYDRATASE : 6 hits 1dub_c12 naa= 2 ULMN 2 1dve_c01 HEME OXYGENASE-1 user 1 2 # 1 A 140 ASP A 82 ASP^? 20.57 S2 BME A 300 A 144 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 50.80 17.38-128.07 52.55 18.37-127.41 10.12 9.33 8.59 8.15 9.51 7.94 coo 48.41 20.84-131.50 47.60 20.71-131.72 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1dve_c01 HEME OXYGENASE-1 user 2 2 # 2 A 140 ASP A 95 ASP.? 15.99 O1 BME A 300 A 144 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 50.80 17.38-128.07 52.55 18.37-127.41 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 48.41 20.84-131.50 47.60 20.71-131.72 7.18 -11.38 -5.94 7.80 -10.95 -5.54 1dve_c01 source 1dve HEME OXYGENASE-1 : 2 hits 1dve_c01 naa= 2 ULMN 2 1dw9_c00 CYANATE LYASE user 1 2 # 1 A 99 GLU A 29 GLU~? 6.68 S2 BME A 300 F 96 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -18.15 16.27 32.38 -18.04 15.42 34.32 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -16.38 12.12 38.65 -17.03 14.40 36.67 12.31 -11.28 10.33 12.92 -12.61 7.64 1dw9_c00 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c00 naa= 2 ULMN 2 1dw9_c01 CYANATE LYASE user 1 2 # 1 B 96 ARG A 68 ARG~? -4.35 S2 BME A 300s G 99 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 15.50 -15.19 4.21 14.37 -14.08 5.62 1dw9_c01 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c01 naa= 2 ULMN 2 1dw9_c02 CYANATE LYASE user 1 2 # 1 B 99 GLU A 29 GLU~? 6.68 S2 BME A 300 G 96 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 12.31 -11.28 10.33 12.92 -12.61 7.64 1dw9_c02 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c02 naa= 2 ULMN 2 1dw9_c03 CYANATE LYASE user 1 2 # 1 C 99 GLU A 29 GLU~? 6.68 S2 BME A 300 E 96 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 12.31 -11.28 10.33 12.92 -12.61 7.64 1dw9_c03 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c03 naa= 2 ULMN 2 1dw9_c04 CYANATE LYASE user 1 2 # 1 D 96 ARG A 68 ARG~? -4.35 S2 BME A 300s I 99 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -13.55 23.07 13.84 -15.10 22.15 11.37 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -17.67 19.16 8.58 -16.84 20.55 9.92 15.50 -15.19 4.21 14.37 -14.08 5.62 1dw9_c04 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c04 naa= 2 ULMN 2 1dw9_c05 CYANATE LYASE user 1 2 # 1 D 99 GLU A 29 GLU~? 6.68 S2 BME A 300 I 96 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -9.50 19.20 15.72 -9.80 19.81 13.72 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -12.12 20.77 8.60 -10.73 20.87 11.34 12.31 -11.28 10.33 12.92 -12.61 7.64 1dw9_c05 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c05 naa= 2 ULMN 2 1dw9_c06 CYANATE LYASE user 1 2 # 1 H 99 GLU A 29 GLU~? 6.68 S2 BME A 300 J 96 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 12.31 -11.28 10.33 12.92 -12.61 7.64 1dw9_c06 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c06 naa= 2 ULMN 2 1dw9_c07 CYANATE LYASE user 1 2 # 1 H 96 ARG A 68 ARG~? -4.35 S2 BME A 300s J 99 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 15.50 -15.19 4.21 14.37 -14.08 5.62 1dw9_c07 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c07 naa= 2 ULMN 2 1dw9_c08 CYANATE LYASE user 1 2 # 1 A 96 ARG A 68 ARG~? -4.35 S2 BME A 300s F 99 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -13.18 15.76 35.37 -12.72 12.99 36.60 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -12.53 8.23 36.79 -12.25 10.29 36.64 15.50 -15.19 4.21 14.37 -14.08 5.62 1dw9_c08 source 1dw9 CYANATE LYASE : 1 hits 1dw9_c08 naa= 2 ULMN 2 1eb6_c00 NEUTRAL PROTEASE II user 1 2 # 1 A 106 TYR A 59 TYR^? 18.50 S2 BME A 300 A 129 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 8.57 -0.34 51.10 11.35 -0.27 51.24 14.59 5.14 5.72 16.82 6.86 5.68 coo 10.94 7.38 49.06 9.46 8.67 48.23 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1eb6_c00 NEUTRAL PROTEASE II user 2 2 # 2 A 106 TYR A 75 TYR~? 15.90 S2 BME A 300 A 129 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 8.57 -0.34 51.10 11.35 -0.27 51.24 14.46 -0.26 16.60 17.11 0.41 17.22 coo 10.94 7.38 49.06 9.46 8.67 48.23 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1eb6_c00 NEUTRAL PROTEASE II user 3 2 # 3 A 106 TYR A 75 TYR~? 15.90 S2 BME A 300 A 129 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 8.57 -0.34 51.10 11.35 -0.27 51.24 14.46 -0.26 16.60 17.11 0.41 17.22 coo 10.94 7.38 49.06 9.46 8.67 48.23 7.63 5.18 13.95 5.55 5.01 14.48 1eb6_c00 source 1eb6 NEUTRAL PROTEASE II : 3 hits 1eb6_c00 naa= 2 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 1 2 # 1 A 129 GLU A 8 GLU~? 18.47 O1 BME A 300 A 146 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 10.94 7.38 49.06 9.46 8.67 48.23 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 5.52 7.95 39.13 5.05 9.43 41.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 2 2 # 2 A 129 GLU A 15 GLU~? 24.22 S2 BME A 300 A 146 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 10.94 7.38 49.06 9.46 8.67 48.23 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 5.52 7.95 39.13 5.05 9.43 41.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 3 2 # 3 A 129 GLU A 29 GLU~? 6.68 S2 BME A 300 A 146 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 10.94 7.38 49.06 9.46 8.67 48.23 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 5.52 7.95 39.13 5.05 9.43 41.44 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 4 2 # 4 A 129 GLU A 57 GLU.? 23.43 S2 BME A 300 A 146 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 10.94 7.38 49.06 9.46 8.67 48.23 16.30 10.78 3.24 16.87 9.97 1.36 coo 5.52 7.95 39.13 5.05 9.43 41.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 5 2 # 5 A 129 GLU A 77 GLU~? 17.67 S2 BME A 300 A 146 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 10.94 7.38 49.06 9.46 8.67 48.23 7.63 5.18 13.95 5.55 5.01 14.48 coo 5.52 7.95 39.13 5.05 9.43 41.44 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 6 2 # 6 A 129 GLU A 77 GLU~? 17.67 S2 BME A 300 A 146 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 10.94 7.38 49.06 9.46 8.67 48.23 7.63 5.18 13.95 5.55 5.01 14.48 coo 5.52 7.95 39.13 5.05 9.43 41.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1eb6_c01 NEUTRAL PROTEASE II user 7 2 # 7 A 129 GLU A 87 GLU.? 12.12 O1 BME A 300 A 146 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 10.94 7.38 49.06 9.46 8.67 48.23 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 5.52 7.95 39.13 5.05 9.43 41.44 9.00 3.02 1.57 7.75 5.45 1.00 1eb6_c01 source 1eb6 NEUTRAL PROTEASE II : 7 hits 1eb6_c01 naa= 2 ULMN 2 1ebf_c00 HOMOSERINE DEHYDROGENASE user 1 2 # 1 A 219 ASP A 7 ASP~? 16.68 O1 BME A 300 A 223 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 60.73 18.76 -7.87 61.76 20.28 -6.83 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 62.58 16.80 -0.96 62.41 22.46 -3.81 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1ebf_c00 HOMOSERINE DEHYDROGENASE user 2 2 # 2 A 219 ASP A 23 ASP^? 9.45 S2 BME A 300 A 223 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 60.73 18.76 -7.87 61.76 20.28 -6.83 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 62.58 16.80 -0.96 62.41 22.46 -3.81 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ebf_c00 HOMOSERINE DEHYDROGENASE user 3 2 # 3 A 219 ASP A 82 ASP^? 20.57 S2 BME A 300 A 223 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 60.73 18.76 -7.87 61.76 20.28 -6.83 10.12 9.33 8.59 8.15 9.51 7.94 coo 62.58 16.80 -0.96 62.41 22.46 -3.81 15.98 12.20 9.88 16.28 11.97 16.11 1ebf_c00 source 1ebf HOMOSERINE DEHYDROGENASE : 3 hits 1ebf_c00 naa= 2 ULMN 2 1ebf_c01 HOMOSERINE DEHYDROGENASE user 1 2 # 1 B 219 ASP A 7 ASP~? 16.68 O1 BME A 300 B 223 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 59.29 40.80 28.55 60.72 39.27 28.67 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 63.53 41.41 22.67 60.48 36.70 25.37 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1ebf_c01 HOMOSERINE DEHYDROGENASE user 2 2 # 2 B 219 ASP A 23 ASP^? 9.45 S2 BME A 300 B 223 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 59.29 40.80 28.55 60.72 39.27 28.67 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 63.53 41.41 22.67 60.48 36.70 25.37 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ebf_c01 HOMOSERINE DEHYDROGENASE user 3 2 # 3 B 219 ASP A 82 ASP^? 20.57 S2 BME A 300 B 223 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 59.29 40.80 28.55 60.72 39.27 28.67 10.12 9.33 8.59 8.15 9.51 7.94 coo 63.53 41.41 22.67 60.48 36.70 25.37 15.98 12.20 9.88 16.28 11.97 16.11 1ebf_c01 source 1ebf HOMOSERINE DEHYDROGENASE : 3 hits 1ebf_c01 naa= 2 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 A 113 GLU A 15 GLU~? 24.22 S2 BME A 300 A 133 PRO A 18 PRO.? 24.94 S2 BME A 300 coo 17.89 4.28 6.66 17.21 3.76 4.71 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 25.19 8.51 2.90 27.26 7.49 2.69 16.63 8.94 -5.90 14.42 8.45 -5.71 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 A 113 GLU A 28 GLU~? 14.38 S2 BME A 300 A 133 PRO A 42 PRO~? 11.96 S2 BME A 300 coo 17.89 4.28 6.66 17.21 3.76 4.71 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 25.19 8.51 2.90 27.26 7.49 2.69 21.20 -8.68 7.66 19.62 -7.16 8.23 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 A 113 GLU A 29 GLU~? 6.68 S2 BME A 300 A 133 PRO A 42 PRO~? 11.96 S2 BME A 300 coo 17.89 4.28 6.66 17.21 3.76 4.71 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 25.19 8.51 2.90 27.26 7.49 2.69 21.20 -8.68 7.66 19.62 -7.16 8.23 ULMN 2 1ef8_c03 METHYLMALONYL COA DECARBOXYLASE user 4 2 # 4 A 113 GLU A 57 GLU.? 23.43 S2 BME A 300 A 133 PRO A 18 PRO.? 24.94 S2 BME A 300 coo 17.89 4.28 6.66 17.21 3.76 4.71 16.30 10.78 3.24 16.87 9.97 1.36 coo 25.19 8.51 2.90 27.26 7.49 2.69 16.63 8.94 -5.90 14.42 8.45 -5.71 1ef8_c03 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c03 naa= 2 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 B 113 GLU A 15 GLU~? 24.22 S2 BME A 300 B 133 PRO A 18 PRO.? 24.94 S2 BME A 300 coo 14.64 32.39 9.30 13.61 33.26 7.68 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 9.44 37.34 14.98 10.09 39.37 15.91 16.63 8.94 -5.90 14.42 8.45 -5.71 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 B 113 GLU A 28 GLU~? 14.38 S2 BME A 300 B 133 PRO A 42 PRO~? 11.96 S2 BME A 300 coo 14.64 32.39 9.30 13.61 33.26 7.68 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 9.44 37.34 14.98 10.09 39.37 15.91 21.20 -8.68 7.66 19.62 -7.16 8.23 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 B 113 GLU A 29 GLU~? 6.68 S2 BME A 300 B 133 PRO A 42 PRO~? 11.96 S2 BME A 300 coo 14.64 32.39 9.30 13.61 33.26 7.68 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 9.44 37.34 14.98 10.09 39.37 15.91 21.20 -8.68 7.66 19.62 -7.16 8.23 ULMN 2 1ef8_c04 METHYLMALONYL COA DECARBOXYLASE user 4 2 # 4 B 113 GLU A 57 GLU.? 23.43 S2 BME A 300 B 133 PRO A 18 PRO.? 24.94 S2 BME A 300 coo 14.64 32.39 9.30 13.61 33.26 7.68 16.30 10.78 3.24 16.87 9.97 1.36 coo 9.44 37.34 14.98 10.09 39.37 15.91 16.63 8.94 -5.90 14.42 8.45 -5.71 1ef8_c04 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c04 naa= 2 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 C 113 GLU A 15 GLU~? 24.22 S2 BME A 300 C 133 PRO A 18 PRO.? 24.94 S2 BME A 300 coo -3.18 14.73 22.76 -5.01 14.47 21.69 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -2.61 5.73 24.31 -3.35 4.61 26.16 16.63 8.94 -5.90 14.42 8.45 -5.71 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 C 113 GLU A 28 GLU~? 14.38 S2 BME A 300 C 133 PRO A 42 PRO~? 11.96 S2 BME A 300 coo -3.18 14.73 22.76 -5.01 14.47 21.69 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -2.61 5.73 24.31 -3.35 4.61 26.16 21.20 -8.68 7.66 19.62 -7.16 8.23 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 C 113 GLU A 29 GLU~? 6.68 S2 BME A 300 C 133 PRO A 42 PRO~? 11.96 S2 BME A 300 coo -3.18 14.73 22.76 -5.01 14.47 21.69 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -2.61 5.73 24.31 -3.35 4.61 26.16 21.20 -8.68 7.66 19.62 -7.16 8.23 ULMN 2 1ef8_c05 METHYLMALONYL COA DECARBOXYLASE user 4 2 # 4 C 113 GLU A 57 GLU.? 23.43 S2 BME A 300 C 133 PRO A 18 PRO.? 24.94 S2 BME A 300 coo -3.18 14.73 22.76 -5.01 14.47 21.69 16.30 10.78 3.24 16.87 9.97 1.36 coo -2.61 5.73 24.31 -3.35 4.61 26.16 16.63 8.94 -5.90 14.42 8.45 -5.71 1ef8_c05 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c05 naa= 2 ULMN 2 1eix_c00 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 A 71 ASP A 7 ASP~? 16.68 O1 BME A 300 A 73 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 23.19 26.70 106.03 22.83 25.75 107.86 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 27.86 26.05 110.45 22.68 24.67 109.97 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1eix_c00 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 A 71 ASP A 23 ASP^? 9.45 S2 BME A 300 A 73 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 23.19 26.70 106.03 22.83 25.75 107.86 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 27.86 26.05 110.45 22.68 24.67 109.97 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eix_c00 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 3 2 # 3 A 71 ASP A 82 ASP^? 20.57 S2 BME A 300 A 73 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 23.19 26.70 106.03 22.83 25.75 107.86 10.12 9.33 8.59 8.15 9.51 7.94 coo 27.86 26.05 110.45 22.68 24.67 109.97 15.98 12.20 9.88 16.28 11.97 16.11 1eix_c00 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 3 hits 1eix_c00 naa= 2 ULMN 2 1eix_c01 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 B 71 ASP A 7 ASP~? 16.68 O1 BME A 300 B 73 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 38.06 17.61 107.95 37.94 18.87 109.63 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 32.65 18.53 110.98 37.67 20.13 111.67 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1eix_c01 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 B 71 ASP A 23 ASP^? 9.45 S2 BME A 300 B 73 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 38.06 17.61 107.95 37.94 18.87 109.63 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 32.65 18.53 110.98 37.67 20.13 111.67 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eix_c01 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 3 2 # 3 B 71 ASP A 82 ASP^? 20.57 S2 BME A 300 B 73 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 38.06 17.61 107.95 37.94 18.87 109.63 10.12 9.33 8.59 8.15 9.51 7.94 coo 32.65 18.53 110.98 37.67 20.13 111.67 15.98 12.20 9.88 16.28 11.97 16.11 1eix_c01 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 3 hits 1eix_c01 naa= 2 ULMN 2 1eix_c02 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 C 71 ASP A 7 ASP~? 16.68 O1 BME A 300 C 73 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 41.24 46.44 65.36 41.30 47.43 67.22 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 46.67 48.87 67.69 41.63 48.86 69.39 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1eix_c02 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 C 71 ASP A 23 ASP^? 9.45 S2 BME A 300 C 73 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 41.24 46.44 65.36 41.30 47.43 67.22 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 46.67 48.87 67.69 41.63 48.86 69.39 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eix_c02 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 3 2 # 3 C 71 ASP A 82 ASP^? 20.57 S2 BME A 300 C 73 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 41.24 46.44 65.36 41.30 47.43 67.22 10.12 9.33 8.59 8.15 9.51 7.94 coo 46.67 48.87 67.69 41.63 48.86 69.39 15.98 12.20 9.88 16.28 11.97 16.11 1eix_c02 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 3 hits 1eix_c02 naa= 2 ULMN 2 1eix_c03 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 2 # 1 D 71 ASP A 7 ASP~? 16.68 O1 BME A 300 D 73 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 56.16 40.71 72.48 56.48 42.77 72.42 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 51.52 44.76 73.92 56.76 45.26 72.14 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1eix_c03 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 2 # 2 D 71 ASP A 23 ASP^? 9.45 S2 BME A 300 D 73 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 56.16 40.71 72.48 56.48 42.77 72.42 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 51.52 44.76 73.92 56.76 45.26 72.14 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eix_c03 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 3 2 # 3 D 71 ASP A 82 ASP^? 20.57 S2 BME A 300 D 73 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 56.16 40.71 72.48 56.48 42.77 72.42 10.12 9.33 8.59 8.15 9.51 7.94 coo 51.52 44.76 73.92 56.76 45.26 72.14 15.98 12.20 9.88 16.28 11.97 16.11 1eix_c03 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 3 hits 1eix_c03 naa= 2 ULMN 2 1els_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 2 # 1 191 HIS A 91 HIS~? 7.63 O1 BME A 300 345 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 87.80 42.73 46.74 88.64 40.96 46.01 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 103.59 43.46 23.85 98.61 47.18 23.58 13.04 11.19 -6.33 8.80 12.60 -2.10 1els_c02 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 1 hits 1els_c02 naa= 2 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 2 # 1 242 LYS A 10 LYS~? 16.18 O1 BME A 300 345 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 103.59 43.46 23.85 98.61 47.18 23.58 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 2 2 # 2 242 LYS A 10 LYS~? 16.18 O1 BME A 300 345 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 103.59 43.46 23.85 98.61 47.18 23.58 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 3 2 # 3 242 LYS A 10 LYS~? 16.18 O1 BME A 300 345 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 99.58 55.20 43.27 102.49 58.24 46.31 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 103.59 43.46 23.85 98.61 47.18 23.58 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 4 2 # 4 242 LYS A 12 LYS~? 21.81 S2 BME A 300 345 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 103.59 43.46 23.85 98.61 47.18 23.58 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 5 2 # 5 242 LYS A 12 LYS~? 21.81 S2 BME A 300 345 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 99.58 55.20 43.27 102.49 58.24 46.31 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 103.59 43.46 23.85 98.61 47.18 23.58 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 6 2 # 6 242 LYS A 17 LYS.? 25.68 S2 BME A 300 345 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 99.58 55.20 43.27 102.49 58.24 46.31 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 103.59 43.46 23.85 98.61 47.18 23.58 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 7 2 # 7 242 LYS A 55 LYS.? 25.54 S2 BME A 300 345 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 15.98 12.20 9.88 16.28 11.97 16.11 coo 103.59 43.46 23.85 98.61 47.18 23.58 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 8 2 # 8 242 LYS A 71 LYS~? 8.54 S2 BME A 300 345 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 9 2 # 9 242 LYS A 71 LYS~? 8.54 S2 BME A 300 345 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 10 2 # 10 242 LYS A 101 LYS.? -19.93 S2 BME A 300s 345 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 11 2 # 11 242 LYS A 101 LYS.? -19.93 S2 BME A 300s 345 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1els_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 12 2 # 12 242 LYS A 101 LYS.? -19.93 S2 BME A 300s 345 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 99.58 55.20 43.27 102.49 58.24 46.31 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 103.59 43.46 23.85 98.61 47.18 23.58 13.04 11.19 -6.33 8.80 12.60 -2.10 1els_c03 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 12 hits 1els_c03 naa= 2 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 2 # 1 150 ASP A 23 ASP^? 9.45 S2 BME A 300 178 SER A 69 SER~? 5.63 S2 BME A 300 coo 6.83 2.75 19.17 7.40 0.75 19.11 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1emd_c02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 2 # 2 150 ASP A 48 ASP~? 19.85 S2 BME A 300 178 SER A 52 SER~? 19.64 S2 BME A 300 coo 6.83 2.75 19.17 7.40 0.75 19.11 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 22.49 4.36 7.95 23.43 2.12 7.73 1emd_c02 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 2 hits 1emd_c02 naa= 2 ULMN 2 1eq2_c10 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 A 140 TYR A 34 TYR.? 16.37 S2 BME A 300 A 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 29.60 38.99 53.89 30.10 37.88 51.36 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 32.73 32.94 54.42 29.29 32.83 50.35 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c10 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 A 140 TYR A 34 TYR.? 16.37 S2 BME A 300 A 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 29.60 38.99 53.89 30.10 37.88 51.36 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 32.73 32.94 54.42 29.29 32.83 50.35 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c10 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 A 140 TYR A 59 TYR^? 18.50 S2 BME A 300 A 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 29.60 38.99 53.89 30.10 37.88 51.36 14.59 5.14 5.72 16.82 6.86 5.68 coo 32.73 32.94 54.42 29.29 32.83 50.35 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c10 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 A 140 TYR A 75 TYR~? 15.90 S2 BME A 300 A 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 29.60 38.99 53.89 30.10 37.88 51.36 14.46 -0.26 16.60 17.11 0.41 17.22 coo 32.73 32.94 54.42 29.29 32.83 50.35 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c10 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c10 naa= 2 ULMN 2 1eq2_c11 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 B 140 TYR A 34 TYR.? 16.37 S2 BME A 300 B 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.43 38.83 86.53 27.07 38.03 86.12 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 25.13 32.62 89.49 27.74 32.61 84.91 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c11 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 B 140 TYR A 34 TYR.? 16.37 S2 BME A 300 B 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 24.43 38.83 86.53 27.07 38.03 86.12 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 25.13 32.62 89.49 27.74 32.61 84.91 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c11 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 B 140 TYR A 59 TYR^? 18.50 S2 BME A 300 B 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 24.43 38.83 86.53 27.07 38.03 86.12 14.59 5.14 5.72 16.82 6.86 5.68 coo 25.13 32.62 89.49 27.74 32.61 84.91 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c11 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 B 140 TYR A 60 TYR^? 16.66 S2 BME A 300 B 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 24.43 38.83 86.53 27.07 38.03 86.12 9.00 3.02 1.57 7.75 5.45 1.00 coo 25.13 32.62 89.49 27.74 32.61 84.91 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c11 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 B 140 TYR A 75 TYR~? 15.90 S2 BME A 300 B 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 24.43 38.83 86.53 27.07 38.03 86.12 14.46 -0.26 16.60 17.11 0.41 17.22 coo 25.13 32.62 89.49 27.74 32.61 84.91 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c11 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c11 naa= 2 ULMN 2 1eq2_c12 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 C 140 TYR A 34 TYR.? 16.37 S2 BME A 300 C 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -8.28 37.01 91.79 -6.99 36.16 94.13 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -10.48 30.66 93.19 -5.27 31.07 94.32 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c12 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 C 140 TYR A 34 TYR.? 16.37 S2 BME A 300 C 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -8.28 37.01 91.79 -6.99 36.16 94.13 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -10.48 30.66 93.19 -5.27 31.07 94.32 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c12 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 C 140 TYR A 59 TYR^? 18.50 S2 BME A 300 C 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -8.28 37.01 91.79 -6.99 36.16 94.13 14.59 5.14 5.72 16.82 6.86 5.68 coo -10.48 30.66 93.19 -5.27 31.07 94.32 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c12 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 C 140 TYR A 60 TYR^? 16.66 S2 BME A 300 C 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -8.28 37.01 91.79 -6.99 36.16 94.13 9.00 3.02 1.57 7.75 5.45 1.00 coo -10.48 30.66 93.19 -5.27 31.07 94.32 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c12 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 C 140 TYR A 75 TYR~? 15.90 S2 BME A 300 C 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -8.28 37.01 91.79 -6.99 36.16 94.13 14.46 -0.26 16.60 17.11 0.41 17.22 coo -10.48 30.66 93.19 -5.27 31.07 94.32 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c12 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c12 naa= 2 ULMN 2 1eq2_c13 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 D 140 TYR A 34 TYR.? 16.37 S2 BME A 300 D 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -23.30 35.33 62.20 -25.10 34.24 64.06 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -24.76 28.82 60.31 -24.27 29.01 65.58 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c13 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 D 140 TYR A 34 TYR.? 16.37 S2 BME A 300 D 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -23.30 35.33 62.20 -25.10 34.24 64.06 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -24.76 28.82 60.31 -24.27 29.01 65.58 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c13 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 D 140 TYR A 59 TYR^? 18.50 S2 BME A 300 D 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -23.30 35.33 62.20 -25.10 34.24 64.06 14.59 5.14 5.72 16.82 6.86 5.68 coo -24.76 28.82 60.31 -24.27 29.01 65.58 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c13 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 D 140 TYR A 60 TYR^? 16.66 S2 BME A 300 D 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -23.30 35.33 62.20 -25.10 34.24 64.06 9.00 3.02 1.57 7.75 5.45 1.00 coo -24.76 28.82 60.31 -24.27 29.01 65.58 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c13 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 D 140 TYR A 75 TYR~? 15.90 S2 BME A 300 D 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -23.30 35.33 62.20 -25.10 34.24 64.06 14.46 -0.26 16.60 17.11 0.41 17.22 coo -24.76 28.82 60.31 -24.27 29.01 65.58 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c13 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c13 naa= 2 ULMN 2 1eq2_c14 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 E 140 TYR A 34 TYR.? 16.37 S2 BME A 300 E 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 0.04 36.70 38.68 -2.21 35.46 37.50 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 1.93 30.52 36.31 -2.84 30.18 38.54 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c14 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 E 140 TYR A 34 TYR.? 16.37 S2 BME A 300 E 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 0.04 36.70 38.68 -2.21 35.46 37.50 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 1.93 30.52 36.31 -2.84 30.18 38.54 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c14 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 E 140 TYR A 59 TYR^? 18.50 S2 BME A 300 E 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 0.04 36.70 38.68 -2.21 35.46 37.50 14.59 5.14 5.72 16.82 6.86 5.68 coo 1.93 30.52 36.31 -2.84 30.18 38.54 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c14 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 E 140 TYR A 60 TYR^? 16.66 S2 BME A 300 E 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 0.04 36.70 38.68 -2.21 35.46 37.50 9.00 3.02 1.57 7.75 5.45 1.00 coo 1.93 30.52 36.31 -2.84 30.18 38.54 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c14 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 E 140 TYR A 75 TYR~? 15.90 S2 BME A 300 E 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 0.04 36.70 38.68 -2.21 35.46 37.50 14.46 -0.26 16.60 17.11 0.41 17.22 coo 1.93 30.52 36.31 -2.84 30.18 38.54 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c14 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c14 naa= 2 ULMN 2 1eq2_c15 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 F 140 TYR A 34 TYR.? 16.37 S2 BME A 300 F 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 54.49 89.31 49.65 53.35 90.16 52.06 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 56.78 95.62 51.15 51.59 95.31 52.37 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c15 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 F 140 TYR A 34 TYR.? 16.37 S2 BME A 300 F 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 54.49 89.31 49.65 53.35 90.16 52.06 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 56.78 95.62 51.15 51.59 95.31 52.37 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c15 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 F 140 TYR A 59 TYR^? 18.50 S2 BME A 300 F 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 54.49 89.31 49.65 53.35 90.16 52.06 14.59 5.14 5.72 16.82 6.86 5.68 coo 56.78 95.62 51.15 51.59 95.31 52.37 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c15 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 F 140 TYR A 60 TYR^? 16.66 S2 BME A 300 F 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 54.49 89.31 49.65 53.35 90.16 52.06 9.00 3.02 1.57 7.75 5.45 1.00 coo 56.78 95.62 51.15 51.59 95.31 52.37 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c15 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 F 140 TYR A 75 TYR~? 15.90 S2 BME A 300 F 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 54.49 89.31 49.65 53.35 90.16 52.06 14.46 -0.26 16.60 17.11 0.41 17.22 coo 56.78 95.62 51.15 51.59 95.31 52.37 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c15 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c15 naa= 2 ULMN 2 1eq2_c16 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 G 140 TYR A 34 TYR.? 16.37 S2 BME A 300 G 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 69.78 91.62 20.06 71.51 92.68 22.02 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 71.19 98.21 18.32 70.69 97.75 23.67 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c16 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 G 140 TYR A 34 TYR.? 16.37 S2 BME A 300 G 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 69.78 91.62 20.06 71.51 92.68 22.02 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 71.19 98.21 18.32 70.69 97.75 23.67 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c16 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 G 140 TYR A 59 TYR^? 18.50 S2 BME A 300 G 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 69.78 91.62 20.06 71.51 92.68 22.02 14.59 5.14 5.72 16.82 6.86 5.68 coo 71.19 98.21 18.32 70.69 97.75 23.67 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c16 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 G 140 TYR A 60 TYR^? 16.66 S2 BME A 300 G 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 69.78 91.62 20.06 71.51 92.68 22.02 9.00 3.02 1.57 7.75 5.45 1.00 coo 71.19 98.21 18.32 70.69 97.75 23.67 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c16 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 G 140 TYR A 75 TYR~? 15.90 S2 BME A 300 G 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 69.78 91.62 20.06 71.51 92.68 22.02 14.46 -0.26 16.60 17.11 0.41 17.22 coo 71.19 98.21 18.32 70.69 97.75 23.67 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c16 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c16 naa= 2 ULMN 2 1eq2_c17 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 H 140 TYR A 34 TYR.? 16.37 S2 BME A 300 H 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 21.92 87.58 44.67 19.30 88.41 44.23 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 21.26 93.70 47.67 18.47 93.68 43.08 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c17 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 H 140 TYR A 34 TYR.? 16.37 S2 BME A 300 H 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 21.92 87.58 44.67 19.30 88.41 44.23 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 21.26 93.70 47.67 18.47 93.68 43.08 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c17 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 H 140 TYR A 59 TYR^? 18.50 S2 BME A 300 H 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 21.92 87.58 44.67 19.30 88.41 44.23 14.59 5.14 5.72 16.82 6.86 5.68 coo 21.26 93.70 47.67 18.47 93.68 43.08 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c17 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 H 140 TYR A 60 TYR^? 16.66 S2 BME A 300 H 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 21.92 87.58 44.67 19.30 88.41 44.23 9.00 3.02 1.57 7.75 5.45 1.00 coo 21.26 93.70 47.67 18.47 93.68 43.08 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c17 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 H 140 TYR A 75 TYR~? 15.90 S2 BME A 300 H 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 21.92 87.58 44.67 19.30 88.41 44.23 14.46 -0.26 16.60 17.11 0.41 17.22 coo 21.26 93.70 47.67 18.47 93.68 43.08 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c17 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c17 naa= 2 ULMN 2 1eq2_c18 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 I 140 TYR A 34 TYR.? 16.37 S2 BME A 300 I 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 16.78 87.76 12.19 16.39 88.69 9.59 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 13.67 93.83 12.65 17.08 93.94 8.58 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c18 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 I 140 TYR A 34 TYR.? 16.37 S2 BME A 300 I 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 16.78 87.76 12.19 16.39 88.69 9.59 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 13.67 93.83 12.65 17.08 93.94 8.58 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c18 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 I 140 TYR A 59 TYR^? 18.50 S2 BME A 300 I 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 16.78 87.76 12.19 16.39 88.69 9.59 14.59 5.14 5.72 16.82 6.86 5.68 coo 13.67 93.83 12.65 17.08 93.94 8.58 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c18 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 I 140 TYR A 75 TYR~? 15.90 S2 BME A 300 I 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 16.78 87.76 12.19 16.39 88.69 9.59 14.46 -0.26 16.60 17.11 0.41 17.22 coo 13.67 93.83 12.65 17.08 93.94 8.58 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c18 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c18 naa= 2 ULMN 2 1eq2_c19 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 J 140 TYR A 34 TYR.? 16.37 S2 BME A 300 J 144 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1eq2_c19 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 2 # 2 J 140 TYR A 34 TYR.? 16.37 S2 BME A 300 J 144 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 46.51 90.06 -3.08 48.69 91.36 -4.30 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1eq2_c19 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 2 # 3 J 140 TYR A 59 TYR^? 18.50 S2 BME A 300 J 144 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 14.59 5.14 5.72 16.82 6.86 5.68 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1eq2_c19 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 2 # 4 J 140 TYR A 60 TYR^? 16.66 S2 BME A 300 J 144 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 9.00 3.02 1.57 7.75 5.45 1.00 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1eq2_c19 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 2 # 5 J 140 TYR A 75 TYR~? 15.90 S2 BME A 300 J 144 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 14.46 -0.26 16.60 17.11 0.41 17.22 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 8.82 -4.39 14.42 10.42 -10.04 16.23 1eq2_c19 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 5 hits 1eq2_c19 naa= 2 ULMN 2 1eso_c00 CU, ZN SUPEROXIDE DISMUTASE user 1 2 # 1 61 HIS A 91 HIS~? 7.63 O1 BME A 300 141 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 9.30 6.84 14.05 8.96 5.17 15.26 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 16.06 0.88 14.70 16.24 4.03 14.68 13.39 -11.16 2.90 14.53 -11.26 0.04 1eso_c00 source 1eso CU, ZN SUPEROXIDE DISMUTASE : 1 hits 1eso_c00 naa= 2 ULMN 2 1eug_c00 GLYCOSYLASE user 1 2 # 1 A 64 ASP A 95 ASP.? 15.99 O1 BME A 300 A 187 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 8.78 5.95 13.35 7.37 7.06 12.26 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 16.78 -0.75 14.60 15.02 -0.07 15.53 3.84 -13.89 0.30 2.26 -15.26 0.08 1eug_c00 source 1eug GLYCOSYLASE : 1 hits 1eug_c00 naa= 2 ULMN 2 1evy_c00 GLYCEROL-3-PHOSPHATE DEHYDROGENASE user 1 2 # 1 A 210 LYS A 10 LYS~? 16.18 O1 BME A 300 A 267 THR A 5 THR~? 15.55 O1 BME A 300 coo 41.87 54.40 8.08 43.44 49.84 12.08 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 41.37 47.71 7.16 41.46 49.18 8.80 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1evy_c00 GLYCEROL-3-PHOSPHATE DEHYDROGENASE user 2 2 # 2 A 210 LYS A 10 LYS~? 16.18 O1 BME A 300 A 267 THR A 6 THR~? 12.27 O1 BME A 300 coo 41.87 54.40 8.08 43.44 49.84 12.08 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 41.37 47.71 7.16 41.46 49.18 8.80 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1evy_c00 source 1evy GLYCEROL-3-PHOSPHATE DEHYDROGENASE : 2 hits 1evy_c00 naa= 2 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 1 2 # 1 A 285 ASP A 7 ASP~? 16.68 O1 BME A 300 A 491 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 28.57 22.90 36.39 26.87 24.09 36.82 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 23.17 29.31 41.02 24.36 29.21 39.27 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 2 2 # 2 A 285 ASP A 23 ASP^? 9.45 S2 BME A 300 A 491 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 28.57 22.90 36.39 26.87 24.09 36.82 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 23.17 29.31 41.02 24.36 29.21 39.27 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 3 2 # 3 A 285 ASP A 23 ASP^? 9.45 S2 BME A 300 A 491 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 28.57 22.90 36.39 26.87 24.09 36.82 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 23.17 29.31 41.02 24.36 29.21 39.27 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 4 2 # 4 A 285 ASP A 27 ASP~? 15.09 S2 BME A 300 A 491 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 28.57 22.90 36.39 26.87 24.09 36.82 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 23.17 29.31 41.02 24.36 29.21 39.27 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1ex1_c00 BETA-D-GLUCAN EXOHYDROLASE ISOENZYMEuser 5 2 # 5 A 285 ASP A 82 ASP^? 20.57 S2 BME A 300 A 491 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 28.57 22.90 36.39 26.87 24.09 36.82 10.12 9.33 8.59 8.15 9.51 7.94 coo 23.17 29.31 41.02 24.36 29.21 39.27 16.30 10.78 3.24 16.87 9.97 1.36 1ex1_c00 source 1ex1 BETA-D-GLUCAN EXOHYDROLASE ISOENZYME EXO1 : 5 hits 1ex1_c00 naa= 2 ULMN 2 1f7l_c02 HOLO-(ACYL CARRIER PROTEIN) SYNTHASEuser 1 2 # 1 A 62 LYS A 2 LYS.? 20.18 S2 BME A 300 A 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 9.16 8.08 45.36 8.29 5.91 51.34 2.39 3.95 8.25 5.67 8.88 7.74 coo -7.37 8.81 56.82 -6.87 10.59 55.84 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f7l_c02 HOLO-(ACYL CARRIER PROTEIN) SYNTHASEuser 2 2 # 2 A 62 LYS A 12 LYS~? 21.81 S2 BME A 300 A 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 9.16 8.08 45.36 8.29 5.91 51.34 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -7.37 8.81 56.82 -6.87 10.59 55.84 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f7l_c02 HOLO-(ACYL CARRIER PROTEIN) SYNTHASEuser 3 2 # 3 A 62 LYS A 39 LYS^? 20.06 S2 BME A 300 A 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 9.16 8.08 45.36 8.29 5.91 51.34 19.85 -1.20 1.64 21.03 4.07 2.80 coo -7.37 8.81 56.82 -6.87 10.59 55.84 3.84 -13.89 0.30 2.26 -15.26 0.08 1f7l_c02 source 1f7l HOLO-(ACYL CARRIER PROTEIN) SYNTHASE : 3 hits 1f7l_c02 naa= 2 ULMN 2 1f80_c00 ACYL CARRIER PROTEIN user 1 2 # 1 A 62 LYS A 2 LYS.? 20.18 S2 BME A 300 A 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 20.51 39.76 8.83 21.23 37.38 14.18 2.39 3.95 8.25 5.67 8.88 7.74 coo 15.40 22.79 16.66 13.93 24.10 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c00 ACYL CARRIER PROTEIN user 2 2 # 2 A 62 LYS A 12 LYS~? 21.81 S2 BME A 300 A 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 20.51 39.76 8.83 21.23 37.38 14.18 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 15.40 22.79 16.66 13.93 24.10 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c00 ACYL CARRIER PROTEIN user 3 2 # 3 A 62 LYS A 39 LYS^? 20.06 S2 BME A 300 A 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 20.51 39.76 8.83 21.23 37.38 14.18 19.85 -1.20 1.64 21.03 4.07 2.80 coo 15.40 22.79 16.66 13.93 24.10 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c00 ACYL CARRIER PROTEIN user 4 2 # 4 A 62 LYS A 71 LYS~? 8.54 S2 BME A 300 A 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 20.51 39.76 8.83 21.23 37.38 14.18 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 15.40 22.79 16.66 13.93 24.10 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 1f80_c00 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c00 naa= 2 ULMN 2 1f80_c01 ACYL CARRIER PROTEIN user 1 2 # 1 B 62 LYS A 2 LYS.? 20.18 S2 BME A 300 B 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 38.76 28.25 7.87 36.33 26.41 13.58 2.39 3.95 8.25 5.67 8.88 7.74 coo 27.18 37.56 20.68 29.07 38.28 20.13 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c01 ACYL CARRIER PROTEIN user 2 2 # 2 B 62 LYS A 12 LYS~? 21.81 S2 BME A 300 B 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 38.76 28.25 7.87 36.33 26.41 13.58 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 27.18 37.56 20.68 29.07 38.28 20.13 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c01 ACYL CARRIER PROTEIN user 3 2 # 3 B 62 LYS A 39 LYS^? 20.06 S2 BME A 300 B 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 38.76 28.25 7.87 36.33 26.41 13.58 19.85 -1.20 1.64 21.03 4.07 2.80 coo 27.18 37.56 20.68 29.07 38.28 20.13 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c01 ACYL CARRIER PROTEIN user 4 2 # 4 B 62 LYS A 71 LYS~? 8.54 S2 BME A 300 B 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 38.76 28.25 7.87 36.33 26.41 13.58 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 27.18 37.56 20.68 29.07 38.28 20.13 3.84 -13.89 0.30 2.26 -15.26 0.08 1f80_c01 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c01 naa= 2 ULMN 2 1f80_c02 ACYL CARRIER PROTEIN user 1 2 # 1 C 62 LYS A 2 LYS.? 20.18 S2 BME A 300 C 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 19.95 18.98 4.81 18.82 20.94 10.49 2.39 3.95 8.25 5.67 8.88 7.74 coo 34.93 19.72 17.37 34.72 18.17 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c02 ACYL CARRIER PROTEIN user 2 2 # 2 C 62 LYS A 12 LYS~? 21.81 S2 BME A 300 C 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 19.95 18.98 4.81 18.82 20.94 10.49 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 34.93 19.72 17.37 34.72 18.17 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c02 ACYL CARRIER PROTEIN user 3 2 # 3 C 62 LYS A 39 LYS^? 20.06 S2 BME A 300 C 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 19.95 18.98 4.81 18.82 20.94 10.49 19.85 -1.20 1.64 21.03 4.07 2.80 coo 34.93 19.72 17.37 34.72 18.17 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1f80_c02 ACYL CARRIER PROTEIN user 4 2 # 4 C 62 LYS A 71 LYS~? 8.54 S2 BME A 300 C 105 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 19.95 18.98 4.81 18.82 20.94 10.49 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 34.93 19.72 17.37 34.72 18.17 15.98 3.84 -13.89 0.30 2.26 -15.26 0.08 1f80_c02 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c02 naa= 2 ULMN 2 1f8r_c00 L-AMINO ACID OXIDASE user 1 2 # 1 A 223 HIS A 91 HIS~? 7.63 O1 BME A 300 A 326 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 32.14 47.24 95.55 33.29 47.43 93.81 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 31.81 59.38 82.93 29.11 53.63 83.59 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1f8r_c00 L-AMINO ACID OXIDASE user 2 2 # 2 A 223 HIS A 91 HIS~? 7.63 O1 BME A 300 A 326 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 32.14 47.24 95.55 33.29 47.43 93.81 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 31.81 59.38 82.93 29.11 53.63 83.59 8.82 -4.39 14.42 10.42 -10.04 16.23 1f8r_c00 source 1f8r L-AMINO ACID OXIDASE : 2 hits 1f8r_c00 naa= 2 ULMN 2 1f8r_c01 L-AMINO ACID OXIDASE user 1 2 # 1 B 223 HIS A 91 HIS~? 7.63 O1 BME A 300 B 326 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 26.95 108.36 54.79 28.84 107.50 55.13 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 31.78 95.33 65.42 31.80 101.69 65.97 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1f8r_c01 L-AMINO ACID OXIDASE user 2 2 # 2 B 223 HIS A 91 HIS~? 7.63 O1 BME A 300 B 326 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 26.95 108.36 54.79 28.84 107.50 55.13 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 31.78 95.33 65.42 31.80 101.69 65.97 8.82 -4.39 14.42 10.42 -10.04 16.23 1f8r_c01 source 1f8r L-AMINO ACID OXIDASE : 2 hits 1f8r_c01 naa= 2 ULMN 2 1f8r_c02 L-AMINO ACID OXIDASE user 1 2 # 1 C 223 HIS A 91 HIS~? 7.63 O1 BME A 300 C 326 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 33.25 74.67 113.67 31.48 75.77 113.48 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 25.07 80.73 99.44 29.33 83.19 103.51 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1f8r_c02 L-AMINO ACID OXIDASE user 2 2 # 2 C 223 HIS A 91 HIS~? 7.63 O1 BME A 300 C 326 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 33.25 74.67 113.67 31.48 75.77 113.48 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 25.07 80.73 99.44 29.33 83.19 103.51 8.82 -4.39 14.42 10.42 -10.04 16.23 1f8r_c02 source 1f8r L-AMINO ACID OXIDASE : 2 hits 1f8r_c02 naa= 2 ULMN 2 1f8r_c03 L-AMINO ACID OXIDASE user 1 2 # 1 D 223 HIS A 91 HIS~? 7.63 O1 BME A 300 D 326 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 4.66 85.67 46.64 3.37 85.25 48.25 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 8.23 80.75 63.06 6.88 77.61 57.64 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1f8r_c03 L-AMINO ACID OXIDASE user 2 2 # 2 D 223 HIS A 91 HIS~? 7.63 O1 BME A 300 D 326 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 4.66 85.67 46.64 3.37 85.25 48.25 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 8.23 80.75 63.06 6.88 77.61 57.64 8.82 -4.39 14.42 10.42 -10.04 16.23 1f8r_c03 source 1f8r L-AMINO ACID OXIDASE : 2 hits 1f8r_c03 naa= 2 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 1 2 # 1 A 286 GLU A 8 GLU~? 18.47 O1 BME A 300 A 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 34.33 303.48 222.19 37.83 307.04 219.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 2 2 # 2 A 286 GLU A 8 GLU~? 18.47 O1 BME A 300 A 362 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 34.33 303.48 222.19 37.83 307.04 219.88 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 3 2 # 3 A 286 GLU A 15 GLU~? 24.22 S2 BME A 300 A 362 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 34.33 303.48 222.19 37.83 307.04 219.88 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 4 2 # 4 A 286 GLU A 28 GLU~? 14.38 S2 BME A 300 A 362 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 34.33 303.48 222.19 37.83 307.04 219.88 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 5 2 # 5 A 286 GLU A 29 GLU~? 6.68 S2 BME A 300 A 362 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 34.33 303.48 222.19 37.83 307.04 219.88 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 6 2 # 6 A 286 GLU A 57 GLU.? 23.43 S2 BME A 300 A 362 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 16.30 10.78 3.24 16.87 9.97 1.36 coo 34.33 303.48 222.19 37.83 307.04 219.88 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 7 2 # 7 A 286 GLU A 74 GLU~? 13.09 S2 BME A 300 A 362 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 34.33 303.48 222.19 37.83 307.04 219.88 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 8 2 # 8 A 286 GLU A 74 GLU~? 13.09 S2 BME A 300 A 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 34.33 303.48 222.19 37.83 307.04 219.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 9 2 # 9 A 286 GLU A 77 GLU~? 17.67 S2 BME A 300 A 362 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 7.63 5.18 13.95 5.55 5.01 14.48 coo 34.33 303.48 222.19 37.83 307.04 219.88 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 10 2 # 10 A 286 GLU A 77 GLU~? 17.67 S2 BME A 300 A 362 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 7.63 5.18 13.95 5.55 5.01 14.48 coo 34.33 303.48 222.19 37.83 307.04 219.88 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 11 2 # 11 A 286 GLU A 77 GLU~? 17.67 S2 BME A 300 A 362 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 7.63 5.18 13.95 5.55 5.01 14.48 coo 34.33 303.48 222.19 37.83 307.04 219.88 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 12 2 # 12 A 286 GLU A 87 GLU.? 12.12 O1 BME A 300 A 362 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 34.33 303.48 222.19 37.83 307.04 219.88 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 13 2 # 13 A 286 GLU A 87 GLU.? 12.12 O1 BME A 300 A 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 34.33 303.48 222.19 37.83 307.04 219.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 14 2 # 14 A 286 GLU A 96 GLU.? 20.00 O1 BME A 300 A 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 34.33 303.48 222.19 37.83 307.04 219.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c02 UBIQUINOL OXIDASE user 15 2 # 15 A 286 GLU A 99 GLU.? 20.82 S2 BME A 300 A 362 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 44.33 299.22 203.95 43.60 300.74 202.69 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 34.33 303.48 222.19 37.83 307.04 219.88 13.04 11.19 -6.33 8.80 12.60 -2.10 1fft_c02 source 1fft UBIQUINOL OXIDASE : 15 hits 1fft_c02 naa= 2 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 1 2 # 1 F 286 GLU A 8 GLU~? 18.47 O1 BME A 300 F 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -12.12 171.74 105.52 -8.57 175.32 103.28 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 2 2 # 2 F 286 GLU A 8 GLU~? 18.47 O1 BME A 300 F 362 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -12.12 171.74 105.52 -8.57 175.32 103.28 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 3 2 # 3 F 286 GLU A 15 GLU~? 24.22 S2 BME A 300 F 362 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -12.12 171.74 105.52 -8.57 175.32 103.28 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 4 2 # 4 F 286 GLU A 28 GLU~? 14.38 S2 BME A 300 F 362 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -12.12 171.74 105.52 -8.57 175.32 103.28 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 5 2 # 5 F 286 GLU A 29 GLU~? 6.68 S2 BME A 300 F 362 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -12.12 171.74 105.52 -8.57 175.32 103.28 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 6 2 # 6 F 286 GLU A 57 GLU.? 23.43 S2 BME A 300 F 362 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 16.30 10.78 3.24 16.87 9.97 1.36 coo -12.12 171.74 105.52 -8.57 175.32 103.28 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 7 2 # 7 F 286 GLU A 74 GLU~? 13.09 S2 BME A 300 F 362 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -12.12 171.74 105.52 -8.57 175.32 103.28 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 8 2 # 8 F 286 GLU A 74 GLU~? 13.09 S2 BME A 300 F 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -12.12 171.74 105.52 -8.57 175.32 103.28 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 9 2 # 9 F 286 GLU A 77 GLU~? 17.67 S2 BME A 300 F 362 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 7.63 5.18 13.95 5.55 5.01 14.48 coo -12.12 171.74 105.52 -8.57 175.32 103.28 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 10 2 # 10 F 286 GLU A 77 GLU~? 17.67 S2 BME A 300 F 362 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 7.63 5.18 13.95 5.55 5.01 14.48 coo -12.12 171.74 105.52 -8.57 175.32 103.28 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 11 2 # 11 F 286 GLU A 77 GLU~? 17.67 S2 BME A 300 F 362 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 7.63 5.18 13.95 5.55 5.01 14.48 coo -12.12 171.74 105.52 -8.57 175.32 103.28 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 12 2 # 12 F 286 GLU A 87 GLU.? 12.12 O1 BME A 300 F 362 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -12.12 171.74 105.52 -8.57 175.32 103.28 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 13 2 # 13 F 286 GLU A 87 GLU.? 12.12 O1 BME A 300 F 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -12.12 171.74 105.52 -8.57 175.32 103.28 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 14 2 # 14 F 286 GLU A 96 GLU.? 20.00 O1 BME A 300 F 362 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -12.12 171.74 105.52 -8.57 175.32 103.28 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1fft_c03 UBIQUINOL OXIDASE user 15 2 # 15 F 286 GLU A 99 GLU.? 20.82 S2 BME A 300 F 362 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -1.93 167.64 87.36 -2.65 169.16 86.08 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -12.12 171.74 105.52 -8.57 175.32 103.28 13.04 11.19 -6.33 8.80 12.60 -2.10 1fft_c03 source 1fft UBIQUINOL OXIDASE : 15 hits 1fft_c03 naa= 2 ULMN 2 1fiq_c01 XANTHINE OXIDASE user 1 2 # 1 C 880 ARG A 68 ARG~? -4.35 S2 BME A 300s C1261 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 31.02 9.69 109.34 29.24 7.24 108.82 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 26.56 13.30 104.79 26.46 12.34 106.65 15.50 -15.19 4.21 14.37 -14.08 5.62 1fiq_c01 source 1fiq XANTHINE OXIDASE : 1 hits 1fiq_c01 naa= 2 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 1 2 # 1 126 ARG A 25 ARG.? 9.68 S2 BME A 300 253 PHE A 53 PHE~? 16.58 S2 BME A 300 coo 11.87 35.64 105.40 9.89 33.34 105.30 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 10.33 21.73 96.74 11.72 23.84 97.98 17.96 4.29 9.15 17.54 1.52 8.86 ULMN 2 1fps_c00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 2 2 # 2 126 ARG A 68 ARG~? -4.35 S2 BME A 300s 253 PHE A 53 PHE~? 16.58 S2 BME A 300 coo 11.87 35.64 105.40 9.89 33.34 105.30 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 10.33 21.73 96.74 11.72 23.84 97.98 17.96 4.29 9.15 17.54 1.52 8.86 1fps_c00 source 1fps AVIAN FARNESYL DIPHOSPHATE SYNTHASE (FPS) (E.C: 2 hits 1fps_c00 naa= 2 ULMN 2 1fq0_c00 KDPG ALDOLASE user 1 2 # 1 A 45 GLU A 8 GLU~? 18.47 O1 BME A 300 A 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 18.26 19.92 32.68 20.05 22.35 36.35 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c00 KDPG ALDOLASE user 2 2 # 2 A 45 GLU A 8 GLU~? 18.47 O1 BME A 300 A 133 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 18.26 19.92 32.68 20.05 22.35 36.35 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1fq0_c00 KDPG ALDOLASE user 3 2 # 3 A 45 GLU A 15 GLU~? 24.22 S2 BME A 300 A 133 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 18.26 19.92 32.68 20.05 22.35 36.35 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fq0_c00 KDPG ALDOLASE user 4 2 # 4 A 45 GLU A 57 GLU.? 23.43 S2 BME A 300 A 133 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 16.30 10.78 3.24 16.87 9.97 1.36 coo 18.26 19.92 32.68 20.05 22.35 36.35 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1fq0_c00 KDPG ALDOLASE user 5 2 # 5 A 45 GLU A 74 GLU~? 13.09 S2 BME A 300 A 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 18.26 19.92 32.68 20.05 22.35 36.35 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c00 KDPG ALDOLASE user 6 2 # 6 A 45 GLU A 77 GLU~? 17.67 S2 BME A 300 A 133 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 7.63 5.18 13.95 5.55 5.01 14.48 coo 18.26 19.92 32.68 20.05 22.35 36.35 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1fq0_c00 KDPG ALDOLASE user 7 2 # 7 A 45 GLU A 77 GLU~? 17.67 S2 BME A 300 A 133 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 7.63 5.18 13.95 5.55 5.01 14.48 coo 18.26 19.92 32.68 20.05 22.35 36.35 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fq0_c00 KDPG ALDOLASE user 8 2 # 8 A 45 GLU A 87 GLU.? 12.12 O1 BME A 300 A 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 18.26 19.92 32.68 20.05 22.35 36.35 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c00 KDPG ALDOLASE user 9 2 # 9 A 45 GLU A 99 GLU.? 20.82 S2 BME A 300 A 133 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.81 25.32 38.82 23.00 25.16 37.74 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 18.26 19.92 32.68 20.05 22.35 36.35 19.85 -1.20 1.64 21.03 4.07 2.80 1fq0_c00 source 1fq0 KDPG ALDOLASE : 9 hits 1fq0_c00 naa= 2 ULMN 2 1fq0_c01 KDPG ALDOLASE user 1 2 # 1 B 45 GLU A 8 GLU~? 18.47 O1 BME A 300 B 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 4.24 17.15 12.78 2.73 12.27 13.50 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c01 KDPG ALDOLASE user 2 2 # 2 B 45 GLU A 8 GLU~? 18.47 O1 BME A 300 B 133 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 4.24 17.15 12.78 2.73 12.27 13.50 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1fq0_c01 KDPG ALDOLASE user 3 2 # 3 B 45 GLU A 15 GLU~? 24.22 S2 BME A 300 B 133 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 4.24 17.15 12.78 2.73 12.27 13.50 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fq0_c01 KDPG ALDOLASE user 4 2 # 4 B 45 GLU A 57 GLU.? 23.43 S2 BME A 300 B 133 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 16.30 10.78 3.24 16.87 9.97 1.36 coo 4.24 17.15 12.78 2.73 12.27 13.50 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1fq0_c01 KDPG ALDOLASE user 5 2 # 5 B 45 GLU A 74 GLU~? 13.09 S2 BME A 300 B 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 4.24 17.15 12.78 2.73 12.27 13.50 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c01 KDPG ALDOLASE user 6 2 # 6 B 45 GLU A 77 GLU~? 17.67 S2 BME A 300 B 133 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 7.63 5.18 13.95 5.55 5.01 14.48 coo 4.24 17.15 12.78 2.73 12.27 13.50 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1fq0_c01 KDPG ALDOLASE user 7 2 # 7 B 45 GLU A 77 GLU~? 17.67 S2 BME A 300 B 133 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 7.63 5.18 13.95 5.55 5.01 14.48 coo 4.24 17.15 12.78 2.73 12.27 13.50 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fq0_c01 KDPG ALDOLASE user 8 2 # 8 B 45 GLU A 87 GLU.? 12.12 O1 BME A 300 B 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 4.24 17.15 12.78 2.73 12.27 13.50 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c01 KDPG ALDOLASE user 9 2 # 9 B 45 GLU A 99 GLU.? 20.82 S2 BME A 300 B 133 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 3.94 6.65 13.38 3.87 8.55 14.36 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 4.24 17.15 12.78 2.73 12.27 13.50 19.85 -1.20 1.64 21.03 4.07 2.80 1fq0_c01 source 1fq0 KDPG ALDOLASE : 9 hits 1fq0_c01 naa= 2 ULMN 2 1fq0_c02 KDPG ALDOLASE user 1 2 # 1 C 45 GLU A 8 GLU~? 18.47 O1 BME A 300 C 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 12.43 39.26 19.13 9.45 41.97 16.24 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c02 KDPG ALDOLASE user 2 2 # 2 C 45 GLU A 8 GLU~? 18.47 O1 BME A 300 C 133 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 12.43 39.26 19.13 9.45 41.97 16.24 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1fq0_c02 KDPG ALDOLASE user 3 2 # 3 C 45 GLU A 15 GLU~? 24.22 S2 BME A 300 C 133 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 12.43 39.26 19.13 9.45 41.97 16.24 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1fq0_c02 KDPG ALDOLASE user 4 2 # 4 C 45 GLU A 57 GLU.? 23.43 S2 BME A 300 C 133 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 16.30 10.78 3.24 16.87 9.97 1.36 coo 12.43 39.26 19.13 9.45 41.97 16.24 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1fq0_c02 KDPG ALDOLASE user 5 2 # 5 C 45 GLU A 74 GLU~? 13.09 S2 BME A 300 C 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 12.43 39.26 19.13 9.45 41.97 16.24 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c02 KDPG ALDOLASE user 6 2 # 6 C 45 GLU A 77 GLU~? 17.67 S2 BME A 300 C 133 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 7.63 5.18 13.95 5.55 5.01 14.48 coo 12.43 39.26 19.13 9.45 41.97 16.24 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1fq0_c02 KDPG ALDOLASE user 7 2 # 7 C 45 GLU A 77 GLU~? 17.67 S2 BME A 300 C 133 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 7.63 5.18 13.95 5.55 5.01 14.48 coo 12.43 39.26 19.13 9.45 41.97 16.24 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1fq0_c02 KDPG ALDOLASE user 8 2 # 8 C 45 GLU A 87 GLU.? 12.12 O1 BME A 300 C 133 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 12.43 39.26 19.13 9.45 41.97 16.24 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1fq0_c02 KDPG ALDOLASE user 9 2 # 9 C 45 GLU A 99 GLU.? 20.82 S2 BME A 300 C 133 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 8.38 43.77 10.65 8.15 42.35 12.20 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 12.43 39.26 19.13 9.45 41.97 16.24 19.85 -1.20 1.64 21.03 4.07 2.80 1fq0_c02 source 1fq0 KDPG ALDOLASE : 9 hits 1fq0_c02 naa= 2 ULMN 2 1fsg_c04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 118 TYR A 34 TYR.? 16.37 S2 BME A 300 A 150 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fsg_c04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 A 118 TYR A 59 TYR^? 18.50 S2 BME A 300 A 150 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 14.59 5.14 5.72 16.82 6.86 5.68 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fsg_c04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 A 118 TYR A 60 TYR^? 16.66 S2 BME A 300 A 150 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 9.00 3.02 1.57 7.75 5.45 1.00 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 10.12 9.33 8.59 8.15 9.51 7.94 1fsg_c04 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1fsg_c04 naa= 2 ULMN 2 1fsg_c05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 118 TYR A 34 TYR.? 16.37 S2 BME A 300 C 150 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 21.17 33.18 32.58 18.59 34.12 32.22 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 15.48 36.57 28.52 14.54 34.69 28.40 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fsg_c05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 118 TYR A 59 TYR^? 18.50 S2 BME A 300 C 150 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 21.17 33.18 32.58 18.59 34.12 32.22 14.59 5.14 5.72 16.82 6.86 5.68 coo 15.48 36.57 28.52 14.54 34.69 28.40 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fsg_c05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 C 118 TYR A 60 TYR^? 16.66 S2 BME A 300 C 150 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 21.17 33.18 32.58 18.59 34.12 32.22 9.00 3.02 1.57 7.75 5.45 1.00 coo 15.48 36.57 28.52 14.54 34.69 28.40 10.12 9.33 8.59 8.15 9.51 7.94 1fsg_c05 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1fsg_c05 naa= 2 ULMN 2 1fua_c00 L-FUCULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 73 GLU A 96 GLU.? 20.00 O1 BME A 300 113 TYR A 75 TYR~? 15.90 S2 BME A 300 coo -24.82 41.20 27.84 -23.33 41.85 29.24 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -9.67 68.24 34.92 -8.38 68.44 32.44 14.46 -0.26 16.60 17.11 0.41 17.22 1fua_c00 source 1fua L-FUCULOSE-1-PHOSPHATE ALDOLASE : 1 hits 1fua_c00 naa= 2 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 1 2 # 1 A 337 GLU A 29 GLU~? 6.68 S2 BME A 300 A 361 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 121.24 38.44 100.14 121.43 39.72 101.85 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 123.79 45.29 105.61 123.06 43.58 104.60 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 2 2 # 2 A 337 GLU A 29 GLU~? 6.68 S2 BME A 300 A 361 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 121.24 38.44 100.14 121.43 39.72 101.85 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 123.79 45.29 105.61 123.06 43.58 104.60 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 3 2 # 3 A 337 GLU A 57 GLU.? 23.43 S2 BME A 300 A 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 121.24 38.44 100.14 121.43 39.72 101.85 16.30 10.78 3.24 16.87 9.97 1.36 coo 123.79 45.29 105.61 123.06 43.58 104.60 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 4 2 # 4 A 337 GLU A 77 GLU~? 17.67 S2 BME A 300 A 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 121.24 38.44 100.14 121.43 39.72 101.85 7.63 5.18 13.95 5.55 5.01 14.48 coo 123.79 45.29 105.61 123.06 43.58 104.60 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c00 L-FUCOSE ISOMERASE user 5 2 # 5 A 337 GLU A 87 GLU.? 12.12 O1 BME A 300 A 361 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 121.24 38.44 100.14 121.43 39.72 101.85 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 123.79 45.29 105.61 123.06 43.58 104.60 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1fui_c00 source 1fui L-FUCOSE ISOMERASE : 5 hits 1fui_c00 naa= 2 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 1 2 # 1 B 337 GLU A 29 GLU~? 6.68 S2 BME A 300 B 361 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 107.33 88.10 66.30 109.04 88.21 67.57 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 112.60 90.49 73.35 111.61 89.74 71.61 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 2 2 # 2 B 337 GLU A 29 GLU~? 6.68 S2 BME A 300 B 361 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 107.33 88.10 66.30 109.04 88.21 67.57 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 112.60 90.49 73.35 111.61 89.74 71.61 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 3 2 # 3 B 337 GLU A 57 GLU.? 23.43 S2 BME A 300 B 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 107.33 88.10 66.30 109.04 88.21 67.57 16.30 10.78 3.24 16.87 9.97 1.36 coo 112.60 90.49 73.35 111.61 89.74 71.61 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 4 2 # 4 B 337 GLU A 77 GLU~? 17.67 S2 BME A 300 B 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 107.33 88.10 66.30 109.04 88.21 67.57 7.63 5.18 13.95 5.55 5.01 14.48 coo 112.60 90.49 73.35 111.61 89.74 71.61 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c01 L-FUCOSE ISOMERASE user 5 2 # 5 B 337 GLU A 87 GLU.? 12.12 O1 BME A 300 B 361 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 107.33 88.10 66.30 109.04 88.21 67.57 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 112.60 90.49 73.35 111.61 89.74 71.61 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1fui_c01 source 1fui L-FUCOSE ISOMERASE : 5 hits 1fui_c01 naa= 2 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 1 2 # 1 C 337 GLU A 29 GLU~? 6.68 S2 BME A 300 C 361 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 72.24 72.88 114.67 73.47 74.62 114.75 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 79.16 78.14 117.33 77.48 77.13 116.54 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 2 2 # 2 C 337 GLU A 29 GLU~? 6.68 S2 BME A 300 C 361 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 72.24 72.88 114.67 73.47 74.62 114.75 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 79.16 78.14 117.33 77.48 77.13 116.54 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 3 2 # 3 C 337 GLU A 57 GLU.? 23.43 S2 BME A 300 C 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 72.24 72.88 114.67 73.47 74.62 114.75 16.30 10.78 3.24 16.87 9.97 1.36 coo 79.16 78.14 117.33 77.48 77.13 116.54 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 4 2 # 4 C 337 GLU A 77 GLU~? 17.67 S2 BME A 300 C 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 72.24 72.88 114.67 73.47 74.62 114.75 7.63 5.18 13.95 5.55 5.01 14.48 coo 79.16 78.14 117.33 77.48 77.13 116.54 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c02 L-FUCOSE ISOMERASE user 5 2 # 5 C 337 GLU A 87 GLU.? 12.12 O1 BME A 300 C 361 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 72.24 72.88 114.67 73.47 74.62 114.75 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 79.16 78.14 117.33 77.48 77.13 116.54 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1fui_c02 source 1fui L-FUCOSE ISOMERASE : 5 hits 1fui_c02 naa= 2 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 1 2 # 1 D 337 GLU A 29 GLU~? 6.68 S2 BME A 300 D 361 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 88.24 74.80 51.29 86.40 73.84 50.89 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 82.09 68.51 48.80 83.27 70.10 49.47 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 2 2 # 2 D 337 GLU A 29 GLU~? 6.68 S2 BME A 300 D 361 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 88.24 74.80 51.29 86.40 73.84 50.89 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 82.09 68.51 48.80 83.27 70.10 49.47 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 3 2 # 3 D 337 GLU A 57 GLU.? 23.43 S2 BME A 300 D 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 88.24 74.80 51.29 86.40 73.84 50.89 16.30 10.78 3.24 16.87 9.97 1.36 coo 82.09 68.51 48.80 83.27 70.10 49.47 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 4 2 # 4 D 337 GLU A 77 GLU~? 17.67 S2 BME A 300 D 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 88.24 74.80 51.29 86.40 73.84 50.89 7.63 5.18 13.95 5.55 5.01 14.48 coo 82.09 68.51 48.80 83.27 70.10 49.47 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c03 L-FUCOSE ISOMERASE user 5 2 # 5 D 337 GLU A 87 GLU.? 12.12 O1 BME A 300 D 361 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 88.24 74.80 51.29 86.40 73.84 50.89 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 82.09 68.51 48.80 83.27 70.10 49.47 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1fui_c03 source 1fui L-FUCOSE ISOMERASE : 5 hits 1fui_c03 naa= 2 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 1 2 # 1 E 337 GLU A 29 GLU~? 6.68 S2 BME A 300 E 361 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 107.93 24.28 80.50 106.97 23.96 78.62 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 101.66 22.07 74.20 103.27 22.69 75.42 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 2 2 # 2 E 337 GLU A 29 GLU~? 6.68 S2 BME A 300 E 361 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 107.93 24.28 80.50 106.97 23.96 78.62 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 101.66 22.07 74.20 103.27 22.69 75.42 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 3 2 # 3 E 337 GLU A 57 GLU.? 23.43 S2 BME A 300 E 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 107.93 24.28 80.50 106.97 23.96 78.62 16.30 10.78 3.24 16.87 9.97 1.36 coo 101.66 22.07 74.20 103.27 22.69 75.42 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 4 2 # 4 E 337 GLU A 77 GLU~? 17.67 S2 BME A 300 E 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 107.93 24.28 80.50 106.97 23.96 78.62 7.63 5.18 13.95 5.55 5.01 14.48 coo 101.66 22.07 74.20 103.27 22.69 75.42 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 5 2 # 5 E 337 GLU A 87 GLU.? 12.12 O1 BME A 300 E 361 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 107.93 24.28 80.50 106.97 23.96 78.62 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 101.66 22.07 74.20 103.27 22.69 75.42 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1fui_c04 L-FUCOSE ISOMERASE user 6 2 # 6 E 337 GLU A 99 GLU.? 20.82 S2 BME A 300 E 361 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 107.93 24.28 80.50 106.97 23.96 78.62 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 101.66 22.07 74.20 103.27 22.69 75.42 15.97 -5.82 2.06 15.42 -7.84 1.89 1fui_c04 source 1fui L-FUCOSE ISOMERASE : 6 hits 1fui_c04 naa= 2 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 1 2 # 1 F 337 GLU A 29 GLU~? 6.68 S2 BME A 300 F 361 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 57.76 53.97 100.56 57.50 52.10 99.61 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 55.55 47.88 94.16 56.19 49.11 95.81 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 2 2 # 2 F 337 GLU A 29 GLU~? 6.68 S2 BME A 300 F 361 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 57.76 53.97 100.56 57.50 52.10 99.61 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 55.55 47.88 94.16 56.19 49.11 95.81 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 3 2 # 3 F 337 GLU A 57 GLU.? 23.43 S2 BME A 300 F 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 57.76 53.97 100.56 57.50 52.10 99.61 16.30 10.78 3.24 16.87 9.97 1.36 coo 55.55 47.88 94.16 56.19 49.11 95.81 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 4 2 # 4 F 337 GLU A 77 GLU~? 17.67 S2 BME A 300 F 361 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 57.76 53.97 100.56 57.50 52.10 99.61 7.63 5.18 13.95 5.55 5.01 14.48 coo 55.55 47.88 94.16 56.19 49.11 95.81 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1fui_c05 L-FUCOSE ISOMERASE user 5 2 # 5 F 337 GLU A 87 GLU.? 12.12 O1 BME A 300 F 361 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 57.76 53.97 100.56 57.50 52.10 99.61 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 55.55 47.88 94.16 56.19 49.11 95.81 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1fui_c05 source 1fui L-FUCOSE ISOMERASE : 5 hits 1fui_c05 naa= 2 ULMN 2 1g64_c00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 1 2 # 1 A 41 LYS A 10 LYS~? 16.18 O1 BME A 300 A 43 THR A 6 THR~? 12.27 O1 BME A 300 coo 3.40 35.69 42.25 -0.97 35.48 38.92 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 3.69 33.32 46.92 2.58 31.52 46.50 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1g64_c00 source 1g64 COB(I)ALAMIN ADENOSYLTRANSFERASE : 1 hits 1g64_c00 naa= 2 ULMN 2 1g64_c01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 1 2 # 1 B 241 LYS A 10 LYS~? 16.18 O1 BME A 300 B 243 THR A 6 THR~? 12.27 O1 BME A 300 coo 11.27 29.31 41.91 14.46 29.97 38.30 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 11.07 31.88 46.68 12.01 33.74 46.14 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1g64_c01 source 1g64 COB(I)ALAMIN ADENOSYLTRANSFERASE : 1 hits 1g64_c01 naa= 2 ULMN 2 1ge7_c00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 A 100 PHE A 53 PHE~? 16.58 S2 BME A 300 A 118 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 17.96 4.29 9.15 17.54 1.52 8.86 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 16.30 10.78 3.24 16.87 9.97 1.36 1ge7_c00 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 1 hits 1ge7_c00 naa= 2 ULMN 2 1ge7_c01 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 B 100 PHE A 53 PHE~? 16.58 S2 BME A 300 B 118 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 3.67 17.54 51.97 6.00 19.03 52.32 17.96 4.29 9.15 17.54 1.52 8.86 coo 4.10 21.86 44.74 2.66 21.47 43.23 16.30 10.78 3.24 16.87 9.97 1.36 1ge7_c01 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 1 hits 1ge7_c01 naa= 2 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 A 118 GLU A 8 GLU~? 18.47 O1 BME A 300 A 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 26.98 8.80 3.58 27.20 8.50 0.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 2 2 # 2 A 118 GLU A 15 GLU~? 24.22 S2 BME A 300 A 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 26.98 8.80 3.58 27.20 8.50 0.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 3 2 # 3 A 118 GLU A 28 GLU~? 14.38 S2 BME A 300 A 133 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 26.98 8.80 3.58 27.20 8.50 0.81 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 4 2 # 4 A 118 GLU A 29 GLU~? 6.68 S2 BME A 300 A 133 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 26.98 8.80 3.58 27.20 8.50 0.81 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 5 2 # 5 A 118 GLU A 57 GLU.? 23.43 S2 BME A 300 A 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 16.30 10.78 3.24 16.87 9.97 1.36 coo 26.98 8.80 3.58 27.20 8.50 0.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 6 2 # 6 A 118 GLU A 77 GLU~? 17.67 S2 BME A 300 A 133 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 7.63 5.18 13.95 5.55 5.01 14.48 coo 26.98 8.80 3.58 27.20 8.50 0.81 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 7 2 # 7 A 118 GLU A 77 GLU~? 17.67 S2 BME A 300 A 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 7.63 5.18 13.95 5.55 5.01 14.48 coo 26.98 8.80 3.58 27.20 8.50 0.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 8 2 # 8 A 118 GLU A 87 GLU.? 12.12 O1 BME A 300 A 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 26.98 8.80 3.58 27.20 8.50 0.81 9.00 3.02 1.57 7.75 5.45 1.00 1ge7_c02 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 8 hits 1ge7_c02 naa= 2 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 B 118 GLU A 8 GLU~? 18.47 O1 BME A 300 B 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 1.98 12.55 38.35 1.73 12.30 41.13 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 2 2 # 2 B 118 GLU A 15 GLU~? 24.22 S2 BME A 300 B 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 1.98 12.55 38.35 1.73 12.30 41.13 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 3 2 # 3 B 118 GLU A 28 GLU~? 14.38 S2 BME A 300 B 133 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 1.98 12.55 38.35 1.73 12.30 41.13 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 4 2 # 4 B 118 GLU A 29 GLU~? 6.68 S2 BME A 300 B 133 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 1.98 12.55 38.35 1.73 12.30 41.13 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 5 2 # 5 B 118 GLU A 57 GLU.? 23.43 S2 BME A 300 B 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 16.30 10.78 3.24 16.87 9.97 1.36 coo 1.98 12.55 38.35 1.73 12.30 41.13 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 6 2 # 6 B 118 GLU A 77 GLU~? 17.67 S2 BME A 300 B 133 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 7.63 5.18 13.95 5.55 5.01 14.48 coo 1.98 12.55 38.35 1.73 12.30 41.13 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 7 2 # 7 B 118 GLU A 77 GLU~? 17.67 S2 BME A 300 B 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 7.63 5.18 13.95 5.55 5.01 14.48 coo 1.98 12.55 38.35 1.73 12.30 41.13 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ge7_c03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 8 2 # 8 B 118 GLU A 87 GLU.? 12.12 O1 BME A 300 B 133 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 4.10 21.86 44.74 2.66 21.47 43.23 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 1.98 12.55 38.35 1.73 12.30 41.13 9.00 3.02 1.57 7.75 5.45 1.00 1ge7_c03 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 8 hits 1ge7_c03 naa= 2 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 2 # 1 B 231 GLU A 8 GLU~? 18.47 O1 BME A 300 B 288 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 2 # 2 B 231 GLU A 15 GLU~? 24.22 S2 BME A 300 B 288 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 2 # 3 B 231 GLU A 96 GLU.? 20.00 O1 BME A 300 B 288 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1ghs_c02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 2 # 4 B 231 GLU A 99 GLU.? 20.82 S2 BME A 300 B 288 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1ghs_c02 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 4 hits 1ghs_c02 naa= 2 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 2 # 1 A 231 GLU A 8 GLU~? 18.47 O1 BME A 300 A 288 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 54.40 -0.12 97.85 55.58 0.51 96.24 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 2 # 2 A 231 GLU A 15 GLU~? 24.22 S2 BME A 300 A 288 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 56.45 0.46 86.18 56.87 -0.85 87.80 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 2 # 3 A 231 GLU A 96 GLU.? 20.00 O1 BME A 300 A 288 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 56.45 0.46 86.18 56.87 -0.85 87.80 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 54.40 -0.12 97.85 55.58 0.51 96.24 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1ghs_c03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 2 # 4 A 231 GLU A 99 GLU.? 20.82 S2 BME A 300 A 288 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 56.45 0.46 86.18 56.87 -0.85 87.80 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 54.40 -0.12 97.85 55.58 0.51 96.24 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1ghs_c03 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 4 hits 1ghs_c03 naa= 2 ULMN 2 1gpj_c01 GLUTAMYL-TRNA REDUCTASE user 1 2 # 1 A 48 SER A 3 SER^? 13.09 C1 BME A 300 A 84 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 73.61 56.25 53.64 74.51 58.42 54.29 2.01 1.27 5.67 0.61 -0.61 5.33 coo 60.00 60.51 47.62 61.47 59.95 49.01 3.84 -13.89 0.30 2.26 -15.26 0.08 1gpj_c01 source 1gpj GLUTAMYL-TRNA REDUCTASE : 1 hits 1gpj_c01 naa= 2 ULMN 2 1grc_c05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 2 # 1 B 108 HIS A 91 HIS~? 7.63 O1 BME A 300 B 144 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 41.00 107.18 12.86 42.70 107.82 11.96 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 31.60 110.69 6.14 29.69 109.74 5.94 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1grc_c05 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c05 naa= 2 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 A 117 GLU A 15 GLU~? 24.22 S2 BME A 300 A 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -46.59 50.85 67.63 -45.19 49.65 68.72 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 A 117 GLU A 15 GLU~? 24.22 S2 BME A 300 A 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -46.59 50.85 67.63 -45.19 49.65 68.72 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 A 117 GLU A 28 GLU~? 14.38 S2 BME A 300 A 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -46.59 50.85 67.63 -45.19 49.65 68.72 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 A 117 GLU A 28 GLU~? 14.38 S2 BME A 300 A 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -46.59 50.85 67.63 -45.19 49.65 68.72 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 A 117 GLU A 28 GLU~? 14.38 S2 BME A 300 A 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -46.59 50.85 67.63 -45.19 49.65 68.72 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 A 117 GLU A 29 GLU~? 6.68 S2 BME A 300 A 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -46.59 50.85 67.63 -45.19 49.65 68.72 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 A 117 GLU A 29 GLU~? 6.68 S2 BME A 300 A 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -46.59 50.85 67.63 -45.19 49.65 68.72 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 A 117 GLU A 57 GLU.? 23.43 S2 BME A 300 A 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 16.30 10.78 3.24 16.87 9.97 1.36 coo -46.59 50.85 67.63 -45.19 49.65 68.72 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 A 117 GLU A 57 GLU.? 23.43 S2 BME A 300 A 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 16.30 10.78 3.24 16.87 9.97 1.36 coo -46.59 50.85 67.63 -45.19 49.65 68.72 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 A 117 GLU A 74 GLU~? 13.09 S2 BME A 300 A 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -46.59 50.85 67.63 -45.19 49.65 68.72 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 A 117 GLU A 74 GLU~? 13.09 S2 BME A 300 A 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -46.59 50.85 67.63 -45.19 49.65 68.72 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 A 117 GLU A 74 GLU~? 13.09 S2 BME A 300 A 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -46.59 50.85 67.63 -45.19 49.65 68.72 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 A 117 GLU A 77 GLU~? 17.67 S2 BME A 300 A 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 7.63 5.18 13.95 5.55 5.01 14.48 coo -46.59 50.85 67.63 -45.19 49.65 68.72 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 A 117 GLU A 77 GLU~? 17.67 S2 BME A 300 A 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 7.63 5.18 13.95 5.55 5.01 14.48 coo -46.59 50.85 67.63 -45.19 49.65 68.72 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 A 117 GLU A 87 GLU.? 12.12 O1 BME A 300 A 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -46.59 50.85 67.63 -45.19 49.65 68.72 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 A 117 GLU A 96 GLU.? 20.00 O1 BME A 300 A 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -46.59 50.85 67.63 -45.19 49.65 68.72 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 A 117 GLU A 99 GLU.? 20.82 S2 BME A 300 A 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -46.59 50.85 67.63 -45.19 49.65 68.72 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 A 117 GLU A 99 GLU.? 20.82 S2 BME A 300 A 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -26.84 69.09 69.06 -26.63 69.70 67.04 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -46.59 50.85 67.63 -45.19 49.65 68.72 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c00 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c00 naa= 2 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 B 117 GLU A 15 GLU~? 24.22 S2 BME A 300 B 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -20.24 61.05 64.55 -21.33 59.84 65.93 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 B 117 GLU A 15 GLU~? 24.22 S2 BME A 300 B 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -20.24 61.05 64.55 -21.33 59.84 65.93 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 B 117 GLU A 28 GLU~? 14.38 S2 BME A 300 B 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -20.24 61.05 64.55 -21.33 59.84 65.93 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 B 117 GLU A 28 GLU~? 14.38 S2 BME A 300 B 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -20.24 61.05 64.55 -21.33 59.84 65.93 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 B 117 GLU A 28 GLU~? 14.38 S2 BME A 300 B 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -20.24 61.05 64.55 -21.33 59.84 65.93 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 B 117 GLU A 29 GLU~? 6.68 S2 BME A 300 B 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -20.24 61.05 64.55 -21.33 59.84 65.93 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 B 117 GLU A 29 GLU~? 6.68 S2 BME A 300 B 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -20.24 61.05 64.55 -21.33 59.84 65.93 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 B 117 GLU A 57 GLU.? 23.43 S2 BME A 300 B 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 16.30 10.78 3.24 16.87 9.97 1.36 coo -20.24 61.05 64.55 -21.33 59.84 65.93 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 B 117 GLU A 57 GLU.? 23.43 S2 BME A 300 B 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 16.30 10.78 3.24 16.87 9.97 1.36 coo -20.24 61.05 64.55 -21.33 59.84 65.93 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 B 117 GLU A 74 GLU~? 13.09 S2 BME A 300 B 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -20.24 61.05 64.55 -21.33 59.84 65.93 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 B 117 GLU A 74 GLU~? 13.09 S2 BME A 300 B 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -20.24 61.05 64.55 -21.33 59.84 65.93 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 B 117 GLU A 74 GLU~? 13.09 S2 BME A 300 B 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -20.24 61.05 64.55 -21.33 59.84 65.93 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 B 117 GLU A 77 GLU~? 17.67 S2 BME A 300 B 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 7.63 5.18 13.95 5.55 5.01 14.48 coo -20.24 61.05 64.55 -21.33 59.84 65.93 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 B 117 GLU A 77 GLU~? 17.67 S2 BME A 300 B 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 7.63 5.18 13.95 5.55 5.01 14.48 coo -20.24 61.05 64.55 -21.33 59.84 65.93 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 B 117 GLU A 87 GLU.? 12.12 O1 BME A 300 B 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -20.24 61.05 64.55 -21.33 59.84 65.93 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 B 117 GLU A 96 GLU.? 20.00 O1 BME A 300 B 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -20.24 61.05 64.55 -21.33 59.84 65.93 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 B 117 GLU A 99 GLU.? 20.82 S2 BME A 300 B 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -20.24 61.05 64.55 -21.33 59.84 65.93 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 B 117 GLU A 99 GLU.? 20.82 S2 BME A 300 B 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -1.79 41.80 68.17 -1.22 41.21 66.22 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -20.24 61.05 64.55 -21.33 59.84 65.93 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c01 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c01 naa= 2 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 C 117 GLU A 15 GLU~? 24.22 S2 BME A 300 C 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -9.92 34.54 65.04 -11.08 35.85 66.27 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 C 117 GLU A 15 GLU~? 24.22 S2 BME A 300 C 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -9.92 34.54 65.04 -11.08 35.85 66.27 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 C 117 GLU A 28 GLU~? 14.38 S2 BME A 300 C 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -9.92 34.54 65.04 -11.08 35.85 66.27 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 C 117 GLU A 28 GLU~? 14.38 S2 BME A 300 C 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -9.92 34.54 65.04 -11.08 35.85 66.27 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 C 117 GLU A 28 GLU~? 14.38 S2 BME A 300 C 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -9.92 34.54 65.04 -11.08 35.85 66.27 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 C 117 GLU A 29 GLU~? 6.68 S2 BME A 300 C 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -9.92 34.54 65.04 -11.08 35.85 66.27 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 C 117 GLU A 29 GLU~? 6.68 S2 BME A 300 C 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -9.92 34.54 65.04 -11.08 35.85 66.27 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 C 117 GLU A 57 GLU.? 23.43 S2 BME A 300 C 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 16.30 10.78 3.24 16.87 9.97 1.36 coo -9.92 34.54 65.04 -11.08 35.85 66.27 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 C 117 GLU A 57 GLU.? 23.43 S2 BME A 300 C 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 16.30 10.78 3.24 16.87 9.97 1.36 coo -9.92 34.54 65.04 -11.08 35.85 66.27 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 C 117 GLU A 74 GLU~? 13.09 S2 BME A 300 C 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -9.92 34.54 65.04 -11.08 35.85 66.27 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 C 117 GLU A 74 GLU~? 13.09 S2 BME A 300 C 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -9.92 34.54 65.04 -11.08 35.85 66.27 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 C 117 GLU A 74 GLU~? 13.09 S2 BME A 300 C 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -9.92 34.54 65.04 -11.08 35.85 66.27 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 C 117 GLU A 77 GLU~? 17.67 S2 BME A 300 C 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 7.63 5.18 13.95 5.55 5.01 14.48 coo -9.92 34.54 65.04 -11.08 35.85 66.27 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 C 117 GLU A 77 GLU~? 17.67 S2 BME A 300 C 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 7.63 5.18 13.95 5.55 5.01 14.48 coo -9.92 34.54 65.04 -11.08 35.85 66.27 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 C 117 GLU A 87 GLU.? 12.12 O1 BME A 300 C 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -9.92 34.54 65.04 -11.08 35.85 66.27 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 C 117 GLU A 96 GLU.? 20.00 O1 BME A 300 C 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -9.92 34.54 65.04 -11.08 35.85 66.27 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 C 117 GLU A 99 GLU.? 20.82 S2 BME A 300 C 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -9.92 34.54 65.04 -11.08 35.85 66.27 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 C 117 GLU A 99 GLU.? 20.82 S2 BME A 300 C 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -28.87 16.75 72.09 -29.49 15.92 70.20 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -9.92 34.54 65.04 -11.08 35.85 66.27 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c02 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c02 naa= 2 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 D 117 GLU A 15 GLU~? 24.22 S2 BME A 300 D 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -36.31 24.35 68.07 -34.99 25.71 69.07 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 D 117 GLU A 15 GLU~? 24.22 S2 BME A 300 D 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -36.31 24.35 68.07 -34.99 25.71 69.07 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 D 117 GLU A 28 GLU~? 14.38 S2 BME A 300 D 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -36.31 24.35 68.07 -34.99 25.71 69.07 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 D 117 GLU A 28 GLU~? 14.38 S2 BME A 300 D 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -36.31 24.35 68.07 -34.99 25.71 69.07 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 D 117 GLU A 28 GLU~? 14.38 S2 BME A 300 D 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -36.31 24.35 68.07 -34.99 25.71 69.07 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 D 117 GLU A 29 GLU~? 6.68 S2 BME A 300 D 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -36.31 24.35 68.07 -34.99 25.71 69.07 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 D 117 GLU A 29 GLU~? 6.68 S2 BME A 300 D 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -36.31 24.35 68.07 -34.99 25.71 69.07 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 D 117 GLU A 57 GLU.? 23.43 S2 BME A 300 D 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 16.30 10.78 3.24 16.87 9.97 1.36 coo -36.31 24.35 68.07 -34.99 25.71 69.07 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 D 117 GLU A 57 GLU.? 23.43 S2 BME A 300 D 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 16.30 10.78 3.24 16.87 9.97 1.36 coo -36.31 24.35 68.07 -34.99 25.71 69.07 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 D 117 GLU A 74 GLU~? 13.09 S2 BME A 300 D 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -36.31 24.35 68.07 -34.99 25.71 69.07 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 D 117 GLU A 74 GLU~? 13.09 S2 BME A 300 D 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -36.31 24.35 68.07 -34.99 25.71 69.07 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 D 117 GLU A 74 GLU~? 13.09 S2 BME A 300 D 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -36.31 24.35 68.07 -34.99 25.71 69.07 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 D 117 GLU A 77 GLU~? 17.67 S2 BME A 300 D 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 7.63 5.18 13.95 5.55 5.01 14.48 coo -36.31 24.35 68.07 -34.99 25.71 69.07 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 D 117 GLU A 77 GLU~? 17.67 S2 BME A 300 D 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 7.63 5.18 13.95 5.55 5.01 14.48 coo -36.31 24.35 68.07 -34.99 25.71 69.07 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 D 117 GLU A 87 GLU.? 12.12 O1 BME A 300 D 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -36.31 24.35 68.07 -34.99 25.71 69.07 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 D 117 GLU A 96 GLU.? 20.00 O1 BME A 300 D 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -36.31 24.35 68.07 -34.99 25.71 69.07 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 D 117 GLU A 99 GLU.? 20.82 S2 BME A 300 D 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -36.31 24.35 68.07 -34.99 25.71 69.07 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 D 117 GLU A 99 GLU.? 20.82 S2 BME A 300 D 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -53.93 44.08 73.08 -54.84 44.43 71.23 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -36.31 24.35 68.07 -34.99 25.71 69.07 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c03 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c03 naa= 2 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 E 117 GLU A 15 GLU~? 24.22 S2 BME A 300 E 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -6.51 111.39 54.71 -6.90 112.52 56.48 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 E 117 GLU A 15 GLU~? 24.22 S2 BME A 300 E 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -6.51 111.39 54.71 -6.90 112.52 56.48 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 E 117 GLU A 28 GLU~? 14.38 S2 BME A 300 E 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -6.51 111.39 54.71 -6.90 112.52 56.48 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 E 117 GLU A 28 GLU~? 14.38 S2 BME A 300 E 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -6.51 111.39 54.71 -6.90 112.52 56.48 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 E 117 GLU A 28 GLU~? 14.38 S2 BME A 300 E 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -6.51 111.39 54.71 -6.90 112.52 56.48 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 E 117 GLU A 29 GLU~? 6.68 S2 BME A 300 E 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -6.51 111.39 54.71 -6.90 112.52 56.48 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 E 117 GLU A 29 GLU~? 6.68 S2 BME A 300 E 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -6.51 111.39 54.71 -6.90 112.52 56.48 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 E 117 GLU A 57 GLU.? 23.43 S2 BME A 300 E 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 16.30 10.78 3.24 16.87 9.97 1.36 coo -6.51 111.39 54.71 -6.90 112.52 56.48 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 E 117 GLU A 57 GLU.? 23.43 S2 BME A 300 E 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 16.30 10.78 3.24 16.87 9.97 1.36 coo -6.51 111.39 54.71 -6.90 112.52 56.48 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 E 117 GLU A 74 GLU~? 13.09 S2 BME A 300 E 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -6.51 111.39 54.71 -6.90 112.52 56.48 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 E 117 GLU A 74 GLU~? 13.09 S2 BME A 300 E 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -6.51 111.39 54.71 -6.90 112.52 56.48 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 E 117 GLU A 74 GLU~? 13.09 S2 BME A 300 E 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -6.51 111.39 54.71 -6.90 112.52 56.48 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 E 117 GLU A 77 GLU~? 17.67 S2 BME A 300 E 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 7.63 5.18 13.95 5.55 5.01 14.48 coo -6.51 111.39 54.71 -6.90 112.52 56.48 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 E 117 GLU A 77 GLU~? 17.67 S2 BME A 300 E 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 7.63 5.18 13.95 5.55 5.01 14.48 coo -6.51 111.39 54.71 -6.90 112.52 56.48 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 E 117 GLU A 87 GLU.? 12.12 O1 BME A 300 E 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -6.51 111.39 54.71 -6.90 112.52 56.48 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 E 117 GLU A 96 GLU.? 20.00 O1 BME A 300 E 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -6.51 111.39 54.71 -6.90 112.52 56.48 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 E 117 GLU A 99 GLU.? 20.82 S2 BME A 300 E 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -6.51 111.39 54.71 -6.90 112.52 56.48 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 E 117 GLU A 99 GLU.? 20.82 S2 BME A 300 E 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -21.36 92.92 67.45 -22.82 92.33 66.01 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -6.51 111.39 54.71 -6.90 112.52 56.48 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c04 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c04 naa= 2 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 F 117 GLU A 15 GLU~? 24.22 S2 BME A 300 F 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -29.32 100.98 68.24 -27.58 102.15 68.60 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 F 117 GLU A 15 GLU~? 24.22 S2 BME A 300 F 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -29.32 100.98 68.24 -27.58 102.15 68.60 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 F 117 GLU A 28 GLU~? 14.38 S2 BME A 300 F 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -29.32 100.98 68.24 -27.58 102.15 68.60 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 F 117 GLU A 28 GLU~? 14.38 S2 BME A 300 F 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -29.32 100.98 68.24 -27.58 102.15 68.60 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 F 117 GLU A 28 GLU~? 14.38 S2 BME A 300 F 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -29.32 100.98 68.24 -27.58 102.15 68.60 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 F 117 GLU A 29 GLU~? 6.68 S2 BME A 300 F 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -29.32 100.98 68.24 -27.58 102.15 68.60 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 F 117 GLU A 29 GLU~? 6.68 S2 BME A 300 F 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -29.32 100.98 68.24 -27.58 102.15 68.60 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 F 117 GLU A 57 GLU.? 23.43 S2 BME A 300 F 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 16.30 10.78 3.24 16.87 9.97 1.36 coo -29.32 100.98 68.24 -27.58 102.15 68.60 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 F 117 GLU A 57 GLU.? 23.43 S2 BME A 300 F 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 16.30 10.78 3.24 16.87 9.97 1.36 coo -29.32 100.98 68.24 -27.58 102.15 68.60 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 F 117 GLU A 74 GLU~? 13.09 S2 BME A 300 F 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -29.32 100.98 68.24 -27.58 102.15 68.60 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 F 117 GLU A 74 GLU~? 13.09 S2 BME A 300 F 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -29.32 100.98 68.24 -27.58 102.15 68.60 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 F 117 GLU A 74 GLU~? 13.09 S2 BME A 300 F 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -29.32 100.98 68.24 -27.58 102.15 68.60 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 F 117 GLU A 77 GLU~? 17.67 S2 BME A 300 F 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 7.63 5.18 13.95 5.55 5.01 14.48 coo -29.32 100.98 68.24 -27.58 102.15 68.60 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 F 117 GLU A 77 GLU~? 17.67 S2 BME A 300 F 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 7.63 5.18 13.95 5.55 5.01 14.48 coo -29.32 100.98 68.24 -27.58 102.15 68.60 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 F 117 GLU A 87 GLU.? 12.12 O1 BME A 300 F 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -29.32 100.98 68.24 -27.58 102.15 68.60 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 F 117 GLU A 96 GLU.? 20.00 O1 BME A 300 F 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -29.32 100.98 68.24 -27.58 102.15 68.60 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 F 117 GLU A 99 GLU.? 20.82 S2 BME A 300 F 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -29.32 100.98 68.24 -27.58 102.15 68.60 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 F 117 GLU A 99 GLU.? 20.82 S2 BME A 300 F 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -41.57 119.98 82.85 -43.21 120.52 81.59 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -29.32 100.98 68.24 -27.58 102.15 68.60 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c05 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c05 naa= 2 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 G 117 GLU A 15 GLU~? 24.22 S2 BME A 300 G 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -36.98 127.38 75.58 -35.31 126.04 75.81 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 G 117 GLU A 15 GLU~? 24.22 S2 BME A 300 G 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -36.98 127.38 75.58 -35.31 126.04 75.81 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 G 117 GLU A 28 GLU~? 14.38 S2 BME A 300 G 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -36.98 127.38 75.58 -35.31 126.04 75.81 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 G 117 GLU A 28 GLU~? 14.38 S2 BME A 300 G 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -36.98 127.38 75.58 -35.31 126.04 75.81 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 G 117 GLU A 28 GLU~? 14.38 S2 BME A 300 G 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -36.98 127.38 75.58 -35.31 126.04 75.81 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 G 117 GLU A 29 GLU~? 6.68 S2 BME A 300 G 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -36.98 127.38 75.58 -35.31 126.04 75.81 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 G 117 GLU A 29 GLU~? 6.68 S2 BME A 300 G 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -36.98 127.38 75.58 -35.31 126.04 75.81 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 G 117 GLU A 57 GLU.? 23.43 S2 BME A 300 G 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 16.30 10.78 3.24 16.87 9.97 1.36 coo -36.98 127.38 75.58 -35.31 126.04 75.81 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 G 117 GLU A 57 GLU.? 23.43 S2 BME A 300 G 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 16.30 10.78 3.24 16.87 9.97 1.36 coo -36.98 127.38 75.58 -35.31 126.04 75.81 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 G 117 GLU A 74 GLU~? 13.09 S2 BME A 300 G 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -36.98 127.38 75.58 -35.31 126.04 75.81 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 G 117 GLU A 74 GLU~? 13.09 S2 BME A 300 G 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -36.98 127.38 75.58 -35.31 126.04 75.81 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 G 117 GLU A 74 GLU~? 13.09 S2 BME A 300 G 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -36.98 127.38 75.58 -35.31 126.04 75.81 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 G 117 GLU A 77 GLU~? 17.67 S2 BME A 300 G 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 7.63 5.18 13.95 5.55 5.01 14.48 coo -36.98 127.38 75.58 -35.31 126.04 75.81 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 G 117 GLU A 77 GLU~? 17.67 S2 BME A 300 G 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 7.63 5.18 13.95 5.55 5.01 14.48 coo -36.98 127.38 75.58 -35.31 126.04 75.81 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 G 117 GLU A 87 GLU.? 12.12 O1 BME A 300 G 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -36.98 127.38 75.58 -35.31 126.04 75.81 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 G 117 GLU A 96 GLU.? 20.00 O1 BME A 300 G 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -36.98 127.38 75.58 -35.31 126.04 75.81 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 G 117 GLU A 99 GLU.? 20.82 S2 BME A 300 G 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -36.98 127.38 75.58 -35.31 126.04 75.81 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 G 117 GLU A 99 GLU.? 20.82 S2 BME A 300 G 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -17.54 145.16 69.99 -18.24 146.04 68.15 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -36.98 127.38 75.58 -35.31 126.04 75.81 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c06 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c06 naa= 2 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 H 117 GLU A 15 GLU~? 24.22 S2 BME A 300 H 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -14.22 137.71 62.12 -14.71 136.33 63.70 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 H 117 GLU A 15 GLU~? 24.22 S2 BME A 300 H 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -14.22 137.71 62.12 -14.71 136.33 63.70 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 H 117 GLU A 28 GLU~? 14.38 S2 BME A 300 H 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -14.22 137.71 62.12 -14.71 136.33 63.70 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 H 117 GLU A 28 GLU~? 14.38 S2 BME A 300 H 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -14.22 137.71 62.12 -14.71 136.33 63.70 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 H 117 GLU A 28 GLU~? 14.38 S2 BME A 300 H 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -14.22 137.71 62.12 -14.71 136.33 63.70 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 H 117 GLU A 29 GLU~? 6.68 S2 BME A 300 H 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -14.22 137.71 62.12 -14.71 136.33 63.70 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 H 117 GLU A 29 GLU~? 6.68 S2 BME A 300 H 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -14.22 137.71 62.12 -14.71 136.33 63.70 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 H 117 GLU A 57 GLU.? 23.43 S2 BME A 300 H 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 16.30 10.78 3.24 16.87 9.97 1.36 coo -14.22 137.71 62.12 -14.71 136.33 63.70 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 H 117 GLU A 57 GLU.? 23.43 S2 BME A 300 H 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 16.30 10.78 3.24 16.87 9.97 1.36 coo -14.22 137.71 62.12 -14.71 136.33 63.70 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 H 117 GLU A 74 GLU~? 13.09 S2 BME A 300 H 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -14.22 137.71 62.12 -14.71 136.33 63.70 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 H 117 GLU A 74 GLU~? 13.09 S2 BME A 300 H 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -14.22 137.71 62.12 -14.71 136.33 63.70 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 H 117 GLU A 74 GLU~? 13.09 S2 BME A 300 H 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -14.22 137.71 62.12 -14.71 136.33 63.70 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 H 117 GLU A 77 GLU~? 17.67 S2 BME A 300 H 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 7.63 5.18 13.95 5.55 5.01 14.48 coo -14.22 137.71 62.12 -14.71 136.33 63.70 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 H 117 GLU A 77 GLU~? 17.67 S2 BME A 300 H 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 7.63 5.18 13.95 5.55 5.01 14.48 coo -14.22 137.71 62.12 -14.71 136.33 63.70 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 H 117 GLU A 87 GLU.? 12.12 O1 BME A 300 H 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -14.22 137.71 62.12 -14.71 136.33 63.70 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 H 117 GLU A 96 GLU.? 20.00 O1 BME A 300 H 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -14.22 137.71 62.12 -14.71 136.33 63.70 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 H 117 GLU A 99 GLU.? 20.82 S2 BME A 300 H 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -14.22 137.71 62.12 -14.71 136.33 63.70 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 H 117 GLU A 99 GLU.? 20.82 S2 BME A 300 H 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 2.65 118.13 54.75 2.20 117.91 52.65 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -14.22 137.71 62.12 -14.71 136.33 63.70 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c07 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c07 naa= 2 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 I 117 GLU A 15 GLU~? 24.22 S2 BME A 300 I 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 39.40 18.83 55.43 40.64 19.47 57.06 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 I 117 GLU A 15 GLU~? 24.22 S2 BME A 300 I 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 39.40 18.83 55.43 40.64 19.47 57.06 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 I 117 GLU A 28 GLU~? 14.38 S2 BME A 300 I 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 39.40 18.83 55.43 40.64 19.47 57.06 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 I 117 GLU A 28 GLU~? 14.38 S2 BME A 300 I 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 39.40 18.83 55.43 40.64 19.47 57.06 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 I 117 GLU A 28 GLU~? 14.38 S2 BME A 300 I 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 39.40 18.83 55.43 40.64 19.47 57.06 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 I 117 GLU A 29 GLU~? 6.68 S2 BME A 300 I 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 39.40 18.83 55.43 40.64 19.47 57.06 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 I 117 GLU A 29 GLU~? 6.68 S2 BME A 300 I 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 39.40 18.83 55.43 40.64 19.47 57.06 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 I 117 GLU A 57 GLU.? 23.43 S2 BME A 300 I 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 16.30 10.78 3.24 16.87 9.97 1.36 coo 39.40 18.83 55.43 40.64 19.47 57.06 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 I 117 GLU A 57 GLU.? 23.43 S2 BME A 300 I 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 16.30 10.78 3.24 16.87 9.97 1.36 coo 39.40 18.83 55.43 40.64 19.47 57.06 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 I 117 GLU A 74 GLU~? 13.09 S2 BME A 300 I 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 39.40 18.83 55.43 40.64 19.47 57.06 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 I 117 GLU A 74 GLU~? 13.09 S2 BME A 300 I 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 39.40 18.83 55.43 40.64 19.47 57.06 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 I 117 GLU A 74 GLU~? 13.09 S2 BME A 300 I 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 39.40 18.83 55.43 40.64 19.47 57.06 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 I 117 GLU A 77 GLU~? 17.67 S2 BME A 300 I 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 7.63 5.18 13.95 5.55 5.01 14.48 coo 39.40 18.83 55.43 40.64 19.47 57.06 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 I 117 GLU A 77 GLU~? 17.67 S2 BME A 300 I 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 7.63 5.18 13.95 5.55 5.01 14.48 coo 39.40 18.83 55.43 40.64 19.47 57.06 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 I 117 GLU A 87 GLU.? 12.12 O1 BME A 300 I 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 39.40 18.83 55.43 40.64 19.47 57.06 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 I 117 GLU A 96 GLU.? 20.00 O1 BME A 300 I 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 39.40 18.83 55.43 40.64 19.47 57.06 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 I 117 GLU A 99 GLU.? 20.82 S2 BME A 300 I 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 39.40 18.83 55.43 40.64 19.47 57.06 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 I 117 GLU A 99 GLU.? 20.82 S2 BME A 300 I 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 21.75 35.77 66.58 21.06 37.00 64.94 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 39.40 18.83 55.43 40.64 19.47 57.06 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c08 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c08 naa= 2 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 J 117 GLU A 15 GLU~? 24.22 S2 BME A 300 J 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 29.89 43.66 65.68 31.09 41.98 66.25 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 J 117 GLU A 15 GLU~? 24.22 S2 BME A 300 J 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 29.89 43.66 65.68 31.09 41.98 66.25 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 J 117 GLU A 28 GLU~? 14.38 S2 BME A 300 J 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 29.89 43.66 65.68 31.09 41.98 66.25 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 J 117 GLU A 28 GLU~? 14.38 S2 BME A 300 J 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 29.89 43.66 65.68 31.09 41.98 66.25 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 J 117 GLU A 28 GLU~? 14.38 S2 BME A 300 J 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 29.89 43.66 65.68 31.09 41.98 66.25 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 J 117 GLU A 29 GLU~? 6.68 S2 BME A 300 J 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 29.89 43.66 65.68 31.09 41.98 66.25 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 J 117 GLU A 29 GLU~? 6.68 S2 BME A 300 J 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 29.89 43.66 65.68 31.09 41.98 66.25 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 J 117 GLU A 57 GLU.? 23.43 S2 BME A 300 J 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 16.30 10.78 3.24 16.87 9.97 1.36 coo 29.89 43.66 65.68 31.09 41.98 66.25 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 J 117 GLU A 57 GLU.? 23.43 S2 BME A 300 J 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 16.30 10.78 3.24 16.87 9.97 1.36 coo 29.89 43.66 65.68 31.09 41.98 66.25 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 J 117 GLU A 74 GLU~? 13.09 S2 BME A 300 J 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 29.89 43.66 65.68 31.09 41.98 66.25 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 J 117 GLU A 74 GLU~? 13.09 S2 BME A 300 J 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 29.89 43.66 65.68 31.09 41.98 66.25 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 J 117 GLU A 74 GLU~? 13.09 S2 BME A 300 J 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 29.89 43.66 65.68 31.09 41.98 66.25 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 J 117 GLU A 77 GLU~? 17.67 S2 BME A 300 J 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 7.63 5.18 13.95 5.55 5.01 14.48 coo 29.89 43.66 65.68 31.09 41.98 66.25 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 J 117 GLU A 77 GLU~? 17.67 S2 BME A 300 J 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 7.63 5.18 13.95 5.55 5.01 14.48 coo 29.89 43.66 65.68 31.09 41.98 66.25 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 J 117 GLU A 87 GLU.? 12.12 O1 BME A 300 J 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 29.89 43.66 65.68 31.09 41.98 66.25 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 J 117 GLU A 96 GLU.? 20.00 O1 BME A 300 J 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 29.89 43.66 65.68 31.09 41.98 66.25 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 J 117 GLU A 99 GLU.? 20.82 S2 BME A 300 J 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.89 43.66 65.68 31.09 41.98 66.25 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 J 117 GLU A 99 GLU.? 20.82 S2 BME A 300 J 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 49.72 57.74 77.19 50.16 59.17 75.67 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 29.89 43.66 65.68 31.09 41.98 66.25 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c09 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c09 naa= 2 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 K 117 GLU A 15 GLU~? 24.22 S2 BME A 300 K 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 56.59 52.03 70.37 55.28 50.47 70.94 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 K 117 GLU A 15 GLU~? 24.22 S2 BME A 300 K 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 56.59 52.03 70.37 55.28 50.47 70.94 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 K 117 GLU A 28 GLU~? 14.38 S2 BME A 300 K 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 56.59 52.03 70.37 55.28 50.47 70.94 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 K 117 GLU A 28 GLU~? 14.38 S2 BME A 300 K 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 56.59 52.03 70.37 55.28 50.47 70.94 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 K 117 GLU A 28 GLU~? 14.38 S2 BME A 300 K 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 56.59 52.03 70.37 55.28 50.47 70.94 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 K 117 GLU A 29 GLU~? 6.68 S2 BME A 300 K 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 56.59 52.03 70.37 55.28 50.47 70.94 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 K 117 GLU A 29 GLU~? 6.68 S2 BME A 300 K 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 56.59 52.03 70.37 55.28 50.47 70.94 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 K 117 GLU A 57 GLU.? 23.43 S2 BME A 300 K 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 16.30 10.78 3.24 16.87 9.97 1.36 coo 56.59 52.03 70.37 55.28 50.47 70.94 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 K 117 GLU A 57 GLU.? 23.43 S2 BME A 300 K 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 16.30 10.78 3.24 16.87 9.97 1.36 coo 56.59 52.03 70.37 55.28 50.47 70.94 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 K 117 GLU A 74 GLU~? 13.09 S2 BME A 300 K 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 56.59 52.03 70.37 55.28 50.47 70.94 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 K 117 GLU A 74 GLU~? 13.09 S2 BME A 300 K 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 56.59 52.03 70.37 55.28 50.47 70.94 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 K 117 GLU A 74 GLU~? 13.09 S2 BME A 300 K 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 56.59 52.03 70.37 55.28 50.47 70.94 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 K 117 GLU A 77 GLU~? 17.67 S2 BME A 300 K 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 7.63 5.18 13.95 5.55 5.01 14.48 coo 56.59 52.03 70.37 55.28 50.47 70.94 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 K 117 GLU A 77 GLU~? 17.67 S2 BME A 300 K 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 7.63 5.18 13.95 5.55 5.01 14.48 coo 56.59 52.03 70.37 55.28 50.47 70.94 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 K 117 GLU A 87 GLU.? 12.12 O1 BME A 300 K 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 56.59 52.03 70.37 55.28 50.47 70.94 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 K 117 GLU A 96 GLU.? 20.00 O1 BME A 300 K 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 56.59 52.03 70.37 55.28 50.47 70.94 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 K 117 GLU A 99 GLU.? 20.82 S2 BME A 300 K 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 56.59 52.03 70.37 55.28 50.47 70.94 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 K 117 GLU A 99 GLU.? 20.82 S2 BME A 300 K 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 73.94 31.71 67.00 74.74 32.13 65.03 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 56.59 52.03 70.37 55.28 50.47 70.94 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c10 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c10 naa= 2 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 L 117 GLU A 15 GLU~? 24.22 S2 BME A 300 L 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 66.14 27.14 60.19 64.84 27.91 61.76 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 L 117 GLU A 15 GLU~? 24.22 S2 BME A 300 L 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 66.14 27.14 60.19 64.84 27.91 61.76 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 L 117 GLU A 28 GLU~? 14.38 S2 BME A 300 L 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 66.14 27.14 60.19 64.84 27.91 61.76 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 L 117 GLU A 28 GLU~? 14.38 S2 BME A 300 L 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 66.14 27.14 60.19 64.84 27.91 61.76 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 L 117 GLU A 28 GLU~? 14.38 S2 BME A 300 L 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 66.14 27.14 60.19 64.84 27.91 61.76 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 L 117 GLU A 29 GLU~? 6.68 S2 BME A 300 L 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 66.14 27.14 60.19 64.84 27.91 61.76 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 L 117 GLU A 29 GLU~? 6.68 S2 BME A 300 L 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 66.14 27.14 60.19 64.84 27.91 61.76 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 L 117 GLU A 57 GLU.? 23.43 S2 BME A 300 L 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 16.30 10.78 3.24 16.87 9.97 1.36 coo 66.14 27.14 60.19 64.84 27.91 61.76 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 L 117 GLU A 57 GLU.? 23.43 S2 BME A 300 L 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 16.30 10.78 3.24 16.87 9.97 1.36 coo 66.14 27.14 60.19 64.84 27.91 61.76 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 L 117 GLU A 74 GLU~? 13.09 S2 BME A 300 L 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 66.14 27.14 60.19 64.84 27.91 61.76 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 L 117 GLU A 74 GLU~? 13.09 S2 BME A 300 L 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 66.14 27.14 60.19 64.84 27.91 61.76 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 L 117 GLU A 74 GLU~? 13.09 S2 BME A 300 L 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 66.14 27.14 60.19 64.84 27.91 61.76 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 L 117 GLU A 77 GLU~? 17.67 S2 BME A 300 L 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 7.63 5.18 13.95 5.55 5.01 14.48 coo 66.14 27.14 60.19 64.84 27.91 61.76 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 L 117 GLU A 77 GLU~? 17.67 S2 BME A 300 L 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 7.63 5.18 13.95 5.55 5.01 14.48 coo 66.14 27.14 60.19 64.84 27.91 61.76 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 L 117 GLU A 87 GLU.? 12.12 O1 BME A 300 L 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 66.14 27.14 60.19 64.84 27.91 61.76 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 L 117 GLU A 96 GLU.? 20.00 O1 BME A 300 L 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 66.14 27.14 60.19 64.84 27.91 61.76 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 L 117 GLU A 99 GLU.? 20.82 S2 BME A 300 L 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 66.14 27.14 60.19 64.84 27.91 61.76 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 L 117 GLU A 99 GLU.? 20.82 S2 BME A 300 L 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 45.97 9.66 56.63 45.65 9.77 54.50 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 66.14 27.14 60.19 64.84 27.91 61.76 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c11 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c11 naa= 2 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 M 117 GLU A 15 GLU~? 24.22 S2 BME A 300 M 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 M 117 GLU A 15 GLU~? 24.22 S2 BME A 300 M 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 M 117 GLU A 28 GLU~? 14.38 S2 BME A 300 M 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 M 117 GLU A 28 GLU~? 14.38 S2 BME A 300 M 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 M 117 GLU A 28 GLU~? 14.38 S2 BME A 300 M 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 M 117 GLU A 29 GLU~? 6.68 S2 BME A 300 M 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 M 117 GLU A 29 GLU~? 6.68 S2 BME A 300 M 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 M 117 GLU A 57 GLU.? 23.43 S2 BME A 300 M 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 16.30 10.78 3.24 16.87 9.97 1.36 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 M 117 GLU A 57 GLU.? 23.43 S2 BME A 300 M 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 16.30 10.78 3.24 16.87 9.97 1.36 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 M 117 GLU A 74 GLU~? 13.09 S2 BME A 300 M 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 M 117 GLU A 74 GLU~? 13.09 S2 BME A 300 M 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 M 117 GLU A 74 GLU~? 13.09 S2 BME A 300 M 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 M 117 GLU A 77 GLU~? 17.67 S2 BME A 300 M 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 7.63 5.18 13.95 5.55 5.01 14.48 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 M 117 GLU A 77 GLU~? 17.67 S2 BME A 300 M 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 7.63 5.18 13.95 5.55 5.01 14.48 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 M 117 GLU A 87 GLU.? 12.12 O1 BME A 300 M 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 M 117 GLU A 96 GLU.? 20.00 O1 BME A 300 M 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 M 117 GLU A 99 GLU.? 20.82 S2 BME A 300 M 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 M 117 GLU A 99 GLU.? 20.82 S2 BME A 300 M 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c12 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c12 naa= 2 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 N 117 GLU A 15 GLU~? 24.22 S2 BME A 300 N 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 N 117 GLU A 15 GLU~? 24.22 S2 BME A 300 N 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 N 117 GLU A 28 GLU~? 14.38 S2 BME A 300 N 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 N 117 GLU A 28 GLU~? 14.38 S2 BME A 300 N 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 N 117 GLU A 28 GLU~? 14.38 S2 BME A 300 N 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 N 117 GLU A 29 GLU~? 6.68 S2 BME A 300 N 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 N 117 GLU A 29 GLU~? 6.68 S2 BME A 300 N 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 N 117 GLU A 57 GLU.? 23.43 S2 BME A 300 N 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 16.30 10.78 3.24 16.87 9.97 1.36 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 N 117 GLU A 57 GLU.? 23.43 S2 BME A 300 N 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 16.30 10.78 3.24 16.87 9.97 1.36 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 N 117 GLU A 74 GLU~? 13.09 S2 BME A 300 N 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 N 117 GLU A 74 GLU~? 13.09 S2 BME A 300 N 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 N 117 GLU A 74 GLU~? 13.09 S2 BME A 300 N 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 N 117 GLU A 77 GLU~? 17.67 S2 BME A 300 N 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 7.63 5.18 13.95 5.55 5.01 14.48 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 N 117 GLU A 77 GLU~? 17.67 S2 BME A 300 N 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 7.63 5.18 13.95 5.55 5.01 14.48 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 N 117 GLU A 87 GLU.? 12.12 O1 BME A 300 N 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 N 117 GLU A 96 GLU.? 20.00 O1 BME A 300 N 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 N 117 GLU A 99 GLU.? 20.82 S2 BME A 300 N 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 N 117 GLU A 99 GLU.? 20.82 S2 BME A 300 N 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c13 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c13 naa= 2 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 O 117 GLU A 15 GLU~? 24.22 S2 BME A 300 O 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 O 117 GLU A 15 GLU~? 24.22 S2 BME A 300 O 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 O 117 GLU A 28 GLU~? 14.38 S2 BME A 300 O 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 O 117 GLU A 28 GLU~? 14.38 S2 BME A 300 O 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 O 117 GLU A 28 GLU~? 14.38 S2 BME A 300 O 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 O 117 GLU A 29 GLU~? 6.68 S2 BME A 300 O 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 O 117 GLU A 29 GLU~? 6.68 S2 BME A 300 O 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 O 117 GLU A 57 GLU.? 23.43 S2 BME A 300 O 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 16.30 10.78 3.24 16.87 9.97 1.36 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 O 117 GLU A 57 GLU.? 23.43 S2 BME A 300 O 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 16.30 10.78 3.24 16.87 9.97 1.36 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 O 117 GLU A 74 GLU~? 13.09 S2 BME A 300 O 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 O 117 GLU A 74 GLU~? 13.09 S2 BME A 300 O 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 O 117 GLU A 74 GLU~? 13.09 S2 BME A 300 O 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 O 117 GLU A 77 GLU~? 17.67 S2 BME A 300 O 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 7.63 5.18 13.95 5.55 5.01 14.48 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 O 117 GLU A 77 GLU~? 17.67 S2 BME A 300 O 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 7.63 5.18 13.95 5.55 5.01 14.48 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 O 117 GLU A 87 GLU.? 12.12 O1 BME A 300 O 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 O 117 GLU A 96 GLU.? 20.00 O1 BME A 300 O 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 O 117 GLU A 99 GLU.? 20.82 S2 BME A 300 O 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 O 117 GLU A 99 GLU.? 20.82 S2 BME A 300 O 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c14 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c14 naa= 2 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 P 117 GLU A 15 GLU~? 24.22 S2 BME A 300 P 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 P 117 GLU A 15 GLU~? 24.22 S2 BME A 300 P 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 P 117 GLU A 28 GLU~? 14.38 S2 BME A 300 P 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 P 117 GLU A 28 GLU~? 14.38 S2 BME A 300 P 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 P 117 GLU A 28 GLU~? 14.38 S2 BME A 300 P 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 P 117 GLU A 29 GLU~? 6.68 S2 BME A 300 P 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 P 117 GLU A 29 GLU~? 6.68 S2 BME A 300 P 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 P 117 GLU A 57 GLU.? 23.43 S2 BME A 300 P 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 16.30 10.78 3.24 16.87 9.97 1.36 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 P 117 GLU A 57 GLU.? 23.43 S2 BME A 300 P 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 16.30 10.78 3.24 16.87 9.97 1.36 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 P 117 GLU A 74 GLU~? 13.09 S2 BME A 300 P 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 P 117 GLU A 74 GLU~? 13.09 S2 BME A 300 P 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 P 117 GLU A 74 GLU~? 13.09 S2 BME A 300 P 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 P 117 GLU A 77 GLU~? 17.67 S2 BME A 300 P 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 7.63 5.18 13.95 5.55 5.01 14.48 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 P 117 GLU A 77 GLU~? 17.67 S2 BME A 300 P 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 7.63 5.18 13.95 5.55 5.01 14.48 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 P 117 GLU A 87 GLU.? 12.12 O1 BME A 300 P 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 P 117 GLU A 96 GLU.? 20.00 O1 BME A 300 P 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 P 117 GLU A 99 GLU.? 20.82 S2 BME A 300 P 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 P 117 GLU A 99 GLU.? 20.82 S2 BME A 300 P 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c15 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c15 naa= 2 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 Q 117 GLU A 15 GLU~? 24.22 S2 BME A 300 Q 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -97.34 64.74 65.50 -98.24 64.34 67.42 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 Q 117 GLU A 15 GLU~? 24.22 S2 BME A 300 Q 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -97.34 64.74 65.50 -98.24 64.34 67.42 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 Q 117 GLU A 28 GLU~? 14.38 S2 BME A 300 Q 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -97.34 64.74 65.50 -98.24 64.34 67.42 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 Q 117 GLU A 28 GLU~? 14.38 S2 BME A 300 Q 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -97.34 64.74 65.50 -98.24 64.34 67.42 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 Q 117 GLU A 28 GLU~? 14.38 S2 BME A 300 Q 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -97.34 64.74 65.50 -98.24 64.34 67.42 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 Q 117 GLU A 29 GLU~? 6.68 S2 BME A 300 Q 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -97.34 64.74 65.50 -98.24 64.34 67.42 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 Q 117 GLU A 29 GLU~? 6.68 S2 BME A 300 Q 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -97.34 64.74 65.50 -98.24 64.34 67.42 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 Q 117 GLU A 57 GLU.? 23.43 S2 BME A 300 Q 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 16.30 10.78 3.24 16.87 9.97 1.36 coo -97.34 64.74 65.50 -98.24 64.34 67.42 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 Q 117 GLU A 57 GLU.? 23.43 S2 BME A 300 Q 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 16.30 10.78 3.24 16.87 9.97 1.36 coo -97.34 64.74 65.50 -98.24 64.34 67.42 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 Q 117 GLU A 74 GLU~? 13.09 S2 BME A 300 Q 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -97.34 64.74 65.50 -98.24 64.34 67.42 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 Q 117 GLU A 74 GLU~? 13.09 S2 BME A 300 Q 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -97.34 64.74 65.50 -98.24 64.34 67.42 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 Q 117 GLU A 74 GLU~? 13.09 S2 BME A 300 Q 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -97.34 64.74 65.50 -98.24 64.34 67.42 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 Q 117 GLU A 77 GLU~? 17.67 S2 BME A 300 Q 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 7.63 5.18 13.95 5.55 5.01 14.48 coo -97.34 64.74 65.50 -98.24 64.34 67.42 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 Q 117 GLU A 77 GLU~? 17.67 S2 BME A 300 Q 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 7.63 5.18 13.95 5.55 5.01 14.48 coo -97.34 64.74 65.50 -98.24 64.34 67.42 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 Q 117 GLU A 87 GLU.? 12.12 O1 BME A 300 Q 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -97.34 64.74 65.50 -98.24 64.34 67.42 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 Q 117 GLU A 96 GLU.? 20.00 O1 BME A 300 Q 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -97.34 64.74 65.50 -98.24 64.34 67.42 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 Q 117 GLU A 99 GLU.? 20.82 S2 BME A 300 Q 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -97.34 64.74 65.50 -98.24 64.34 67.42 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 Q 117 GLU A 99 GLU.? 20.82 S2 BME A 300 Q 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -77.43 49.49 75.25 -77.06 48.11 73.69 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -97.34 64.74 65.50 -98.24 64.34 67.42 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c16 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c16 naa= 2 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 R 117 GLU A 15 GLU~? 24.22 S2 BME A 300 R 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -85.39 41.55 76.77 -86.50 43.25 77.42 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 R 117 GLU A 15 GLU~? 24.22 S2 BME A 300 R 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -85.39 41.55 76.77 -86.50 43.25 77.42 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 R 117 GLU A 28 GLU~? 14.38 S2 BME A 300 R 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -85.39 41.55 76.77 -86.50 43.25 77.42 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 R 117 GLU A 28 GLU~? 14.38 S2 BME A 300 R 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -85.39 41.55 76.77 -86.50 43.25 77.42 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 R 117 GLU A 28 GLU~? 14.38 S2 BME A 300 R 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -85.39 41.55 76.77 -86.50 43.25 77.42 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 R 117 GLU A 29 GLU~? 6.68 S2 BME A 300 R 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -85.39 41.55 76.77 -86.50 43.25 77.42 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 R 117 GLU A 29 GLU~? 6.68 S2 BME A 300 R 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -85.39 41.55 76.77 -86.50 43.25 77.42 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 R 117 GLU A 57 GLU.? 23.43 S2 BME A 300 R 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 16.30 10.78 3.24 16.87 9.97 1.36 coo -85.39 41.55 76.77 -86.50 43.25 77.42 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 R 117 GLU A 57 GLU.? 23.43 S2 BME A 300 R 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 16.30 10.78 3.24 16.87 9.97 1.36 coo -85.39 41.55 76.77 -86.50 43.25 77.42 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 R 117 GLU A 74 GLU~? 13.09 S2 BME A 300 R 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -85.39 41.55 76.77 -86.50 43.25 77.42 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 R 117 GLU A 74 GLU~? 13.09 S2 BME A 300 R 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -85.39 41.55 76.77 -86.50 43.25 77.42 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 R 117 GLU A 74 GLU~? 13.09 S2 BME A 300 R 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -85.39 41.55 76.77 -86.50 43.25 77.42 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 R 117 GLU A 77 GLU~? 17.67 S2 BME A 300 R 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 7.63 5.18 13.95 5.55 5.01 14.48 coo -85.39 41.55 76.77 -86.50 43.25 77.42 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 R 117 GLU A 77 GLU~? 17.67 S2 BME A 300 R 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 7.63 5.18 13.95 5.55 5.01 14.48 coo -85.39 41.55 76.77 -86.50 43.25 77.42 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 R 117 GLU A 87 GLU.? 12.12 O1 BME A 300 R 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -85.39 41.55 76.77 -86.50 43.25 77.42 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 R 117 GLU A 96 GLU.? 20.00 O1 BME A 300 R 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -85.39 41.55 76.77 -86.50 43.25 77.42 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 R 117 GLU A 99 GLU.? 20.82 S2 BME A 300 R 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -85.39 41.55 76.77 -86.50 43.25 77.42 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 R 117 GLU A 99 GLU.? 20.82 S2 BME A 300 R 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -102.35 28.87 93.43 -103.07 27.30 92.22 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -85.39 41.55 76.77 -86.50 43.25 77.42 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c17 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c17 naa= 2 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 S 117 GLU A 15 GLU~? 24.22 S2 BME A 300 S 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -110.62 33.78 87.40 -109.26 35.43 87.52 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 S 117 GLU A 15 GLU~? 24.22 S2 BME A 300 S 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -110.62 33.78 87.40 -109.26 35.43 87.52 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 S 117 GLU A 28 GLU~? 14.38 S2 BME A 300 S 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -110.62 33.78 87.40 -109.26 35.43 87.52 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 S 117 GLU A 28 GLU~? 14.38 S2 BME A 300 S 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -110.62 33.78 87.40 -109.26 35.43 87.52 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 S 117 GLU A 28 GLU~? 14.38 S2 BME A 300 S 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -110.62 33.78 87.40 -109.26 35.43 87.52 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 S 117 GLU A 29 GLU~? 6.68 S2 BME A 300 S 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -110.62 33.78 87.40 -109.26 35.43 87.52 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 S 117 GLU A 29 GLU~? 6.68 S2 BME A 300 S 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -110.62 33.78 87.40 -109.26 35.43 87.52 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 S 117 GLU A 57 GLU.? 23.43 S2 BME A 300 S 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 16.30 10.78 3.24 16.87 9.97 1.36 coo -110.62 33.78 87.40 -109.26 35.43 87.52 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 S 117 GLU A 57 GLU.? 23.43 S2 BME A 300 S 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 16.30 10.78 3.24 16.87 9.97 1.36 coo -110.62 33.78 87.40 -109.26 35.43 87.52 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 S 117 GLU A 74 GLU~? 13.09 S2 BME A 300 S 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -110.62 33.78 87.40 -109.26 35.43 87.52 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 S 117 GLU A 74 GLU~? 13.09 S2 BME A 300 S 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -110.62 33.78 87.40 -109.26 35.43 87.52 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 S 117 GLU A 74 GLU~? 13.09 S2 BME A 300 S 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -110.62 33.78 87.40 -109.26 35.43 87.52 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 S 117 GLU A 77 GLU~? 17.67 S2 BME A 300 S 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 7.63 5.18 13.95 5.55 5.01 14.48 coo -110.62 33.78 87.40 -109.26 35.43 87.52 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 S 117 GLU A 77 GLU~? 17.67 S2 BME A 300 S 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 7.63 5.18 13.95 5.55 5.01 14.48 coo -110.62 33.78 87.40 -109.26 35.43 87.52 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 S 117 GLU A 87 GLU.? 12.12 O1 BME A 300 S 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -110.62 33.78 87.40 -109.26 35.43 87.52 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 S 117 GLU A 96 GLU.? 20.00 O1 BME A 300 S 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -110.62 33.78 87.40 -109.26 35.43 87.52 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 S 117 GLU A 99 GLU.? 20.82 S2 BME A 300 S 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -110.62 33.78 87.40 -109.26 35.43 87.52 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 S 117 GLU A 99 GLU.? 20.82 S2 BME A 300 S 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -128.80 53.44 84.81 -129.90 52.80 83.09 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -110.62 33.78 87.40 -109.26 35.43 87.52 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c18 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c18 naa= 2 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 T 117 GLU A 15 GLU~? 24.22 S2 BME A 300 T 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -122.53 56.99 76.12 -120.96 56.46 77.45 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 T 117 GLU A 15 GLU~? 24.22 S2 BME A 300 T 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -122.53 56.99 76.12 -120.96 56.46 77.45 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 T 117 GLU A 28 GLU~? 14.38 S2 BME A 300 T 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -122.53 56.99 76.12 -120.96 56.46 77.45 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 T 117 GLU A 28 GLU~? 14.38 S2 BME A 300 T 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -122.53 56.99 76.12 -120.96 56.46 77.45 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 T 117 GLU A 28 GLU~? 14.38 S2 BME A 300 T 171 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -122.53 56.99 76.12 -120.96 56.46 77.45 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 T 117 GLU A 29 GLU~? 6.68 S2 BME A 300 T 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -122.53 56.99 76.12 -120.96 56.46 77.45 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 T 117 GLU A 29 GLU~? 6.68 S2 BME A 300 T 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -122.53 56.99 76.12 -120.96 56.46 77.45 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 T 117 GLU A 57 GLU.? 23.43 S2 BME A 300 T 171 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 16.30 10.78 3.24 16.87 9.97 1.36 coo -122.53 56.99 76.12 -120.96 56.46 77.45 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 T 117 GLU A 57 GLU.? 23.43 S2 BME A 300 T 171 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 16.30 10.78 3.24 16.87 9.97 1.36 coo -122.53 56.99 76.12 -120.96 56.46 77.45 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 T 117 GLU A 74 GLU~? 13.09 S2 BME A 300 T 171 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -122.53 56.99 76.12 -120.96 56.46 77.45 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 T 117 GLU A 74 GLU~? 13.09 S2 BME A 300 T 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -122.53 56.99 76.12 -120.96 56.46 77.45 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 T 117 GLU A 74 GLU~? 13.09 S2 BME A 300 T 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -122.53 56.99 76.12 -120.96 56.46 77.45 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 T 117 GLU A 77 GLU~? 17.67 S2 BME A 300 T 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 7.63 5.18 13.95 5.55 5.01 14.48 coo -122.53 56.99 76.12 -120.96 56.46 77.45 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 14 2 # 14 T 117 GLU A 77 GLU~? 17.67 S2 BME A 300 T 171 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 7.63 5.18 13.95 5.55 5.01 14.48 coo -122.53 56.99 76.12 -120.96 56.46 77.45 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 15 2 # 15 T 117 GLU A 87 GLU.? 12.12 O1 BME A 300 T 171 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -122.53 56.99 76.12 -120.96 56.46 77.45 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 16 2 # 16 T 117 GLU A 96 GLU.? 20.00 O1 BME A 300 T 171 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -122.53 56.99 76.12 -120.96 56.46 77.45 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 17 2 # 17 T 117 GLU A 99 GLU.? 20.82 S2 BME A 300 T 171 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -122.53 56.99 76.12 -120.96 56.46 77.45 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1gt7_c19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 18 2 # 18 T 117 GLU A 99 GLU.? 20.82 S2 BME A 300 T 171 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -103.87 73.97 66.64 -103.95 73.55 64.53 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -122.53 56.99 76.12 -120.96 56.46 77.45 7.63 5.18 13.95 5.55 5.01 14.48 1gt7_c19 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 18 hits 1gt7_c19 naa= 2 ULMN 2 1guf_c02 2,4-DIENOYL-COA REDUCTASE user 1 2 # 1 A 70 SER A 3 SER^? 13.09 C1 BME A 300 A 73 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 2.01 1.27 5.67 0.61 -0.61 5.33 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1guf_c02 2,4-DIENOYL-COA REDUCTASE user 2 2 # 2 A 70 SER A 52 SER~? 19.64 S2 BME A 300 A 73 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 22.49 4.36 7.95 23.43 2.12 7.73 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1guf_c02 2,4-DIENOYL-COA REDUCTASE user 3 2 # 3 A 70 SER A 52 SER~? 19.64 S2 BME A 300 A 73 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 22.49 4.36 7.95 23.43 2.12 7.73 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 1guf_c02 2,4-DIENOYL-COA REDUCTASE user 4 2 # 4 A 70 SER A 69 SER~? 5.63 S2 BME A 300 A 73 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 5.01 -1.60 7.62 5.37 -3.69 7.71 1guf_c02 source 1guf 2,4-DIENOYL-COA REDUCTASE : 4 hits 1guf_c02 naa= 2 ULMN 2 1guf_c03 2,4-DIENOYL-COA REDUCTASE user 1 2 # 1 B 70 SER A 3 SER^? 13.09 C1 BME A 300 B 73 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 2.01 1.27 5.67 0.61 -0.61 5.33 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1guf_c03 2,4-DIENOYL-COA REDUCTASE user 2 2 # 2 B 70 SER A 52 SER~? 19.64 S2 BME A 300 B 73 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 22.49 4.36 7.95 23.43 2.12 7.73 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1guf_c03 2,4-DIENOYL-COA REDUCTASE user 3 2 # 3 B 70 SER A 52 SER~? 19.64 S2 BME A 300 B 73 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 22.49 4.36 7.95 23.43 2.12 7.73 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 1guf_c03 2,4-DIENOYL-COA REDUCTASE user 4 2 # 4 B 70 SER A 69 SER~? 5.63 S2 BME A 300 B 73 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 5.01 -1.60 7.62 5.37 -3.69 7.71 1guf_c03 source 1guf 2,4-DIENOYL-COA REDUCTASE : 4 hits 1guf_c03 naa= 2 ULMN 2 1gz6_c04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 A 161 GLN A 20 GLN^? 20.58 S2 BME A 300 A 168 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 30.61 60.18 43.12 32.20 58.75 43.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 26.96 50.99 47.03 31.03 48.83 44.33 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1gz6_c04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 A 161 GLN A 20 GLN^? 20.58 S2 BME A 300 A 168 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 30.61 60.18 43.12 32.20 58.75 43.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 26.96 50.99 47.03 31.03 48.83 44.33 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1gz6_c04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 A 161 GLN A 20 GLN^? 20.58 S2 BME A 300 A 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 30.61 60.18 43.12 32.20 58.75 43.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 26.96 50.99 47.03 31.03 48.83 44.33 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 A 161 GLN A 20 GLN^? 20.58 S2 BME A 300 A 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 30.61 60.18 43.12 32.20 58.75 43.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 26.96 50.99 47.03 31.03 48.83 44.33 15.98 12.20 9.88 16.28 11.97 16.11 1gz6_c04 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c04 naa= 2 ULMN 2 1gz6_c05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 B 161 GLN A 20 GLN^? 20.58 S2 BME A 300 B 168 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 11.63 41.41 53.68 10.57 43.11 54.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 15.72 50.86 51.22 10.77 52.35 51.39 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1gz6_c05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 B 161 GLN A 20 GLN^? 20.58 S2 BME A 300 B 168 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 11.63 41.41 53.68 10.57 43.11 54.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 15.72 50.86 51.22 10.77 52.35 51.39 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1gz6_c05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 B 161 GLN A 20 GLN^? 20.58 S2 BME A 300 B 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 11.63 41.41 53.68 10.57 43.11 54.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 15.72 50.86 51.22 10.77 52.35 51.39 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 B 161 GLN A 20 GLN^? 20.58 S2 BME A 300 B 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 11.63 41.41 53.68 10.57 43.11 54.39 15.94 6.48 1.05 18.02 6.17 1.31 coo 15.72 50.86 51.22 10.77 52.35 51.39 15.98 12.20 9.88 16.28 11.97 16.11 1gz6_c05 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c05 naa= 2 ULMN 2 1gz6_c06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 C 161 GLN A 20 GLN^? 20.58 S2 BME A 300 C 168 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 9.35 43.88 85.05 8.40 42.18 84.19 15.94 6.48 1.05 18.02 6.17 1.31 coo 12.98 34.46 88.14 8.11 32.96 87.14 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1gz6_c06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 C 161 GLN A 20 GLN^? 20.58 S2 BME A 300 C 168 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 9.35 43.88 85.05 8.40 42.18 84.19 15.94 6.48 1.05 18.02 6.17 1.31 coo 12.98 34.46 88.14 8.11 32.96 87.14 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1gz6_c06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 C 161 GLN A 20 GLN^? 20.58 S2 BME A 300 C 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 9.35 43.88 85.05 8.40 42.18 84.19 15.94 6.48 1.05 18.02 6.17 1.31 coo 12.98 34.46 88.14 8.11 32.96 87.14 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 C 161 GLN A 20 GLN^? 20.58 S2 BME A 300 C 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 9.35 43.88 85.05 8.40 42.18 84.19 15.94 6.48 1.05 18.02 6.17 1.31 coo 12.98 34.46 88.14 8.11 32.96 87.14 15.98 12.20 9.88 16.28 11.97 16.11 1gz6_c06 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c06 naa= 2 ULMN 2 1gz6_c07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 D 161 GLN A 20 GLN^? 20.58 S2 BME A 300 D 168 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 26.49 25.12 98.45 28.11 26.53 98.40 15.94 6.48 1.05 18.02 6.17 1.31 coo 23.46 34.31 94.02 27.08 36.46 97.29 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1gz6_c07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 D 161 GLN A 20 GLN^? 20.58 S2 BME A 300 D 168 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 26.49 25.12 98.45 28.11 26.53 98.40 15.94 6.48 1.05 18.02 6.17 1.31 coo 23.46 34.31 94.02 27.08 36.46 97.29 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1gz6_c07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 D 161 GLN A 20 GLN^? 20.58 S2 BME A 300 D 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 26.49 25.12 98.45 28.11 26.53 98.40 15.94 6.48 1.05 18.02 6.17 1.31 coo 23.46 34.31 94.02 27.08 36.46 97.29 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 D 161 GLN A 20 GLN^? 20.58 S2 BME A 300 D 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 26.49 25.12 98.45 28.11 26.53 98.40 15.94 6.48 1.05 18.02 6.17 1.31 coo 23.46 34.31 94.02 27.08 36.46 97.29 15.98 12.20 9.88 16.28 11.97 16.11 1gz6_c07 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c07 naa= 2 ULMN 2 1gz6_c08 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 A 164 TYR A 34 TYR.? 16.37 S2 BME A 300 A 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 29.69 55.04 42.83 31.98 53.56 43.49 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 26.96 50.99 47.03 31.03 48.83 44.33 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c08 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 A 164 TYR A 34 TYR.? 16.37 S2 BME A 300 A 168 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 29.69 55.04 42.83 31.98 53.56 43.49 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 26.96 50.99 47.03 31.03 48.83 44.33 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1gz6_c08 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 A 164 TYR A 59 TYR^? 18.50 S2 BME A 300 A 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 29.69 55.04 42.83 31.98 53.56 43.49 14.59 5.14 5.72 16.82 6.86 5.68 coo 26.96 50.99 47.03 31.03 48.83 44.33 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1gz6_c08 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 A 164 TYR A 75 TYR~? 15.90 S2 BME A 300 A 168 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 29.69 55.04 42.83 31.98 53.56 43.49 14.46 -0.26 16.60 17.11 0.41 17.22 coo 26.96 50.99 47.03 31.03 48.83 44.33 8.82 -4.39 14.42 10.42 -10.04 16.23 1gz6_c08 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c08 naa= 2 ULMN 2 1gz6_c09 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 B 164 TYR A 34 TYR.? 16.37 S2 BME A 300 B 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 11.52 46.03 51.32 10.06 47.90 52.76 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 15.72 50.86 51.22 10.77 52.35 51.39 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c09 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 B 164 TYR A 34 TYR.? 16.37 S2 BME A 300 B 168 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 11.52 46.03 51.32 10.06 47.90 52.76 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 15.72 50.86 51.22 10.77 52.35 51.39 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1gz6_c09 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 B 164 TYR A 59 TYR^? 18.50 S2 BME A 300 B 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 11.52 46.03 51.32 10.06 47.90 52.76 14.59 5.14 5.72 16.82 6.86 5.68 coo 15.72 50.86 51.22 10.77 52.35 51.39 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1gz6_c09 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 B 164 TYR A 75 TYR~? 15.90 S2 BME A 300 B 168 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 11.52 46.03 51.32 10.06 47.90 52.76 14.46 -0.26 16.60 17.11 0.41 17.22 coo 15.72 50.86 51.22 10.77 52.35 51.39 8.82 -4.39 14.42 10.42 -10.04 16.23 1gz6_c09 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c09 naa= 2 ULMN 2 1gz6_c10 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 C 164 TYR A 34 TYR.? 16.37 S2 BME A 300 C 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 8.83 39.27 87.38 7.60 37.43 85.69 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 12.98 34.46 88.14 8.11 32.96 87.14 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c10 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 C 164 TYR A 34 TYR.? 16.37 S2 BME A 300 C 168 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 8.83 39.27 87.38 7.60 37.43 85.69 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 12.98 34.46 88.14 8.11 32.96 87.14 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1gz6_c10 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 C 164 TYR A 59 TYR^? 18.50 S2 BME A 300 C 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 8.83 39.27 87.38 7.60 37.43 85.69 14.59 5.14 5.72 16.82 6.86 5.68 coo 12.98 34.46 88.14 8.11 32.96 87.14 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1gz6_c10 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 C 164 TYR A 75 TYR~? 15.90 S2 BME A 300 C 168 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 8.83 39.27 87.38 7.60 37.43 85.69 14.46 -0.26 16.60 17.11 0.41 17.22 coo 12.98 34.46 88.14 8.11 32.96 87.14 8.82 -4.39 14.42 10.42 -10.04 16.23 1gz6_c10 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c10 naa= 2 ULMN 2 1gz6_c11 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 D 164 TYR A 34 TYR.? 16.37 S2 BME A 300 D 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 25.49 30.28 98.59 27.88 31.73 98.26 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 23.46 34.31 94.02 27.08 36.46 97.29 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1gz6_c11 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 D 164 TYR A 34 TYR.? 16.37 S2 BME A 300 D 168 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 25.49 30.28 98.59 27.88 31.73 98.26 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 23.46 34.31 94.02 27.08 36.46 97.29 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1gz6_c11 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 D 164 TYR A 59 TYR^? 18.50 S2 BME A 300 D 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 25.49 30.28 98.59 27.88 31.73 98.26 14.59 5.14 5.72 16.82 6.86 5.68 coo 23.46 34.31 94.02 27.08 36.46 97.29 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1gz6_c11 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 D 164 TYR A 75 TYR~? 15.90 S2 BME A 300 D 168 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 25.49 30.28 98.59 27.88 31.73 98.26 14.46 -0.26 16.60 17.11 0.41 17.22 coo 23.46 34.31 94.02 27.08 36.46 97.29 8.82 -4.39 14.42 10.42 -10.04 16.23 1gz6_c11 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c11 naa= 2 ULMN 2 1h3i_c00 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 1 2 # 1 A 293 HIS A 91 HIS~? 7.63 O1 BME A 300 A 335 TYR A 34 TYR.? 16.37 S2 BME A 300 coo -2.26 -1.00 -46.64 -4.18 -1.85 -46.58 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 8.78 9.27 -52.41 7.07 9.24 -54.63 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1h3i_c00 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 2 2 # 2 A 293 HIS A 91 HIS~? 7.63 O1 BME A 300 A 335 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -2.26 -1.00 -46.64 -4.18 -1.85 -46.58 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 8.78 9.27 -52.41 7.07 9.24 -54.63 9.00 3.02 1.57 7.75 5.45 1.00 1h3i_c00 source 1h3i HISTONE H3 LYSINE 4 SPECIFIC METHYLTRANSFERASE: 2 hits 1h3i_c00 naa= 2 ULMN 2 1h3i_c01 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 1 2 # 1 B 293 HIS A 91 HIS~? 7.63 O1 BME A 300 B 335 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 29.22 13.17 -7.68 31.08 14.14 -7.64 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 14.33 10.29 -1.79 15.33 11.66 0.43 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1h3i_c01 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 2 2 # 2 B 293 HIS A 91 HIS~? 7.63 O1 BME A 300 B 335 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 29.22 13.17 -7.68 31.08 14.14 -7.64 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 14.33 10.29 -1.79 15.33 11.66 0.43 9.00 3.02 1.57 7.75 5.45 1.00 1h3i_c01 source 1h3i HISTONE H3 LYSINE 4 SPECIFIC METHYLTRANSFERASE: 2 hits 1h3i_c01 naa= 2 ULMN 2 1h4g_c00 XYLANASE user 1 2 # 1 A 94 GLU A 8 GLU~? 18.47 O1 BME A 300 A 184 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -4.48 18.79 18.25 -4.56 20.59 17.17 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1h4g_c00 XYLANASE user 2 2 # 2 A 94 GLU A 87 GLU.? 12.12 O1 BME A 300 A 184 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -0.61 25.90 13.61 -2.32 25.64 14.83 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1h4g_c00 source 1h4g XYLANASE : 2 hits 1h4g_c00 naa= 2 ULMN 2 1h4g_c01 XYLANASE user 1 2 # 1 B 94 GLU A 8 GLU~? 18.47 O1 BME A 300 B 184 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -24.12 22.11 20.80 -23.56 23.90 21.78 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1h4g_c01 XYLANASE user 2 2 # 2 B 94 GLU A 87 GLU.? 12.12 O1 BME A 300 B 184 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -25.64 30.33 24.82 -24.05 29.57 23.64 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1h4g_c01 source 1h4g XYLANASE : 2 hits 1h4g_c01 naa= 2 ULMN 2 1hfe_c02 FE-ONLY HYDROGENASE (SMALLER SUBUNITuser 1 2 # 1 L 178 CYH A 63 CYH.? -3.36 S2 BME A 300s L 237 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -4.05 26.62 30.38 -4.37 29.15 31.48 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 3.43 24.66 24.28 -1.03 26.98 26.24 8.82 -4.39 14.42 10.42 -10.04 16.23 1hfe_c02 source 1hfe FE-ONLY HYDROGENASE (SMALLER SUBUNIT) : 1 hits 1hfe_c02 naa= 2 ULMN 2 1hfe_c03 FE-ONLY HYDROGENASE (SMALLER SUBUNITuser 1 2 # 1 M 178 CYH A 63 CYH.? -3.36 S2 BME A 300s M 237 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -30.58 3.73 3.41 -31.70 1.18 3.67 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -24.56 6.02 -4.03 -26.50 3.59 0.41 8.82 -4.39 14.42 10.42 -10.04 16.23 1hfe_c03 source 1hfe FE-ONLY HYDROGENASE (SMALLER SUBUNIT) : 1 hits 1hfe_c03 naa= 2 ULMN 2 1hfs_c00 STROMELYSIN-1 user 1 2 # 1 202 GLU A 28 GLU~? 14.38 S2 BME A 300 219 MET A 32 MET?? 16.29 S2 BME A 300 coo 30.26 31.02 25.22 30.56 33.10 25.01 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 34.01 35.68 33.47 31.29 34.11 32.92 18.33 -15.35 -3.27 19.07 -18.39 -2.47 ULMN 2 1hfs_c00 STROMELYSIN-1 user 2 2 # 2 202 GLU A 29 GLU~? 6.68 S2 BME A 300 219 MET A 43 MET?? 7.50 S2 BME A 300 coo 30.26 31.02 25.22 30.56 33.10 25.01 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 34.01 35.68 33.47 31.29 34.11 32.92 16.84 -7.02 11.44 13.26 -8.32 13.33 ULMN 2 1hfs_c00 STROMELYSIN-1 user 3 2 # 3 202 GLU A 29 GLU~? 6.68 S2 BME A 300 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 30.26 31.02 25.22 30.56 33.10 25.01 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 34.01 35.68 33.47 31.29 34.11 32.92 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1hfs_c00 STROMELYSIN-1 user 4 2 # 4 202 GLU A 87 GLU.? 12.12 O1 BME A 300 219 MET A 1 MET?? 11.79 S2 BME A 300 coo 30.26 31.02 25.22 30.56 33.10 25.01 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 34.01 35.68 33.47 31.29 34.11 32.92 1.73 2.69 11.74 3.89 -0.91 11.26 ULMN 2 1hfs_c00 STROMELYSIN-1 user 5 2 # 5 202 GLU A 87 GLU.? 12.12 O1 BME A 300 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 30.26 31.02 25.22 30.56 33.10 25.01 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 34.01 35.68 33.47 31.29 34.11 32.92 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1hfs_c00 STROMELYSIN-1 user 6 2 # 6 202 GLU A 96 GLU.? 20.00 O1 BME A 300 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 30.26 31.02 25.22 30.56 33.10 25.01 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 34.01 35.68 33.47 31.29 34.11 32.92 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1hfs_c00 STROMELYSIN-1 user 7 2 # 7 202 GLU A 99 GLU.? 20.82 S2 BME A 300 219 MET A 32 MET?? 16.29 S2 BME A 300 coo 30.26 31.02 25.22 30.56 33.10 25.01 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 34.01 35.68 33.47 31.29 34.11 32.92 18.33 -15.35 -3.27 19.07 -18.39 -2.47 1hfs_c00 source 1hfs STROMELYSIN-1 : 7 hits 1hfs_c00 naa= 2 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 1 2 # 1 A 25 ASP A 44 ASP~? 11.03 S2 BME A 300 B 25 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 1.46 1.38 19.19 2.92 0.53 17.93 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 8.70 2.26 18.89 7.00 1.20 18.15 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1hiv_c01 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 2 2 # 2 A 25 ASP A 48 ASP~? 19.85 S2 BME A 300 B 25 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 1.46 1.38 19.19 2.92 0.53 17.93 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 8.70 2.26 18.89 7.00 1.20 18.15 19.36 -9.90 14.44 17.51 -11.01 14.77 1hiv_c01 source 1hiv HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 : 2 hits 1hiv_c01 naa= 2 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 1 2 # 1 82 ARG A 25 ARG.? 9.68 S2 BME A 300 92 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -23.57 14.27 45.50 -26.54 13.45 45.12 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -19.84 19.95 38.99 -22.62 18.73 39.19 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1hka_c00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 2 2 # 2 82 ARG A 68 ARG~? -4.35 S2 BME A 300s 92 ARG A 25 ARG.? 9.68 S2 BME A 300 coo -23.57 14.27 45.50 -26.54 13.45 45.12 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -19.84 19.95 38.99 -22.62 18.73 39.19 13.39 -11.16 2.90 14.53 -11.26 0.04 1hka_c00 source 1hka 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOK: 2 hits 1hka_c00 naa= 2 ULMN 2 1hqc_c02 RUVB user 1 2 # 1 A 146 THR A 30 THR~? 11.99 S2 BME A 300 A 205 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 69.27 81.27 188.40 69.36 79.49 187.14 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 60.88 74.26 187.44 62.57 76.37 185.94 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1hqc_c02 RUVB user 2 2 # 2 A 146 THR A 45 THR~? 14.85 S2 BME A 300 A 205 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 69.27 81.27 188.40 69.36 79.49 187.14 21.81 -5.88 13.03 22.64 -6.51 11.11 coo 60.88 74.26 187.44 62.57 76.37 185.94 12.31 -11.28 10.33 12.92 -12.61 7.64 1hqc_c02 source 1hqc RUVB : 2 hits 1hqc_c02 naa= 2 ULMN 2 1hqc_c03 RUVB user 1 2 # 1 B 146 THR A 30 THR~? 11.99 S2 BME A 300 B 205 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 88.07 98.17 129.05 89.88 98.18 130.23 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 95.53 106.44 130.09 93.33 104.73 131.40 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1hqc_c03 RUVB user 2 2 # 2 B 146 THR A 45 THR~? 14.85 S2 BME A 300 B 205 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 88.07 98.17 129.05 89.88 98.18 130.23 21.81 -5.88 13.03 22.64 -6.51 11.11 coo 95.53 106.44 130.09 93.33 104.73 131.40 12.31 -11.28 10.33 12.92 -12.61 7.64 1hqc_c03 source 1hqc RUVB : 2 hits 1hqc_c03 naa= 2 ULMN 2 1hrd_c00 GLUTAMATE DEHYDROGENASE user 1 2 # 1 A 125 LYS A 2 LYS.? 20.18 S2 BME A 300 A 165 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -12.11 9.09 75.66 -16.07 12.06 73.09 2.39 3.95 8.25 5.67 8.88 7.74 coo -13.97 15.80 71.16 -15.66 15.86 72.38 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1hrd_c00 GLUTAMATE DEHYDROGENASE user 2 2 # 2 A 125 LYS A 10 LYS~? 16.18 O1 BME A 300 A 165 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -12.11 9.09 75.66 -16.07 12.06 73.09 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -13.97 15.80 71.16 -15.66 15.86 72.38 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1hrd_c00 GLUTAMATE DEHYDROGENASE user 3 2 # 3 A 125 LYS A 12 LYS~? 21.81 S2 BME A 300 A 165 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -12.11 9.09 75.66 -16.07 12.06 73.09 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -13.97 15.80 71.16 -15.66 15.86 72.38 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1hrd_c00 GLUTAMATE DEHYDROGENASE user 4 2 # 4 A 125 LYS A 55 LYS.? 25.54 S2 BME A 300 A 165 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -12.11 9.09 75.66 -16.07 12.06 73.09 15.98 12.20 9.88 16.28 11.97 16.11 coo -13.97 15.80 71.16 -15.66 15.86 72.38 10.12 9.33 8.59 8.15 9.51 7.94 1hrd_c00 source 1hrd GLUTAMATE DEHYDROGENASE : 4 hits 1hrd_c00 naa= 2 ULMN 2 1hrd_c01 GLUTAMATE DEHYDROGENASE user 1 2 # 1 B 125 LYS A 2 LYS.? 20.18 S2 BME A 300 B 165 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -1.76 -27.80 63.57 -6.45 -30.23 62.00 2.39 3.95 8.25 5.67 8.88 7.74 coo -9.50 -29.26 65.93 -9.12 -30.88 64.62 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1hrd_c01 GLUTAMATE DEHYDROGENASE user 2 2 # 2 B 125 LYS A 10 LYS~? 16.18 O1 BME A 300 B 165 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -1.76 -27.80 63.57 -6.45 -30.23 62.00 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -9.50 -29.26 65.93 -9.12 -30.88 64.62 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1hrd_c01 GLUTAMATE DEHYDROGENASE user 3 2 # 3 B 125 LYS A 12 LYS~? 21.81 S2 BME A 300 B 165 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -1.76 -27.80 63.57 -6.45 -30.23 62.00 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -9.50 -29.26 65.93 -9.12 -30.88 64.62 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1hrd_c01 GLUTAMATE DEHYDROGENASE user 4 2 # 4 B 125 LYS A 55 LYS.? 25.54 S2 BME A 300 B 165 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -1.76 -27.80 63.57 -6.45 -30.23 62.00 15.98 12.20 9.88 16.28 11.97 16.11 coo -9.50 -29.26 65.93 -9.12 -30.88 64.62 10.12 9.33 8.59 8.15 9.51 7.94 1hrd_c01 source 1hrd GLUTAMATE DEHYDROGENASE : 4 hits 1hrd_c01 naa= 2 ULMN 2 1hrd_c02 GLUTAMATE DEHYDROGENASE user 1 2 # 1 C 125 LYS A 2 LYS.? 20.18 S2 BME A 300 C 165 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 13.93 4.30 45.25 12.27 3.78 39.81 2.39 3.95 8.25 5.67 8.88 7.74 coo 13.73 -0.85 38.89 13.44 0.98 37.94 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1hrd_c02 GLUTAMATE DEHYDROGENASE user 2 2 # 2 C 125 LYS A 10 LYS~? 16.18 O1 BME A 300 C 165 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 13.93 4.30 45.25 12.27 3.78 39.81 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 13.73 -0.85 38.89 13.44 0.98 37.94 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1hrd_c02 GLUTAMATE DEHYDROGENASE user 3 2 # 3 C 125 LYS A 12 LYS~? 21.81 S2 BME A 300 C 165 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 13.93 4.30 45.25 12.27 3.78 39.81 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 13.73 -0.85 38.89 13.44 0.98 37.94 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1hrd_c02 GLUTAMATE DEHYDROGENASE user 4 2 # 4 C 125 LYS A 55 LYS.? 25.54 S2 BME A 300 C 165 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 13.93 4.30 45.25 12.27 3.78 39.81 15.98 12.20 9.88 16.28 11.97 16.11 coo 13.73 -0.85 38.89 13.44 0.98 37.94 10.12 9.33 8.59 8.15 9.51 7.94 1hrd_c02 source 1hrd GLUTAMATE DEHYDROGENASE : 4 hits 1hrd_c02 naa= 2 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 A 209 GLU A 77 GLU~? 17.67 S2 BME A 300 A 217 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 7.63 5.18 13.95 5.55 5.01 14.48 coo 28.99 1.64 37.28 29.39 1.00 37.06 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 A 209 GLU A 87 GLU.? 12.12 O1 BME A 300 A 217 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 29.51 -1.57 42.43 30.35 -3.27 41.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.99 1.64 37.28 29.39 1.00 37.06 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 A 209 GLU A 87 GLU.? 12.12 O1 BME A 300 A 217 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.99 1.64 37.28 29.39 1.00 37.06 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 A 209 GLU A 87 GLU.? 12.12 O1 BME A 300 A 217 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.99 1.64 37.28 29.39 1.00 37.06 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 A 209 GLU A 96 GLU.? 20.00 O1 BME A 300 A 217 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 28.99 1.64 37.28 29.39 1.00 37.06 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 A 209 GLU A 96 GLU.? 20.00 O1 BME A 300 A 217 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 28.99 1.64 37.28 29.39 1.00 37.06 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1hzd_c06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 A 209 GLU A 99 GLU.? 20.82 S2 BME A 300 A 217 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 28.99 1.64 37.28 29.39 1.00 37.06 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1hzd_c06 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 7 hits 1hzd_c06 naa= 2 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 B 209 GLU A 77 GLU~? 17.67 S2 BME A 300 B 217 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 7.63 5.18 13.95 5.55 5.01 14.48 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 B 209 GLU A 87 GLU.? 12.12 O1 BME A 300 B 217 GLY A 66 GLY.? -4.48 C1 BME A 300s coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 B 209 GLU A 87 GLU.? 12.12 O1 BME A 300 B 217 GLY A 88 GLY~? 6.95 O1 BME A 300 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 B 209 GLU A 87 GLU.? 12.12 O1 BME A 300 B 217 GLY A 89 GLY~? 6.94 S2 BME A 300 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 B 209 GLU A 96 GLU.? 20.00 O1 BME A 300 B 217 GLY A 94 GLY~? 13.27 O1 BME A 300 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 B 209 GLU A 96 GLU.? 20.00 O1 BME A 300 B 217 GLY A 97 GLY.? 20.00 S2 BME A 300 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1hzd_c07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 B 209 GLU A 99 GLU.? 20.82 S2 BME A 300 B 217 GLY A 33 GLY.? 15.27 S2 BME A 300 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1hzd_c07 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 7 hits 1hzd_c07 naa= 2 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 C 209 GLU A 77 GLU~? 17.67 S2 BME A 300 C 217 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 7.63 5.18 13.95 5.55 5.01 14.48 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 C 209 GLU A 87 GLU.? 12.12 O1 BME A 300 C 217 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 28.83 -17.90 5.95 27.84 -19.51 6.89 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 C 209 GLU A 87 GLU.? 12.12 O1 BME A 300 C 217 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 C 209 GLU A 87 GLU.? 12.12 O1 BME A 300 C 217 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 C 209 GLU A 96 GLU.? 20.00 O1 BME A 300 C 217 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 C 209 GLU A 96 GLU.? 20.00 O1 BME A 300 C 217 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1hzd_c08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 C 209 GLU A 99 GLU.? 20.82 S2 BME A 300 C 217 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1hzd_c08 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 7 hits 1hzd_c08 naa= 2 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 D 209 GLU A 77 GLU~? 17.67 S2 BME A 300 D 217 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -9.98 2.96 6.77 -8.83 4.39 5.71 7.63 5.18 13.95 5.55 5.01 14.48 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 D 209 GLU A 87 GLU.? 12.12 O1 BME A 300 D 217 GLY A 66 GLY.? -4.48 C1 BME A 300s coo -9.98 2.96 6.77 -8.83 4.39 5.71 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 D 209 GLU A 87 GLU.? 12.12 O1 BME A 300 D 217 GLY A 88 GLY~? 6.95 O1 BME A 300 coo -9.98 2.96 6.77 -8.83 4.39 5.71 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 D 209 GLU A 87 GLU.? 12.12 O1 BME A 300 D 217 GLY A 89 GLY~? 6.94 S2 BME A 300 coo -9.98 2.96 6.77 -8.83 4.39 5.71 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 D 209 GLU A 96 GLU.? 20.00 O1 BME A 300 D 217 GLY A 94 GLY~? 13.27 O1 BME A 300 coo -9.98 2.96 6.77 -8.83 4.39 5.71 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 D 209 GLU A 96 GLU.? 20.00 O1 BME A 300 D 217 GLY A 97 GLY.? 20.00 S2 BME A 300 coo -9.98 2.96 6.77 -8.83 4.39 5.71 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1hzd_c09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 D 209 GLU A 99 GLU.? 20.82 S2 BME A 300 D 217 GLY A 33 GLY.? 15.27 S2 BME A 300 coo -9.98 2.96 6.77 -8.83 4.39 5.71 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1hzd_c09 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 7 hits 1hzd_c09 naa= 2 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 E 209 GLU A 77 GLU~? 17.67 S2 BME A 300 E 217 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 10.22 22.22 35.51 8.60 22.81 34.29 7.63 5.18 13.95 5.55 5.01 14.48 coo 8.99 16.32 35.57 8.40 16.60 35.14 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 E 209 GLU A 87 GLU.? 12.12 O1 BME A 300 E 217 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 10.22 22.22 35.51 8.60 22.81 34.29 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 8.99 16.32 35.57 8.40 16.60 35.14 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 E 209 GLU A 87 GLU.? 12.12 O1 BME A 300 E 217 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 10.22 22.22 35.51 8.60 22.81 34.29 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 8.99 16.32 35.57 8.40 16.60 35.14 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 E 209 GLU A 87 GLU.? 12.12 O1 BME A 300 E 217 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 10.22 22.22 35.51 8.60 22.81 34.29 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 8.99 16.32 35.57 8.40 16.60 35.14 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 E 209 GLU A 96 GLU.? 20.00 O1 BME A 300 E 217 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 10.22 22.22 35.51 8.60 22.81 34.29 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 8.99 16.32 35.57 8.40 16.60 35.14 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 E 209 GLU A 96 GLU.? 20.00 O1 BME A 300 E 217 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 10.22 22.22 35.51 8.60 22.81 34.29 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 8.99 16.32 35.57 8.40 16.60 35.14 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1hzd_c10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 E 209 GLU A 99 GLU.? 20.82 S2 BME A 300 E 217 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 10.22 22.22 35.51 8.60 22.81 34.29 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 8.99 16.32 35.57 8.40 16.60 35.14 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1hzd_c10 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 7 hits 1hzd_c10 naa= 2 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 F 209 GLU A 77 GLU~? 17.67 S2 BME A 300 F 217 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 28.20 13.18 0.91 27.61 14.93 1.92 7.63 5.18 13.95 5.55 5.01 14.48 coo 28.90 10.06 6.12 28.78 10.83 6.32 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 F 209 GLU A 87 GLU.? 12.12 O1 BME A 300 F 217 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 28.20 13.18 0.91 27.61 14.93 1.92 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.90 10.06 6.12 28.78 10.83 6.32 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 F 209 GLU A 87 GLU.? 12.12 O1 BME A 300 F 217 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 28.20 13.18 0.91 27.61 14.93 1.92 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.90 10.06 6.12 28.78 10.83 6.32 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 F 209 GLU A 87 GLU.? 12.12 O1 BME A 300 F 217 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 28.20 13.18 0.91 27.61 14.93 1.92 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.90 10.06 6.12 28.78 10.83 6.32 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 F 209 GLU A 96 GLU.? 20.00 O1 BME A 300 F 217 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 28.20 13.18 0.91 27.61 14.93 1.92 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 28.90 10.06 6.12 28.78 10.83 6.32 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 F 209 GLU A 96 GLU.? 20.00 O1 BME A 300 F 217 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 28.20 13.18 0.91 27.61 14.93 1.92 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 28.90 10.06 6.12 28.78 10.83 6.32 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1hzd_c11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 7 2 # 7 F 209 GLU A 99 GLU.? 20.82 S2 BME A 300 F 217 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 28.20 13.18 0.91 27.61 14.93 1.92 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 28.90 10.06 6.12 28.78 10.83 6.32 17.51 -11.85 -4.66 17.42 -11.88 -3.82 1hzd_c11 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 7 hits 1hzd_c11 naa= 2 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 A 189 GLU A 8 GLU~? 18.47 O1 BME A 300 A 209 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 A 189 GLU A 28 GLU~? 14.38 S2 BME A 300 A 209 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 A 189 GLU A 29 GLU~? 6.68 S2 BME A 300 A 209 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 A 189 GLU A 74 GLU~? 13.09 S2 BME A 300 A 209 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 A 189 GLU A 77 GLU~? 17.67 S2 BME A 300 A 209 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 7.63 5.18 13.95 5.55 5.01 14.48 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1hzd_c12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 A 189 GLU A 87 GLU.? 12.12 O1 BME A 300 A 209 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1hzd_c12 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 6 hits 1hzd_c12 naa= 2 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 B 189 GLU A 8 GLU~? 18.47 O1 BME A 300 B 209 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 B 189 GLU A 28 GLU~? 14.38 S2 BME A 300 B 209 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 B 189 GLU A 29 GLU~? 6.68 S2 BME A 300 B 209 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 B 189 GLU A 74 GLU~? 13.09 S2 BME A 300 B 209 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 B 189 GLU A 77 GLU~? 17.67 S2 BME A 300 B 209 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 7.63 5.18 13.95 5.55 5.01 14.48 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1hzd_c13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 B 189 GLU A 87 GLU.? 12.12 O1 BME A 300 B 209 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1hzd_c13 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 6 hits 1hzd_c13 naa= 2 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 C 189 GLU A 8 GLU~? 18.47 O1 BME A 300 C 209 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 C 189 GLU A 28 GLU~? 14.38 S2 BME A 300 C 209 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 C 189 GLU A 29 GLU~? 6.68 S2 BME A 300 C 209 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 C 189 GLU A 74 GLU~? 13.09 S2 BME A 300 C 209 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 C 189 GLU A 77 GLU~? 17.67 S2 BME A 300 C 209 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 7.63 5.18 13.95 5.55 5.01 14.48 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1hzd_c14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 C 189 GLU A 87 GLU.? 12.12 O1 BME A 300 C 209 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1hzd_c14 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 6 hits 1hzd_c14 naa= 2 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 D 189 GLU A 8 GLU~? 18.47 O1 BME A 300 D 209 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo -9.98 2.96 6.77 -8.83 4.39 5.71 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 D 189 GLU A 28 GLU~? 14.38 S2 BME A 300 D 209 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -2.98 4.12 3.98 -4.11 2.53 4.76 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -9.98 2.96 6.77 -8.83 4.39 5.71 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 D 189 GLU A 29 GLU~? 6.68 S2 BME A 300 D 209 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -2.98 4.12 3.98 -4.11 2.53 4.76 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -9.98 2.96 6.77 -8.83 4.39 5.71 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 D 189 GLU A 74 GLU~? 13.09 S2 BME A 300 D 209 GLU A 77 GLU~? 17.67 S2 BME A 300 coo -2.98 4.12 3.98 -4.11 2.53 4.76 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -9.98 2.96 6.77 -8.83 4.39 5.71 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 D 189 GLU A 77 GLU~? 17.67 S2 BME A 300 D 209 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -2.98 4.12 3.98 -4.11 2.53 4.76 7.63 5.18 13.95 5.55 5.01 14.48 coo -9.98 2.96 6.77 -8.83 4.39 5.71 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1hzd_c15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 D 189 GLU A 87 GLU.? 12.12 O1 BME A 300 D 209 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -2.98 4.12 3.98 -4.11 2.53 4.76 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1hzd_c15 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 6 hits 1hzd_c15 naa= 2 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 E 189 GLU A 8 GLU~? 18.47 O1 BME A 300 E 209 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 4.93 18.46 31.25 6.09 18.34 33.00 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 10.22 22.22 35.51 8.60 22.81 34.29 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 E 189 GLU A 28 GLU~? 14.38 S2 BME A 300 E 209 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 4.93 18.46 31.25 6.09 18.34 33.00 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 10.22 22.22 35.51 8.60 22.81 34.29 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 E 189 GLU A 29 GLU~? 6.68 S2 BME A 300 E 209 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 4.93 18.46 31.25 6.09 18.34 33.00 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 10.22 22.22 35.51 8.60 22.81 34.29 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 E 189 GLU A 74 GLU~? 13.09 S2 BME A 300 E 209 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 4.93 18.46 31.25 6.09 18.34 33.00 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 10.22 22.22 35.51 8.60 22.81 34.29 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 E 189 GLU A 77 GLU~? 17.67 S2 BME A 300 E 209 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 4.93 18.46 31.25 6.09 18.34 33.00 7.63 5.18 13.95 5.55 5.01 14.48 coo 10.22 22.22 35.51 8.60 22.81 34.29 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1hzd_c16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 E 189 GLU A 87 GLU.? 12.12 O1 BME A 300 E 209 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 4.93 18.46 31.25 6.09 18.34 33.00 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 10.22 22.22 35.51 8.60 22.81 34.29 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1hzd_c16 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 6 hits 1hzd_c16 naa= 2 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 F 189 GLU A 8 GLU~? 18.47 O1 BME A 300 F 209 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 26.45 15.67 7.87 27.70 14.18 7.03 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 28.20 13.18 0.91 27.61 14.93 1.92 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 F 189 GLU A 28 GLU~? 14.38 S2 BME A 300 F 209 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 26.45 15.67 7.87 27.70 14.18 7.03 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 28.20 13.18 0.91 27.61 14.93 1.92 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 F 189 GLU A 29 GLU~? 6.68 S2 BME A 300 F 209 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 26.45 15.67 7.87 27.70 14.18 7.03 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 28.20 13.18 0.91 27.61 14.93 1.92 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 4 2 # 4 F 189 GLU A 74 GLU~? 13.09 S2 BME A 300 F 209 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 26.45 15.67 7.87 27.70 14.18 7.03 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 28.20 13.18 0.91 27.61 14.93 1.92 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 5 2 # 5 F 189 GLU A 77 GLU~? 17.67 S2 BME A 300 F 209 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 26.45 15.67 7.87 27.70 14.18 7.03 7.63 5.18 13.95 5.55 5.01 14.48 coo 28.20 13.18 0.91 27.61 14.93 1.92 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1hzd_c17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 6 2 # 6 F 189 GLU A 87 GLU.? 12.12 O1 BME A 300 F 209 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 26.45 15.67 7.87 27.70 14.18 7.03 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 28.20 13.18 0.91 27.61 14.93 1.92 -0.20 1.85 -3.14 -1.06 2.30 -1.20 1hzd_c17 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 6 hits 1hzd_c17 naa= 2 ULMN 2 1i1i_c00 NEUROLYSIN user 1 2 # 1 P 503 GLU A 57 GLU.? 23.43 S2 BME A 300 P 613 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 24.56 14.95 15.74 26.34 15.44 14.68 16.30 10.78 3.24 16.87 9.97 1.36 coo 22.44 18.36 18.57 25.20 18.77 18.75 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1i1i_c00 NEUROLYSIN user 2 2 # 2 P 503 GLU A 99 GLU.? 20.82 S2 BME A 300 P 613 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 24.56 14.95 15.74 26.34 15.44 14.68 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 22.44 18.36 18.57 25.20 18.77 18.75 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1i1i_c00 source 1i1i NEUROLYSIN : 2 hits 1i1i_c00 naa= 2 ULMN 2 1i29_c02 CSDB user 1 2 # 1 A 226 LYS A 2 LYS.? 20.18 S2 BME A 300 A 364 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 34.47 51.09 7.19 28.58 51.18 7.53 2.39 3.95 8.25 5.67 8.88 7.74 coo 21.18 48.73 0.09 23.82 48.36 -0.97 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 2 1i29_c02 CSDB user 2 2 # 2 A 226 LYS A 10 LYS~? 16.18 O1 BME A 300 A 364 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 34.47 51.09 7.19 28.58 51.18 7.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 21.18 48.73 0.09 23.82 48.36 -0.97 10.91 -8.39 4.98 11.88 -9.73 7.18 1i29_c02 source 1i29 CSDB : 2 hits 1i29_c02 naa= 2 ULMN 2 1i6p_c00 CARBONIC ANHYDRASE user 1 2 # 1 A 44 ASP A 23 ASP^? 9.45 S2 BME A 300 A 46 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 8.35 49.41 35.76 6.30 49.41 35.15 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 9.94 45.87 34.71 8.97 43.01 35.28 13.39 -11.16 2.90 14.53 -11.26 0.04 1i6p_c00 source 1i6p CARBONIC ANHYDRASE : 1 hits 1i6p_c00 naa= 2 ULMN 2 1idj_c00 PECTIN LYASE A user 1 2 # 1 A 176 ARG A 25 ARG.? 9.68 S2 BME A 300 A 236 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 23.79 24.41 46.33 21.03 24.63 45.00 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 24.08 20.68 39.34 22.77 19.80 41.96 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1idj_c00 PECTIN LYASE A user 2 2 # 2 A 176 ARG A 68 ARG~? -4.35 S2 BME A 300s A 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 23.79 24.41 46.33 21.03 24.63 45.00 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 24.08 20.68 39.34 22.77 19.80 41.96 13.39 -11.16 2.90 14.53 -11.26 0.04 1idj_c00 source 1idj PECTIN LYASE A : 2 hits 1idj_c00 naa= 2 ULMN 2 1idj_c01 PECTIN LYASE A user 1 2 # 1 B 176 ARG A 25 ARG.? 9.68 S2 BME A 300 B 236 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 34.55 75.64 62.53 31.79 75.41 63.86 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 34.83 79.32 69.54 33.52 80.22 66.94 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1idj_c01 PECTIN LYASE A user 2 2 # 2 B 176 ARG A 68 ARG~? -4.35 S2 BME A 300s B 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 34.55 75.64 62.53 31.79 75.41 63.86 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 34.83 79.32 69.54 33.52 80.22 66.94 13.39 -11.16 2.90 14.53 -11.26 0.04 1idj_c01 source 1idj PECTIN LYASE A : 2 hits 1idj_c01 naa= 2 ULMN 2 1idj_c02 PECTIN LYASE A user 1 2 # 1 A 154 ASP A 23 ASP^? 9.45 S2 BME A 300 A 236 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 23.38 30.01 45.27 22.92 28.01 45.81 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 24.08 20.68 39.34 22.77 19.80 41.96 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1idj_c02 PECTIN LYASE A user 2 2 # 2 A 154 ASP A 27 ASP~? 15.09 S2 BME A 300 A 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 23.38 30.01 45.27 22.92 28.01 45.81 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 24.08 20.68 39.34 22.77 19.80 41.96 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1idj_c02 PECTIN LYASE A user 3 2 # 3 A 154 ASP A 27 ASP~? 15.09 S2 BME A 300 A 236 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 23.38 30.01 45.27 22.92 28.01 45.81 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 24.08 20.68 39.34 22.77 19.80 41.96 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1idj_c02 PECTIN LYASE A user 4 2 # 4 A 154 ASP A 44 ASP~? 11.03 S2 BME A 300 A 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 23.38 30.01 45.27 22.92 28.01 45.81 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 24.08 20.68 39.34 22.77 19.80 41.96 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1idj_c02 PECTIN LYASE A user 5 2 # 5 A 154 ASP A 95 ASP.? 15.99 O1 BME A 300 A 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 23.38 30.01 45.27 22.92 28.01 45.81 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 24.08 20.68 39.34 22.77 19.80 41.96 13.39 -11.16 2.90 14.53 -11.26 0.04 1idj_c02 source 1idj PECTIN LYASE A : 5 hits 1idj_c02 naa= 2 ULMN 2 1idj_c03 PECTIN LYASE A user 1 2 # 1 B 154 ASP A 23 ASP^? 9.45 S2 BME A 300 B 236 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 34.14 70.03 63.55 33.67 72.04 63.02 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 34.83 79.32 69.54 33.52 80.22 66.94 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1idj_c03 PECTIN LYASE A user 2 2 # 2 B 154 ASP A 27 ASP~? 15.09 S2 BME A 300 B 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 34.14 70.03 63.55 33.67 72.04 63.02 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 34.83 79.32 69.54 33.52 80.22 66.94 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1idj_c03 PECTIN LYASE A user 3 2 # 3 B 154 ASP A 27 ASP~? 15.09 S2 BME A 300 B 236 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 34.14 70.03 63.55 33.67 72.04 63.02 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 34.83 79.32 69.54 33.52 80.22 66.94 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1idj_c03 PECTIN LYASE A user 4 2 # 4 B 154 ASP A 44 ASP~? 11.03 S2 BME A 300 B 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 34.14 70.03 63.55 33.67 72.04 63.02 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 34.83 79.32 69.54 33.52 80.22 66.94 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1idj_c03 PECTIN LYASE A user 5 2 # 5 B 154 ASP A 95 ASP.? 15.99 O1 BME A 300 B 236 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 34.14 70.03 63.55 33.67 72.04 63.02 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 34.83 79.32 69.54 33.52 80.22 66.94 13.39 -11.16 2.90 14.53 -11.26 0.04 1idj_c03 source 1idj PECTIN LYASE A : 5 hits 1idj_c03 naa= 2 ULMN 2 1idt_c02 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 2 # 1 A 14 LYS A 10 LYS~? 16.18 O1 BME A 300 A 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1idt_c02 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 2 # 2 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1idt_c02 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 2 # 3 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1idt_c02 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 2 # 4 A 14 LYS A 17 LYS.? 25.68 S2 BME A 300 A 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 7.13 5.12 -6.84 5.25 7.73 -2.58 1idt_c02 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c02 naa= 2 ULMN 2 1idt_c03 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 2 # 1 B 14 LYS A 10 LYS~? 16.18 O1 BME A 300 B 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1idt_c03 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 2 # 2 B 14 LYS A 12 LYS~? 21.81 S2 BME A 300 B 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1idt_c03 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 2 # 3 B 14 LYS A 12 LYS~? 21.81 S2 BME A 300 B 74 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1idt_c03 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 2 # 4 B 14 LYS A 17 LYS.? 25.68 S2 BME A 300 B 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 13.04 11.19 -6.33 8.80 12.60 -2.10 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 7.13 5.12 -6.84 5.25 7.73 -2.58 1idt_c03 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 4 hits 1idt_c03 naa= 2 ULMN 2 1ima_c00 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 1 2 # 1 A 70 GLU A 28 GLU~? 14.38 S2 BME A 300 A 95 THR A 30 THR~? 11.99 S2 BME A 300 coo 9.44 55.07 5.90 7.73 55.00 7.18 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 0.81 57.04 9.53 1.79 56.94 7.62 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1ima_c00 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 2 2 # 2 A 70 GLU A 99 GLU.? 20.82 S2 BME A 300 A 95 THR A 30 THR~? 11.99 S2 BME A 300 coo 9.44 55.07 5.90 7.73 55.00 7.18 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 0.81 57.04 9.53 1.79 56.94 7.62 18.48 -11.65 0.55 19.28 -10.22 2.01 1ima_c00 source 1ima INOSITOL MONOPHOSPHATASE (E.C.3.1.3.25) COMPLE: 2 hits 1ima_c00 naa= 2 ULMN 2 1ima_c01 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 1 2 # 1 B 70 GLU A 28 GLU~? 14.38 S2 BME A 300 B 95 THR A 30 THR~? 11.99 S2 BME A 300 coo -14.76 52.04 41.84 -13.24 52.19 40.40 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -6.40 55.00 38.40 -7.32 54.60 40.33 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1ima_c01 INOSITOL MONOPHOSPHATASE (E.C.3.1.3.user 2 2 # 2 B 70 GLU A 99 GLU.? 20.82 S2 BME A 300 B 95 THR A 30 THR~? 11.99 S2 BME A 300 coo -14.76 52.04 41.84 -13.24 52.19 40.40 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -6.40 55.00 38.40 -7.32 54.60 40.33 18.48 -11.65 0.55 19.28 -10.22 2.01 1ima_c01 source 1ima INOSITOL MONOPHOSPHATASE (E.C.3.1.3.25) COMPLE: 2 hits 1ima_c01 naa= 2 ULMN 2 1inp_c00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 133 ASP A 7 ASP~? 16.68 O1 BME A 300 158 THR A 45 THR~? 14.85 S2 BME A 300 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -5.30 12.75 41.86 -4.34 13.05 39.99 21.81 -5.88 13.03 22.64 -6.51 11.11 ULMN 2 1inp_c00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 133 ASP A 48 ASP~? 19.85 S2 BME A 300 158 THR A 5 THR~? 15.55 O1 BME A 300 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -5.30 12.75 41.86 -4.34 13.05 39.99 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1inp_c00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 2 # 3 133 ASP A 48 ASP~? 19.85 S2 BME A 300 158 THR A 6 THR~? 12.27 O1 BME A 300 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -5.30 12.75 41.86 -4.34 13.05 39.99 3.82 -3.37 -2.85 3.90 -5.51 -2.59 1inp_c00 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 3 hits 1inp_c00 naa= 2 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 37 LYS A 2 LYS.? 20.18 S2 BME A 300 158 THR A 5 THR~? 15.55 O1 BME A 300 coo 2.85 17.07 38.64 -1.64 15.65 41.27 2.39 3.95 8.25 5.67 8.88 7.74 coo -5.30 12.75 41.86 -4.34 13.05 39.99 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 37 LYS A 10 LYS~? 16.18 O1 BME A 300 158 THR A 5 THR~? 15.55 O1 BME A 300 coo 2.85 17.07 38.64 -1.64 15.65 41.27 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -5.30 12.75 41.86 -4.34 13.05 39.99 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 2 # 3 37 LYS A 12 LYS~? 21.81 S2 BME A 300 158 THR A 5 THR~? 15.55 O1 BME A 300 coo 2.85 17.07 38.64 -1.64 15.65 41.27 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -5.30 12.75 41.86 -4.34 13.05 39.99 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 2 # 4 37 LYS A 12 LYS~? 21.81 S2 BME A 300 158 THR A 6 THR~? 12.27 O1 BME A 300 coo 2.85 17.07 38.64 -1.64 15.65 41.27 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -5.30 12.75 41.86 -4.34 13.05 39.99 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 2 # 5 37 LYS A 39 LYS^? 20.06 S2 BME A 300 158 THR A 30 THR~? 11.99 S2 BME A 300 coo 2.85 17.07 38.64 -1.64 15.65 41.27 19.85 -1.20 1.64 21.03 4.07 2.80 coo -5.30 12.75 41.86 -4.34 13.05 39.99 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1inp_c01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 2 # 6 37 LYS A 101 LYS.? -19.93 S2 BME A 300s 158 THR A 30 THR~? 11.99 S2 BME A 300 coo 2.85 17.07 38.64 -1.64 15.65 41.27 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo -5.30 12.75 41.86 -4.34 13.05 39.99 18.48 -11.65 0.55 19.28 -10.22 2.01 1inp_c01 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 6 hits 1inp_c01 naa= 2 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 79 GLU A 28 GLU~? 14.38 S2 BME A 300 158 THR A 30 THR~? 11.99 S2 BME A 300 coo -6.22 13.24 31.73 -5.30 13.57 33.58 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -5.30 12.75 41.86 -4.34 13.05 39.99 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1inp_c03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 79 GLU A 99 GLU.? 20.82 S2 BME A 300 158 THR A 30 THR~? 11.99 S2 BME A 300 coo -6.22 13.24 31.73 -5.30 13.57 33.58 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -5.30 12.75 41.86 -4.34 13.05 39.99 18.48 -11.65 0.55 19.28 -10.22 2.01 1inp_c03 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c03 naa= 2 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 1 2 # 1 A1132 ASP A 23 ASP^? 9.45 S2 BME A 300 A1136 ARG A 25 ARG.? 9.68 S2 BME A 300 coo -27.05 34.58 17.12 -25.81 32.84 17.16 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -21.15 30.60 15.10 -21.49 31.93 17.86 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1ir3_c00 INSULIN RECEPTOR user 2 2 # 2 A1132 ASP A 44 ASP~? 11.03 S2 BME A 300 A1136 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -27.05 34.58 17.12 -25.81 32.84 17.16 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -21.15 30.60 15.10 -21.49 31.93 17.86 12.31 -11.28 10.33 12.92 -12.61 7.64 1ir3_c00 source 1ir3 INSULIN RECEPTOR : 2 hits 1ir3_c00 naa= 2 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 1 2 # 1 A1132 ASP A 23 ASP^? 9.45 S2 BME A 300 A1134 ALA A 38 ALA.? 14.54 S2 BME A 300 coo -27.05 34.58 17.12 -25.81 32.84 17.16 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -20.53 36.39 15.81 -20.80 35.01 16.40 17.61 -1.66 -1.41 16.80 -2.91 -1.17 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 2 2 # 2 A1132 ASP A 27 ASP~? 15.09 S2 BME A 300 A1134 ALA A 31 ALA~? 16.01 S2 BME A 300 coo -27.05 34.58 17.12 -25.81 32.84 17.16 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -20.53 36.39 15.81 -20.80 35.01 16.40 21.12 -13.83 -1.18 21.96 -14.90 -0.48 ULMN 2 1ir3_c01 INSULIN RECEPTOR user 3 2 # 3 A1132 ASP A 82 ASP^? 20.57 S2 BME A 300 A1134 ALA A 83 ALA^? 14.63 S2 BME A 300 coo -27.05 34.58 17.12 -25.81 32.84 17.16 10.12 9.33 8.59 8.15 9.51 7.94 coo -20.53 36.39 15.81 -20.80 35.01 16.40 9.58 4.45 8.44 10.26 3.43 9.36 1ir3_c01 source 1ir3 INSULIN RECEPTOR : 3 hits 1ir3_c01 naa= 2 ULMN 2 1itq_c00 RENAL DIPEPTIDASE user 1 2 # 1 A 152 HIS A 91 HIS~? 7.63 O1 BME A 300 A 288 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 71.51 57.76 30.86 69.53 58.08 31.47 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 61.38 52.36 29.26 62.76 53.82 29.93 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1itq_c00 source 1itq RENAL DIPEPTIDASE : 1 hits 1itq_c00 naa= 2 ULMN 2 1itq_c01 RENAL DIPEPTIDASE user 1 2 # 1 B 152 HIS A 91 HIS~? 7.63 O1 BME A 300 B 288 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 95.85 54.81 55.16 97.89 54.70 54.70 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 104.39 47.30 56.49 103.35 49.00 55.82 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1itq_c01 source 1itq RENAL DIPEPTIDASE : 1 hits 1itq_c01 naa= 2 ULMN 2 1itx_c01 GLYCOSYL HYDROLASE user 1 2 # 1 A 202 ASP A 7 ASP~? 16.68 O1 BME A 300 A 204 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 5.85 5.60 30.32 5.00 7.49 29.88 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 7.79 1.83 27.81 9.08 3.25 26.92 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1itx_c01 GLYCOSYL HYDROLASE user 2 2 # 2 A 202 ASP A 27 ASP~? 15.09 S2 BME A 300 A 204 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 5.85 5.60 30.32 5.00 7.49 29.88 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 7.79 1.83 27.81 9.08 3.25 26.92 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1itx_c01 GLYCOSYL HYDROLASE user 3 2 # 3 A 202 ASP A 95 ASP.? 15.99 O1 BME A 300 A 204 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 5.85 5.60 30.32 5.00 7.49 29.88 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 7.79 1.83 27.81 9.08 3.25 26.92 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1itx_c01 source 1itx GLYCOSYL HYDROLASE : 3 hits 1itx_c01 naa= 2 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 1 2 # 1 A 200 ASP A 7 ASP~? 16.68 O1 BME A 300 A 204 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 1.52 9.98 32.08 2.12 9.01 30.34 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 7.79 1.83 27.81 9.08 3.25 26.92 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 2 2 # 2 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 204 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 1.52 9.98 32.08 2.12 9.01 30.34 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 7.79 1.83 27.81 9.08 3.25 26.92 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 3 2 # 3 A 200 ASP A 23 ASP^? 9.45 S2 BME A 300 A 204 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 1.52 9.98 32.08 2.12 9.01 30.34 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 7.79 1.83 27.81 9.08 3.25 26.92 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 4 2 # 4 A 200 ASP A 44 ASP~? 11.03 S2 BME A 300 A 204 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 1.52 9.98 32.08 2.12 9.01 30.34 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 7.79 1.83 27.81 9.08 3.25 26.92 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 5 2 # 5 A 200 ASP A 44 ASP~? 11.03 S2 BME A 300 A 204 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 1.52 9.98 32.08 2.12 9.01 30.34 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 7.79 1.83 27.81 9.08 3.25 26.92 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 6 2 # 6 A 200 ASP A 95 ASP.? 15.99 O1 BME A 300 A 204 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 1.52 9.98 32.08 2.12 9.01 30.34 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 7.79 1.83 27.81 9.08 3.25 26.92 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1itx_c02 GLYCOSYL HYDROLASE user 7 2 # 7 A 200 ASP A 95 ASP.? 15.99 O1 BME A 300 A 204 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 1.52 9.98 32.08 2.12 9.01 30.34 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 7.79 1.83 27.81 9.08 3.25 26.92 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1itx_c02 source 1itx GLYCOSYL HYDROLASE : 7 hits 1itx_c02 naa= 2 ULMN 2 1j2u_c00 CREATININE AMIDOHYDROLASE user 1 2 # 1 A 122 GLU A 87 GLU.? 12.12 O1 BME A 300 A 178 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 42.98 33.31 2.79 43.30 34.53 1.09 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 44.23 39.49 -3.62 43.02 38.27 -4.82 3.84 -13.89 0.30 2.26 -15.26 0.08 1j2u_c00 source 1j2u CREATININE AMIDOHYDROLASE : 1 hits 1j2u_c00 naa= 2 ULMN 2 1j2u_c01 CREATININE AMIDOHYDROLASE user 1 2 # 1 B 122 GLU A 87 GLU.? 12.12 O1 BME A 300 B 178 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 49.99 28.69 16.34 50.95 29.64 17.98 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 55.20 32.37 22.74 54.49 30.76 23.90 3.84 -13.89 0.30 2.26 -15.26 0.08 1j2u_c01 source 1j2u CREATININE AMIDOHYDROLASE : 1 hits 1j2u_c01 naa= 2 ULMN 2 1j2u_c02 CREATININE AMIDOHYDROLASE user 1 2 # 1 C 122 GLU A 87 GLU.? 12.12 O1 BME A 300 C 178 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 23.20 14.25 29.20 22.73 15.29 30.98 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 19.80 18.84 36.22 20.48 20.49 35.12 3.84 -13.89 0.30 2.26 -15.26 0.08 1j2u_c02 source 1j2u CREATININE AMIDOHYDROLASE : 1 hits 1j2u_c02 naa= 2 ULMN 2 1j2u_c03 CREATININE AMIDOHYDROLASE user 1 2 # 1 D 122 GLU A 87 GLU.? 12.12 O1 BME A 300 D 178 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 27.82 -0.87 26.08 27.19 -2.83 26.63 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 25.93 -9.15 29.14 26.70 -9.78 27.29 3.84 -13.89 0.30 2.26 -15.26 0.08 1j2u_c03 source 1j2u CREATININE AMIDOHYDROLASE : 1 hits 1j2u_c03 naa= 2 ULMN 2 1j2u_c04 CREATININE AMIDOHYDROLASE user 1 2 # 1 E 122 GLU A 87 GLU.? 12.12 O1 BME A 300 E 178 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 24.34 1.37 -6.89 22.72 0.10 -7.34 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 17.34 -3.49 -9.86 16.45 -3.05 -8.02 3.84 -13.89 0.30 2.26 -15.26 0.08 1j2u_c04 source 1j2u CREATININE AMIDOHYDROLASE : 1 hits 1j2u_c04 naa= 2 ULMN 2 1j2u_c05 CREATININE AMIDOHYDROLASE user 1 2 # 1 F 122 GLU A 87 GLU.? 12.12 O1 BME A 300 F 178 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 39.98 2.89 -10.07 41.09 2.80 -11.86 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 45.55 1.53 -17.14 46.83 2.81 -16.07 3.84 -13.89 0.30 2.26 -15.26 0.08 1j2u_c05 source 1j2u CREATININE AMIDOHYDROLASE : 1 hits 1j2u_c05 naa= 2 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 1 2 # 1 A 70 GLU A 29 GLU~? 6.68 S2 BME A 300 A 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 41.69 114.28 15.66 40.58 112.97 16.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 35.72 115.53 15.77 35.79 117.41 13.37 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c00 DEOXYGUANOSINE KINASE user 2 2 # 2 A 70 GLU A 29 GLU~? 6.68 S2 BME A 300 A 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 41.69 114.28 15.66 40.58 112.97 16.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 35.72 115.53 15.77 35.79 117.41 13.37 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c00 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c00 naa= 2 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 1 2 # 1 B 70 GLU A 29 GLU~? 6.68 S2 BME A 300 B 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 31.07 79.69 19.07 32.57 81.08 19.72 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 36.62 78.39 16.92 35.66 76.33 14.89 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c01 DEOXYGUANOSINE KINASE user 2 2 # 2 B 70 GLU A 29 GLU~? 6.68 S2 BME A 300 B 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 31.07 79.69 19.07 32.57 81.08 19.72 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 36.62 78.39 16.92 35.66 76.33 14.89 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c01 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c01 naa= 2 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 1 2 # 1 C 70 GLU A 29 GLU~? 6.68 S2 BME A 300 C 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 55.48 107.82 136.32 56.60 106.34 135.24 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 61.38 109.25 135.73 61.32 111.53 137.75 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c02 DEOXYGUANOSINE KINASE user 2 2 # 2 C 70 GLU A 29 GLU~? 6.68 S2 BME A 300 C 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 55.48 107.82 136.32 56.60 106.34 135.24 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 61.38 109.25 135.73 61.32 111.53 137.75 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c02 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c02 naa= 2 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 1 2 # 1 D 70 GLU A 29 GLU~? 6.68 S2 BME A 300 D 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 67.23 73.46 138.83 65.67 74.68 137.98 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 61.78 72.49 141.39 62.87 70.87 143.74 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c03 DEOXYGUANOSINE KINASE user 2 2 # 2 D 70 GLU A 29 GLU~? 6.68 S2 BME A 300 D 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 67.23 73.46 138.83 65.67 74.68 137.98 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 61.78 72.49 141.39 62.87 70.87 143.74 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c03 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c03 naa= 2 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 1 2 # 1 E 70 GLU A 29 GLU~? 6.68 S2 BME A 300 E 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 59.48 65.31 58.13 60.88 63.94 57.24 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 65.31 66.97 58.90 64.71 69.12 60.98 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c04 DEOXYGUANOSINE KINASE user 2 2 # 2 E 70 GLU A 29 GLU~? 6.68 S2 BME A 300 E 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 59.48 65.31 58.13 60.88 63.94 57.24 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 65.31 66.97 58.90 64.71 69.12 60.98 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c04 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c04 naa= 2 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 1 2 # 1 F 70 GLU A 29 GLU~? 6.68 S2 BME A 300 F 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 72.50 31.52 60.99 71.07 32.72 59.92 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 66.72 30.06 62.29 67.42 28.32 64.70 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c05 DEOXYGUANOSINE KINASE user 2 2 # 2 F 70 GLU A 29 GLU~? 6.68 S2 BME A 300 F 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 72.50 31.52 60.99 71.07 32.72 59.92 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 66.72 30.06 62.29 67.42 28.32 64.70 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c05 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c05 naa= 2 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 1 2 # 1 G 70 GLU A 29 GLU~? 6.68 S2 BME A 300 G 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 23.29 16.67 58.82 24.61 15.29 57.84 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 29.15 18.37 59.04 28.72 20.55 61.13 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c06 DEOXYGUANOSINE KINASE user 2 2 # 2 G 70 GLU A 29 GLU~? 6.68 S2 BME A 300 G 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 23.29 16.67 58.82 24.61 15.29 57.84 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 29.15 18.37 59.04 28.72 20.55 61.13 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c06 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c06 naa= 2 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 1 2 # 1 H 70 GLU A 29 GLU~? 6.68 S2 BME A 300 H 142 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1jag_c07 DEOXYGUANOSINE KINASE user 2 2 # 2 H 70 GLU A 29 GLU~? 6.68 S2 BME A 300 H 142 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 36.70 -17.02 61.11 35.17 -15.85 60.14 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 12.31 -11.28 10.33 12.92 -12.61 7.64 1jag_c07 source 1jag DEOXYGUANOSINE KINASE : 2 hits 1jag_c07 naa= 2 ULMN 2 1jrp_c04 XANTHINE DEHYDROGENASE user 1 2 # 1 B 310 ARG A 68 ARG~? -4.35 S2 BME A 300s B 730 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 21.65 14.36 26.83 22.79 11.61 26.21 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 22.19 14.33 19.31 20.96 13.74 20.93 15.50 -15.19 4.21 14.37 -14.08 5.62 1jrp_c04 source 1jrp XANTHINE DEHYDROGENASE : 1 hits 1jrp_c04 naa= 2 ULMN 2 1jrp_c05 XANTHINE DEHYDROGENASE user 1 2 # 1 D 310 ARG A 68 ARG~? -4.35 S2 BME A 300s D 730 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 15.50 -15.19 4.21 14.37 -14.08 5.62 1jrp_c05 source 1jrp XANTHINE DEHYDROGENASE : 1 hits 1jrp_c05 naa= 2 ULMN 2 1jrp_c06 XANTHINE DEHYDROGENASE user 1 2 # 1 F 310 ARG A 68 ARG~? -4.35 S2 BME A 300s F 730 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 5.26 36.61 70.62 3.67 36.04 68.06 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 8.70 41.35 66.26 6.78 41.28 67.16 15.50 -15.19 4.21 14.37 -14.08 5.62 1jrp_c06 source 1jrp XANTHINE DEHYDROGENASE : 1 hits 1jrp_c06 naa= 2 ULMN 2 1jrp_c07 XANTHINE DEHYDROGENASE user 1 2 # 1 H 310 ARG A 68 ARG~? -4.35 S2 BME A 300s H 730 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -28.90 76.02 33.83 -29.02 73.00 34.22 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -29.55 75.84 41.31 -28.10 75.67 39.75 15.50 -15.19 4.21 14.37 -14.08 5.62 1jrp_c07 source 1jrp XANTHINE DEHYDROGENASE : 1 hits 1jrp_c07 naa= 2 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 1 2 # 1 A 176 LYS A 2 LYS.? 20.18 S2 BME A 300 A 210 GLY A 65 GLY.? -2.84 O1 BME A 300s coo 34.14 63.09 78.07 32.63 58.11 75.17 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.03 52.38 67.66 33.41 53.06 67.61 6.04 -11.31 4.77 6.43 -10.68 5.09 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 2 2 # 2 A 176 LYS A 2 LYS.? 20.18 S2 BME A 300 A 210 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.03 52.38 67.66 33.41 53.06 67.61 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 3 2 # 3 A 176 LYS A 2 LYS.? 20.18 S2 BME A 300 A 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.03 52.38 67.66 33.41 53.06 67.61 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 4 2 # 4 A 176 LYS A 2 LYS.? 20.18 S2 BME A 300 A 210 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.03 52.38 67.66 33.41 53.06 67.61 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 5 2 # 5 A 176 LYS A 10 LYS~? 16.18 O1 BME A 300 A 210 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 33.03 52.38 67.66 33.41 53.06 67.61 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 6 2 # 6 A 176 LYS A 10 LYS~? 16.18 O1 BME A 300 A 210 GLY A 65 GLY.? -2.84 O1 BME A 300s coo 34.14 63.09 78.07 32.63 58.11 75.17 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 33.03 52.38 67.66 33.41 53.06 67.61 6.04 -11.31 4.77 6.43 -10.68 5.09 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 7 2 # 7 A 176 LYS A 10 LYS~? 16.18 O1 BME A 300 A 210 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 34.14 63.09 78.07 32.63 58.11 75.17 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 33.03 52.38 67.66 33.41 53.06 67.61 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 8 2 # 8 A 176 LYS A 10 LYS~? 16.18 O1 BME A 300 A 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 33.03 52.38 67.66 33.41 53.06 67.61 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 9 2 # 9 A 176 LYS A 12 LYS~? 21.81 S2 BME A 300 A 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 33.03 52.38 67.66 33.41 53.06 67.61 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 10 2 # 10 A 176 LYS A 12 LYS~? 21.81 S2 BME A 300 A 210 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 33.03 52.38 67.66 33.41 53.06 67.61 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 11 2 # 11 A 176 LYS A 12 LYS~? 21.81 S2 BME A 300 A 210 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 33.03 52.38 67.66 33.41 53.06 67.61 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 12 2 # 12 A 176 LYS A 12 LYS~? 21.81 S2 BME A 300 A 210 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 33.03 52.38 67.66 33.41 53.06 67.61 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 13 2 # 13 A 176 LYS A 39 LYS^? 20.06 S2 BME A 300 A 210 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 34.14 63.09 78.07 32.63 58.11 75.17 19.85 -1.20 1.64 21.03 4.07 2.80 coo 33.03 52.38 67.66 33.41 53.06 67.61 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 14 2 # 14 A 176 LYS A 39 LYS^? 20.06 S2 BME A 300 A 210 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 19.85 -1.20 1.64 21.03 4.07 2.80 coo 33.03 52.38 67.66 33.41 53.06 67.61 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 15 2 # 15 A 176 LYS A 39 LYS^? 20.06 S2 BME A 300 A 210 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 19.85 -1.20 1.64 21.03 4.07 2.80 coo 33.03 52.38 67.66 33.41 53.06 67.61 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 16 2 # 16 A 176 LYS A 71 LYS~? 8.54 S2 BME A 300 A 210 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 33.03 52.38 67.66 33.41 53.06 67.61 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 17 2 # 17 A 176 LYS A 71 LYS~? 8.54 S2 BME A 300 A 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 33.03 52.38 67.66 33.41 53.06 67.61 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c00 PHOSPHOMETHYLPYRIMIDINE KINASE user 18 2 # 18 A 176 LYS A 101 LYS.? -19.93 S2 BME A 300s A 210 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 34.14 63.09 78.07 32.63 58.11 75.17 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 33.03 52.38 67.66 33.41 53.06 67.61 13.13 -8.12 -11.42 13.24 -8.65 -10.80 1jxh_c00 source 1jxh PHOSPHOMETHYLPYRIMIDINE KINASE : 18 hits 1jxh_c00 naa= 2 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 1 2 # 1 B 176 LYS A 2 LYS.? 20.18 S2 BME A 300 B 210 GLY A 65 GLY.? -2.84 O1 BME A 300s coo 37.67 14.56 60.47 35.43 19.31 63.31 2.39 3.95 8.25 5.67 8.88 7.74 coo 34.81 25.02 70.85 35.27 24.39 70.91 6.04 -11.31 4.77 6.43 -10.68 5.09 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 2 2 # 2 B 176 LYS A 2 LYS.? 20.18 S2 BME A 300 B 210 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 2.39 3.95 8.25 5.67 8.88 7.74 coo 34.81 25.02 70.85 35.27 24.39 70.91 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 3 2 # 3 B 176 LYS A 2 LYS.? 20.18 S2 BME A 300 B 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 2.39 3.95 8.25 5.67 8.88 7.74 coo 34.81 25.02 70.85 35.27 24.39 70.91 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 4 2 # 4 B 176 LYS A 2 LYS.? 20.18 S2 BME A 300 B 210 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 2.39 3.95 8.25 5.67 8.88 7.74 coo 34.81 25.02 70.85 35.27 24.39 70.91 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 5 2 # 5 B 176 LYS A 10 LYS~? 16.18 O1 BME A 300 B 210 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 34.81 25.02 70.85 35.27 24.39 70.91 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 6 2 # 6 B 176 LYS A 10 LYS~? 16.18 O1 BME A 300 B 210 GLY A 65 GLY.? -2.84 O1 BME A 300s coo 37.67 14.56 60.47 35.43 19.31 63.31 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 34.81 25.02 70.85 35.27 24.39 70.91 6.04 -11.31 4.77 6.43 -10.68 5.09 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 7 2 # 7 B 176 LYS A 10 LYS~? 16.18 O1 BME A 300 B 210 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 37.67 14.56 60.47 35.43 19.31 63.31 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 34.81 25.02 70.85 35.27 24.39 70.91 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 8 2 # 8 B 176 LYS A 10 LYS~? 16.18 O1 BME A 300 B 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 34.81 25.02 70.85 35.27 24.39 70.91 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 9 2 # 9 B 176 LYS A 12 LYS~? 21.81 S2 BME A 300 B 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 34.81 25.02 70.85 35.27 24.39 70.91 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 10 2 # 10 B 176 LYS A 12 LYS~? 21.81 S2 BME A 300 B 210 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 34.81 25.02 70.85 35.27 24.39 70.91 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 11 2 # 11 B 176 LYS A 12 LYS~? 21.81 S2 BME A 300 B 210 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 34.81 25.02 70.85 35.27 24.39 70.91 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 12 2 # 12 B 176 LYS A 12 LYS~? 21.81 S2 BME A 300 B 210 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 34.81 25.02 70.85 35.27 24.39 70.91 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 13 2 # 13 B 176 LYS A 39 LYS^? 20.06 S2 BME A 300 B 210 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 37.67 14.56 60.47 35.43 19.31 63.31 19.85 -1.20 1.64 21.03 4.07 2.80 coo 34.81 25.02 70.85 35.27 24.39 70.91 5.61 -7.93 6.44 5.80 -8.57 6.93 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 14 2 # 14 B 176 LYS A 39 LYS^? 20.06 S2 BME A 300 B 210 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 19.85 -1.20 1.64 21.03 4.07 2.80 coo 34.81 25.02 70.85 35.27 24.39 70.91 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 15 2 # 15 B 176 LYS A 39 LYS^? 20.06 S2 BME A 300 B 210 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 19.85 -1.20 1.64 21.03 4.07 2.80 coo 34.81 25.02 70.85 35.27 24.39 70.91 13.13 -8.12 -11.42 13.24 -8.65 -10.80 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 16 2 # 16 B 176 LYS A 71 LYS~? 8.54 S2 BME A 300 B 210 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 34.81 25.02 70.85 35.27 24.39 70.91 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 17 2 # 17 B 176 LYS A 71 LYS~? 8.54 S2 BME A 300 B 210 GLY A 88 GLY~? 6.95 O1 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 34.81 25.02 70.85 35.27 24.39 70.91 2.96 -8.32 2.51 3.58 -7.86 2.69 ULMN 2 1jxh_c01 PHOSPHOMETHYLPYRIMIDINE KINASE user 18 2 # 18 B 176 LYS A 101 LYS.? -19.93 S2 BME A 300s B 210 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 37.67 14.56 60.47 35.43 19.31 63.31 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 34.81 25.02 70.85 35.27 24.39 70.91 13.13 -8.12 -11.42 13.24 -8.65 -10.80 1jxh_c01 source 1jxh PHOSPHOMETHYLPYRIMIDINE KINASE : 18 hits 1jxh_c01 naa= 2 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 1 2 # 1 A 145 GLU A 8 GLU~? 18.47 O1 BME A 300 A 149 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 38.29 43.93 28.58 37.89 45.59 29.77 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 40.71 37.48 29.08 37.62 41.79 32.12 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 2 2 # 2 A 145 GLU A 8 GLU~? 18.47 O1 BME A 300 A 149 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 38.29 43.93 28.58 37.89 45.59 29.77 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 40.71 37.48 29.08 37.62 41.79 32.12 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 3 2 # 3 A 145 GLU A 15 GLU~? 24.22 S2 BME A 300 A 149 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 38.29 43.93 28.58 37.89 45.59 29.77 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 40.71 37.48 29.08 37.62 41.79 32.12 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 4 2 # 4 A 145 GLU A 57 GLU.? 23.43 S2 BME A 300 A 149 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 38.29 43.93 28.58 37.89 45.59 29.77 16.30 10.78 3.24 16.87 9.97 1.36 coo 40.71 37.48 29.08 37.62 41.79 32.12 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 5 2 # 5 A 145 GLU A 77 GLU~? 17.67 S2 BME A 300 A 149 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 38.29 43.93 28.58 37.89 45.59 29.77 7.63 5.18 13.95 5.55 5.01 14.48 coo 40.71 37.48 29.08 37.62 41.79 32.12 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1kny_c00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 6 2 # 6 A 145 GLU A 99 GLU.? 20.82 S2 BME A 300 A 149 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 38.29 43.93 28.58 37.89 45.59 29.77 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 40.71 37.48 29.08 37.62 41.79 32.12 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1kny_c00 source 1kny KANAMYCIN NUCLEOTIDYLTRANSFERASE : 6 hits 1kny_c00 naa= 2 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 1 2 # 1 B 145 GLU A 8 GLU~? 18.47 O1 BME A 300 B 149 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 16.16 40.65 44.70 16.29 42.36 43.62 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 15.03 33.77 42.69 17.13 39.10 39.90 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 2 2 # 2 B 145 GLU A 8 GLU~? 18.47 O1 BME A 300 B 149 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 16.16 40.65 44.70 16.29 42.36 43.62 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 15.03 33.77 42.69 17.13 39.10 39.90 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 3 2 # 3 B 145 GLU A 15 GLU~? 24.22 S2 BME A 300 B 149 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 16.16 40.65 44.70 16.29 42.36 43.62 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 15.03 33.77 42.69 17.13 39.10 39.90 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 4 2 # 4 B 145 GLU A 57 GLU.? 23.43 S2 BME A 300 B 149 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 16.16 40.65 44.70 16.29 42.36 43.62 16.30 10.78 3.24 16.87 9.97 1.36 coo 15.03 33.77 42.69 17.13 39.10 39.90 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 5 2 # 5 B 145 GLU A 77 GLU~? 17.67 S2 BME A 300 B 149 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 16.16 40.65 44.70 16.29 42.36 43.62 7.63 5.18 13.95 5.55 5.01 14.48 coo 15.03 33.77 42.69 17.13 39.10 39.90 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1kny_c01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 6 2 # 6 B 145 GLU A 99 GLU.? 20.82 S2 BME A 300 B 149 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 16.16 40.65 44.70 16.29 42.36 43.62 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 15.03 33.77 42.69 17.13 39.10 39.90 25.21 -9.57 -6.43 25.99 -6.47 -1.23 1kny_c01 source 1kny KANAMYCIN NUCLEOTIDYLTRANSFERASE : 6 hits 1kny_c01 naa= 2 ULMN 2 1kp2_c00 ARGININOSUCCINATE SYNTHETASE user 1 2 # 1 A 106 ARG A 25 ARG.? 9.68 S2 BME A 300 A 135 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 27.12 14.95 42.29 27.92 17.73 41.22 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 31.19 14.02 39.72 30.95 15.42 41.26 15.97 -5.82 2.06 15.42 -7.84 1.89 1kp2_c00 source 1kp2 ARGININOSUCCINATE SYNTHETASE : 1 hits 1kp2_c00 naa= 2 ULMN 2 1kqc_c04 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 A 14 LYS A 10 LYS~? 16.18 O1 BME A 300 A 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 24.97 5.82 58.78 26.79 1.97 55.46 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 19.46 3.44 61.93 23.95 1.12 60.13 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1kqc_c04 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 24.97 5.82 58.78 26.79 1.97 55.46 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 19.46 3.44 61.93 23.95 1.12 60.13 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1kqc_c04 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 2 # 3 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 24.97 5.82 58.78 26.79 1.97 55.46 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 19.46 3.44 61.93 23.95 1.12 60.13 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1kqc_c04 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 2 # 4 A 14 LYS A 17 LYS.? 25.68 S2 BME A 300 A 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 24.97 5.82 58.78 26.79 1.97 55.46 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 19.46 3.44 61.93 23.95 1.12 60.13 7.13 5.12 -6.84 5.25 7.73 -2.58 1kqc_c04 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c04 naa= 2 ULMN 2 1kqc_c05 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 B 14 LYS A 10 LYS~? 16.18 O1 BME A 300 B 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 4.84 5.09 23.75 3.30 1.39 27.48 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 10.43 2.88 20.75 5.72 0.41 23.95 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1kqc_c05 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 B 14 LYS A 12 LYS~? 21.81 S2 BME A 300 B 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 4.84 5.09 23.75 3.30 1.39 27.48 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 10.43 2.88 20.75 5.72 0.41 23.95 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1kqc_c05 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 2 # 3 B 14 LYS A 12 LYS~? 21.81 S2 BME A 300 B 74 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 4.84 5.09 23.75 3.30 1.39 27.48 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 10.43 2.88 20.75 5.72 0.41 23.95 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1kqc_c05 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 2 # 4 B 14 LYS A 17 LYS.? 25.68 S2 BME A 300 B 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 4.84 5.09 23.75 3.30 1.39 27.48 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 10.43 2.88 20.75 5.72 0.41 23.95 7.13 5.12 -6.84 5.25 7.73 -2.58 1kqc_c05 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c05 naa= 2 ULMN 2 1kqc_c06 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 C 14 LYS A 10 LYS~? 16.18 O1 BME A 300 C 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 17.59 37.25 25.80 19.64 34.15 21.60 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 12.29 34.52 28.11 16.84 32.47 25.43 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1kqc_c06 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 C 14 LYS A 12 LYS~? 21.81 S2 BME A 300 C 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 17.59 37.25 25.80 19.64 34.15 21.60 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 12.29 34.52 28.11 16.84 32.47 25.43 6.34 -0.11 -7.21 5.79 -6.41 -7.72 1kqc_c06 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1kqc_c06 naa= 2 ULMN 2 1kqc_c07 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 D 14 LYS A 10 LYS~? 16.18 O1 BME A 300 D 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1kqc_c07 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 D 14 LYS A 12 LYS~? 21.81 S2 BME A 300 D 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1kqc_c07 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 2 # 3 D 14 LYS A 12 LYS~? 21.81 S2 BME A 300 D 74 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1kqc_c07 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 2 # 4 D 14 LYS A 17 LYS.? 25.68 S2 BME A 300 D 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 7.13 5.12 -6.84 5.25 7.73 -2.58 1kqc_c07 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c07 naa= 2 ULMN 2 1l0o_c00 ANTI-SIGMA F FACTOR user 1 2 # 1 A 46 GLU A 28 GLU~? 14.38 S2 BME A 300 A 105 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 4.64 17.62 61.98 3.43 16.11 62.87 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -1.86 8.63 61.10 0.28 9.55 63.06 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1l0o_c00 ANTI-SIGMA F FACTOR user 2 2 # 2 A 46 GLU A 28 GLU~? 14.38 S2 BME A 300 A 105 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 4.64 17.62 61.98 3.43 16.11 62.87 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -1.86 8.63 61.10 0.28 9.55 63.06 12.31 -11.28 10.33 12.92 -12.61 7.64 1l0o_c00 source 1l0o ANTI-SIGMA F FACTOR : 2 hits 1l0o_c00 naa= 2 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 1 2 # 1 A 63 ARG A 25 ARG.? 9.68 S2 BME A 300 A 100 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 9.84 40.26 39.90 8.84 37.40 40.32 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 2.80 29.73 38.19 4.17 29.64 39.81 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 2 2 # 2 A 63 ARG A 68 ARG~? -4.35 S2 BME A 300s A 100 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 9.84 40.26 39.90 8.84 37.40 40.32 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 2.80 29.73 38.19 4.17 29.64 39.81 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1l1r_c00 ADENINE PHOSPHORIBOSYLTRANSFERASE user 3 2 # 3 A 63 ARG A 68 ARG~? -4.35 S2 BME A 300s A 100 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 9.84 40.26 39.90 8.84 37.40 40.32 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 2.80 29.73 38.19 4.17 29.64 39.81 6.36 -0.87 15.92 5.32 -2.36 17.02 1l1r_c00 source 1l1r ADENINE PHOSPHORIBOSYLTRANSFERASE : 3 hits 1l1r_c00 naa= 2 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 1 2 # 1 A 44 LYS A 2 LYS.? 20.18 S2 BME A 300 A 190 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 2.39 3.95 8.25 5.67 8.88 7.74 coo 62.52 10.21-280.32 62.21 11.74-278.89 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 2 2 # 2 A 44 LYS A 10 LYS~? 16.18 O1 BME A 300 A 190 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 62.52 10.21-280.32 62.21 11.74-278.89 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 3 2 # 3 A 44 LYS A 10 LYS~? 16.18 O1 BME A 300 A 190 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 62.52 10.21-280.32 62.21 11.74-278.89 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 4 2 # 4 A 44 LYS A 12 LYS~? 21.81 S2 BME A 300 A 190 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 62.52 10.21-280.32 62.21 11.74-278.89 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 5 2 # 5 A 44 LYS A 12 LYS~? 21.81 S2 BME A 300 A 190 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 62.52 10.21-280.32 62.21 11.74-278.89 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 6 2 # 6 A 44 LYS A 17 LYS.? 25.68 S2 BME A 300 A 190 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 62.52 10.21-280.32 62.21 11.74-278.89 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 7 2 # 7 A 44 LYS A 39 LYS^? 20.06 S2 BME A 300 A 190 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 19.85 -1.20 1.64 21.03 4.07 2.80 coo 62.52 10.21-280.32 62.21 11.74-278.89 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 8 2 # 8 A 44 LYS A 39 LYS^? 20.06 S2 BME A 300 A 190 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 19.85 -1.20 1.64 21.03 4.07 2.80 coo 62.52 10.21-280.32 62.21 11.74-278.89 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 9 2 # 9 A 44 LYS A 39 LYS^? 20.06 S2 BME A 300 A 190 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 19.85 -1.20 1.64 21.03 4.07 2.80 coo 62.52 10.21-280.32 62.21 11.74-278.89 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 10 2 # 10 A 44 LYS A 71 LYS~? 8.54 S2 BME A 300 A 190 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 62.52 10.21-280.32 62.21 11.74-278.89 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 11 2 # 11 A 44 LYS A 71 LYS~? 8.54 S2 BME A 300 A 190 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 62.52 10.21-280.32 62.21 11.74-278.89 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 12 2 # 12 A 44 LYS A 71 LYS~? 8.54 S2 BME A 300 A 190 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 62.52 10.21-280.32 62.21 11.74-278.89 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 13 2 # 13 A 44 LYS A 101 LYS.? -19.93 S2 BME A 300s A 190 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 62.52 10.21-280.32 62.21 11.74-278.89 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1l8t_c00 AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASEuser 14 2 # 14 A 44 LYS A 101 LYS.? -19.93 S2 BME A 300s A 190 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 64.41 0.88-268.84 63.58 4.71-273.83 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 62.52 10.21-280.32 62.21 11.74-278.89 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1l8t_c00 source 1l8t AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE : 14 hits 1l8t_c00 naa= 2 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 1 2 # 1 46 TYR A 34 TYR.? 16.37 S2 BME A 300 128 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 11.19 7.41 4.40 7.40 9.71 0.49 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 2 2 # 2 46 TYR A 59 TYR^? 18.50 S2 BME A 300 128 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 14.59 5.14 5.72 16.82 6.86 5.68 coo 11.19 7.41 4.40 7.40 9.71 0.49 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 3 2 # 3 46 TYR A 59 TYR^? 18.50 S2 BME A 300 128 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 14.59 5.14 5.72 16.82 6.86 5.68 coo 11.19 7.41 4.40 7.40 9.71 0.49 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 4 2 # 4 46 TYR A 59 TYR^? 18.50 S2 BME A 300 128 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 14.59 5.14 5.72 16.82 6.86 5.68 coo 11.19 7.41 4.40 7.40 9.71 0.49 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 5 2 # 5 46 TYR A 59 TYR^? 18.50 S2 BME A 300 128 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 14.59 5.14 5.72 16.82 6.86 5.68 coo 11.19 7.41 4.40 7.40 9.71 0.49 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 6 2 # 6 46 TYR A 60 TYR^? 16.66 S2 BME A 300 128 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 9.00 3.02 1.57 7.75 5.45 1.00 coo 11.19 7.41 4.40 7.40 9.71 0.49 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 7 2 # 7 46 TYR A 60 TYR^? 16.66 S2 BME A 300 128 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 9.00 3.02 1.57 7.75 5.45 1.00 coo 11.19 7.41 4.40 7.40 9.71 0.49 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 8 2 # 8 46 TYR A 75 TYR~? 15.90 S2 BME A 300 128 LYS A 2 LYS.? 20.18 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 14.46 -0.26 16.60 17.11 0.41 17.22 coo 11.19 7.41 4.40 7.40 9.71 0.49 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 9 2 # 9 46 TYR A 75 TYR~? 15.90 S2 BME A 300 128 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 14.46 -0.26 16.60 17.11 0.41 17.22 coo 11.19 7.41 4.40 7.40 9.71 0.49 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1lba_c00 LYSOZYME (E.C.3.5.1.28) MUTANT WITH user 10 2 # 10 46 TYR A 75 TYR~? 15.90 S2 BME A 300 128 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -1.50 15.16 7.45 1.01 15.23 6.34 14.46 -0.26 16.60 17.11 0.41 17.22 coo 11.19 7.41 4.40 7.40 9.71 0.49 15.98 12.20 9.88 16.28 11.97 16.11 1lba_c00 source 1lba LYSOZYME (E.C.3.5.1.28) MUTANT WITH ALA 6 REPL: 10 hits 1lba_c00 naa= 2 ULMN 2 1lij_c00 ADENOSINE KINASE user 1 2 # 1 A 136 ARG A 25 ARG.? 9.68 S2 BME A 300 A 318 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1lij_c00 ADENOSINE KINASE user 2 2 # 2 A 136 ARG A 25 ARG.? 9.68 S2 BME A 300 A 318 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1lij_c00 ADENOSINE KINASE user 3 2 # 3 A 136 ARG A 68 ARG~? -4.35 S2 BME A 300s A 318 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1lij_c00 ADENOSINE KINASE user 4 2 # 4 A 136 ARG A 68 ARG~? -4.35 S2 BME A 300s A 318 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 19.36 -9.90 14.44 17.51 -11.01 14.77 1lij_c00 source 1lij ADENOSINE KINASE : 4 hits 1lij_c00 naa= 2 ULMN 2 1lio_c00 ADENOSINE KINASE user 1 2 # 1 A 136 ARG A 25 ARG.? 9.68 S2 BME A 300 A 318 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 29.35 33.68 50.39 31.26 31.83 51.65 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 32.11 22.71 40.58 33.42 24.22 39.78 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1lio_c00 ADENOSINE KINASE user 2 2 # 2 A 136 ARG A 68 ARG~? -4.35 S2 BME A 300s A 318 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 29.35 33.68 50.39 31.26 31.83 51.65 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 32.11 22.71 40.58 33.42 24.22 39.78 24.97 -2.58 14.97 24.99 -3.62 16.79 1lio_c00 source 1lio ADENOSINE KINASE : 2 hits 1lio_c00 naa= 2 ULMN 2 1lvh_c00 BETA-PHOSPHOGLUCOMUTASE user 1 2 # 1 A 114 SER A 16 SER.? 30.21 S2 BME A 300 A 145 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 27.66 16.80 6.19 25.59 17.18 7.43 11.56 11.57 -9.82 9.89 13.31 -9.94 coo 31.20 9.00 6.53 30.50 13.87 7.97 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1lvh_c00 BETA-PHOSPHOGLUCOMUTASE user 2 2 # 2 A 114 SER A 52 SER~? 19.64 S2 BME A 300 A 145 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 27.66 16.80 6.19 25.59 17.18 7.43 22.49 4.36 7.95 23.43 2.12 7.73 coo 31.20 9.00 6.53 30.50 13.87 7.97 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1lvh_c00 BETA-PHOSPHOGLUCOMUTASE user 3 2 # 3 A 114 SER A 52 SER~? 19.64 S2 BME A 300 A 145 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 27.66 16.80 6.19 25.59 17.18 7.43 22.49 4.36 7.95 23.43 2.12 7.73 coo 31.20 9.00 6.53 30.50 13.87 7.97 15.98 12.20 9.88 16.28 11.97 16.11 1lvh_c00 source 1lvh BETA-PHOSPHOGLUCOMUTASE : 3 hits 1lvh_c00 naa= 2 ULMN 2 1lvh_c01 BETA-PHOSPHOGLUCOMUTASE user 1 2 # 1 B 114 SER A 16 SER.? 30.21 S2 BME A 300 B 145 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 15.11 62.46 6.13 13.14 62.37 7.55 11.56 11.57 -9.82 9.89 13.31 -9.94 coo 19.98 55.49 6.03 18.53 60.51 7.46 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1lvh_c01 BETA-PHOSPHOGLUCOMUTASE user 2 2 # 2 B 114 SER A 52 SER~? 19.64 S2 BME A 300 B 145 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 15.11 62.46 6.13 13.14 62.37 7.55 22.49 4.36 7.95 23.43 2.12 7.73 coo 19.98 55.49 6.03 18.53 60.51 7.46 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1lvh_c01 BETA-PHOSPHOGLUCOMUTASE user 3 2 # 3 B 114 SER A 52 SER~? 19.64 S2 BME A 300 B 145 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 15.11 62.46 6.13 13.14 62.37 7.55 22.49 4.36 7.95 23.43 2.12 7.73 coo 19.98 55.49 6.03 18.53 60.51 7.46 15.98 12.20 9.88 16.28 11.97 16.11 1lvh_c01 source 1lvh BETA-PHOSPHOGLUCOMUTASE : 3 hits 1lvh_c01 naa= 2 ULMN 2 1lya_c00 CATHEPSIN D (E.C.3.4.23.5) user 1 2 # 1 A 33 ASP A 44 ASP~? 11.03 S2 BME A 300 B 231 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 15.90 92.23 15.07 17.09 93.64 14.08 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 23.08 94.21 15.45 21.39 94.32 14.19 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1lya_c00 CATHEPSIN D (E.C.3.4.23.5) user 2 2 # 2 A 33 ASP A 48 ASP~? 19.85 S2 BME A 300 B 231 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 15.90 92.23 15.07 17.09 93.64 14.08 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 23.08 94.21 15.45 21.39 94.32 14.19 19.36 -9.90 14.44 17.51 -11.01 14.77 1lya_c00 source 1lya CATHEPSIN D (E.C.3.4.23.5) : 2 hits 1lya_c00 naa= 2 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 1 2 # 1 C 33 ASP A 44 ASP~? 11.03 S2 BME A 300 D 231 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -5.36 44.72 8.41 -3.34 44.21 8.70 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 0.87 48.30 6.85 0.22 46.73 8.13 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1lya_c01 CATHEPSIN D (E.C.3.4.23.5) user 2 2 # 2 C 33 ASP A 48 ASP~? 19.85 S2 BME A 300 D 231 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -5.36 44.72 8.41 -3.34 44.21 8.70 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 0.87 48.30 6.85 0.22 46.73 8.13 19.36 -9.90 14.44 17.51 -11.01 14.77 1lya_c01 source 1lya CATHEPSIN D (E.C.3.4.23.5) : 2 hits 1lya_c01 naa= 2 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 1 2 # 1 35 GLU A 29 GLU~? 6.68 S2 BME A 300 53 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 13.77 10.94 24.74 13.94 8.84 25.14 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 8.07 6.88 28.19 9.18 5.27 28.79 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 2 2 # 2 35 GLU A 29 GLU~? 6.68 S2 BME A 300 53 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 13.77 10.94 24.74 13.94 8.84 25.14 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 8.07 6.88 28.19 9.18 5.27 28.79 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 3 2 # 3 35 GLU A 57 GLU.? 23.43 S2 BME A 300 53 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 13.77 10.94 24.74 13.94 8.84 25.14 16.30 10.78 3.24 16.87 9.97 1.36 coo 8.07 6.88 28.19 9.18 5.27 28.79 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 4 2 # 4 35 GLU A 77 GLU~? 17.67 S2 BME A 300 53 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 13.77 10.94 24.74 13.94 8.84 25.14 7.63 5.18 13.95 5.55 5.01 14.48 coo 8.07 6.88 28.19 9.18 5.27 28.79 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1lz1_c00 LYSOZYME (E.C.3.2.1.17) user 5 2 # 5 35 GLU A 87 GLU.? 12.12 O1 BME A 300 53 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 13.77 10.94 24.74 13.94 8.84 25.14 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 8.07 6.88 28.19 9.18 5.27 28.79 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1lz1_c00 source 1lz1 LYSOZYME (E.C.3.2.1.17) : 5 hits 1lz1_c00 naa= 2 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 1 2 # 1 A 241 ASP A 7 ASP~? 16.68 O1 BME A 300 A 295 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 16.11 33.72 80.99 14.10 33.54 81.63 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 2 2 # 2 A 241 ASP A 27 ASP~? 15.09 S2 BME A 300 A 295 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 16.11 33.72 80.99 14.10 33.54 81.63 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 3 2 # 3 A 241 ASP A 27 ASP~? 15.09 S2 BME A 300 A 295 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 16.11 33.72 80.99 14.10 33.54 81.63 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 4 2 # 4 A 241 ASP A 82 ASP^? 20.57 S2 BME A 300 A 295 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.12 9.33 8.59 8.15 9.51 7.94 coo 16.11 33.72 80.99 14.10 33.54 81.63 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1m53_c01 ISOMALTULOSE SYNTHASE user 5 2 # 5 A 241 ASP A 95 ASP.? 15.99 O1 BME A 300 A 295 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 16.11 33.72 80.99 14.10 33.54 81.63 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1m53_c01 source 1m53 ISOMALTULOSE SYNTHASE : 5 hits 1m53_c01 naa= 2 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 A 119 LYS A 2 LYS.? 20.18 S2 BME A 300 A 349 SER A 69 SER~? 5.63 S2 BME A 300 coo 3.13 2.91 12.86 6.03 -0.38 15.33 2.39 3.95 8.25 5.67 8.88 7.74 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 A 119 LYS A 10 LYS~? 16.18 O1 BME A 300 A 349 SER A 3 SER^? 13.09 C1 BME A 300 coo 3.13 2.91 12.86 6.03 -0.38 15.33 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 A 119 LYS A 10 LYS~? 16.18 O1 BME A 300 A 349 SER A 16 SER.? 30.21 S2 BME A 300 coo 3.13 2.91 12.86 6.03 -0.38 15.33 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 4 2 # 4 A 119 LYS A 12 LYS~? 21.81 S2 BME A 300 A 349 SER A 3 SER^? 13.09 C1 BME A 300 coo 3.13 2.91 12.86 6.03 -0.38 15.33 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 5 2 # 5 A 119 LYS A 39 LYS^? 20.06 S2 BME A 300 A 349 SER A 69 SER~? 5.63 S2 BME A 300 coo 3.13 2.91 12.86 6.03 -0.38 15.33 19.85 -1.20 1.64 21.03 4.07 2.80 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c00 CYSTATHIONINE BETA-SYNTHASE user 6 2 # 6 A 119 LYS A 71 LYS~? 8.54 S2 BME A 300 A 349 SER A 3 SER^? 13.09 C1 BME A 300 coo 3.13 2.91 12.86 6.03 -0.38 15.33 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 5.51 -9.50 11.91 4.63 -7.71 13.23 2.01 1.27 5.67 0.61 -0.61 5.33 1m54_c00 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 6 hits 1m54_c00 naa= 2 ULMN 2 1m54_c01 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 B 119 LYS A 2 LYS.? 20.18 S2 BME A 300 B 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 2.39 3.95 8.25 5.67 8.88 7.74 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c01 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 B 119 LYS A 10 LYS~? 16.18 O1 BME A 300 B 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c01 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 B 119 LYS A 10 LYS~? 16.18 O1 BME A 300 B 349 SER A 16 SER.? 30.21 S2 BME A 300 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1m54_c01 CYSTATHIONINE BETA-SYNTHASE user 4 2 # 4 B 119 LYS A 12 LYS~? 21.81 S2 BME A 300 B 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c01 CYSTATHIONINE BETA-SYNTHASE user 5 2 # 5 B 119 LYS A 39 LYS^? 20.06 S2 BME A 300 B 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 19.85 -1.20 1.64 21.03 4.07 2.80 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c01 CYSTATHIONINE BETA-SYNTHASE user 6 2 # 6 B 119 LYS A 55 LYS.? 25.54 S2 BME A 300 B 349 SER A 52 SER~? 19.64 S2 BME A 300 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 15.98 12.20 9.88 16.28 11.97 16.11 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 22.49 4.36 7.95 23.43 2.12 7.73 ULMN 2 1m54_c01 CYSTATHIONINE BETA-SYNTHASE user 7 2 # 7 B 119 LYS A 71 LYS~? 8.54 S2 BME A 300 B 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 2.01 1.27 5.67 0.61 -0.61 5.33 1m54_c01 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 7 hits 1m54_c01 naa= 2 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 C 119 LYS A 2 LYS.? 20.18 S2 BME A 300 C 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -20.84 30.72 17.88 -25.98 31.63 17.66 2.39 3.95 8.25 5.67 8.88 7.74 coo -29.13 36.71 25.20 -26.79 36.20 25.00 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 C 119 LYS A 10 LYS~? 16.18 O1 BME A 300 C 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -20.84 30.72 17.88 -25.98 31.63 17.66 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -29.13 36.71 25.20 -26.79 36.20 25.00 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 C 119 LYS A 10 LYS~? 16.18 O1 BME A 300 C 349 SER A 16 SER.? 30.21 S2 BME A 300 coo -20.84 30.72 17.88 -25.98 31.63 17.66 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -29.13 36.71 25.20 -26.79 36.20 25.00 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 4 2 # 4 C 119 LYS A 12 LYS~? 21.81 S2 BME A 300 C 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -20.84 30.72 17.88 -25.98 31.63 17.66 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -29.13 36.71 25.20 -26.79 36.20 25.00 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 5 2 # 5 C 119 LYS A 39 LYS^? 20.06 S2 BME A 300 C 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -20.84 30.72 17.88 -25.98 31.63 17.66 19.85 -1.20 1.64 21.03 4.07 2.80 coo -29.13 36.71 25.20 -26.79 36.20 25.00 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c02 CYSTATHIONINE BETA-SYNTHASE user 6 2 # 6 C 119 LYS A 71 LYS~? 8.54 S2 BME A 300 C 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -20.84 30.72 17.88 -25.98 31.63 17.66 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -29.13 36.71 25.20 -26.79 36.20 25.00 2.01 1.27 5.67 0.61 -0.61 5.33 1m54_c02 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 6 hits 1m54_c02 naa= 2 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 D 119 LYS A 2 LYS.? 20.18 S2 BME A 300 D 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -5.37 44.26 36.87 -2.80 48.80 34.89 2.39 3.95 8.25 5.67 8.88 7.74 coo -0.72 48.15 25.83 -2.20 46.60 26.98 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 D 119 LYS A 10 LYS~? 16.18 O1 BME A 300 D 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -5.37 44.26 36.87 -2.80 48.80 34.89 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -0.72 48.15 25.83 -2.20 46.60 26.98 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 D 119 LYS A 10 LYS~? 16.18 O1 BME A 300 D 349 SER A 16 SER.? 30.21 S2 BME A 300 coo -5.37 44.26 36.87 -2.80 48.80 34.89 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -0.72 48.15 25.83 -2.20 46.60 26.98 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 4 2 # 4 D 119 LYS A 12 LYS~? 21.81 S2 BME A 300 D 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -5.37 44.26 36.87 -2.80 48.80 34.89 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -0.72 48.15 25.83 -2.20 46.60 26.98 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 5 2 # 5 D 119 LYS A 39 LYS^? 20.06 S2 BME A 300 D 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -5.37 44.26 36.87 -2.80 48.80 34.89 19.85 -1.20 1.64 21.03 4.07 2.80 coo -0.72 48.15 25.83 -2.20 46.60 26.98 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c03 CYSTATHIONINE BETA-SYNTHASE user 6 2 # 6 D 119 LYS A 71 LYS~? 8.54 S2 BME A 300 D 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -5.37 44.26 36.87 -2.80 48.80 34.89 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -0.72 48.15 25.83 -2.20 46.60 26.98 2.01 1.27 5.67 0.61 -0.61 5.33 1m54_c03 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 6 hits 1m54_c03 naa= 2 ULMN 2 1m54_c04 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 E 119 LYS A 2 LYS.? 20.18 S2 BME A 300 E 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -4.84 35.54 84.77 -8.56 37.12 86.14 2.39 3.95 8.25 5.67 8.88 7.74 coo -16.84 35.71 81.57 -14.88 34.62 80.63 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c04 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 E 119 LYS A 10 LYS~? 16.18 O1 BME A 300 E 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -4.84 35.54 84.77 -8.56 37.12 86.14 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -16.84 35.71 81.57 -14.88 34.62 80.63 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c04 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 E 119 LYS A 10 LYS~? 16.18 O1 BME A 300 E 349 SER A 16 SER.? 30.21 S2 BME A 300 coo -4.84 35.54 84.77 -8.56 37.12 86.14 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -16.84 35.71 81.57 -14.88 34.62 80.63 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1m54_c04 CYSTATHIONINE BETA-SYNTHASE user 4 2 # 4 E 119 LYS A 12 LYS~? 21.81 S2 BME A 300 E 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -4.84 35.54 84.77 -8.56 37.12 86.14 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -16.84 35.71 81.57 -14.88 34.62 80.63 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c04 CYSTATHIONINE BETA-SYNTHASE user 5 2 # 5 E 119 LYS A 39 LYS^? 20.06 S2 BME A 300 E 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -4.84 35.54 84.77 -8.56 37.12 86.14 19.85 -1.20 1.64 21.03 4.07 2.80 coo -16.84 35.71 81.57 -14.88 34.62 80.63 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c04 CYSTATHIONINE BETA-SYNTHASE user 6 2 # 6 E 119 LYS A 71 LYS~? 8.54 S2 BME A 300 E 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -4.84 35.54 84.77 -8.56 37.12 86.14 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -16.84 35.71 81.57 -14.88 34.62 80.63 2.01 1.27 5.67 0.61 -0.61 5.33 1m54_c04 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 6 hits 1m54_c04 naa= 2 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 F 119 LYS A 2 LYS.? 20.18 S2 BME A 300 F 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -7.84 18.42 63.15 -7.36 13.76 64.43 2.39 3.95 8.25 5.67 8.88 7.74 coo -1.89 11.37 72.02 -3.31 13.25 71.54 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 F 119 LYS A 10 LYS~? 16.18 O1 BME A 300 F 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -7.84 18.42 63.15 -7.36 13.76 64.43 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -1.89 11.37 72.02 -3.31 13.25 71.54 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 3 2 # 3 F 119 LYS A 10 LYS~? 16.18 O1 BME A 300 F 349 SER A 16 SER.? 30.21 S2 BME A 300 coo -7.84 18.42 63.15 -7.36 13.76 64.43 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -1.89 11.37 72.02 -3.31 13.25 71.54 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 4 2 # 4 F 119 LYS A 12 LYS~? 21.81 S2 BME A 300 F 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -7.84 18.42 63.15 -7.36 13.76 64.43 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -1.89 11.37 72.02 -3.31 13.25 71.54 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 5 2 # 5 F 119 LYS A 39 LYS^? 20.06 S2 BME A 300 F 349 SER A 69 SER~? 5.63 S2 BME A 300 coo -7.84 18.42 63.15 -7.36 13.76 64.43 19.85 -1.20 1.64 21.03 4.07 2.80 coo -1.89 11.37 72.02 -3.31 13.25 71.54 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1m54_c05 CYSTATHIONINE BETA-SYNTHASE user 6 2 # 6 F 119 LYS A 71 LYS~? 8.54 S2 BME A 300 F 349 SER A 3 SER^? 13.09 C1 BME A 300 coo -7.84 18.42 63.15 -7.36 13.76 64.43 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -1.89 11.37 72.02 -3.31 13.25 71.54 2.01 1.27 5.67 0.61 -0.61 5.33 1m54_c05 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 6 hits 1m54_c05 naa= 2 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 A 156 TYR A 34 TYR.? 16.37 S2 BME A 300 A 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -2.24 26.36 132.99 -0.09 25.82 134.63 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 0.83 29.26 140.07 3.97 24.87 138.74 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 A 156 TYR A 34 TYR.? 16.37 S2 BME A 300 A 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -2.24 26.36 132.99 -0.09 25.82 134.63 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 0.83 29.26 140.07 3.97 24.87 138.74 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 A 156 TYR A 59 TYR^? 18.50 S2 BME A 300 A 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -2.24 26.36 132.99 -0.09 25.82 134.63 14.59 5.14 5.72 16.82 6.86 5.68 coo 0.83 29.26 140.07 3.97 24.87 138.74 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 A 156 TYR A 59 TYR^? 18.50 S2 BME A 300 A 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -2.24 26.36 132.99 -0.09 25.82 134.63 14.59 5.14 5.72 16.82 6.86 5.68 coo 0.83 29.26 140.07 3.97 24.87 138.74 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 A 156 TYR A 60 TYR^? 16.66 S2 BME A 300 A 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo -2.24 26.36 132.99 -0.09 25.82 134.63 9.00 3.02 1.57 7.75 5.45 1.00 coo 0.83 29.26 140.07 3.97 24.87 138.74 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 A 156 TYR A 60 TYR^? 16.66 S2 BME A 300 A 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -2.24 26.36 132.99 -0.09 25.82 134.63 9.00 3.02 1.57 7.75 5.45 1.00 coo 0.83 29.26 140.07 3.97 24.87 138.74 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 A 156 TYR A 60 TYR^? 16.66 S2 BME A 300 A 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -2.24 26.36 132.99 -0.09 25.82 134.63 9.00 3.02 1.57 7.75 5.45 1.00 coo 0.83 29.26 140.07 3.97 24.87 138.74 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1mfp_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 A 156 TYR A 75 TYR~? 15.90 S2 BME A 300 A 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -2.24 26.36 132.99 -0.09 25.82 134.63 14.46 -0.26 16.60 17.11 0.41 17.22 coo 0.83 29.26 140.07 3.97 24.87 138.74 8.82 -4.39 14.42 10.42 -10.04 16.23 1mfp_c00 source 1mfp ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH] : 8 hits 1mfp_c00 naa= 2 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 B1156 TYR A 34 TYR.? 16.37 S2 BME A 300 B1163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -1.56 41.17 153.24 -4.04 41.21 152.01 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -5.16 37.67 146.77 -9.21 40.09 149.15 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 B1156 TYR A 34 TYR.? 16.37 S2 BME A 300 B1163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -1.56 41.17 153.24 -4.04 41.21 152.01 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -5.16 37.67 146.77 -9.21 40.09 149.15 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 B1156 TYR A 59 TYR^? 18.50 S2 BME A 300 B1163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -1.56 41.17 153.24 -4.04 41.21 152.01 14.59 5.14 5.72 16.82 6.86 5.68 coo -5.16 37.67 146.77 -9.21 40.09 149.15 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 B1156 TYR A 59 TYR^? 18.50 S2 BME A 300 B1163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -1.56 41.17 153.24 -4.04 41.21 152.01 14.59 5.14 5.72 16.82 6.86 5.68 coo -5.16 37.67 146.77 -9.21 40.09 149.15 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 B1156 TYR A 60 TYR^? 16.66 S2 BME A 300 B1163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo -1.56 41.17 153.24 -4.04 41.21 152.01 9.00 3.02 1.57 7.75 5.45 1.00 coo -5.16 37.67 146.77 -9.21 40.09 149.15 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 B1156 TYR A 60 TYR^? 16.66 S2 BME A 300 B1163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -1.56 41.17 153.24 -4.04 41.21 152.01 9.00 3.02 1.57 7.75 5.45 1.00 coo -5.16 37.67 146.77 -9.21 40.09 149.15 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 B1156 TYR A 60 TYR^? 16.66 S2 BME A 300 B1163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -1.56 41.17 153.24 -4.04 41.21 152.01 9.00 3.02 1.57 7.75 5.45 1.00 coo -5.16 37.67 146.77 -9.21 40.09 149.15 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1mfp_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 B1156 TYR A 75 TYR~? 15.90 S2 BME A 300 B1163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -1.56 41.17 153.24 -4.04 41.21 152.01 14.46 -0.26 16.60 17.11 0.41 17.22 coo -5.16 37.67 146.77 -9.21 40.09 149.15 8.82 -4.39 14.42 10.42 -10.04 16.23 1mfp_c01 source 1mfp ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH] : 8 hits 1mfp_c01 naa= 2 ULMN 2 1mht_c00 HHAI METHYLTRANSFERASE user 1 2 # 1 A 81 CYH A 63 CYH.? -3.36 S2 BME A 300s A 119 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -14.24 38.25 87.68 -17.04 38.68 87.49 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -16.93 37.35 78.96 -17.46 37.15 81.01 15.50 -15.19 4.21 14.37 -14.08 5.62 1mht_c00 source 1mht HHAI METHYLTRANSFERASE : 1 hits 1mht_c00 naa= 2 ULMN 2 1mhy_c00 METHANE MONOOXYGENASE HYDROXYLASE user 1 2 # 1 D 151 CYH A 63 CYH.? -3.36 S2 BME A 300s D 213 THR A 5 THR~? 15.55 O1 BME A 300 coo -42.45 81.56 14.53 -42.56 80.44 17.02 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -44.48 73.73 25.06 -42.89 75.12 24.56 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1mhy_c00 METHANE MONOOXYGENASE HYDROXYLASE user 2 2 # 2 D 151 CYH A 63 CYH.? -3.36 S2 BME A 300s D 213 THR A 6 THR~? 12.27 O1 BME A 300 coo -42.45 81.56 14.53 -42.56 80.44 17.02 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -44.48 73.73 25.06 -42.89 75.12 24.56 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1mhy_c00 METHANE MONOOXYGENASE HYDROXYLASE user 3 2 # 3 D 151 CYH A 63 CYH.? -3.36 S2 BME A 300s D 213 THR A 45 THR~? 14.85 S2 BME A 300 coo -42.45 81.56 14.53 -42.56 80.44 17.02 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -44.48 73.73 25.06 -42.89 75.12 24.56 21.81 -5.88 13.03 22.64 -6.51 11.11 1mhy_c00 source 1mhy METHANE MONOOXYGENASE HYDROXYLASE : 3 hits 1mhy_c00 naa= 2 ULMN 2 1mj9_c00 ESA1 PROTEIN user 1 2 # 1 A 304 SER A 3 SER^? 13.09 C1 BME A 300 A 338 GLU A 8 GLU~? 18.47 O1 BME A 300 coo -4.46 89.97 21.66 -6.05 90.10 19.82 2.01 1.27 5.67 0.61 -0.61 5.33 coo -8.51 84.09 23.34 -9.53 85.71 22.43 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1mj9_c00 ESA1 PROTEIN user 2 2 # 2 A 304 SER A 3 SER^? 13.09 C1 BME A 300 A 338 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -4.46 89.97 21.66 -6.05 90.10 19.82 2.01 1.27 5.67 0.61 -0.61 5.33 coo -8.51 84.09 23.34 -9.53 85.71 22.43 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1mj9_c00 ESA1 PROTEIN user 3 2 # 3 A 304 SER A 16 SER.? 30.21 S2 BME A 300 A 338 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -4.46 89.97 21.66 -6.05 90.10 19.82 11.56 11.57 -9.82 9.89 13.31 -9.94 coo -8.51 84.09 23.34 -9.53 85.71 22.43 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1mj9_c00 ESA1 PROTEIN user 4 2 # 4 A 304 SER A 69 SER~? 5.63 S2 BME A 300 A 338 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -4.46 89.97 21.66 -6.05 90.10 19.82 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -8.51 84.09 23.34 -9.53 85.71 22.43 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1mj9_c00 ESA1 PROTEIN user 5 2 # 5 A 304 SER A 102 SER.? -26.95 S2 BME A 300s A 338 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -4.46 89.97 21.66 -6.05 90.10 19.82 28.10 -11.09 -8.44 28.33 -11.90 -10.72 coo -8.51 84.09 23.34 -9.53 85.71 22.43 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1mj9_c00 source 1mj9 ESA1 PROTEIN : 5 hits 1mj9_c00 naa= 2 ULMN 2 1mqw_c00 ADPR PYROPHOSPHATASE user 1 2 # 1 A 64 ARG A 25 ARG.? 9.68 S2 BME A 300 A 142 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 26.57 14.26 3.78 24.66 16.62 4.01 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 22.97 20.75 -2.81 21.68 22.37 -2.40 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1mqw_c00 ADPR PYROPHOSPHATASE user 2 2 # 2 A 64 ARG A 68 ARG~? -4.35 S2 BME A 300s A 142 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 26.57 14.26 3.78 24.66 16.62 4.01 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 22.97 20.75 -2.81 21.68 22.37 -2.40 15.50 -15.19 4.21 14.37 -14.08 5.62 1mqw_c00 source 1mqw ADPR PYROPHOSPHATASE : 2 hits 1mqw_c00 naa= 2 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 2 # 1 A 55 TYR A 34 TYR.? 16.37 S2 BME A 300 A 84 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 4.60 40.33 20.42 7.25 39.50 20.05 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 9.71 44.83 15.47 10.13 41.43 19.93 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 2 # 2 A 55 TYR A 34 TYR.? 16.37 S2 BME A 300 A 84 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 4.60 40.33 20.42 7.25 39.50 20.05 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 9.71 44.83 15.47 10.13 41.43 19.93 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 2 # 3 A 55 TYR A 59 TYR^? 18.50 S2 BME A 300 A 84 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.59 5.14 5.72 16.82 6.86 5.68 coo 9.71 44.83 15.47 10.13 41.43 19.93 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 2 # 4 A 55 TYR A 59 TYR^? 18.50 S2 BME A 300 A 84 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.59 5.14 5.72 16.82 6.86 5.68 coo 9.71 44.83 15.47 10.13 41.43 19.93 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 2 # 5 A 55 TYR A 60 TYR^? 16.66 S2 BME A 300 A 84 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 4.60 40.33 20.42 7.25 39.50 20.05 9.00 3.02 1.57 7.75 5.45 1.00 coo 9.71 44.83 15.47 10.13 41.43 19.93 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 2 # 6 A 55 TYR A 60 TYR^? 16.66 S2 BME A 300 A 84 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 4.60 40.33 20.42 7.25 39.50 20.05 9.00 3.02 1.57 7.75 5.45 1.00 coo 9.71 44.83 15.47 10.13 41.43 19.93 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 2 # 7 A 55 TYR A 60 TYR^? 16.66 S2 BME A 300 A 84 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 4.60 40.33 20.42 7.25 39.50 20.05 9.00 3.02 1.57 7.75 5.45 1.00 coo 9.71 44.83 15.47 10.13 41.43 19.93 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1mrq_c01 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 2 # 8 A 55 TYR A 75 TYR~? 15.90 S2 BME A 300 A 84 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.46 -0.26 16.60 17.11 0.41 17.22 coo 9.71 44.83 15.47 10.13 41.43 19.93 8.82 -4.39 14.42 10.42 -10.04 16.23 1mrq_c01 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 8 hits 1mrq_c01 naa= 2 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 1 2 # 1 A 169 LYS A 2 LYS.? 20.18 S2 BME A 300 A 273 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 2.39 3.95 8.25 5.67 8.88 7.74 coo 21.97 20.82 9.99 24.04 16.31 13.83 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 2 2 # 2 A 169 LYS A 2 LYS.? 20.18 S2 BME A 300 A 273 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 2.39 3.95 8.25 5.67 8.88 7.74 coo 21.97 20.82 9.99 24.04 16.31 13.83 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 3 2 # 3 A 169 LYS A 2 LYS.? 20.18 S2 BME A 300 A 273 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 2.39 3.95 8.25 5.67 8.88 7.74 coo 21.97 20.82 9.99 24.04 16.31 13.83 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 4 2 # 4 A 169 LYS A 2 LYS.? 20.18 S2 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 2.39 3.95 8.25 5.67 8.88 7.74 coo 21.97 20.82 9.99 24.04 16.31 13.83 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 5 2 # 5 A 169 LYS A 2 LYS.? 20.18 S2 BME A 300 A 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 2.39 3.95 8.25 5.67 8.88 7.74 coo 21.97 20.82 9.99 24.04 16.31 13.83 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 6 2 # 6 A 169 LYS A 10 LYS~? 16.18 O1 BME A 300 A 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 21.97 20.82 9.99 24.04 16.31 13.83 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 7 2 # 7 A 169 LYS A 10 LYS~? 16.18 O1 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 21.97 20.82 9.99 24.04 16.31 13.83 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 8 2 # 8 A 169 LYS A 12 LYS~? 21.81 S2 BME A 300 A 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 21.97 20.82 9.99 24.04 16.31 13.83 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 9 2 # 9 A 169 LYS A 12 LYS~? 21.81 S2 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 21.97 20.82 9.99 24.04 16.31 13.83 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 10 2 # 10 A 169 LYS A 17 LYS.? 25.68 S2 BME A 300 A 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 21.97 20.82 9.99 24.04 16.31 13.83 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 11 2 # 11 A 169 LYS A 17 LYS.? 25.68 S2 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 21.97 20.82 9.99 24.04 16.31 13.83 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 12 2 # 12 A 169 LYS A 17 LYS.? 25.68 S2 BME A 300 A 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 21.97 20.82 9.99 24.04 16.31 13.83 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 13 2 # 13 A 169 LYS A 39 LYS^? 20.06 S2 BME A 300 A 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 19.85 -1.20 1.64 21.03 4.07 2.80 coo 21.97 20.82 9.99 24.04 16.31 13.83 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 14 2 # 14 A 169 LYS A 39 LYS^? 20.06 S2 BME A 300 A 273 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 19.85 -1.20 1.64 21.03 4.07 2.80 coo 21.97 20.82 9.99 24.04 16.31 13.83 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 15 2 # 15 A 169 LYS A 39 LYS^? 20.06 S2 BME A 300 A 273 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 19.85 -1.20 1.64 21.03 4.07 2.80 coo 21.97 20.82 9.99 24.04 16.31 13.83 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 16 2 # 16 A 169 LYS A 39 LYS^? 20.06 S2 BME A 300 A 273 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 19.85 -1.20 1.64 21.03 4.07 2.80 coo 21.97 20.82 9.99 24.04 16.31 13.83 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 17 2 # 17 A 169 LYS A 39 LYS^? 20.06 S2 BME A 300 A 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 19.85 -1.20 1.64 21.03 4.07 2.80 coo 21.97 20.82 9.99 24.04 16.31 13.83 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 18 2 # 18 A 169 LYS A 39 LYS^? 20.06 S2 BME A 300 A 273 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 19.85 -1.20 1.64 21.03 4.07 2.80 coo 21.97 20.82 9.99 24.04 16.31 13.83 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 19 2 # 19 A 169 LYS A 55 LYS.? 25.54 S2 BME A 300 A 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.98 12.20 9.88 16.28 11.97 16.11 coo 21.97 20.82 9.99 24.04 16.31 13.83 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 20 2 # 20 A 169 LYS A 55 LYS.? 25.54 S2 BME A 300 A 273 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.98 12.20 9.88 16.28 11.97 16.11 coo 21.97 20.82 9.99 24.04 16.31 13.83 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 21 2 # 21 A 169 LYS A 55 LYS.? 25.54 S2 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.98 12.20 9.88 16.28 11.97 16.11 coo 21.97 20.82 9.99 24.04 16.31 13.83 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 22 2 # 22 A 169 LYS A 55 LYS.? 25.54 S2 BME A 300 A 273 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 15.98 12.20 9.88 16.28 11.97 16.11 coo 21.97 20.82 9.99 24.04 16.31 13.83 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 23 2 # 23 A 169 LYS A 71 LYS~? 8.54 S2 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 21.97 20.82 9.99 24.04 16.31 13.83 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c02 MUCONATE LACTONIZING ENZYME user 24 2 # 24 A 169 LYS A 71 LYS~? 8.54 S2 BME A 300 A 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 24.31 10.25 23.71 29.02 12.05 20.75 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 21.97 20.82 9.99 24.04 16.31 13.83 15.98 12.20 9.88 16.28 11.97 16.11 1muc_c02 source 1muc MUCONATE LACTONIZING ENZYME : 24 hits 1muc_c02 naa= 2 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 1 2 # 1 B 169 LYS A 2 LYS.? 20.18 S2 BME A 300 B 273 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 2.39 3.95 8.25 5.67 8.88 7.74 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 2 2 # 2 B 169 LYS A 2 LYS.? 20.18 S2 BME A 300 B 273 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 2.39 3.95 8.25 5.67 8.88 7.74 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 3 2 # 3 B 169 LYS A 2 LYS.? 20.18 S2 BME A 300 B 273 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 2.39 3.95 8.25 5.67 8.88 7.74 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 4 2 # 4 B 169 LYS A 2 LYS.? 20.18 S2 BME A 300 B 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 2.39 3.95 8.25 5.67 8.88 7.74 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 5 2 # 5 B 169 LYS A 2 LYS.? 20.18 S2 BME A 300 B 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 2.39 3.95 8.25 5.67 8.88 7.74 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 6 2 # 6 B 169 LYS A 10 LYS~? 16.18 O1 BME A 300 B 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 7 2 # 7 B 169 LYS A 10 LYS~? 16.18 O1 BME A 300 B 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 8 2 # 8 B 169 LYS A 12 LYS~? 21.81 S2 BME A 300 B 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 9 2 # 9 B 169 LYS A 12 LYS~? 21.81 S2 BME A 300 B 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 10 2 # 10 B 169 LYS A 17 LYS.? 25.68 S2 BME A 300 B 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 11 2 # 11 B 169 LYS A 17 LYS.? 25.68 S2 BME A 300 B 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 12 2 # 12 B 169 LYS A 17 LYS.? 25.68 S2 BME A 300 B 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 13 2 # 13 B 169 LYS A 39 LYS^? 20.06 S2 BME A 300 B 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 19.85 -1.20 1.64 21.03 4.07 2.80 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 14 2 # 14 B 169 LYS A 39 LYS^? 20.06 S2 BME A 300 B 273 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 19.85 -1.20 1.64 21.03 4.07 2.80 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 15 2 # 15 B 169 LYS A 39 LYS^? 20.06 S2 BME A 300 B 273 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 19.85 -1.20 1.64 21.03 4.07 2.80 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 16 2 # 16 B 169 LYS A 39 LYS^? 20.06 S2 BME A 300 B 273 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 19.85 -1.20 1.64 21.03 4.07 2.80 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 17 2 # 17 B 169 LYS A 39 LYS^? 20.06 S2 BME A 300 B 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 19.85 -1.20 1.64 21.03 4.07 2.80 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 18 2 # 18 B 169 LYS A 39 LYS^? 20.06 S2 BME A 300 B 273 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 19.85 -1.20 1.64 21.03 4.07 2.80 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 19 2 # 19 B 169 LYS A 55 LYS.? 25.54 S2 BME A 300 B 273 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.98 12.20 9.88 16.28 11.97 16.11 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 20 2 # 20 B 169 LYS A 55 LYS.? 25.54 S2 BME A 300 B 273 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.98 12.20 9.88 16.28 11.97 16.11 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 21 2 # 21 B 169 LYS A 55 LYS.? 25.54 S2 BME A 300 B 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.98 12.20 9.88 16.28 11.97 16.11 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 22 2 # 22 B 169 LYS A 55 LYS.? 25.54 S2 BME A 300 B 273 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 15.98 12.20 9.88 16.28 11.97 16.11 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 23 2 # 23 B 169 LYS A 71 LYS~? 8.54 S2 BME A 300 B 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1muc_c03 MUCONATE LACTONIZING ENZYME user 24 2 # 24 B 169 LYS A 71 LYS~? 8.54 S2 BME A 300 B 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 30.30 -1.32 -9.98 28.78 3.34 -13.88 15.98 12.20 9.88 16.28 11.97 16.11 1muc_c03 source 1muc MUCONATE LACTONIZING ENZYME : 24 hits 1muc_c03 naa= 2 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 1 2 # 1 A 37 GLU A 15 GLU~? 24.22 S2 BME A 300 A 138 ASN A 11 ASN~? 22.08 O1 BME A 300 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 3.09 3.41 -8.04 1.54 2.11 -8.64 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 2 2 # 2 A 37 GLU A 74 GLU~? 13.09 S2 BME A 300 A 138 ASN A 85 ASN^? 8.15 S2 BME A 300 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 3 2 # 3 A 37 GLU A 77 GLU~? 17.67 S2 BME A 300 A 138 ASN A 79 ASN.? 19.89 S2 BME A 300 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 7.63 5.18 13.95 5.55 5.01 14.48 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 4 2 # 4 A 37 GLU A 77 GLU~? 17.67 S2 BME A 300 A 138 ASN A 85 ASN^? 8.15 S2 BME A 300 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 7.63 5.18 13.95 5.55 5.01 14.48 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 5 2 # 5 A 37 GLU A 87 GLU.? 12.12 O1 BME A 300 A 138 ASN A 85 ASN^? 8.15 S2 BME A 300 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1mud_c00 ADENINE GLYCOSYLASE user 6 2 # 6 A 37 GLU A 99 GLU.? 20.82 S2 BME A 300 A 138 ASN A 37 ASN.? 22.15 S2 BME A 300 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 18.58 0.66 -5.47 19.39 1.00 -7.43 1mud_c00 source 1mud ADENINE GLYCOSYLASE : 6 hits 1mud_c00 naa= 2 ULMN 2 1myr_c01 MYROSINASE user 1 2 # 1 187 GLN A 20 GLN^? 20.58 S2 BME A 300 409 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 45.09 114.33 52.30 45.59 116.18 51.29 15.94 6.48 1.05 18.02 6.17 1.31 coo 42.69 118.64 56.27 44.58 118.34 55.45 16.30 10.78 3.24 16.87 9.97 1.36 1myr_c01 source 1myr MYROSINASE : 1 hits 1myr_c01 naa= 2 ULMN 2 1n2c_c00 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 E 12 GLY A 33 GLY.? 15.27 S2 BME A 300 E 15 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -2.44 154.43 53.79 -2.04 154.61 53.14 17.51 -11.85 -4.66 17.42 -11.88 -3.82 coo -6.07 154.37 47.56 -2.16 152.62 49.36 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1n2c_c00 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 E 12 GLY A 80 GLY.? 22.31 S2 BME A 300 E 15 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -2.44 154.43 53.79 -2.04 154.61 53.14 13.21 9.55 15.29 13.34 8.86 14.89 coo -6.07 154.37 47.56 -2.16 152.62 49.36 15.98 12.20 9.88 16.28 11.97 16.11 1n2c_c00 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_c00 naa= 2 ULMN 2 1n2c_c01 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 F 12 GLY A 33 GLY.? 15.27 S2 BME A 300 F 15 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 1.70 155.20 55.76 1.33 154.96 56.40 17.51 -11.85 -4.66 17.42 -11.88 -3.82 coo 5.42 154.93 61.93 2.65 152.21 59.38 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1n2c_c01 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 F 12 GLY A 80 GLY.? 22.31 S2 BME A 300 F 15 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 1.70 155.20 55.76 1.33 154.96 56.40 13.21 9.55 15.29 13.34 8.86 14.89 coo 5.42 154.93 61.93 2.65 152.21 59.38 15.98 12.20 9.88 16.28 11.97 16.11 1n2c_c01 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_c01 naa= 2 ULMN 2 1n2c_c02 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 G 12 GLY A 33 GLY.? 15.27 S2 BME A 300 G 15 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 8.39 23.19 11.96 7.87 23.40 11.41 17.51 -11.85 -4.66 17.42 -11.88 -3.82 coo 10.78 26.96 6.29 7.40 27.17 9.46 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1n2c_c02 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 G 12 GLY A 80 GLY.? 22.31 S2 BME A 300 G 15 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 8.39 23.19 11.96 7.87 23.40 11.41 13.21 9.55 15.29 13.34 8.86 14.89 coo 10.78 26.96 6.29 7.40 27.17 9.46 15.98 12.20 9.88 16.28 11.97 16.11 1n2c_c02 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_c02 naa= 2 ULMN 2 1n2c_c03 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 H 12 GLY A 33 GLY.? 15.27 S2 BME A 300 H 15 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 4.68 21.14 13.82 5.18 21.00 14.40 17.51 -11.85 -4.66 17.42 -11.88 -3.82 coo 2.21 17.68 19.65 4.60 21.51 18.60 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1n2c_c03 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 H 12 GLY A 80 GLY.? 22.31 S2 BME A 300 H 15 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 4.68 21.14 13.82 5.18 21.00 14.40 13.21 9.55 15.29 13.34 8.86 14.89 coo 2.21 17.68 19.65 4.60 21.51 18.60 15.98 12.20 9.88 16.28 11.97 16.11 1n2c_c03 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_c03 naa= 2 ULMN 2 1n2c_c07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 D 153 CYH A 63 CYH.? -3.36 S2 BME A 300s D 157 VAL A 24 VAL.? 8.05 S2 BME A 300 coo 1.13 50.61 23.79 0.62 51.39 26.43 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 2.55 45.49 21.08 2.56 44.84 23.18 15.68 -6.47 6.85 14.25 -5.17 7.91 ULMN 2 1n2c_c07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 D 153 CYH A 63 CYH.? -3.36 S2 BME A 300s D 157 VAL A 67 VAL~? -3.24 C1 BME A 300s coo 1.13 50.61 23.79 0.62 51.39 26.43 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 2.55 45.49 21.08 2.56 44.84 23.18 5.93 -9.15 10.02 5.29 -10.97 11.03 1n2c_c07 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_c07 naa= 2 ULMN 2 1n2c_c11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 F 10 LYS A 2 LYS.? 20.18 S2 BME A 300 F 129 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -1.94 151.72 59.48 -5.47 151.68 55.29 2.39 3.95 8.25 5.67 8.88 7.74 coo 0.38 145.91 54.70 -0.99 147.21 53.73 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1n2c_c11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 F 10 LYS A 10 LYS~? 16.18 O1 BME A 300 F 129 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -1.94 151.72 59.48 -5.47 151.68 55.29 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 0.38 145.91 54.70 -0.99 147.21 53.73 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1n2c_c11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 F 10 LYS A 39 LYS^? 20.06 S2 BME A 300 F 129 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -1.94 151.72 59.48 -5.47 151.68 55.29 19.85 -1.20 1.64 21.03 4.07 2.80 coo 0.38 145.91 54.70 -0.99 147.21 53.73 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1n2c_c11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 F 10 LYS A 55 LYS.? 25.54 S2 BME A 300 F 129 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -1.94 151.72 59.48 -5.47 151.68 55.29 15.98 12.20 9.88 16.28 11.97 16.11 coo 0.38 145.91 54.70 -0.99 147.21 53.73 10.12 9.33 8.59 8.15 9.51 7.94 1n2c_c11 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 4 hits 1n2c_c11 naa= 2 ULMN 2 1n2c_c12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 G 10 LYS A 2 LYS.? 20.18 S2 BME A 300 G 129 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 3.13 25.39 9.37 0.51 22.53 13.25 2.39 3.95 8.25 5.67 8.88 7.74 coo 3.03 29.98 15.78 2.55 27.96 16.26 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1n2c_c12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 G 10 LYS A 10 LYS~? 16.18 O1 BME A 300 G 129 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 3.13 25.39 9.37 0.51 22.53 13.25 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 3.03 29.98 15.78 2.55 27.96 16.26 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1n2c_c12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 G 10 LYS A 39 LYS^? 20.06 S2 BME A 300 G 129 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 3.13 25.39 9.37 0.51 22.53 13.25 19.85 -1.20 1.64 21.03 4.07 2.80 coo 3.03 29.98 15.78 2.55 27.96 16.26 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1n2c_c12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 G 10 LYS A 55 LYS.? 25.54 S2 BME A 300 G 129 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 3.13 25.39 9.37 0.51 22.53 13.25 15.98 12.20 9.88 16.28 11.97 16.11 coo 3.03 29.98 15.78 2.55 27.96 16.26 10.12 9.33 8.59 8.15 9.51 7.94 1n2c_c12 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 4 hits 1n2c_c12 naa= 2 ULMN 2 1n2c_c13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 H 10 LYS A 2 LYS.? 20.18 S2 BME A 300 H 129 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 9.16 22.13 18.08 11.83 24.73 14.07 2.39 3.95 8.25 5.67 8.88 7.74 coo 6.32 29.49 17.94 7.41 29.04 16.17 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1n2c_c13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 H 10 LYS A 10 LYS~? 16.18 O1 BME A 300 H 129 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 9.16 22.13 18.08 11.83 24.73 14.07 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 6.32 29.49 17.94 7.41 29.04 16.17 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1n2c_c13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 H 10 LYS A 39 LYS^? 20.06 S2 BME A 300 H 129 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 9.16 22.13 18.08 11.83 24.73 14.07 19.85 -1.20 1.64 21.03 4.07 2.80 coo 6.32 29.49 17.94 7.41 29.04 16.17 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1n2c_c13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 H 10 LYS A 55 LYS.? 25.54 S2 BME A 300 H 129 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 9.16 22.13 18.08 11.83 24.73 14.07 15.98 12.20 9.88 16.28 11.97 16.11 coo 6.32 29.49 17.94 7.41 29.04 16.17 10.12 9.33 8.59 8.15 9.51 7.94 1n2c_c13 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 4 hits 1n2c_c13 naa= 2 ULMN 2 1n2c_c15 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 E 15 LYS A 2 LYS.? 20.18 S2 BME A 300 E 41 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -6.07 154.37 47.56 -2.16 152.62 49.36 2.39 3.95 8.25 5.67 8.88 7.74 coo -8.41 143.69 55.43 -6.79 147.82 55.36 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1n2c_c15 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 E 15 LYS A 10 LYS~? 16.18 O1 BME A 300 E 41 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -6.07 154.37 47.56 -2.16 152.62 49.36 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -8.41 143.69 55.43 -6.79 147.82 55.36 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1n2c_c15 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 E 15 LYS A 17 LYS.? 25.68 S2 BME A 300 E 41 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -6.07 154.37 47.56 -2.16 152.62 49.36 13.04 11.19 -6.33 8.80 12.60 -2.10 coo -8.41 143.69 55.43 -6.79 147.82 55.36 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1n2c_c15 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 E 15 LYS A 39 LYS^? 20.06 S2 BME A 300 E 41 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -6.07 154.37 47.56 -2.16 152.62 49.36 19.85 -1.20 1.64 21.03 4.07 2.80 coo -8.41 143.69 55.43 -6.79 147.82 55.36 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1n2c_c15 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 E 15 LYS A 71 LYS~? 8.54 S2 BME A 300 E 41 LYS A 2 LYS.? 20.18 S2 BME A 300 coo -6.07 154.37 47.56 -2.16 152.62 49.36 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -8.41 143.69 55.43 -6.79 147.82 55.36 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1n2c_c15 NITROGENASE MOLYBDENUM-IRON PROTEIN user 6 2 # 6 E 15 LYS A 101 LYS.? -19.93 S2 BME A 300s E 41 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -6.07 154.37 47.56 -2.16 152.62 49.36 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo -8.41 143.69 55.43 -6.79 147.82 55.36 19.85 -1.20 1.64 21.03 4.07 2.80 1n2c_c15 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 6 hits 1n2c_c15 naa= 2 ULMN 2 1n2c_c16 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 G 15 LYS A 2 LYS.? 20.18 S2 BME A 300 G 41 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 10.78 26.96 6.29 7.40 27.17 9.46 2.39 3.95 8.25 5.67 8.88 7.74 coo 15.22 31.47 18.19 13.37 28.02 16.12 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1n2c_c16 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 G 15 LYS A 10 LYS~? 16.18 O1 BME A 300 G 41 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 10.78 26.96 6.29 7.40 27.17 9.46 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 15.22 31.47 18.19 13.37 28.02 16.12 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1n2c_c16 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 G 15 LYS A 17 LYS.? 25.68 S2 BME A 300 G 41 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 10.78 26.96 6.29 7.40 27.17 9.46 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 15.22 31.47 18.19 13.37 28.02 16.12 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1n2c_c16 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 G 15 LYS A 39 LYS^? 20.06 S2 BME A 300 G 41 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 10.78 26.96 6.29 7.40 27.17 9.46 19.85 -1.20 1.64 21.03 4.07 2.80 coo 15.22 31.47 18.19 13.37 28.02 16.12 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1n2c_c16 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 G 15 LYS A 71 LYS~? 8.54 S2 BME A 300 G 41 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 10.78 26.96 6.29 7.40 27.17 9.46 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 15.22 31.47 18.19 13.37 28.02 16.12 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1n2c_c16 NITROGENASE MOLYBDENUM-IRON PROTEIN user 6 2 # 6 G 15 LYS A 101 LYS.? -19.93 S2 BME A 300s G 41 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 10.78 26.96 6.29 7.40 27.17 9.46 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 15.22 31.47 18.19 13.37 28.02 16.12 19.85 -1.20 1.64 21.03 4.07 2.80 1n2c_c16 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 6 hits 1n2c_c16 naa= 2 ULMN 2 1n2c_c17 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 H 15 LYS A 2 LYS.? 20.18 S2 BME A 300 H 41 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 2.21 17.68 19.65 4.60 21.51 18.60 2.39 3.95 8.25 5.67 8.88 7.74 coo -5.78 27.65 15.36 -2.42 24.99 14.21 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1n2c_c17 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 H 15 LYS A 10 LYS~? 16.18 O1 BME A 300 H 41 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 2.21 17.68 19.65 4.60 21.51 18.60 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -5.78 27.65 15.36 -2.42 24.99 14.21 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1n2c_c17 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 H 15 LYS A 17 LYS.? 25.68 S2 BME A 300 H 41 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 2.21 17.68 19.65 4.60 21.51 18.60 13.04 11.19 -6.33 8.80 12.60 -2.10 coo -5.78 27.65 15.36 -2.42 24.99 14.21 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1n2c_c17 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 H 15 LYS A 39 LYS^? 20.06 S2 BME A 300 H 41 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 2.21 17.68 19.65 4.60 21.51 18.60 19.85 -1.20 1.64 21.03 4.07 2.80 coo -5.78 27.65 15.36 -2.42 24.99 14.21 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1n2c_c17 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 H 15 LYS A 71 LYS~? 8.54 S2 BME A 300 H 41 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 2.21 17.68 19.65 4.60 21.51 18.60 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -5.78 27.65 15.36 -2.42 24.99 14.21 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1n2c_c17 NITROGENASE MOLYBDENUM-IRON PROTEIN user 6 2 # 6 H 15 LYS A 101 LYS.? -19.93 S2 BME A 300s H 41 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 2.21 17.68 19.65 4.60 21.51 18.60 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo -5.78 27.65 15.36 -2.42 24.99 14.21 19.85 -1.20 1.64 21.03 4.07 2.80 1n2c_c17 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 6 hits 1n2c_c17 naa= 2 ULMN 2 1nhx_c01 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 2 # 1 A 264 HIS A 91 HIS~? 7.63 O1 BME A 300 A 405 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 41.33 25.99 28.05 41.95 26.95 29.80 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 42.28 27.98 41.30 43.16 28.14 38.35 12.31 -11.28 10.33 12.92 -12.61 7.64 1nhx_c01 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 1 hits 1nhx_c01 naa= 2 ULMN 2 1nid_c00 NITRITE REDUCTASE user 1 2 # 1 A 64 PHE A 53 PHE~? 16.58 S2 BME A 300 A 66 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 17.96 4.29 9.15 17.54 1.52 8.86 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 13.21 9.55 15.29 13.34 8.86 14.89 1nid_c00 source 1nid NITRITE REDUCTASE : 1 hits 1nid_c00 naa= 2 ULMN 2 1nml_c00 DI-HAEM CYTOCHROME C PEROXIDASE user 1 2 # 1 A 94 TRP A 93 TRP~? 14.44 S2 BME A 300 A 114 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 39.74 24.82 20.22 40.15 25.23 24.11 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 44.34 21.01 32.31 43.64 21.69 30.42 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1nml_c00 DI-HAEM CYTOCHROME C PEROXIDASE user 2 2 # 2 A 94 TRP A 93 TRP~? 14.44 S2 BME A 300 A 114 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 39.74 24.82 20.22 40.15 25.23 24.11 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 44.34 21.01 32.31 43.64 21.69 30.42 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1nml_c00 DI-HAEM CYTOCHROME C PEROXIDASE user 3 2 # 3 A 94 TRP A 93 TRP~? 14.44 S2 BME A 300 A 114 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 39.74 24.82 20.22 40.15 25.23 24.11 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 44.34 21.01 32.31 43.64 21.69 30.42 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1nml_c00 DI-HAEM CYTOCHROME C PEROXIDASE user 4 2 # 4 A 94 TRP A 93 TRP~? 14.44 S2 BME A 300 A 114 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 39.74 24.82 20.22 40.15 25.23 24.11 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 44.34 21.01 32.31 43.64 21.69 30.42 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1nml_c00 source 1nml DI-HAEM CYTOCHROME C PEROXIDASE : 4 hits 1nml_c00 naa= 2 ULMN 2 1nsj_c00 PHOSPHORIBOSYL ANTHRANILATE ISOMERASuser 1 2 # 1 7 CYH A 63 CYH.? -3.36 S2 BME A 300s 126 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 10.76 29.56 55.88 9.84 31.65 57.57 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 5.60 29.99 66.94 7.71 29.76 66.83 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1nsj_c00 PHOSPHORIBOSYL ANTHRANILATE ISOMERASuser 2 2 # 2 7 CYH A 63 CYH.? -3.36 S2 BME A 300s 126 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 10.76 29.56 55.88 9.84 31.65 57.57 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 5.60 29.99 66.94 7.71 29.76 66.83 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1nsj_c00 PHOSPHORIBOSYL ANTHRANILATE ISOMERASuser 3 2 # 3 7 CYH A 63 CYH.? -3.36 S2 BME A 300s 126 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 10.76 29.56 55.88 9.84 31.65 57.57 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 5.60 29.99 66.94 7.71 29.76 66.83 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1nsj_c00 source 1nsj PHOSPHORIBOSYL ANTHRANILATE ISOMERASE : 3 hits 1nsj_c00 naa= 2 ULMN 2 1nsp_c00 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 1 2 # 1 A 16 LYS A 39 LYS^? 20.06 S2 BME A 300 A 119 ASN A 37 ASN.? 22.15 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 19.85 -1.20 1.64 21.03 4.07 2.80 coo -6.02 27.15 11.24 -7.88 26.67 10.45 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 1nsp_c00 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 2 2 # 2 A 16 LYS A 39 LYS^? 20.06 S2 BME A 300 A 119 ASN A 49 ASN~? 18.38 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 19.85 -1.20 1.64 21.03 4.07 2.80 coo -6.02 27.15 11.24 -7.88 26.67 10.45 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1nsp_c00 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 3 2 # 3 A 16 LYS A 55 LYS.? 25.54 S2 BME A 300 A 119 ASN A 79 ASN.? 19.89 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 15.98 12.20 9.88 16.28 11.97 16.11 coo -6.02 27.15 11.24 -7.88 26.67 10.45 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1nsp_c00 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 4 2 # 4 A 16 LYS A 71 LYS~? 8.54 S2 BME A 300 A 119 ASN A 85 ASN^? 8.15 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -6.02 27.15 11.24 -7.88 26.67 10.45 5.01 -1.60 7.62 5.37 -3.69 7.71 1nsp_c00 source 1nsp NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2.7.4.6) : 4 hits 1nsp_c00 naa= 2 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 1 2 # 1 A 16 LYS A 2 LYS.? 20.18 S2 BME A 300 A 56 TYR A 59 TYR^? 18.50 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 2.39 3.95 8.25 5.67 8.88 7.74 coo -17.06 21.36 8.56 -15.07 22.55 10.13 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 2 2 # 2 A 16 LYS A 2 LYS.? 20.18 S2 BME A 300 A 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 2.39 3.95 8.25 5.67 8.88 7.74 coo -17.06 21.36 8.56 -15.07 22.55 10.13 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 3 2 # 3 A 16 LYS A 10 LYS~? 16.18 O1 BME A 300 A 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -17.06 21.36 8.56 -15.07 22.55 10.13 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 4 2 # 4 A 16 LYS A 17 LYS.? 25.68 S2 BME A 300 A 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 13.04 11.19 -6.33 8.80 12.60 -2.10 coo -17.06 21.36 8.56 -15.07 22.55 10.13 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1nsp_c01 NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2user 5 2 # 5 A 16 LYS A 39 LYS^? 20.06 S2 BME A 300 A 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -11.95 25.45 17.71 -10.57 25.01 12.04 19.85 -1.20 1.64 21.03 4.07 2.80 coo -17.06 21.36 8.56 -15.07 22.55 10.13 9.00 3.02 1.57 7.75 5.45 1.00 1nsp_c01 source 1nsp NUCLEOSIDE DIPHOSPHATE KINASE (E.C.2.7.4.6) : 5 hits 1nsp_c01 naa= 2 ULMN 2 1nzy_c03 4-CHLOROBENZOYL COENZYME A DEHALOGENuser 1 2 # 1 A 137 TRP A 93 TRP~? 14.44 S2 BME A 300 A 145 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 13.05 114.78 45.88 14.93 111.67 47.43 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 8.87 111.26 47.06 9.71 111.38 45.12 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1nzy_c03 source 1nzy 4-CHLOROBENZOYL COENZYME A DEHALOGENASE : 1 hits 1nzy_c03 naa= 2 ULMN 2 1nzy_c04 4-CHLOROBENZOYL COENZYME A DEHALOGENuser 1 2 # 1 C 137 TRP A 93 TRP~? 14.44 S2 BME A 300 C 145 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 15.88 81.48 64.71 17.00 84.36 67.13 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 11.10 83.77 67.09 11.95 82.09 68.02 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1nzy_c04 source 1nzy 4-CHLOROBENZOYL COENZYME A DEHALOGENASE : 1 hits 1nzy_c04 naa= 2 ULMN 2 1nzy_c05 4-CHLOROBENZOYL COENZYME A DEHALOGENuser 1 2 # 1 B 137 TRP A 93 TRP~? 14.44 S2 BME A 300 B 145 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 13.08 114.51 84.60 14.55 114.95 80.97 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 8.57 114.70 81.13 9.19 116.41 82.14 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1nzy_c05 source 1nzy 4-CHLOROBENZOYL COENZYME A DEHALOGENASE : 1 hits 1nzy_c05 naa= 2 ULMN 2 1o8a_c00 ANGIOTENSIN CONVERTING ENZYME user 1 2 # 1 A 411 GLU A 57 GLU.? 23.43 S2 BME A 300 A 523 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 42.59 41.82 44.54 42.65 40.34 46.03 16.30 10.78 3.24 16.87 9.97 1.36 coo 39.81 39.01 41.64 39.68 38.13 44.30 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1o8a_c00 ANGIOTENSIN CONVERTING ENZYME user 2 2 # 2 A 411 GLU A 99 GLU.? 20.82 S2 BME A 300 A 523 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 42.59 41.82 44.54 42.65 40.34 46.03 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 39.81 39.01 41.64 39.68 38.13 44.30 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1o8a_c00 source 1o8a ANGIOTENSIN CONVERTING ENZYME : 2 hits 1o8a_c00 naa= 2 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 A 41 LYS A 2 LYS.? 20.18 S2 BME A 300 A 272 SER A 69 SER~? 5.63 S2 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 2.39 3.95 8.25 5.67 8.88 7.74 coo 9.36 2.57 41.22 10.95 4.31 40.56 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 2 2 # 2 A 41 LYS A 10 LYS~? 16.18 O1 BME A 300 A 272 SER A 3 SER^? 13.09 C1 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 9.36 2.57 41.22 10.95 4.31 40.56 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 3 2 # 3 A 41 LYS A 10 LYS~? 16.18 O1 BME A 300 A 272 SER A 16 SER.? 30.21 S2 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 9.36 2.57 41.22 10.95 4.31 40.56 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 4 2 # 4 A 41 LYS A 12 LYS~? 21.81 S2 BME A 300 A 272 SER A 3 SER^? 13.09 C1 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 9.36 2.57 41.22 10.95 4.31 40.56 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 5 2 # 5 A 41 LYS A 39 LYS^? 20.06 S2 BME A 300 A 272 SER A 69 SER~? 5.63 S2 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 19.85 -1.20 1.64 21.03 4.07 2.80 coo 9.36 2.57 41.22 10.95 4.31 40.56 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1oas_c00 O-ACETYLSERINE SULFHYDRYLASE user 6 2 # 6 A 41 LYS A 71 LYS~? 8.54 S2 BME A 300 A 272 SER A 3 SER^? 13.09 C1 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 9.36 2.57 41.22 10.95 4.31 40.56 2.01 1.27 5.67 0.61 -0.61 5.33 1oas_c00 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 6 hits 1oas_c00 naa= 2 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 B 41 LYS A 2 LYS.? 20.18 S2 BME A 300 B 272 SER A 69 SER~? 5.63 S2 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 2.39 3.95 8.25 5.67 8.88 7.74 coo 26.69 21.30 59.90 26.75 18.87 59.68 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 2 2 # 2 B 41 LYS A 10 LYS~? 16.18 O1 BME A 300 B 272 SER A 3 SER^? 13.09 C1 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 26.69 21.30 59.90 26.75 18.87 59.68 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 3 2 # 3 B 41 LYS A 10 LYS~? 16.18 O1 BME A 300 B 272 SER A 16 SER.? 30.21 S2 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 26.69 21.30 59.90 26.75 18.87 59.68 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 4 2 # 4 B 41 LYS A 12 LYS~? 21.81 S2 BME A 300 B 272 SER A 3 SER^? 13.09 C1 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 26.69 21.30 59.90 26.75 18.87 59.68 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 5 2 # 5 B 41 LYS A 39 LYS^? 20.06 S2 BME A 300 B 272 SER A 69 SER~? 5.63 S2 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 19.85 -1.20 1.64 21.03 4.07 2.80 coo 26.69 21.30 59.90 26.75 18.87 59.68 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1oas_c01 O-ACETYLSERINE SULFHYDRYLASE user 6 2 # 6 B 41 LYS A 71 LYS~? 8.54 S2 BME A 300 B 272 SER A 3 SER^? 13.09 C1 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 26.69 21.30 59.90 26.75 18.87 59.68 2.01 1.27 5.67 0.61 -0.61 5.33 1oas_c01 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 6 hits 1oas_c01 naa= 2 ULMN 2 1oas_c04 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 A 41 LYS A 12 LYS~? 21.81 S2 BME A 300 A 300 SER A 16 SER.? 30.21 S2 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 15.59 6.80 43.55 13.20 7.25 43.46 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1oas_c04 O-ACETYLSERINE SULFHYDRYLASE user 2 2 # 2 A 41 LYS A 39 LYS^? 20.06 S2 BME A 300 A 300 SER A 52 SER~? 19.64 S2 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 19.85 -1.20 1.64 21.03 4.07 2.80 coo 15.59 6.80 43.55 13.20 7.25 43.46 22.49 4.36 7.95 23.43 2.12 7.73 ULMN 2 1oas_c04 O-ACETYLSERINE SULFHYDRYLASE user 3 2 # 3 A 41 LYS A 55 LYS.? 25.54 S2 BME A 300 A 300 SER A 52 SER~? 19.64 S2 BME A 300 coo 17.84 11.94 36.57 13.01 10.24 35.93 15.98 12.20 9.88 16.28 11.97 16.11 coo 15.59 6.80 43.55 13.20 7.25 43.46 22.49 4.36 7.95 23.43 2.12 7.73 1oas_c04 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 3 hits 1oas_c04 naa= 2 ULMN 2 1oas_c05 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 B 41 LYS A 12 LYS~? 21.81 S2 BME A 300 B 300 SER A 16 SER.? 30.21 S2 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 24.97 15.19 55.18 23.91 16.19 57.11 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1oas_c05 O-ACETYLSERINE SULFHYDRYLASE user 2 2 # 2 B 41 LYS A 39 LYS^? 20.06 S2 BME A 300 B 300 SER A 52 SER~? 19.64 S2 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 19.85 -1.20 1.64 21.03 4.07 2.80 coo 24.97 15.19 55.18 23.91 16.19 57.11 22.49 4.36 7.95 23.43 2.12 7.73 ULMN 2 1oas_c05 O-ACETYLSERINE SULFHYDRYLASE user 3 2 # 3 B 41 LYS A 55 LYS.? 25.54 S2 BME A 300 B 300 SER A 52 SER~? 19.64 S2 BME A 300 coo 27.89 7.89 59.43 27.49 11.76 62.82 15.98 12.20 9.88 16.28 11.97 16.11 coo 24.97 15.19 55.18 23.91 16.19 57.11 22.49 4.36 7.95 23.43 2.12 7.73 1oas_c05 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 3 hits 1oas_c05 naa= 2 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 1 2 # 1 A 129 LYS A 2 LYS.? 20.18 S2 BME A 300 A 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 2.39 3.95 8.25 5.67 8.88 7.74 coo 51.44 31.34 6.28 50.30 31.71 3.80 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 2 2 # 2 A 129 LYS A 10 LYS~? 16.18 O1 BME A 300 A 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 51.44 31.34 6.28 50.30 31.71 3.80 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 3 2 # 3 A 129 LYS A 12 LYS~? 21.81 S2 BME A 300 A 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 51.44 31.34 6.28 50.30 31.71 3.80 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 4 2 # 4 A 129 LYS A 39 LYS^? 20.06 S2 BME A 300 A 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 19.85 -1.20 1.64 21.03 4.07 2.80 coo 51.44 31.34 6.28 50.30 31.71 3.80 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 5 2 # 5 A 129 LYS A 39 LYS^? 20.06 S2 BME A 300 A 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 19.85 -1.20 1.64 21.03 4.07 2.80 coo 51.44 31.34 6.28 50.30 31.71 3.80 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 6 2 # 6 A 129 LYS A 55 LYS.? 25.54 S2 BME A 300 A 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 15.98 12.20 9.88 16.28 11.97 16.11 coo 51.44 31.34 6.28 50.30 31.71 3.80 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 7 2 # 7 A 129 LYS A 71 LYS~? 8.54 S2 BME A 300 A 217 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 51.44 31.34 6.28 50.30 31.71 3.80 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ofg_c00 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 8 2 # 8 A 129 LYS A 101 LYS.? -19.93 S2 BME A 300s A 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 54.07 28.25 -1.99 49.70 28.36 0.96 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 51.44 31.34 6.28 50.30 31.71 3.80 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ofg_c00 source 1ofg GLUCOSE-FRUCTOSE OXIDOREDUCTASE : 8 hits 1ofg_c00 naa= 2 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 1 2 # 1 B 129 LYS A 2 LYS.? 20.18 S2 BME A 300 B 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 2.39 3.95 8.25 5.67 8.88 7.74 coo 50.27 29.83 36.42 50.62 30.87 38.94 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 2 2 # 2 B 129 LYS A 10 LYS~? 16.18 O1 BME A 300 B 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 50.27 29.83 36.42 50.62 30.87 38.94 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 3 2 # 3 B 129 LYS A 12 LYS~? 21.81 S2 BME A 300 B 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 50.27 29.83 36.42 50.62 30.87 38.94 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 4 2 # 4 B 129 LYS A 39 LYS^? 20.06 S2 BME A 300 B 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 19.85 -1.20 1.64 21.03 4.07 2.80 coo 50.27 29.83 36.42 50.62 30.87 38.94 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 5 2 # 5 B 129 LYS A 39 LYS^? 20.06 S2 BME A 300 B 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 19.85 -1.20 1.64 21.03 4.07 2.80 coo 50.27 29.83 36.42 50.62 30.87 38.94 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 6 2 # 6 B 129 LYS A 55 LYS.? 25.54 S2 BME A 300 B 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 15.98 12.20 9.88 16.28 11.97 16.11 coo 50.27 29.83 36.42 50.62 30.87 38.94 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 7 2 # 7 B 129 LYS A 71 LYS~? 8.54 S2 BME A 300 B 217 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 50.27 29.83 36.42 50.62 30.87 38.94 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ofg_c01 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 8 2 # 8 B 129 LYS A 101 LYS.? -19.93 S2 BME A 300s B 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 51.63 25.56 44.46 53.82 29.45 41.65 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 50.27 29.83 36.42 50.62 30.87 38.94 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ofg_c01 source 1ofg GLUCOSE-FRUCTOSE OXIDOREDUCTASE : 8 hits 1ofg_c01 naa= 2 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 1 2 # 1 C 129 LYS A 2 LYS.? 20.18 S2 BME A 300 C 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.76 62.58 37.36 33.41 61.40 39.82 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 2 2 # 2 C 129 LYS A 10 LYS~? 16.18 O1 BME A 300 C 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 33.76 62.58 37.36 33.41 61.40 39.82 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 3 2 # 3 C 129 LYS A 12 LYS~? 21.81 S2 BME A 300 C 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 33.76 62.58 37.36 33.41 61.40 39.82 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 4 2 # 4 C 129 LYS A 39 LYS^? 20.06 S2 BME A 300 C 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 19.85 -1.20 1.64 21.03 4.07 2.80 coo 33.76 62.58 37.36 33.41 61.40 39.82 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 5 2 # 5 C 129 LYS A 39 LYS^? 20.06 S2 BME A 300 C 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 19.85 -1.20 1.64 21.03 4.07 2.80 coo 33.76 62.58 37.36 33.41 61.40 39.82 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 6 2 # 6 C 129 LYS A 55 LYS.? 25.54 S2 BME A 300 C 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 15.98 12.20 9.88 16.28 11.97 16.11 coo 33.76 62.58 37.36 33.41 61.40 39.82 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 7 2 # 7 C 129 LYS A 71 LYS~? 8.54 S2 BME A 300 C 217 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 33.76 62.58 37.36 33.41 61.40 39.82 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ofg_c02 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 8 2 # 8 C 129 LYS A 101 LYS.? -19.93 S2 BME A 300s C 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 32.39 66.36 45.66 30.20 62.65 42.61 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 33.76 62.58 37.36 33.41 61.40 39.82 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ofg_c02 source 1ofg GLUCOSE-FRUCTOSE OXIDOREDUCTASE : 8 hits 1ofg_c02 naa= 2 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 1 2 # 1 D 129 LYS A 2 LYS.? 20.18 S2 BME A 300 D 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 2.39 3.95 8.25 5.67 8.88 7.74 coo 32.64 62.81 7.18 33.77 62.58 4.68 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 2 2 # 2 D 129 LYS A 10 LYS~? 16.18 O1 BME A 300 D 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 32.64 62.81 7.18 33.77 62.58 4.68 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 3 2 # 3 D 129 LYS A 12 LYS~? 21.81 S2 BME A 300 D 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 32.64 62.81 7.18 33.77 62.58 4.68 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 4 2 # 4 D 129 LYS A 39 LYS^? 20.06 S2 BME A 300 D 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 19.85 -1.20 1.64 21.03 4.07 2.80 coo 32.64 62.81 7.18 33.77 62.58 4.68 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 5 2 # 5 D 129 LYS A 39 LYS^? 20.06 S2 BME A 300 D 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 19.85 -1.20 1.64 21.03 4.07 2.80 coo 32.64 62.81 7.18 33.77 62.58 4.68 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 6 2 # 6 D 129 LYS A 55 LYS.? 25.54 S2 BME A 300 D 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 15.98 12.20 9.88 16.28 11.97 16.11 coo 32.64 62.81 7.18 33.77 62.58 4.68 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 7 2 # 7 D 129 LYS A 71 LYS~? 8.54 S2 BME A 300 D 217 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 32.64 62.81 7.18 33.77 62.58 4.68 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ofg_c03 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 8 2 # 8 D 129 LYS A 101 LYS.? -19.93 S2 BME A 300s D 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 29.99 66.35 -0.91 34.37 66.07 2.03 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 32.64 62.81 7.18 33.77 62.58 4.68 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ofg_c03 source 1ofg GLUCOSE-FRUCTOSE OXIDOREDUCTASE : 8 hits 1ofg_c03 naa= 2 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 1 2 # 1 E 129 LYS A 2 LYS.? 20.18 S2 BME A 300 E 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 2.39 3.95 8.25 5.67 8.88 7.74 coo 51.51 126.04 8.76 50.38 126.35 6.26 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 2 2 # 2 E 129 LYS A 10 LYS~? 16.18 O1 BME A 300 E 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 51.51 126.04 8.76 50.38 126.35 6.26 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 3 2 # 3 E 129 LYS A 12 LYS~? 21.81 S2 BME A 300 E 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 51.51 126.04 8.76 50.38 126.35 6.26 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 4 2 # 4 E 129 LYS A 39 LYS^? 20.06 S2 BME A 300 E 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 19.85 -1.20 1.64 21.03 4.07 2.80 coo 51.51 126.04 8.76 50.38 126.35 6.26 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 5 2 # 5 E 129 LYS A 39 LYS^? 20.06 S2 BME A 300 E 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 19.85 -1.20 1.64 21.03 4.07 2.80 coo 51.51 126.04 8.76 50.38 126.35 6.26 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 6 2 # 6 E 129 LYS A 55 LYS.? 25.54 S2 BME A 300 E 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 15.98 12.20 9.88 16.28 11.97 16.11 coo 51.51 126.04 8.76 50.38 126.35 6.26 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 7 2 # 7 E 129 LYS A 71 LYS~? 8.54 S2 BME A 300 E 217 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 51.51 126.04 8.76 50.38 126.35 6.26 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ofg_c04 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 8 2 # 8 E 129 LYS A 101 LYS.? -19.93 S2 BME A 300s E 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 54.13 122.71 0.57 49.76 122.94 3.51 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 51.51 126.04 8.76 50.38 126.35 6.26 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ofg_c04 source 1ofg GLUCOSE-FRUCTOSE OXIDOREDUCTASE : 8 hits 1ofg_c04 naa= 2 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 1 2 # 1 F 129 LYS A 2 LYS.? 20.18 S2 BME A 300 F 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 2.39 3.95 8.25 5.67 8.88 7.74 coo 50.32 125.38 38.93 50.68 126.48 41.43 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 2 2 # 2 F 129 LYS A 10 LYS~? 16.18 O1 BME A 300 F 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 50.32 125.38 38.93 50.68 126.48 41.43 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 3 2 # 3 F 129 LYS A 12 LYS~? 21.81 S2 BME A 300 F 217 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 50.32 125.38 38.93 50.68 126.48 41.43 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 4 2 # 4 F 129 LYS A 39 LYS^? 20.06 S2 BME A 300 F 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 19.85 -1.20 1.64 21.03 4.07 2.80 coo 50.32 125.38 38.93 50.68 126.48 41.43 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 5 2 # 5 F 129 LYS A 39 LYS^? 20.06 S2 BME A 300 F 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 19.85 -1.20 1.64 21.03 4.07 2.80 coo 50.32 125.38 38.93 50.68 126.48 41.43 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 6 2 # 6 F 129 LYS A 55 LYS.? 25.54 S2 BME A 300 F 217 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 15.98 12.20 9.88 16.28 11.97 16.11 coo 50.32 125.38 38.93 50.68 126.48 41.43 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 7 2 # 7 F 129 LYS A 71 LYS~? 8.54 S2 BME A 300 F 217 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 50.32 125.38 38.93 50.68 126.48 41.43 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ofg_c05 GLUCOSE-FRUCTOSE OXIDOREDUCTASE user 8 2 # 8 F 129 LYS A 101 LYS.? -19.93 S2 BME A 300s F 217 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 51.63 121.33 47.11 53.87 125.11 44.18 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 50.32 125.38 38.93 50.68 126.48 41.43 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ofg_c05 source 1ofg GLUCOSE-FRUCTOSE OXIDOREDUCTASE : 8 hits 1ofg_c05 naa= 2 ULMN 2 1oj4_c00 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 1 2 # 1 A 10 LYS A 2 LYS.? 20.18 S2 BME A 300 A 141 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 19.64 15.23 16.08 25.15 14.66 17.29 2.39 3.95 8.25 5.67 8.88 7.74 coo 26.09 19.89 14.83 26.89 17.95 15.45 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1oj4_c00 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 2 2 # 2 A 10 LYS A 10 LYS~? 16.18 O1 BME A 300 A 141 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 19.64 15.23 16.08 25.15 14.66 17.29 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 26.09 19.89 14.83 26.89 17.95 15.45 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1oj4_c00 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 3 2 # 3 A 10 LYS A 12 LYS~? 21.81 S2 BME A 300 A 141 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 19.64 15.23 16.08 25.15 14.66 17.29 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 26.09 19.89 14.83 26.89 17.95 15.45 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1oj4_c00 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 4 2 # 4 A 10 LYS A 55 LYS.? 25.54 S2 BME A 300 A 141 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 19.64 15.23 16.08 25.15 14.66 17.29 15.98 12.20 9.88 16.28 11.97 16.11 coo 26.09 19.89 14.83 26.89 17.95 15.45 10.12 9.33 8.59 8.15 9.51 7.94 1oj4_c00 source 1oj4 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KIN: 4 hits 1oj4_c00 naa= 2 ULMN 2 1oj4_c01 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 1 2 # 1 B 10 LYS A 2 LYS.? 20.18 S2 BME A 300 B 141 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 50.48 51.42 16.27 45.03 52.12 17.67 2.39 3.95 8.25 5.67 8.88 7.74 coo 43.77 47.07 15.43 43.03 49.06 15.86 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1oj4_c01 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 2 2 # 2 B 10 LYS A 10 LYS~? 16.18 O1 BME A 300 B 141 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 50.48 51.42 16.27 45.03 52.12 17.67 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 43.77 47.07 15.43 43.03 49.06 15.86 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1oj4_c01 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 3 2 # 3 B 10 LYS A 39 LYS^? 20.06 S2 BME A 300 B 141 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 50.48 51.42 16.27 45.03 52.12 17.67 19.85 -1.20 1.64 21.03 4.07 2.80 coo 43.77 47.07 15.43 43.03 49.06 15.86 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1oj4_c01 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 4 2 # 4 B 10 LYS A 55 LYS.? 25.54 S2 BME A 300 B 141 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 50.48 51.42 16.27 45.03 52.12 17.67 15.98 12.20 9.88 16.28 11.97 16.11 coo 43.77 47.07 15.43 43.03 49.06 15.86 10.12 9.33 8.59 8.15 9.51 7.94 1oj4_c01 source 1oj4 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KIN: 4 hits 1oj4_c01 naa= 2 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 1 2 # 1 A 144 GLU A 8 GLU~? 18.47 O1 BME A 300 A 153 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 5.94 27.66 26.60 4.79 28.74 25.22 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 11.22 39.04 26.68 10.07 39.51 28.37 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 2 2 # 2 A 144 GLU A 15 GLU~? 24.22 S2 BME A 300 A 153 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 5.94 27.66 26.60 4.79 28.74 25.22 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 11.22 39.04 26.68 10.07 39.51 28.37 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 3 2 # 3 A 144 GLU A 96 GLU.? 20.00 O1 BME A 300 A 153 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 5.94 27.66 26.60 4.79 28.74 25.22 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 11.22 39.04 26.68 10.07 39.51 28.37 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1or8_c00 SUBSTRATE PEPTIDE user 4 2 # 4 A 144 GLU A 99 GLU.? 20.82 S2 BME A 300 A 153 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 5.94 27.66 26.60 4.79 28.74 25.22 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 11.22 39.04 26.68 10.07 39.51 28.37 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1or8_c00 source 1or8 SUBSTRATE PEPTIDE : 4 hits 1or8_c00 naa= 2 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 1 2 # 1 A 73 LYS A 2 LYS.? 20.18 S2 BME A 300 A 104 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 2.39 3.95 8.25 5.67 8.88 7.74 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 2 2 # 2 A 73 LYS A 2 LYS.? 20.18 S2 BME A 300 A 104 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 2.39 3.95 8.25 5.67 8.88 7.74 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 3 2 # 3 A 73 LYS A 10 LYS~? 16.18 O1 BME A 300 A 104 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 4 2 # 4 A 73 LYS A 39 LYS^? 20.06 S2 BME A 300 A 104 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 19.85 -1.20 1.64 21.03 4.07 2.80 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 5 2 # 5 A 73 LYS A 55 LYS.? 25.54 S2 BME A 300 A 104 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 15.98 12.20 9.88 16.28 11.97 16.11 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 6 2 # 6 A 73 LYS A 71 LYS~? 8.54 S2 BME A 300 A 104 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 7 2 # 7 A 73 LYS A 71 LYS~? 8.54 S2 BME A 300 A 104 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 8 2 # 8 A 73 LYS A 101 LYS.? -19.93 S2 BME A 300s A 104 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1oro_c01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 9 2 # 9 A 73 LYS A 101 LYS.? -19.93 S2 BME A 300s A 104 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 24.97 -2.58 14.97 24.99 -3.62 16.79 1oro_c01 source 1oro OROTATE PHOSPHORIBOSYLTRANSFERASE : 9 hits 1oro_c01 naa= 2 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 1 2 # 1 246 SER A 3 SER^? 13.09 C1 BME A 300 360 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -2.27 5.01 11.02 -1.56 7.27 11.54 2.01 1.27 5.67 0.61 -0.61 5.33 coo 3.38 8.39 11.51 1.79 8.22 12.92 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 2 2 # 2 246 SER A 16 SER.? 30.21 S2 BME A 300 360 GLU A 15 GLU~? 24.22 S2 BME A 300 coo -2.27 5.01 11.02 -1.56 7.27 11.54 11.56 11.57 -9.82 9.89 13.31 -9.94 coo 3.38 8.39 11.51 1.79 8.22 12.92 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 3 2 # 3 246 SER A 102 SER.? -26.95 S2 BME A 300s 360 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -2.27 5.01 11.02 -1.56 7.27 11.54 28.10 -11.09 -8.44 28.33 -11.90 -10.72 coo 3.38 8.39 11.51 1.79 8.22 12.92 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1oxa_c00 source 1oxa CYTOCHROME P450 ERYF : 3 hits 1oxa_c00 naa= 2 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 39 LYS^? 20.06 S2 BME A 300 X 119 ASN A 37 ASN.? 22.15 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 19.85 -1.20 1.64 21.03 4.07 2.80 coo 11.13 57.62 41.98 10.56 59.50 42.87 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 39 LYS^? 20.06 S2 BME A 300 X 119 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 19.85 -1.20 1.64 21.03 4.07 2.80 coo 11.13 57.62 41.98 10.56 59.50 42.87 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS A 55 LYS.? 25.54 S2 BME A 300 X 119 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 15.98 12.20 9.88 16.28 11.97 16.11 coo 11.13 57.62 41.98 10.56 59.50 42.87 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS A 71 LYS~? 8.54 S2 BME A 300 X 119 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 11.13 57.62 41.98 10.56 59.50 42.87 5.01 -1.60 7.62 5.37 -3.69 7.71 1pae_c00 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 4 hits 1pae_c00 naa= 2 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 2 LYS.? 20.18 S2 BME A 300 X 56 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 2.39 3.95 8.25 5.67 8.88 7.74 coo 10.51 70.44 44.57 10.41 68.10 43.00 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 2 LYS.? 20.18 S2 BME A 300 X 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 2.39 3.95 8.25 5.67 8.88 7.74 coo 10.51 70.44 44.57 10.41 68.10 43.00 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS A 10 LYS~? 16.18 O1 BME A 300 X 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 10.51 70.44 44.57 10.41 68.10 43.00 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS A 17 LYS.? 25.68 S2 BME A 300 X 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 10.51 70.44 44.57 10.41 68.10 43.00 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 5 2 # 5 X 16 LYS A 39 LYS^? 20.06 S2 BME A 300 X 56 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 9.69 63.83 35.55 11.00 62.83 41.36 19.85 -1.20 1.64 21.03 4.07 2.80 coo 10.51 70.44 44.57 10.41 68.10 43.00 9.00 3.02 1.57 7.75 5.45 1.00 1pae_c01 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 5 hits 1pae_c01 naa= 2 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 28 GLU~? 14.38 S2 BME A 300 A 375 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 61.89 10.05 27.30 63.60 9.39 28.40 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 29 GLU~? 6.68 S2 BME A 300 A 375 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 61.89 10.05 27.30 63.60 9.39 28.40 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU A 74 GLU~? 13.09 S2 BME A 300 A 375 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 61.89 10.05 27.30 63.60 9.39 28.40 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU A 77 GLU~? 17.67 S2 BME A 300 A 375 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 7.63 5.18 13.95 5.55 5.01 14.48 coo 61.89 10.05 27.30 63.60 9.39 28.40 6.36 -0.87 15.92 5.32 -2.36 17.02 1pbg_c02 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c02 naa= 2 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 28 GLU~? 14.38 S2 BME A 300 B 375 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 21.67 20.74 89.92 23.35 20.55 88.67 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 29 GLU~? 6.68 S2 BME A 300 B 375 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 21.67 20.74 89.92 23.35 20.55 88.67 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU A 74 GLU~? 13.09 S2 BME A 300 B 375 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 21.67 20.74 89.92 23.35 20.55 88.67 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU A 77 GLU~? 17.67 S2 BME A 300 B 375 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 7.63 5.18 13.95 5.55 5.01 14.48 coo 21.67 20.74 89.92 23.35 20.55 88.67 6.36 -0.87 15.92 5.32 -2.36 17.02 1pbg_c03 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c03 naa= 2 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 15 GLU~? 24.22 S2 BME A 300 A 269 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 15 GLU~? 24.22 S2 BME A 300 A 269 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU A 28 GLU~? 14.38 S2 BME A 300 A 269 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU A 28 GLU~? 14.38 S2 BME A 300 A 269 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 A 160 GLU A 28 GLU~? 14.38 S2 BME A 300 A 269 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 A 160 GLU A 29 GLU~? 6.68 S2 BME A 300 A 269 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 A 160 GLU A 29 GLU~? 6.68 S2 BME A 300 A 269 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 A 160 GLU A 57 GLU.? 23.43 S2 BME A 300 A 269 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 16.30 10.78 3.24 16.87 9.97 1.36 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 A 160 GLU A 57 GLU.? 23.43 S2 BME A 300 A 269 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 16.30 10.78 3.24 16.87 9.97 1.36 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 A 160 GLU A 74 GLU~? 13.09 S2 BME A 300 A 269 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 A 160 GLU A 74 GLU~? 13.09 S2 BME A 300 A 269 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 A 160 GLU A 74 GLU~? 13.09 S2 BME A 300 A 269 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 A 160 GLU A 77 GLU~? 17.67 S2 BME A 300 A 269 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 7.63 5.18 13.95 5.55 5.01 14.48 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 A 160 GLU A 77 GLU~? 17.67 S2 BME A 300 A 269 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 7.63 5.18 13.95 5.55 5.01 14.48 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 A 160 GLU A 87 GLU.? 12.12 O1 BME A 300 A 269 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 A 160 GLU A 96 GLU.? 20.00 O1 BME A 300 A 269 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 A 160 GLU A 99 GLU.? 20.82 S2 BME A 300 A 269 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 A 160 GLU A 99 GLU.? 20.82 S2 BME A 300 A 269 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 63.94 10.02 33.47 64.31 8.24 32.38 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 7.63 5.18 13.95 5.55 5.01 14.48 1pbg_c04 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 18 hits 1pbg_c04 naa= 2 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 15 GLU~? 24.22 S2 BME A 300 B 269 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 21.20 8.49 59.63 20.88 8.62 57.55 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 15 GLU~? 24.22 S2 BME A 300 B 269 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 21.20 8.49 59.63 20.88 8.62 57.55 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU A 28 GLU~? 14.38 S2 BME A 300 B 269 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 21.20 8.49 59.63 20.88 8.62 57.55 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU A 28 GLU~? 14.38 S2 BME A 300 B 269 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 21.20 8.49 59.63 20.88 8.62 57.55 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 B 160 GLU A 28 GLU~? 14.38 S2 BME A 300 B 269 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 21.20 8.49 59.63 20.88 8.62 57.55 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 B 160 GLU A 29 GLU~? 6.68 S2 BME A 300 B 269 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 21.20 8.49 59.63 20.88 8.62 57.55 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 B 160 GLU A 29 GLU~? 6.68 S2 BME A 300 B 269 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 21.20 8.49 59.63 20.88 8.62 57.55 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 B 160 GLU A 57 GLU.? 23.43 S2 BME A 300 B 269 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 16.30 10.78 3.24 16.87 9.97 1.36 coo 21.20 8.49 59.63 20.88 8.62 57.55 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 B 160 GLU A 57 GLU.? 23.43 S2 BME A 300 B 269 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 16.30 10.78 3.24 16.87 9.97 1.36 coo 21.20 8.49 59.63 20.88 8.62 57.55 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 B 160 GLU A 74 GLU~? 13.09 S2 BME A 300 B 269 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 21.20 8.49 59.63 20.88 8.62 57.55 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 B 160 GLU A 74 GLU~? 13.09 S2 BME A 300 B 269 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 21.20 8.49 59.63 20.88 8.62 57.55 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 B 160 GLU A 74 GLU~? 13.09 S2 BME A 300 B 269 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 21.20 8.49 59.63 20.88 8.62 57.55 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 B 160 GLU A 77 GLU~? 17.67 S2 BME A 300 B 269 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 7.63 5.18 13.95 5.55 5.01 14.48 coo 21.20 8.49 59.63 20.88 8.62 57.55 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 B 160 GLU A 77 GLU~? 17.67 S2 BME A 300 B 269 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 7.63 5.18 13.95 5.55 5.01 14.48 coo 21.20 8.49 59.63 20.88 8.62 57.55 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 B 160 GLU A 87 GLU.? 12.12 O1 BME A 300 B 269 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 21.20 8.49 59.63 20.88 8.62 57.55 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 B 160 GLU A 96 GLU.? 20.00 O1 BME A 300 B 269 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 21.20 8.49 59.63 20.88 8.62 57.55 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 B 160 GLU A 99 GLU.? 20.82 S2 BME A 300 B 269 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 21.20 8.49 59.63 20.88 8.62 57.55 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 B 160 GLU A 99 GLU.? 20.82 S2 BME A 300 B 269 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 23.66 16.69 85.20 24.17 18.76 84.94 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 21.20 8.49 59.63 20.88 8.62 57.55 7.63 5.18 13.95 5.55 5.01 14.48 1pbg_c05 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 18 hits 1pbg_c05 naa= 2 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 1 2 # 1 60 ASP A 7 ASP~? 16.68 O1 BME A 300 206 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 2 2 # 2 60 ASP A 23 ASP^? 9.45 S2 BME A 300 206 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 3 2 # 3 60 ASP A 27 ASP~? 15.09 S2 BME A 300 206 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 4 2 # 4 60 ASP A 82 ASP^? 20.57 S2 BME A 300 206 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 10.12 9.33 8.59 8.15 9.51 7.94 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 5 2 # 5 60 ASP A 82 ASP^? 20.57 S2 BME A 300 206 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 10.12 9.33 8.59 8.15 9.51 7.94 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 7.63 5.18 13.95 5.55 5.01 14.48 1pgs_c00 source 1pgs PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSAMINYL) AS: 5 hits 1pgs_c00 naa= 2 ULMN 2 1pii_c01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 1 2 # 1 260 CYH A 63 CYH.? -3.36 S2 BME A 300s 379 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1pii_c01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 2 2 # 2 260 CYH A 63 CYH.? -3.36 S2 BME A 300s 379 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1pii_c01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 3 2 # 3 260 CYH A 63 CYH.? -3.36 S2 BME A 300s 379 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1pii_c01 source 1pii N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOMERASE (E.: 3 hits 1pii_c01 naa= 2 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 2 # 1 A 394 VAL A 24 VAL.? 8.05 S2 BME A 300 A 422 MET A 43 MET?? 7.50 S2 BME A 300 coo 20.28 63.26 5.82 18.13 63.68 5.60 15.68 -6.47 6.85 14.25 -5.17 7.91 coo 19.32 67.77 3.69 20.14 66.07 0.03 16.84 -7.02 11.44 13.26 -8.32 13.33 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 2 # 2 A 394 VAL A 62 VAL^? 8.11 S2 BME A 300 A 422 MET A 90 MET?? 10.03 S2 BME A 300 coo 20.28 63.26 5.82 18.13 63.68 5.60 10.52 -4.83 3.69 10.95 -5.47 1.63 coo 19.32 67.77 3.69 20.14 66.07 0.03 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 2 # 3 A 394 VAL A 72 VAL~? 9.85 S2 BME A 300 A 422 MET A 43 MET?? 7.50 S2 BME A 300 coo 20.28 63.26 5.82 18.13 63.68 5.60 11.63 -2.55 12.61 13.22 -3.01 11.19 coo 19.32 67.77 3.69 20.14 66.07 0.03 16.84 -7.02 11.44 13.26 -8.32 13.33 1pow_c04 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 3 hits 1pow_c04 naa= 2 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 2 # 1 B 394 VAL A 24 VAL.? 8.05 S2 BME A 300 B 422 MET A 43 MET?? 7.50 S2 BME A 300 coo -29.52 83.24 14.45 -27.41 83.13 13.96 15.68 -6.47 6.85 14.25 -5.17 7.91 coo -28.53 81.64 9.59 -29.29 85.60 8.64 16.84 -7.02 11.44 13.26 -8.32 13.33 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 2 # 2 B 394 VAL A 62 VAL^? 8.11 S2 BME A 300 B 422 MET A 90 MET?? 10.03 S2 BME A 300 coo -29.52 83.24 14.45 -27.41 83.13 13.96 10.52 -4.83 3.69 10.95 -5.47 1.63 coo -28.53 81.64 9.59 -29.29 85.60 8.64 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 2 # 3 B 394 VAL A 72 VAL~? 9.85 S2 BME A 300 B 422 MET A 43 MET?? 7.50 S2 BME A 300 coo -29.52 83.24 14.45 -27.41 83.13 13.96 11.63 -2.55 12.61 13.22 -3.01 11.19 coo -28.53 81.64 9.59 -29.29 85.60 8.64 16.84 -7.02 11.44 13.26 -8.32 13.33 1pow_c05 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 3 hits 1pow_c05 naa= 2 ULMN 2 1pwv_c00 LETHAL FACTOR user 1 2 # 1 A 687 GLU A 8 GLU~? 18.47 O1 BME A 300 A 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 84.86 31.94 140.08 85.28 34.63 139.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c00 LETHAL FACTOR user 2 2 # 2 A 687 GLU A 15 GLU~? 24.22 S2 BME A 300 A 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 84.86 31.94 140.08 85.28 34.63 139.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c00 LETHAL FACTOR user 3 2 # 3 A 687 GLU A 29 GLU~? 6.68 S2 BME A 300 A 728 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 84.86 31.94 140.08 85.28 34.63 139.44 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1pwv_c00 LETHAL FACTOR user 4 2 # 4 A 687 GLU A 57 GLU.? 23.43 S2 BME A 300 A 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 16.30 10.78 3.24 16.87 9.97 1.36 coo 84.86 31.94 140.08 85.28 34.63 139.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c00 LETHAL FACTOR user 5 2 # 5 A 687 GLU A 77 GLU~? 17.67 S2 BME A 300 A 728 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 7.63 5.18 13.95 5.55 5.01 14.48 coo 84.86 31.94 140.08 85.28 34.63 139.44 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1pwv_c00 LETHAL FACTOR user 6 2 # 6 A 687 GLU A 77 GLU~? 17.67 S2 BME A 300 A 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 7.63 5.18 13.95 5.55 5.01 14.48 coo 84.86 31.94 140.08 85.28 34.63 139.44 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c00 LETHAL FACTOR user 7 2 # 7 A 687 GLU A 77 GLU~? 17.67 S2 BME A 300 A 728 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 7.63 5.18 13.95 5.55 5.01 14.48 coo 84.86 31.94 140.08 85.28 34.63 139.44 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1pwv_c00 LETHAL FACTOR user 8 2 # 8 A 687 GLU A 87 GLU.? 12.12 O1 BME A 300 A 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 77.63 40.02 139.16 79.74 39.94 138.95 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 84.86 31.94 140.08 85.28 34.63 139.44 9.00 3.02 1.57 7.75 5.45 1.00 1pwv_c00 source 1pwv LETHAL FACTOR : 8 hits 1pwv_c00 naa= 2 ULMN 2 1pwv_c01 LETHAL FACTOR user 1 2 # 1 B 687 GLU A 8 GLU~? 18.47 O1 BME A 300 B 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 105.30 6.94 120.65 104.99 4.15 120.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c01 LETHAL FACTOR user 2 2 # 2 B 687 GLU A 15 GLU~? 24.22 S2 BME A 300 B 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 105.30 6.94 120.65 104.99 4.15 120.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c01 LETHAL FACTOR user 3 2 # 3 B 687 GLU A 29 GLU~? 6.68 S2 BME A 300 B 728 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 105.30 6.94 120.65 104.99 4.15 120.81 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1pwv_c01 LETHAL FACTOR user 4 2 # 4 B 687 GLU A 57 GLU.? 23.43 S2 BME A 300 B 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 16.30 10.78 3.24 16.87 9.97 1.36 coo 105.30 6.94 120.65 104.99 4.15 120.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c01 LETHAL FACTOR user 5 2 # 5 B 687 GLU A 77 GLU~? 17.67 S2 BME A 300 B 728 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 7.63 5.18 13.95 5.55 5.01 14.48 coo 105.30 6.94 120.65 104.99 4.15 120.81 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1pwv_c01 LETHAL FACTOR user 6 2 # 6 B 687 GLU A 77 GLU~? 17.67 S2 BME A 300 B 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 7.63 5.18 13.95 5.55 5.01 14.48 coo 105.30 6.94 120.65 104.99 4.15 120.81 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1pwv_c01 LETHAL FACTOR user 7 2 # 7 B 687 GLU A 77 GLU~? 17.67 S2 BME A 300 B 728 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 7.63 5.18 13.95 5.55 5.01 14.48 coo 105.30 6.94 120.65 104.99 4.15 120.81 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1pwv_c01 LETHAL FACTOR user 8 2 # 8 B 687 GLU A 87 GLU.? 12.12 O1 BME A 300 B 728 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 105.30 6.94 120.65 104.99 4.15 120.81 9.00 3.02 1.57 7.75 5.45 1.00 1pwv_c01 source 1pwv LETHAL FACTOR : 8 hits 1pwv_c01 naa= 2 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 A 62 ASP A 7 ASP~? 16.68 O1 BME A 300 A 64 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 61.71 14.20 19.64 60.68 14.94 21.37 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 55.72 12.42 20.66 58.31 17.81 21.97 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 A 62 ASP A 23 ASP^? 9.45 S2 BME A 300 A 64 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 61.71 14.20 19.64 60.68 14.94 21.37 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 55.72 12.42 20.66 58.31 17.81 21.97 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 A 62 ASP A 82 ASP^? 20.57 S2 BME A 300 A 64 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 61.71 14.20 19.64 60.68 14.94 21.37 10.12 9.33 8.59 8.15 9.51 7.94 coo 55.72 12.42 20.66 58.31 17.81 21.97 15.98 12.20 9.88 16.28 11.97 16.11 1q6l_c00 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 3 hits 1q6l_c00 naa= 2 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 B 62 ASP A 7 ASP~? 16.68 O1 BME A 300 B 64 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 45.81 14.64 11.83 45.04 13.82 13.65 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 48.63 16.35 17.25 45.95 10.72 16.28 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 B 62 ASP A 23 ASP^? 9.45 S2 BME A 300 B 64 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 45.81 14.64 11.83 45.04 13.82 13.65 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 48.63 16.35 17.25 45.95 10.72 16.28 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 B 62 ASP A 82 ASP^? 20.57 S2 BME A 300 B 64 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 45.81 14.64 11.83 45.04 13.82 13.65 10.12 9.33 8.59 8.15 9.51 7.94 coo 48.63 16.35 17.25 45.95 10.72 16.28 15.98 12.20 9.88 16.28 11.97 16.11 1q6l_c01 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 3 hits 1q6l_c01 naa= 2 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 1 2 # 1 A 59 GLU A 8 GLU~? 18.47 O1 BME A 300 A 101 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 17.21 39.80 29.23 17.83 38.53 27.67 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 11.70 33.75 21.15 12.72 34.11 19.33 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 2 2 # 2 A 59 GLU A 57 GLU.? 23.43 S2 BME A 300 A 101 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 17.21 39.80 29.23 17.83 38.53 27.67 16.30 10.78 3.24 16.87 9.97 1.36 coo 11.70 33.75 21.15 12.72 34.11 19.33 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 3 2 # 3 A 59 GLU A 74 GLU~? 13.09 S2 BME A 300 A 101 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 17.21 39.80 29.23 17.83 38.53 27.67 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 11.70 33.75 21.15 12.72 34.11 19.33 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 4 2 # 4 A 59 GLU A 77 GLU~? 17.67 S2 BME A 300 A 101 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 17.21 39.80 29.23 17.83 38.53 27.67 7.63 5.18 13.95 5.55 5.01 14.48 coo 11.70 33.75 21.15 12.72 34.11 19.33 5.01 -1.60 7.62 5.37 -3.69 7.71 1qam_c00 source 1qam ERMC' METHYLTRANSFERASE : 4 hits 1qam_c00 naa= 2 ULMN 2 1qba_c00 CHITOBIASE user 1 2 # 1 539 ASP A 7 ASP~? 16.68 O1 BME A 300 540 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 29.81 50.17 23.56 27.68 49.90 23.71 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 30.20 53.24 26.35 28.57 54.55 26.04 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1qba_c00 CHITOBIASE user 2 2 # 2 539 ASP A 27 ASP~? 15.09 S2 BME A 300 540 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 29.81 50.17 23.56 27.68 49.90 23.71 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 30.20 53.24 26.35 28.57 54.55 26.04 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1qba_c00 CHITOBIASE user 3 2 # 3 539 ASP A 95 ASP.? 15.99 O1 BME A 300 540 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 29.81 50.17 23.56 27.68 49.90 23.71 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 30.20 53.24 26.35 28.57 54.55 26.04 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1qba_c00 source 1qba CHITOBIASE : 3 hits 1qba_c00 naa= 2 ULMN 2 1qfl_c04 ACETOACETYL-COA THIOLASE user 1 2 # 1 A 348 HIS A 91 HIS~? 7.63 O1 BME A 300 A 378 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 28.93 -15.66 12.20 27.40 -15.25 10.79 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 10.91 -8.39 4.98 11.88 -9.73 7.18 1qfl_c04 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c04 naa= 2 ULMN 2 1qfl_c05 ACETOACETYL-COA THIOLASE user 1 2 # 1 B 348 HIS A 91 HIS~? 7.63 O1 BME A 300 B 378 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 13.24 15.55 12.21 14.75 15.10 10.80 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 20.14 17.58 5.68 19.50 18.95 7.99 10.91 -8.39 4.98 11.88 -9.73 7.18 1qfl_c05 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c05 naa= 2 ULMN 2 1qfl_c06 ACETOACETYL-COA THIOLASE user 1 2 # 1 C 348 HIS A 91 HIS~? 7.63 O1 BME A 300 C 378 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 39.92 0.27 55.80 38.80 1.56 57.03 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 38.90 7.44 62.34 40.19 7.59 59.85 10.91 -8.39 4.98 11.88 -9.73 7.18 1qfl_c06 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c06 naa= 2 ULMN 2 1qfl_c07 ACETOACETYL-COA THIOLASE user 1 2 # 1 D 348 HIS A 91 HIS~? 7.63 O1 BME A 300 D 378 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 4.85 0.61 57.13 5.96 -0.63 58.38 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 10.91 -8.39 4.98 11.88 -9.73 7.18 1qfl_c07 source 1qfl ACETOACETYL-COA THIOLASE : 1 hits 1qfl_c07 naa= 2 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 72 GLU A 28 GLU~? 14.38 S2 BME A 300 A 147 THR A 30 THR~? 11.99 S2 BME A 300 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 72 GLU A 99 GLU.? 20.82 S2 BME A 300 A 147 THR A 30 THR~? 11.99 S2 BME A 300 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 18.48 -11.65 0.55 19.28 -10.22 2.01 1qgx_c00 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 2 hits 1qgx_c00 naa= 2 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 32 LYS A 2 LYS.? 20.18 S2 BME A 300 A 147 THR A 5 THR~? 15.55 O1 BME A 300 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 2.39 3.95 8.25 5.67 8.88 7.74 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 32 LYS A 2 LYS.? 20.18 S2 BME A 300 A 147 THR A 6 THR~? 12.27 O1 BME A 300 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 2.39 3.95 8.25 5.67 8.88 7.74 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 3 2 # 3 A 32 LYS A 12 LYS~? 21.81 S2 BME A 300 A 147 THR A 5 THR~? 15.55 O1 BME A 300 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 4 2 # 4 A 32 LYS A 39 LYS^? 20.06 S2 BME A 300 A 147 THR A 26 THR~? 9.55 S2 BME A 300 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 19.85 -1.20 1.64 21.03 4.07 2.80 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 5 2 # 5 A 32 LYS A 39 LYS^? 20.06 S2 BME A 300 A 147 THR A 30 THR~? 11.99 S2 BME A 300 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 19.85 -1.20 1.64 21.03 4.07 2.80 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 6 2 # 6 A 32 LYS A 39 LYS^? 20.06 S2 BME A 300 A 147 THR A 45 THR~? 14.85 S2 BME A 300 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 19.85 -1.20 1.64 21.03 4.07 2.80 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 21.81 -5.88 13.03 22.64 -6.51 11.11 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 7 2 # 7 A 32 LYS A 71 LYS~? 8.54 S2 BME A 300 A 147 THR A 45 THR~? 14.85 S2 BME A 300 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 21.81 -5.88 13.03 22.64 -6.51 11.11 1qgx_c01 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 7 hits 1qgx_c01 naa= 2 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 1 2 # 1 A 118 SER A 16 SER.? 30.21 S2 BME A 300 A 151 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 17.70 9.25 13.10 16.68 11.30 13.99 11.56 11.57 -9.82 9.89 13.31 -9.94 coo 25.75 6.80 15.75 21.60 9.40 11.84 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 2 2 # 2 A 118 SER A 52 SER~? 19.64 S2 BME A 300 A 151 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 17.70 9.25 13.10 16.68 11.30 13.99 22.49 4.36 7.95 23.43 2.12 7.73 coo 25.75 6.80 15.75 21.60 9.40 11.84 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 3 2 # 3 A 118 SER A 52 SER~? 19.64 S2 BME A 300 A 151 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 17.70 9.25 13.10 16.68 11.30 13.99 22.49 4.36 7.95 23.43 2.12 7.73 coo 25.75 6.80 15.75 21.60 9.40 11.84 15.98 12.20 9.88 16.28 11.97 16.11 1qh9_c00 source 1qh9 2-HALOACID DEHALOGENASE : 3 hits 1qh9_c00 naa= 2 ULMN 2 1qho_c00 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 7 ASP~? 16.68 O1 BME A 300 A 253 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 18.60 67.37 33.24 17.63 66.99 31.31 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 2 1qho_c00 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 7 ASP~? 16.68 O1 BME A 300 A 253 LEU A 14 LEU~? 26.41 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 18.60 67.37 33.24 17.63 66.99 31.31 6.47 5.89 -12.18 5.84 4.27 -13.50 ULMN 2 1qho_c00 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 23 ASP^? 9.45 S2 BME A 300 A 253 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 18.60 67.37 33.24 17.63 66.99 31.31 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 2 1qho_c00 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP A 23 ASP^? 9.45 S2 BME A 300 A 253 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 18.60 67.37 33.24 17.63 66.99 31.31 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1qho_c00 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP A 23 ASP^? 9.45 S2 BME A 300 A 253 LEU A 98 LEU.? 15.58 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 18.60 67.37 33.24 17.63 66.99 31.31 14.96 -9.92 -7.39 13.27 -9.83 -6.06 ULMN 2 1qho_c00 ALPHA-AMYLASE user 6 2 # 6 A 228 ASP A 44 ASP~? 11.03 S2 BME A 300 A 253 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 18.60 67.37 33.24 17.63 66.99 31.31 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 2 1qho_c00 ALPHA-AMYLASE user 7 2 # 7 A 228 ASP A 48 ASP~? 19.85 S2 BME A 300 A 253 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 18.60 67.37 33.24 17.63 66.99 31.31 21.19 -5.80 2.30 20.52 -6.59 0.34 ULMN 2 1qho_c00 ALPHA-AMYLASE user 8 2 # 8 A 228 ASP A 48 ASP~? 19.85 S2 BME A 300 A 253 LEU A 76 LEU~? 15.04 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 18.60 67.37 33.24 17.63 66.99 31.31 13.01 3.14 12.38 14.61 2.09 11.22 ULMN 2 1qho_c00 ALPHA-AMYLASE user 9 2 # 9 A 228 ASP A 82 ASP^? 20.57 S2 BME A 300 A 253 LEU A 50 LEU~? 20.27 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.12 9.33 8.59 8.15 9.51 7.94 coo 18.60 67.37 33.24 17.63 66.99 31.31 21.11 4.23 14.59 19.47 3.75 15.94 1qho_c00 source 1qho ALPHA-AMYLASE : 9 hits 1qho_c00 naa= 2 ULMN 2 1qho_c02 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 7 ASP~? 16.68 O1 BME A 300 A 256 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 30.54 71.65 32.58 31.73 72.26 30.92 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1qho_c02 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 27 ASP~? 15.09 S2 BME A 300 A 256 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 30.54 71.65 32.58 31.73 72.26 30.92 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1qho_c02 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 27 ASP~? 15.09 S2 BME A 300 A 256 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 30.54 71.65 32.58 31.73 72.26 30.92 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1qho_c02 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP A 82 ASP^? 20.57 S2 BME A 300 A 256 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.12 9.33 8.59 8.15 9.51 7.94 coo 30.54 71.65 32.58 31.73 72.26 30.92 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1qho_c02 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP A 82 ASP^? 20.57 S2 BME A 300 A 256 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.12 9.33 8.59 8.15 9.51 7.94 coo 30.54 71.65 32.58 31.73 72.26 30.92 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1qho_c02 ALPHA-AMYLASE user 6 2 # 6 A 228 ASP A 95 ASP.? 15.99 O1 BME A 300 A 256 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 30.54 71.65 32.58 31.73 72.26 30.92 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1qho_c02 source 1qho ALPHA-AMYLASE : 6 hits 1qho_c02 naa= 2 ULMN 2 1qib_c00 GELATINASE A user 1 2 # 1 A 202 GLU A 28 GLU~? 14.38 S2 BME A 300 A 219 MET A 32 MET?? 16.29 S2 BME A 300 coo 69.37 28.50 22.00 67.35 27.95 22.47 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 67.80 19.62 26.30 69.14 20.29 23.54 18.33 -15.35 -3.27 19.07 -18.39 -2.47 ULMN 2 1qib_c00 GELATINASE A user 2 2 # 2 A 202 GLU A 29 GLU~? 6.68 S2 BME A 300 A 219 MET A 43 MET?? 7.50 S2 BME A 300 coo 69.37 28.50 22.00 67.35 27.95 22.47 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 67.80 19.62 26.30 69.14 20.29 23.54 16.84 -7.02 11.44 13.26 -8.32 13.33 ULMN 2 1qib_c00 GELATINASE A user 3 2 # 3 A 202 GLU A 29 GLU~? 6.68 S2 BME A 300 A 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 69.37 28.50 22.00 67.35 27.95 22.47 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 67.80 19.62 26.30 69.14 20.29 23.54 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1qib_c00 GELATINASE A user 4 2 # 4 A 202 GLU A 87 GLU.? 12.12 O1 BME A 300 A 219 MET A 1 MET?? 11.79 S2 BME A 300 coo 69.37 28.50 22.00 67.35 27.95 22.47 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 67.80 19.62 26.30 69.14 20.29 23.54 1.73 2.69 11.74 3.89 -0.91 11.26 ULMN 2 1qib_c00 GELATINASE A user 5 2 # 5 A 202 GLU A 87 GLU.? 12.12 O1 BME A 300 A 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 69.37 28.50 22.00 67.35 27.95 22.47 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 67.80 19.62 26.30 69.14 20.29 23.54 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1qib_c00 GELATINASE A user 6 2 # 6 A 202 GLU A 96 GLU.? 20.00 O1 BME A 300 A 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 69.37 28.50 22.00 67.35 27.95 22.47 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 67.80 19.62 26.30 69.14 20.29 23.54 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1qib_c00 GELATINASE A user 7 2 # 7 A 202 GLU A 99 GLU.? 20.82 S2 BME A 300 A 219 MET A 32 MET?? 16.29 S2 BME A 300 coo 69.37 28.50 22.00 67.35 27.95 22.47 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 67.80 19.62 26.30 69.14 20.29 23.54 18.33 -15.35 -3.27 19.07 -18.39 -2.47 1qib_c00 source 1qib GELATINASE A : 7 hits 1qib_c00 naa= 2 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 A 221 ASP A 23 ASP^? 9.45 S2 BME A 300 A 401 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 25.04 36.98 34.15 26.35 36.27 32.62 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 33.28 34.18 40.93 33.02 35.91 42.11 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 A 221 ASP A 27 ASP~? 15.09 S2 BME A 300 A 401 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 25.04 36.98 34.15 26.35 36.27 32.62 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 33.28 34.18 40.93 33.02 35.91 42.11 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 A 221 ASP A 27 ASP~? 15.09 S2 BME A 300 A 401 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 25.04 36.98 34.15 26.35 36.27 32.62 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 33.28 34.18 40.93 33.02 35.91 42.11 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 A 221 ASP A 44 ASP~? 11.03 S2 BME A 300 A 401 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 25.04 36.98 34.15 26.35 36.27 32.62 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 33.28 34.18 40.93 33.02 35.91 42.11 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 A 221 ASP A 44 ASP~? 11.03 S2 BME A 300 A 401 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 25.04 36.98 34.15 26.35 36.27 32.62 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 33.28 34.18 40.93 33.02 35.91 42.11 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 A 221 ASP A 48 ASP~? 19.85 S2 BME A 300 A 401 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 25.04 36.98 34.15 26.35 36.27 32.62 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 33.28 34.18 40.93 33.02 35.91 42.11 19.36 -9.90 14.44 17.51 -11.01 14.77 1qk2_c02 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 6 hits 1qk2_c02 naa= 2 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 B 221 ASP A 23 ASP^? 9.45 S2 BME A 300 B 401 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 39.21 84.85 78.75 40.59 84.11 77.32 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 47.27 82.90 85.84 46.75 84.63 86.91 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 B 221 ASP A 27 ASP~? 15.09 S2 BME A 300 B 401 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 39.21 84.85 78.75 40.59 84.11 77.32 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 47.27 82.90 85.84 46.75 84.63 86.91 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 B 221 ASP A 27 ASP~? 15.09 S2 BME A 300 B 401 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 39.21 84.85 78.75 40.59 84.11 77.32 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 47.27 82.90 85.84 46.75 84.63 86.91 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 B 221 ASP A 44 ASP~? 11.03 S2 BME A 300 B 401 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 39.21 84.85 78.75 40.59 84.11 77.32 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 47.27 82.90 85.84 46.75 84.63 86.91 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 B 221 ASP A 44 ASP~? 11.03 S2 BME A 300 B 401 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 39.21 84.85 78.75 40.59 84.11 77.32 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 47.27 82.90 85.84 46.75 84.63 86.91 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 B 221 ASP A 48 ASP~? 19.85 S2 BME A 300 B 401 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 39.21 84.85 78.75 40.59 84.11 77.32 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 47.27 82.90 85.84 46.75 84.63 86.91 19.36 -9.90 14.44 17.51 -11.01 14.77 1qk2_c03 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 6 hits 1qk2_c03 naa= 2 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 2 # 1 A 182 TYR A 34 TYR.? 16.37 S2 BME A 300 A 186 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 73.61 90.42 31.12 71.36 89.66 29.64 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 73.54 84.00 28.64 69.01 86.68 29.71 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 2 # 2 A 182 TYR A 34 TYR.? 16.37 S2 BME A 300 A 186 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 73.61 90.42 31.12 71.36 89.66 29.64 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 73.54 84.00 28.64 69.01 86.68 29.71 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 2 # 3 A 182 TYR A 59 TYR^? 18.50 S2 BME A 300 A 186 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 73.61 90.42 31.12 71.36 89.66 29.64 14.59 5.14 5.72 16.82 6.86 5.68 coo 73.54 84.00 28.64 69.01 86.68 29.71 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 2 # 4 A 182 TYR A 60 TYR^? 16.66 S2 BME A 300 A 186 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 73.61 90.42 31.12 71.36 89.66 29.64 9.00 3.02 1.57 7.75 5.45 1.00 coo 73.54 84.00 28.64 69.01 86.68 29.71 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 5 2 # 5 A 182 TYR A 75 TYR~? 15.90 S2 BME A 300 A 186 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 73.61 90.42 31.12 71.36 89.66 29.64 14.46 -0.26 16.60 17.11 0.41 17.22 coo 73.54 84.00 28.64 69.01 86.68 29.71 8.82 -4.39 14.42 10.42 -10.04 16.23 1qrr_c02 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 5 hits 1qrr_c02 naa= 2 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 A 156 TYR A 34 TYR.? 16.37 S2 BME A 300 A 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 11.31 14.43 4.90 11.33 12.74 7.13 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 12.44 6.23 6.82 12.36 8.68 11.73 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 A 156 TYR A 34 TYR.? 16.37 S2 BME A 300 A 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 11.31 14.43 4.90 11.33 12.74 7.13 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 12.44 6.23 6.82 12.36 8.68 11.73 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 A 156 TYR A 59 TYR^? 18.50 S2 BME A 300 A 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 11.31 14.43 4.90 11.33 12.74 7.13 14.59 5.14 5.72 16.82 6.86 5.68 coo 12.44 6.23 6.82 12.36 8.68 11.73 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 A 156 TYR A 59 TYR^? 18.50 S2 BME A 300 A 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 11.31 14.43 4.90 11.33 12.74 7.13 14.59 5.14 5.72 16.82 6.86 5.68 coo 12.44 6.23 6.82 12.36 8.68 11.73 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 A 156 TYR A 60 TYR^? 16.66 S2 BME A 300 A 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 11.31 14.43 4.90 11.33 12.74 7.13 9.00 3.02 1.57 7.75 5.45 1.00 coo 12.44 6.23 6.82 12.36 8.68 11.73 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 A 156 TYR A 60 TYR^? 16.66 S2 BME A 300 A 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 11.31 14.43 4.90 11.33 12.74 7.13 9.00 3.02 1.57 7.75 5.45 1.00 coo 12.44 6.23 6.82 12.36 8.68 11.73 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 A 156 TYR A 60 TYR^? 16.66 S2 BME A 300 A 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 11.31 14.43 4.90 11.33 12.74 7.13 9.00 3.02 1.57 7.75 5.45 1.00 coo 12.44 6.23 6.82 12.36 8.68 11.73 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 A 156 TYR A 75 TYR~? 15.90 S2 BME A 300 A 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 11.31 14.43 4.90 11.33 12.74 7.13 14.46 -0.26 16.60 17.11 0.41 17.22 coo 12.44 6.23 6.82 12.36 8.68 11.73 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c00 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c00 naa= 2 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 B 156 TYR A 34 TYR.? 16.37 S2 BME A 300 B 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 B 156 TYR A 34 TYR.? 16.37 S2 BME A 300 B 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 B 156 TYR A 59 TYR^? 18.50 S2 BME A 300 B 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 14.59 5.14 5.72 16.82 6.86 5.68 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 B 156 TYR A 59 TYR^? 18.50 S2 BME A 300 B 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 14.59 5.14 5.72 16.82 6.86 5.68 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 B 156 TYR A 60 TYR^? 16.66 S2 BME A 300 B 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 9.00 3.02 1.57 7.75 5.45 1.00 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 B 156 TYR A 60 TYR^? 16.66 S2 BME A 300 B 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 9.00 3.02 1.57 7.75 5.45 1.00 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 B 156 TYR A 60 TYR^? 16.66 S2 BME A 300 B 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 9.00 3.02 1.57 7.75 5.45 1.00 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 B 156 TYR A 75 TYR~? 15.90 S2 BME A 300 B 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 14.46 -0.26 16.60 17.11 0.41 17.22 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c01 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c01 naa= 2 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 C 156 TYR A 34 TYR.? 16.37 S2 BME A 300 C 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 C 156 TYR A 34 TYR.? 16.37 S2 BME A 300 C 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 C 156 TYR A 59 TYR^? 18.50 S2 BME A 300 C 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 14.59 5.14 5.72 16.82 6.86 5.68 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 C 156 TYR A 59 TYR^? 18.50 S2 BME A 300 C 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 14.59 5.14 5.72 16.82 6.86 5.68 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 C 156 TYR A 60 TYR^? 16.66 S2 BME A 300 C 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 9.00 3.02 1.57 7.75 5.45 1.00 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 C 156 TYR A 60 TYR^? 16.66 S2 BME A 300 C 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 9.00 3.02 1.57 7.75 5.45 1.00 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 C 156 TYR A 60 TYR^? 16.66 S2 BME A 300 C 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 9.00 3.02 1.57 7.75 5.45 1.00 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 C 156 TYR A 75 TYR~? 15.90 S2 BME A 300 C 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 14.46 -0.26 16.60 17.11 0.41 17.22 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c02 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c02 naa= 2 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 D 156 TYR A 34 TYR.? 16.37 S2 BME A 300 D 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 D 156 TYR A 34 TYR.? 16.37 S2 BME A 300 D 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 D 156 TYR A 59 TYR^? 18.50 S2 BME A 300 D 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 14.59 5.14 5.72 16.82 6.86 5.68 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 D 156 TYR A 59 TYR^? 18.50 S2 BME A 300 D 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 14.59 5.14 5.72 16.82 6.86 5.68 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 D 156 TYR A 60 TYR^? 16.66 S2 BME A 300 D 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 9.00 3.02 1.57 7.75 5.45 1.00 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 D 156 TYR A 60 TYR^? 16.66 S2 BME A 300 D 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 9.00 3.02 1.57 7.75 5.45 1.00 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 D 156 TYR A 60 TYR^? 16.66 S2 BME A 300 D 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 9.00 3.02 1.57 7.75 5.45 1.00 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 D 156 TYR A 75 TYR~? 15.90 S2 BME A 300 D 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 14.46 -0.26 16.60 17.11 0.41 17.22 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c03 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c03 naa= 2 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 E 156 TYR A 34 TYR.? 16.37 S2 BME A 300 E 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 58.73 53.92 40.85 59.76 52.11 42.68 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 60.51 45.70 41.25 62.67 47.81 45.91 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 E 156 TYR A 34 TYR.? 16.37 S2 BME A 300 E 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 58.73 53.92 40.85 59.76 52.11 42.68 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 60.51 45.70 41.25 62.67 47.81 45.91 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 E 156 TYR A 59 TYR^? 18.50 S2 BME A 300 E 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 58.73 53.92 40.85 59.76 52.11 42.68 14.59 5.14 5.72 16.82 6.86 5.68 coo 60.51 45.70 41.25 62.67 47.81 45.91 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 E 156 TYR A 59 TYR^? 18.50 S2 BME A 300 E 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 58.73 53.92 40.85 59.76 52.11 42.68 14.59 5.14 5.72 16.82 6.86 5.68 coo 60.51 45.70 41.25 62.67 47.81 45.91 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 E 156 TYR A 60 TYR^? 16.66 S2 BME A 300 E 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 58.73 53.92 40.85 59.76 52.11 42.68 9.00 3.02 1.57 7.75 5.45 1.00 coo 60.51 45.70 41.25 62.67 47.81 45.91 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 E 156 TYR A 60 TYR^? 16.66 S2 BME A 300 E 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 58.73 53.92 40.85 59.76 52.11 42.68 9.00 3.02 1.57 7.75 5.45 1.00 coo 60.51 45.70 41.25 62.67 47.81 45.91 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 E 156 TYR A 60 TYR^? 16.66 S2 BME A 300 E 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 58.73 53.92 40.85 59.76 52.11 42.68 9.00 3.02 1.57 7.75 5.45 1.00 coo 60.51 45.70 41.25 62.67 47.81 45.91 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 E 156 TYR A 75 TYR~? 15.90 S2 BME A 300 E 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 58.73 53.92 40.85 59.76 52.11 42.68 14.46 -0.26 16.60 17.11 0.41 17.22 coo 60.51 45.70 41.25 62.67 47.81 45.91 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c04 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c04 naa= 2 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 F 156 TYR A 34 TYR.? 16.37 S2 BME A 300 F 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 60.02 29.87 32.03 59.43 31.82 30.12 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 58.88 38.21 31.46 58.96 36.46 26.25 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 F 156 TYR A 34 TYR.? 16.37 S2 BME A 300 F 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 60.02 29.87 32.03 59.43 31.82 30.12 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 58.88 38.21 31.46 58.96 36.46 26.25 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 F 156 TYR A 59 TYR^? 18.50 S2 BME A 300 F 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 60.02 29.87 32.03 59.43 31.82 30.12 14.59 5.14 5.72 16.82 6.86 5.68 coo 58.88 38.21 31.46 58.96 36.46 26.25 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 F 156 TYR A 59 TYR^? 18.50 S2 BME A 300 F 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 60.02 29.87 32.03 59.43 31.82 30.12 14.59 5.14 5.72 16.82 6.86 5.68 coo 58.88 38.21 31.46 58.96 36.46 26.25 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 F 156 TYR A 60 TYR^? 16.66 S2 BME A 300 F 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 60.02 29.87 32.03 59.43 31.82 30.12 9.00 3.02 1.57 7.75 5.45 1.00 coo 58.88 38.21 31.46 58.96 36.46 26.25 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 F 156 TYR A 60 TYR^? 16.66 S2 BME A 300 F 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 60.02 29.87 32.03 59.43 31.82 30.12 9.00 3.02 1.57 7.75 5.45 1.00 coo 58.88 38.21 31.46 58.96 36.46 26.25 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 F 156 TYR A 60 TYR^? 16.66 S2 BME A 300 F 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 60.02 29.87 32.03 59.43 31.82 30.12 9.00 3.02 1.57 7.75 5.45 1.00 coo 58.88 38.21 31.46 58.96 36.46 26.25 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 F 156 TYR A 75 TYR~? 15.90 S2 BME A 300 F 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 60.02 29.87 32.03 59.43 31.82 30.12 14.46 -0.26 16.60 17.11 0.41 17.22 coo 58.88 38.21 31.46 58.96 36.46 26.25 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c05 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c05 naa= 2 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 G 156 TYR A 34 TYR.? 16.37 S2 BME A 300 G 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 35.34 25.18 46.17 35.45 26.86 48.38 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 34.29 33.26 48.25 34.81 30.77 53.10 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 G 156 TYR A 34 TYR.? 16.37 S2 BME A 300 G 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 35.34 25.18 46.17 35.45 26.86 48.38 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 34.29 33.26 48.25 34.81 30.77 53.10 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 G 156 TYR A 59 TYR^? 18.50 S2 BME A 300 G 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 35.34 25.18 46.17 35.45 26.86 48.38 14.59 5.14 5.72 16.82 6.86 5.68 coo 34.29 33.26 48.25 34.81 30.77 53.10 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 G 156 TYR A 59 TYR^? 18.50 S2 BME A 300 G 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 35.34 25.18 46.17 35.45 26.86 48.38 14.59 5.14 5.72 16.82 6.86 5.68 coo 34.29 33.26 48.25 34.81 30.77 53.10 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 G 156 TYR A 60 TYR^? 16.66 S2 BME A 300 G 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 35.34 25.18 46.17 35.45 26.86 48.38 9.00 3.02 1.57 7.75 5.45 1.00 coo 34.29 33.26 48.25 34.81 30.77 53.10 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 G 156 TYR A 60 TYR^? 16.66 S2 BME A 300 G 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 35.34 25.18 46.17 35.45 26.86 48.38 9.00 3.02 1.57 7.75 5.45 1.00 coo 34.29 33.26 48.25 34.81 30.77 53.10 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 G 156 TYR A 60 TYR^? 16.66 S2 BME A 300 G 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 35.34 25.18 46.17 35.45 26.86 48.38 9.00 3.02 1.57 7.75 5.45 1.00 coo 34.29 33.26 48.25 34.81 30.77 53.10 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 G 156 TYR A 75 TYR~? 15.90 S2 BME A 300 G 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 35.34 25.18 46.17 35.45 26.86 48.38 14.46 -0.26 16.60 17.11 0.41 17.22 coo 34.29 33.26 48.25 34.81 30.77 53.10 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c06 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c06 naa= 2 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 H 156 TYR A 34 TYR.? 16.37 S2 BME A 300 H 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 30.12 49.87 41.75 29.53 48.20 39.59 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 30.50 41.69 39.85 27.67 43.89 35.58 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 H 156 TYR A 34 TYR.? 16.37 S2 BME A 300 H 163 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 30.12 49.87 41.75 29.53 48.20 39.59 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 30.50 41.69 39.85 27.67 43.89 35.58 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 H 156 TYR A 59 TYR^? 18.50 S2 BME A 300 H 163 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 30.12 49.87 41.75 29.53 48.20 39.59 14.59 5.14 5.72 16.82 6.86 5.68 coo 30.50 41.69 39.85 27.67 43.89 35.58 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 H 156 TYR A 59 TYR^? 18.50 S2 BME A 300 H 163 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 30.12 49.87 41.75 29.53 48.20 39.59 14.59 5.14 5.72 16.82 6.86 5.68 coo 30.50 41.69 39.85 27.67 43.89 35.58 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 H 156 TYR A 60 TYR^? 16.66 S2 BME A 300 H 163 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 30.12 49.87 41.75 29.53 48.20 39.59 9.00 3.02 1.57 7.75 5.45 1.00 coo 30.50 41.69 39.85 27.67 43.89 35.58 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 H 156 TYR A 60 TYR^? 16.66 S2 BME A 300 H 163 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 30.12 49.87 41.75 29.53 48.20 39.59 9.00 3.02 1.57 7.75 5.45 1.00 coo 30.50 41.69 39.85 27.67 43.89 35.58 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 H 156 TYR A 60 TYR^? 16.66 S2 BME A 300 H 163 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 30.12 49.87 41.75 29.53 48.20 39.59 9.00 3.02 1.57 7.75 5.45 1.00 coo 30.50 41.69 39.85 27.67 43.89 35.58 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 H 156 TYR A 75 TYR~? 15.90 S2 BME A 300 H 163 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 30.12 49.87 41.75 29.53 48.20 39.59 14.46 -0.26 16.60 17.11 0.41 17.22 coo 30.50 41.69 39.85 27.67 43.89 35.58 8.82 -4.39 14.42 10.42 -10.04 16.23 1qsg_c07 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c07 naa= 2 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 1 2 # 1 A 204 ASP A 23 ASP^? 9.45 S2 BME A 300 A 341 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 33.05 61.37 6.97 31.64 62.95 7.54 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 33.24 65.52 14.74 32.32 65.05 12.93 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 2 2 # 2 A 204 ASP A 27 ASP~? 15.09 S2 BME A 300 A 341 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 33.05 61.37 6.97 31.64 62.95 7.54 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 33.24 65.52 14.74 32.32 65.05 12.93 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 3 2 # 3 A 204 ASP A 27 ASP~? 15.09 S2 BME A 300 A 341 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 33.05 61.37 6.97 31.64 62.95 7.54 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 33.24 65.52 14.74 32.32 65.05 12.93 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 4 2 # 4 A 204 ASP A 44 ASP~? 11.03 S2 BME A 300 A 341 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 33.05 61.37 6.97 31.64 62.95 7.54 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 33.24 65.52 14.74 32.32 65.05 12.93 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 5 2 # 5 A 204 ASP A 44 ASP~? 11.03 S2 BME A 300 A 341 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 33.05 61.37 6.97 31.64 62.95 7.54 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 33.24 65.52 14.74 32.32 65.05 12.93 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 6 2 # 6 A 204 ASP A 48 ASP~? 19.85 S2 BME A 300 A 341 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 33.05 61.37 6.97 31.64 62.95 7.54 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 33.24 65.52 14.74 32.32 65.05 12.93 19.36 -9.90 14.44 17.51 -11.01 14.77 1qwn_c00 source 1qwn ALPHA-MANNOSIDASE II : 6 hits 1qwn_c00 naa= 2 ULMN 2 1qz9_c00 KYNURENINASE user 1 2 # 1 A 129 PHE A 53 PHE~? 16.58 S2 BME A 300 A 201 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 23.39 49.81 32.16 21.33 51.68 32.26 17.96 4.29 9.15 17.54 1.52 8.86 coo 25.52 45.12 37.98 23.98 46.65 37.85 10.12 9.33 8.59 8.15 9.51 7.94 1qz9_c00 source 1qz9 KYNURENINASE : 1 hits 1qz9_c00 naa= 2 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 1 2 # 1 A 98 GLU A 8 GLU~? 18.47 O1 BME A 300 A 179 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 34.76 2.28 18.45 36.75 1.46 18.65 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 2 2 # 2 A 98 GLU A 15 GLU~? 24.22 S2 BME A 300 A 179 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 34.76 2.28 18.45 36.75 1.46 18.65 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 3 2 # 3 A 98 GLU A 96 GLU.? 20.00 O1 BME A 300 A 179 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 34.76 2.28 18.45 36.75 1.46 18.65 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 4 2 # 4 A 98 GLU A 99 GLU.? 20.82 S2 BME A 300 A 179 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 34.76 2.28 18.45 36.75 1.46 18.65 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1r16_c00 source 1r16 ADP-RIBOSYL CYCLASE : 4 hits 1r16_c00 naa= 2 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 1 2 # 1 B 98 GLU A 8 GLU~? 18.47 O1 BME A 300 B 179 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 2 2 # 2 B 98 GLU A 15 GLU~? 24.22 S2 BME A 300 B 179 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 3 2 # 3 B 98 GLU A 96 GLU.? 20.00 O1 BME A 300 B 179 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 4 2 # 4 B 98 GLU A 99 GLU.? 20.82 S2 BME A 300 B 179 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1r16_c01 source 1r16 ADP-RIBOSYL CYCLASE : 4 hits 1r16_c01 naa= 2 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 A 71 ARG A 25 ARG.? 9.68 S2 BME A 300 A 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 29.52 23.28 0.51 26.83 22.05 1.22 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 18.49 20.71 4.77 20.29 21.80 4.49 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 A 71 ARG A 25 ARG.? 9.68 S2 BME A 300 A 181 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 29.52 23.28 0.51 26.83 22.05 1.22 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 18.49 20.71 4.77 20.29 21.80 4.49 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 A 71 ARG A 68 ARG~? -4.35 S2 BME A 300s A 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 29.52 23.28 0.51 26.83 22.05 1.22 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 18.49 20.71 4.77 20.29 21.80 4.49 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 A 71 ARG A 68 ARG~? -4.35 S2 BME A 300s A 181 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 29.52 23.28 0.51 26.83 22.05 1.22 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 18.49 20.71 4.77 20.29 21.80 4.49 6.36 -0.87 15.92 5.32 -2.36 17.02 1r44_c00 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c00 naa= 2 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 B 71 ARG A 25 ARG.? 9.68 S2 BME A 300 B 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 25.64 17.80 33.30 23.89 16.05 31.49 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 20.92 9.87 25.44 22.46 10.92 26.39 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 B 71 ARG A 25 ARG.? 9.68 S2 BME A 300 B 181 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 25.64 17.80 33.30 23.89 16.05 31.49 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 20.92 9.87 25.44 22.46 10.92 26.39 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 B 71 ARG A 68 ARG~? -4.35 S2 BME A 300s B 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 25.64 17.80 33.30 23.89 16.05 31.49 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 20.92 9.87 25.44 22.46 10.92 26.39 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 B 71 ARG A 68 ARG~? -4.35 S2 BME A 300s B 181 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 25.64 17.80 33.30 23.89 16.05 31.49 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 20.92 9.87 25.44 22.46 10.92 26.39 6.36 -0.87 15.92 5.32 -2.36 17.02 1r44_c01 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c01 naa= 2 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 C 71 ARG A 25 ARG.? 9.68 S2 BME A 300 C 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -2.50 20.54 50.36 -1.04 18.63 52.25 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 0.79 12.24 58.58 -0.51 13.53 57.59 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 C 71 ARG A 25 ARG.? 9.68 S2 BME A 300 C 181 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -2.50 20.54 50.36 -1.04 18.63 52.25 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 0.79 12.24 58.58 -0.51 13.53 57.59 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 C 71 ARG A 68 ARG~? -4.35 S2 BME A 300s C 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -2.50 20.54 50.36 -1.04 18.63 52.25 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 0.79 12.24 58.58 -0.51 13.53 57.59 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 C 71 ARG A 68 ARG~? -4.35 S2 BME A 300s C 181 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -2.50 20.54 50.36 -1.04 18.63 52.25 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 0.79 12.24 58.58 -0.51 13.53 57.59 6.36 -0.87 15.92 5.32 -2.36 17.02 1r44_c02 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c02 naa= 2 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 D 71 ARG A 25 ARG.? 9.68 S2 BME A 300 D 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -8.22 25.82 82.56 -5.47 24.59 82.05 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 2.99 23.21 78.86 1.22 24.31 78.95 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 D 71 ARG A 25 ARG.? 9.68 S2 BME A 300 D 181 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -8.22 25.82 82.56 -5.47 24.59 82.05 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 2.99 23.21 78.86 1.22 24.31 78.95 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 D 71 ARG A 68 ARG~? -4.35 S2 BME A 300s D 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -8.22 25.82 82.56 -5.47 24.59 82.05 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 2.99 23.21 78.86 1.22 24.31 78.95 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 D 71 ARG A 68 ARG~? -4.35 S2 BME A 300s D 181 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -8.22 25.82 82.56 -5.47 24.59 82.05 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 2.99 23.21 78.86 1.22 24.31 78.95 6.36 -0.87 15.92 5.32 -2.36 17.02 1r44_c03 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c03 naa= 2 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 E 71 ARG A 25 ARG.? 9.68 S2 BME A 300 E 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -6.10 4.89 107.96 -5.54 7.53 109.43 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -2.51 13.58 115.60 -2.82 11.62 114.90 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 E 71 ARG A 25 ARG.? 9.68 S2 BME A 300 E 181 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -6.10 4.89 107.96 -5.54 7.53 109.43 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -2.51 13.58 115.60 -2.82 11.62 114.90 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 E 71 ARG A 68 ARG~? -4.35 S2 BME A 300s E 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -6.10 4.89 107.96 -5.54 7.53 109.43 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -2.51 13.58 115.60 -2.82 11.62 114.90 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 E 71 ARG A 68 ARG~? -4.35 S2 BME A 300s E 181 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -6.10 4.89 107.96 -5.54 7.53 109.43 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -2.51 13.58 115.60 -2.82 11.62 114.90 6.36 -0.87 15.92 5.32 -2.36 17.02 1r44_c04 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c04 naa= 2 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 F 71 ARG A 25 ARG.? 9.68 S2 BME A 300 F 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -14.30 2.56 139.83 -15.02 5.20 138.45 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -18.48 11.33 132.65 -18.10 9.35 133.28 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 F 71 ARG A 25 ARG.? 9.68 S2 BME A 300 F 181 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -14.30 2.56 139.83 -15.02 5.20 138.45 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -18.48 11.33 132.65 -18.10 9.35 133.28 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 F 71 ARG A 68 ARG~? -4.35 S2 BME A 300s F 181 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -14.30 2.56 139.83 -15.02 5.20 138.45 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -18.48 11.33 132.65 -18.10 9.35 133.28 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 F 71 ARG A 68 ARG~? -4.35 S2 BME A 300s F 181 GLU A 74 GLU~? 13.09 S2 BME A 300 coo -14.30 2.56 139.83 -15.02 5.20 138.45 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -18.48 11.33 132.65 -18.10 9.35 133.28 6.36 -0.87 15.92 5.32 -2.36 17.02 1r44_c05 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c05 naa= 2 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 1 2 # 1 A 133 ARG A 25 ARG.? 9.68 S2 BME A 300 A 235 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 31.15 12.07 13.86 31.85 13.16 16.74 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 27.79 29.07 13.69 29.71 23.15 14.63 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 2 2 # 2 A 133 ARG A 68 ARG~? -4.35 S2 BME A 300s A 235 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 31.15 12.07 13.86 31.85 13.16 16.74 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 27.79 29.07 13.69 29.71 23.15 14.63 2.39 3.95 8.25 5.67 8.88 7.74 1r6w_c00 source 1r6w O-SUCCINYLBENZOATE SYNTHASE : 2 hits 1r6w_c00 naa= 2 ULMN 2 1r76_c00 PECTATE LYASE user 1 2 # 1 A 172 ASN A 85 ASN^? 8.15 S2 BME A 300 A 307 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 22.99 58.57 18.19 23.89 56.65 18.30 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 20.34 46.40 20.83 22.83 48.18 20.99 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1r76_c00 PECTATE LYASE user 2 2 # 2 A 172 ASN A 85 ASN^? 8.15 S2 BME A 300 A 307 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 22.99 58.57 18.19 23.89 56.65 18.30 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 20.34 46.40 20.83 22.83 48.18 20.99 12.31 -11.28 10.33 12.92 -12.61 7.64 1r76_c00 source 1r76 PECTATE LYASE : 2 hits 1r76_c00 naa= 2 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 1 2 # 1 A 156 GLN A 20 GLN^? 20.58 S2 BME A 300 A 217 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 0.57 24.33 98.25 1.75 23.60 99.87 15.94 6.48 1.05 18.02 6.17 1.31 coo 5.48 17.66 105.85 5.34 19.71 105.34 6.94 9.23 -7.95 6.28 8.57 -6.07 1ra0_c00 source 1ra0 CYTOSINE DEAMINASE : 1 hits 1ra0_c00 naa= 2 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 A 126 THR A 26 THR~? 9.55 S2 BME A 300 A 160 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 51.19 2.52 10.94 50.16 2.43 9.01 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 51.97 0.60 16.16 51.18 3.08 14.54 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 A 126 THR A 26 THR~? 9.55 S2 BME A 300 A 160 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 51.19 2.52 10.94 50.16 2.43 9.01 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 51.97 0.60 16.16 51.18 3.08 14.54 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 3 2 # 3 A 126 THR A 30 THR~? 11.99 S2 BME A 300 A 160 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 51.19 2.52 10.94 50.16 2.43 9.01 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 51.97 0.60 16.16 51.18 3.08 14.54 13.39 -11.16 2.90 14.53 -11.26 0.04 1rql_c00 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 3 hits 1rql_c00 naa= 2 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 B 126 THR A 26 THR~? 9.55 S2 BME A 300 B 160 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 B 126 THR A 26 THR~? 9.55 S2 BME A 300 B 160 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 81.10 -6.09 8.07 81.50 -7.56 6.55 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 3 2 # 3 B 126 THR A 30 THR~? 11.99 S2 BME A 300 B 160 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 18.48 -11.65 0.55 19.28 -10.22 2.01 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 13.39 -11.16 2.90 14.53 -11.26 0.04 1rql_c01 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 3 hits 1rql_c01 naa= 2 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 2 # 1 B 195 SER A 69 SER~? 5.63 S2 BME A 300 B 196 GLY A 66 GLY.? -4.48 C1 BME A 300s coo -2.83 25.96 36.71 -4.77 27.03 37.63 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 0.64 25.09 37.94 0.51 25.31 37.16 5.61 -7.93 6.44 5.80 -8.57 6.93 1rtf_c01 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 1 hits 1rtf_c01 naa= 2 ULMN 2 1ru4_c00 PECTATE LYASE user 1 2 # 1 A 268 ASN A 37 ASN.? 22.15 S2 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 32.75 1.45 1.05 31.55 -0.31 0.97 18.58 0.66 -5.47 19.39 1.00 -7.43 coo 32.12 5.85 8.68 31.39 1.32 5.05 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ru4_c00 PECTATE LYASE user 2 2 # 2 A 268 ASN A 49 ASN~? 18.38 S2 BME A 300 A 273 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 32.75 1.45 1.05 31.55 -0.31 0.97 22.96 -0.28 10.82 24.47 -1.69 10.46 coo 32.12 5.85 8.68 31.39 1.32 5.05 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ru4_c00 PECTATE LYASE user 3 2 # 3 A 268 ASN A 79 ASN.? 19.89 S2 BME A 300 A 273 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 32.75 1.45 1.05 31.55 -0.31 0.97 15.66 5.60 16.72 16.27 4.24 18.24 coo 32.12 5.85 8.68 31.39 1.32 5.05 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1ru4_c00 PECTATE LYASE user 4 2 # 4 A 268 ASN A 85 ASN^? 8.15 S2 BME A 300 A 273 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 32.75 1.45 1.05 31.55 -0.31 0.97 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 32.12 5.85 8.68 31.39 1.32 5.05 8.82 -4.39 14.42 10.42 -10.04 16.23 1ru4_c00 source 1ru4 PECTATE LYASE : 4 hits 1ru4_c00 naa= 2 ULMN 2 1slm_c00 STROMELYSIN-1 user 1 2 # 1 202 GLU A 28 GLU~? 14.38 S2 BME A 300 219 MET A 32 MET?? 16.29 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 21.30 -17.97 5.16 20.86 -18.94 6.97 coo 23.61 94.73 82.41 24.46 93.13 79.93 18.33 -15.35 -3.27 19.07 -18.39 -2.47 ULMN 2 1slm_c00 STROMELYSIN-1 user 2 2 # 2 202 GLU A 29 GLU~? 6.68 S2 BME A 300 219 MET A 32 MET?? 16.29 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 23.61 94.73 82.41 24.46 93.13 79.93 18.33 -15.35 -3.27 19.07 -18.39 -2.47 ULMN 2 1slm_c00 STROMELYSIN-1 user 3 2 # 3 202 GLU A 29 GLU~? 6.68 S2 BME A 300 219 MET A 43 MET?? 7.50 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 23.61 94.73 82.41 24.46 93.13 79.93 16.84 -7.02 11.44 13.26 -8.32 13.33 ULMN 2 1slm_c00 STROMELYSIN-1 user 4 2 # 4 202 GLU A 29 GLU~? 6.68 S2 BME A 300 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 23.61 94.73 82.41 24.46 93.13 79.93 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1slm_c00 STROMELYSIN-1 user 5 2 # 5 202 GLU A 87 GLU.? 12.12 O1 BME A 300 219 MET A 1 MET?? 11.79 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 23.61 94.73 82.41 24.46 93.13 79.93 1.73 2.69 11.74 3.89 -0.91 11.26 ULMN 2 1slm_c00 STROMELYSIN-1 user 6 2 # 6 202 GLU A 87 GLU.? 12.12 O1 BME A 300 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 23.61 94.73 82.41 24.46 93.13 79.93 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1slm_c00 STROMELYSIN-1 user 7 2 # 7 202 GLU A 96 GLU.? 20.00 O1 BME A 300 219 MET A 90 MET?? 10.03 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 23.61 94.73 82.41 24.46 93.13 79.93 8.61 -9.96 -0.54 11.23 -8.07 -1.39 ULMN 2 1slm_c00 STROMELYSIN-1 user 8 2 # 8 202 GLU A 99 GLU.? 20.82 S2 BME A 300 219 MET A 32 MET?? 16.29 S2 BME A 300 coo 17.90 89.78 76.20 17.93 89.03 78.20 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 23.61 94.73 82.41 24.46 93.13 79.93 18.33 -15.35 -3.27 19.07 -18.39 -2.47 1slm_c00 source 1slm STROMELYSIN-1 : 8 hits 1slm_c00 naa= 2 ULMN 2 1sme_c10 PLASMEPSIN II user 1 2 # 1 A 34 ASP A 44 ASP~? 11.03 S2 BME A 300 A 214 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 51.75 60.57 19.10 52.05 60.90 21.19 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 48.59 58.89 25.78 50.13 59.74 24.61 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1sme_c10 PLASMEPSIN II user 2 2 # 2 A 34 ASP A 48 ASP~? 19.85 S2 BME A 300 A 214 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 51.75 60.57 19.10 52.05 60.90 21.19 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 48.59 58.89 25.78 50.13 59.74 24.61 19.36 -9.90 14.44 17.51 -11.01 14.77 1sme_c10 source 1sme PLASMEPSIN II : 2 hits 1sme_c10 naa= 2 ULMN 2 1sme_c11 PLASMEPSIN II user 1 2 # 1 B 34 ASP A 44 ASP~? 11.03 S2 BME A 300 B 214 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 17.69 97.58 52.73 17.33 97.19 54.77 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 12.41 98.71 58.47 14.37 98.17 58.05 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1sme_c11 PLASMEPSIN II user 2 2 # 2 B 34 ASP A 48 ASP~? 19.85 S2 BME A 300 B 214 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 17.69 97.58 52.73 17.33 97.19 54.77 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 12.41 98.71 58.47 14.37 98.17 58.05 19.36 -9.90 14.44 17.51 -11.01 14.77 1sme_c11 source 1sme PLASMEPSIN II : 2 hits 1sme_c11 naa= 2 ULMN 2 1sox_c00 SULFITE OXIDASE user 1 2 # 1 A 138 ARG A 25 ARG.? 9.68 S2 BME A 300 A 322 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 29.11 98.43 27.28 31.52 97.24 28.79 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 28.34 90.08 25.08 29.22 92.59 25.94 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1sox_c00 source 1sox SULFITE OXIDASE : 1 hits 1sox_c00 naa= 2 ULMN 2 1sox_c01 SULFITE OXIDASE user 1 2 # 1 B 138 ARG A 25 ARG.? 9.68 S2 BME A 300 B 322 TYR A 34 TYR.? 16.37 S2 BME A 300 coo -7.30 67.54 21.22 -9.56 67.99 23.16 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -6.47 76.05 22.16 -7.36 73.40 22.11 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1sox_c01 source 1sox SULFITE OXIDASE : 1 hits 1sox_c01 naa= 2 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 7 ASP~? 16.68 O1 BME A 300 E 170 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 2.36 26.80 21.76 1.58 25.84 20.04 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 23 ASP^? 9.45 S2 BME A 300 E 170 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 2.36 26.80 21.76 1.58 25.84 20.04 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP A 23 ASP^? 9.45 S2 BME A 300 E 170 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 2.36 26.80 21.76 1.58 25.84 20.04 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 4 2 # 4 E 166 ASP A 44 ASP~? 11.03 S2 BME A 300 E 170 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 2.36 26.80 21.76 1.58 25.84 20.04 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 5 2 # 5 E 166 ASP A 44 ASP~? 11.03 S2 BME A 300 E 170 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 2.36 26.80 21.76 1.58 25.84 20.04 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 6 2 # 6 E 166 ASP A 95 ASP.? 15.99 O1 BME A 300 E 170 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 2.36 26.80 21.76 1.58 25.84 20.04 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 7 2 # 7 E 166 ASP A 95 ASP.? 15.99 O1 BME A 300 E 170 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 2.36 26.80 21.76 1.58 25.84 20.04 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1stc_c00 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 7 hits 1stc_c00 naa= 2 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 7 ASP~? 16.68 O1 BME A 300 E 168 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 5.06 22.32 18.11 1.02 22.08 22.74 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 23 ASP^? 9.45 S2 BME A 300 E 168 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 5.06 22.32 18.11 1.02 22.08 22.74 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP A 82 ASP^? 20.57 S2 BME A 300 E 168 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 5.36 16.20 22.10 3.88 17.00 23.31 10.12 9.33 8.59 8.15 9.51 7.94 coo 5.06 22.32 18.11 1.02 22.08 22.74 15.98 12.20 9.88 16.28 11.97 16.11 1stc_c01 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 3 hits 1stc_c01 naa= 2 ULMN 2 1szj_c00 D-GLYCERALDEHYDE-3-PHOSPHATE-DEHYDROuser 1 2 # 1 G 149 CYH A 63 CYH.? -3.36 S2 BME A 300s G 176 HIS A 91 HIS~? 7.63 O1 BME A 300 coo -16.25 12.40 11.26 -14.29 10.19 11.00 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -13.23 5.28 7.83 -12.80 6.73 9.19 3.84 -13.89 0.30 2.26 -15.26 0.08 1szj_c00 source 1szj D-GLYCERALDEHYDE-3-PHOSPHATE-DEHYDROGENASE : 1 hits 1szj_c00 naa= 2 ULMN 2 1szj_c01 D-GLYCERALDEHYDE-3-PHOSPHATE-DEHYDROuser 1 2 # 1 R 149 CYH A 63 CYH.? -3.36 S2 BME A 300s R 176 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 16.25 -12.16 11.38 14.36 -9.91 11.14 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 13.19 -4.96 7.88 12.59 -6.32 9.28 3.84 -13.89 0.30 2.26 -15.26 0.08 1szj_c01 source 1szj D-GLYCERALDEHYDE-3-PHOSPHATE-DEHYDROGENASE : 1 hits 1szj_c01 naa= 2 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 2 LYS.? 20.18 S2 BME A 300 288 SER A 69 SER~? 5.63 S2 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 2.39 3.95 8.25 5.67 8.88 7.74 coo -14.37 3.44 26.58 -14.65 5.84 27.07 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 10 LYS~? 16.18 O1 BME A 300 288 SER A 3 SER^? 13.09 C1 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -14.37 3.44 26.58 -14.65 5.84 27.07 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS A 10 LYS~? 16.18 O1 BME A 300 288 SER A 16 SER.? 30.21 S2 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -14.37 3.44 26.58 -14.65 5.84 27.07 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 4 2 # 4 62 LYS A 12 LYS~? 21.81 S2 BME A 300 288 SER A 3 SER^? 13.09 C1 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -14.37 3.44 26.58 -14.65 5.84 27.07 2.01 1.27 5.67 0.61 -0.61 5.33 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 5 2 # 5 62 LYS A 39 LYS^? 20.06 S2 BME A 300 288 SER A 69 SER~? 5.63 S2 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 19.85 -1.20 1.64 21.03 4.07 2.80 coo -14.37 3.44 26.58 -14.65 5.84 27.07 9.36 -5.27 9.06 7.58 -5.59 7.43 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 6 2 # 6 62 LYS A 71 LYS~? 8.54 S2 BME A 300 288 SER A 3 SER^? 13.09 C1 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -14.37 3.44 26.58 -14.65 5.84 27.07 2.01 1.27 5.67 0.61 -0.61 5.33 1tdj_c00 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 6 hits 1tdj_c00 naa= 2 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 12 LYS~? 21.81 S2 BME A 300 315 SER A 16 SER.? 30.21 S2 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -13.07 3.29 19.97 -14.02 3.00 22.17 11.56 11.57 -9.82 9.89 13.31 -9.94 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 39 LYS^? 20.06 S2 BME A 300 315 SER A 52 SER~? 19.64 S2 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 19.85 -1.20 1.64 21.03 4.07 2.80 coo -13.07 3.29 19.97 -14.02 3.00 22.17 22.49 4.36 7.95 23.43 2.12 7.73 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS A 55 LYS.? 25.54 S2 BME A 300 315 SER A 52 SER~? 19.64 S2 BME A 300 coo -13.90 11.27 16.35 -15.53 10.62 20.90 15.98 12.20 9.88 16.28 11.97 16.11 coo -13.07 3.29 19.97 -14.02 3.00 22.17 22.49 4.36 7.95 23.43 2.12 7.73 1tdj_c02 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 3 hits 1tdj_c02 naa= 2 ULMN 2 1ti6_c18 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 2 # 1 A 145 HIS A 91 HIS~? 7.63 O1 BME A 300 A 147 TRP A 93 TRP~? 14.44 S2 BME A 300 coo 13.61 -78.44 -45.07 12.25 -78.68 -46.65 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 8.06 -81.84 -37.62 11.85 -82.65 -36.92 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1ti6_c18 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c18 naa= 2 ULMN 2 1ti6_c19 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 2 # 1 C 145 HIS A 91 HIS~? 7.63 O1 BME A 300 C 147 TRP A 93 TRP~? 14.44 S2 BME A 300 coo -10.61 83.73 -16.13 -9.23 82.30 -16.80 3.84 -13.89 0.30 2.26 -15.26 0.08 coo -4.27 90.44 -12.68 -7.48 92.28 -14.02 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1ti6_c19 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c19 naa= 2 ULMN 2 1ti6_c20 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 2 # 1 E 145 HIS A 91 HIS~? 7.63 O1 BME A 300 E 147 TRP A 93 TRP~? 14.44 S2 BME A 300 coo -10.98-114.26 73.02 -11.90-116.01 72.32 3.84 -13.89 0.30 2.26 -15.26 0.08 coo -16.10-107.79 67.69 -15.07-106.12 71.10 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1ti6_c20 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c20 naa= 2 ULMN 2 1ti6_c21 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 2 # 1 G 145 HIS A 91 HIS~? 7.63 O1 BME A 300 G 147 TRP A 93 TRP~? 14.44 S2 BME A 300 coo 66.01-100.75 51.46 67.45-100.67 52.98 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 65.93 -91.29 48.46 65.27 -93.67 45.39 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1ti6_c21 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c21 naa= 2 ULMN 2 1ti6_c22 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 2 # 1 I 145 HIS A 91 HIS~? 7.63 O1 BME A 300 I 147 TRP A 93 TRP~? 14.44 S2 BME A 300 coo -9.44 -11.03 94.61 -8.55 -9.27 95.32 3.84 -13.89 0.30 2.26 -15.26 0.08 coo -1.33 -15.64 91.43 -3.98 -18.31 92.59 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1ti6_c22 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c22 naa= 2 ULMN 2 1ti6_c23 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 2 # 1 K 145 HIS A 91 HIS~? 7.63 O1 BME A 300 K 147 TRP A 93 TRP~? 14.44 S2 BME A 300 coo 104.51 21.70 -5.85 105.59 20.45 -7.14 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 95.57 17.75 -7.28 95.84 19.16 -3.62 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1ti6_c23 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c23 naa= 2 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 1 2 # 1 E 143 GLU A 29 GLU~? 6.68 S2 BME A 300 E 231 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 50.69 23.59 -3.14 51.24 21.98 -4.34 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 2 2 # 2 E 143 GLU A 87 GLU.? 12.12 O1 BME A 300 E 231 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 50.69 23.59 -3.14 51.24 21.98 -4.34 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 3 2 # 3 E 143 GLU A 96 GLU.? 20.00 O1 BME A 300 E 231 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 50.69 23.59 -3.14 51.24 21.98 -4.34 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 3.84 -13.89 0.30 2.26 -15.26 0.08 1tlp_c00 source 1tlp THERMOLYSIN (E.C.3.4.24.27) COMPLEX WITH PHOSP: 3 hits 1tlp_c00 naa= 2 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 1 2 # 1 117 ASP A 23 ASP^? 9.45 S2 BME A 300 265 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 2 2 # 2 117 ASP A 23 ASP^? 9.45 S2 BME A 300 265 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 3 2 # 3 117 ASP A 27 ASP~? 15.09 S2 BME A 300 265 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 4 2 # 4 117 ASP A 44 ASP~? 11.03 S2 BME A 300 265 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 5 2 # 5 117 ASP A 48 ASP~? 19.85 S2 BME A 300 265 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 6 2 # 6 117 ASP A 95 ASP.? 15.99 O1 BME A 300 265 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 15.97 -5.82 2.06 15.42 -7.84 1.89 1tml_c01 source 1tml ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1.4) : 6 hits 1tml_c01 naa= 2 ULMN 2 1tmo_c02 TRIMETHYLAMINE N-OXIDE REDUCTASE user 1 2 # 1 116 THR A 6 THR~? 12.27 O1 BME A 300 118 TRP A 93 TRP~? 14.44 S2 BME A 300 coo 57.54 43.08 12.99 56.93 42.25 11.08 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 50.24 43.58 16.89 46.55 44.75 16.20 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1tmo_c02 source 1tmo TRIMETHYLAMINE N-OXIDE REDUCTASE : 1 hits 1tmo_c02 naa= 2 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 A 418 GLU A 29 GLU~? 6.68 S2 BME A 300 A 481 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 14.10 66.39 26.65 14.11 68.21 25.54 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 14.95 77.09 31.69 15.34 77.40 29.70 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 A 418 GLU A 87 GLU.? 12.12 O1 BME A 300 A 481 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 14.10 66.39 26.65 14.11 68.21 25.54 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 14.95 77.09 31.69 15.34 77.40 29.70 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 3 2 # 3 A 418 GLU A 96 GLU.? 20.00 O1 BME A 300 A 481 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 14.10 66.39 26.65 14.11 68.21 25.54 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 14.95 77.09 31.69 15.34 77.40 29.70 3.84 -13.89 0.30 2.26 -15.26 0.08 1trk_c04 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 3 hits 1trk_c04 naa= 2 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 B 418 GLU A 29 GLU~? 6.68 S2 BME A 300 B 481 HIS A 91 HIS~? 7.63 O1 BME A 300 coo -2.49 65.64 20.85 -1.68 63.95 19.85 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -6.49 54.97 24.37 -5.59 54.90 22.55 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 B 418 GLU A 87 GLU.? 12.12 O1 BME A 300 B 481 HIS A 91 HIS~? 7.63 O1 BME A 300 coo -2.49 65.64 20.85 -1.68 63.95 19.85 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo -6.49 54.97 24.37 -5.59 54.90 22.55 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 3 2 # 3 B 418 GLU A 96 GLU.? 20.00 O1 BME A 300 B 481 HIS A 91 HIS~? 7.63 O1 BME A 300 coo -2.49 65.64 20.85 -1.68 63.95 19.85 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -6.49 54.97 24.37 -5.59 54.90 22.55 3.84 -13.89 0.30 2.26 -15.26 0.08 1trk_c05 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 3 hits 1trk_c05 naa= 2 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 1 2 # 1 A 130 ASP A 23 ASP^? 9.45 S2 BME A 300 A 185 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 8.81 3.41 29.07 10.49 4.61 29.53 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 17.44 9.63 28.94 15.61 8.68 29.31 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 2 2 # 2 A 130 ASP A 27 ASP~? 15.09 S2 BME A 300 A 185 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 8.81 3.41 29.07 10.49 4.61 29.53 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 17.44 9.63 28.94 15.61 8.68 29.31 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 3 2 # 3 A 130 ASP A 27 ASP~? 15.09 S2 BME A 300 A 185 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 8.81 3.41 29.07 10.49 4.61 29.53 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 17.44 9.63 28.94 15.61 8.68 29.31 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 4 2 # 4 A 130 ASP A 44 ASP~? 11.03 S2 BME A 300 A 185 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 8.81 3.41 29.07 10.49 4.61 29.53 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.44 9.63 28.94 15.61 8.68 29.31 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 5 2 # 5 A 130 ASP A 44 ASP~? 11.03 S2 BME A 300 A 185 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 8.81 3.41 29.07 10.49 4.61 29.53 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 17.44 9.63 28.94 15.61 8.68 29.31 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 6 2 # 6 A 130 ASP A 48 ASP~? 19.85 S2 BME A 300 A 185 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 8.81 3.41 29.07 10.49 4.61 29.53 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 17.44 9.63 28.94 15.61 8.68 29.31 19.36 -9.90 14.44 17.51 -11.01 14.77 1uas_c00 source 1uas ALPHA-GALACTOSIDASE : 6 hits 1uas_c00 naa= 2 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 1 2 # 1 199 ASP A 7 ASP~? 16.68 O1 BME A 300 255 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 52.57 37.12 10.17 53.37 35.95 11.75 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 2 2 # 2 199 ASP A 27 ASP~? 15.09 S2 BME A 300 255 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 52.57 37.12 10.17 53.37 35.95 11.75 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 3 2 # 3 199 ASP A 27 ASP~? 15.09 S2 BME A 300 255 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 52.57 37.12 10.17 53.37 35.95 11.75 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 4 2 # 4 199 ASP A 82 ASP^? 20.57 S2 BME A 300 255 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.12 9.33 8.59 8.15 9.51 7.94 coo 52.57 37.12 10.17 53.37 35.95 11.75 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 5 2 # 5 199 ASP A 82 ASP^? 20.57 S2 BME A 300 255 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.12 9.33 8.59 8.15 9.51 7.94 coo 52.57 37.12 10.17 53.37 35.95 11.75 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 6 2 # 6 199 ASP A 95 ASP.? 15.99 O1 BME A 300 255 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 52.57 37.12 10.17 53.37 35.95 11.75 8.57 -11.88 -11.59 9.67 -13.45 -12.41 1uok_c01 source 1uok OLIGO-1,6-GLUCOSIDASE : 6 hits 1uok_c01 naa= 2 ULMN 2 1uox_c00 URATE OXIDASE user 1 2 # 1 28 THR A 6 THR~? 12.27 O1 BME A 300 76 PRO A 36 PRO.? 18.77 S2 BME A 300 coo 16.78 65.34 48.92 15.62 64.41 47.34 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo 23.62 58.48 37.29 23.51 60.61 36.65 16.36 -4.28 -8.75 16.89 -3.72 -6.60 ULMN 2 1uox_c00 URATE OXIDASE user 2 2 # 2 28 THR A 26 THR~? 9.55 S2 BME A 300 76 PRO A 47 PRO~? 16.35 S2 BME A 300 coo 16.78 65.34 48.92 15.62 64.41 47.34 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 23.62 58.48 37.29 23.51 60.61 36.65 19.20 -3.02 17.30 20.25 -1.76 15.75 1uox_c00 source 1uox URATE OXIDASE : 2 hits 1uox_c00 naa= 2 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 A 154 HIS A 91 HIS~? 7.63 O1 BME A 300 A 361 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 38.53 29.77 11.27 37.61 30.69 9.62 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 36.69 27.02 21.98 35.77 25.65 20.58 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1uqt_c00 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 1 hits 1uqt_c00 naa= 2 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 B 154 HIS A 91 HIS~? 7.63 O1 BME A 300 B 361 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 10.74 -14.23 -6.96 9.54 -15.53 -8.09 1uqt_c01 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 1 hits 1uqt_c01 naa= 2 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 1 2 # 1 A 86 ASP A 23 ASP^? 9.45 S2 BME A 300 A 164 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 9.32 71.14 66.67 9.35 73.22 66.22 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 10.68 80.16 70.30 11.55 80.13 67.63 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 2 2 # 2 A 86 ASP A 23 ASP^? 9.45 S2 BME A 300 A 164 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 9.32 71.14 66.67 9.35 73.22 66.22 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 10.68 80.16 70.30 11.55 80.13 67.63 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 3 2 # 3 A 86 ASP A 27 ASP~? 15.09 S2 BME A 300 A 164 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 9.32 71.14 66.67 9.35 73.22 66.22 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 10.68 80.16 70.30 11.55 80.13 67.63 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 4 2 # 4 A 86 ASP A 44 ASP~? 11.03 S2 BME A 300 A 164 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 9.32 71.14 66.67 9.35 73.22 66.22 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 10.68 80.16 70.30 11.55 80.13 67.63 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 5 2 # 5 A 86 ASP A 48 ASP~? 19.85 S2 BME A 300 A 164 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 9.32 71.14 66.67 9.35 73.22 66.22 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 10.68 80.16 70.30 11.55 80.13 67.63 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 6 2 # 6 A 86 ASP A 82 ASP^? 20.57 S2 BME A 300 A 164 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 9.32 71.14 66.67 9.35 73.22 66.22 10.12 9.33 8.59 8.15 9.51 7.94 coo 10.68 80.16 70.30 11.55 80.13 67.63 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 7 2 # 7 A 86 ASP A 95 ASP.? 15.99 O1 BME A 300 A 164 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 9.32 71.14 66.67 9.35 73.22 66.22 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 10.68 80.16 70.30 11.55 80.13 67.63 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1uro_c00 source 1uro UROPORPHYRINOGEN DECARBOXYLASE : 7 hits 1uro_c00 naa= 2 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 1 2 # 1 A 92 ARG A 25 ARG.? 9.68 S2 BME A 300 A 162 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 22.28 19.87 14.60 19.43 20.27 13.40 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 20.49 15.91 11.17 19.72 15.53 13.15 15.50 -15.19 4.21 14.37 -14.08 5.62 1uw8_c02 source 1uw8 OXALATE DECARBOXYLASE OXDC : 1 hits 1uw8_c02 naa= 2 ULMN 2 1v25_c00 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 1 2 # 1 A 439 LYS A 10 LYS~? 16.18 O1 BME A 300 A 444 TRP A 93 TRP~? 14.44 S2 BME A 300 coo -0.26 64.22 156.87 2.65 58.72 157.59 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 3.93 62.21 161.01 0.25 60.87 160.66 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1v25_c00 source 1v25 LONG-CHAIN-FATTY-ACID-COA SYNTHETASE : 1 hits 1v25_c00 naa= 2 ULMN 2 1v25_c01 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 1 2 # 1 B 439 LYS A 10 LYS~? 16.18 O1 BME A 300 B 444 TRP A 93 TRP~? 14.44 S2 BME A 300 coo 23.39 6.36 151.97 20.82 11.81 153.70 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 21.20 8.21 157.57 24.35 9.59 155.65 9.46 -7.28 -5.55 9.24 -3.36 -5.14 1v25_c01 source 1v25 LONG-CHAIN-FATTY-ACID-COA SYNTHETASE : 1 hits 1v25_c01 naa= 2 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 1 2 # 1 144 LYS A 2 LYS.? 20.18 S2 BME A 300 199 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 2.39 3.95 8.25 5.67 8.88 7.74 coo -29.64 64.57 49.45 -27.60 64.41 50.00 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 2 2 # 2 144 LYS A 10 LYS~? 16.18 O1 BME A 300 199 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -29.64 64.57 49.45 -27.60 64.41 50.00 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 3 2 # 3 144 LYS A 10 LYS~? 16.18 O1 BME A 300 199 GLU A 96 GLU.? 20.00 O1 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -29.64 64.57 49.45 -27.60 64.41 50.00 8.57 -11.88 -11.59 9.67 -13.45 -12.41 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 4 2 # 4 144 LYS A 10 LYS~? 16.18 O1 BME A 300 199 GLU A 99 GLU.? 20.82 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -29.64 64.57 49.45 -27.60 64.41 50.00 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 5 2 # 5 144 LYS A 12 LYS~? 21.81 S2 BME A 300 199 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -29.64 64.57 49.45 -27.60 64.41 50.00 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 6 2 # 6 144 LYS A 12 LYS~? 21.81 S2 BME A 300 199 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -29.64 64.57 49.45 -27.60 64.41 50.00 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 7 2 # 7 144 LYS A 39 LYS^? 20.06 S2 BME A 300 199 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 19.85 -1.20 1.64 21.03 4.07 2.80 coo -29.64 64.57 49.45 -27.60 64.41 50.00 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 8 2 # 8 144 LYS A 39 LYS^? 20.06 S2 BME A 300 199 GLU A 57 GLU.? 23.43 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 19.85 -1.20 1.64 21.03 4.07 2.80 coo -29.64 64.57 49.45 -27.60 64.41 50.00 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 9 2 # 9 144 LYS A 71 LYS~? 8.54 S2 BME A 300 199 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -29.64 64.57 49.45 -27.60 64.41 50.00 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 10 2 # 10 144 LYS A 71 LYS~? 8.54 S2 BME A 300 199 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -29.64 64.57 49.45 -27.60 64.41 50.00 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 11 2 # 11 144 LYS A 101 LYS.? -19.93 S2 BME A 300s 199 GLU A 28 GLU~? 14.38 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo -29.64 64.57 49.45 -27.60 64.41 50.00 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 12 2 # 12 144 LYS A 101 LYS.? -19.93 S2 BME A 300s 199 GLU A 29 GLU~? 6.68 S2 BME A 300 coo -16.96 58.67 52.82 -20.37 61.54 50.53 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo -29.64 64.57 49.45 -27.60 64.41 50.00 15.50 -15.19 4.21 14.37 -14.08 5.62 1vid_c00 source 1vid CATECHOL O-METHYLTRANSFERASE : 12 hits 1vid_c00 naa= 2 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 1 2 # 1 A 501 ARG A 25 ARG.? 9.68 S2 BME A 300 A 869 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 2 2 # 2 A 501 ARG A 68 ARG~? -4.35 S2 BME A 300s A 869 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 15.50 -15.19 4.21 14.37 -14.08 5.62 1vlb_c01 source 1vlb ALDEHYDE OXIDOREDUCTASE : 2 hits 1vlb_c01 naa= 2 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 A 151 ASP A 23 ASP^? 9.45 S2 BME A 300 A 197 ASN A 37 ASN.? 22.15 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 A 151 ASP A 23 ASP^? 9.45 S2 BME A 300 A 197 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 2 # 3 A 151 ASP A 23 ASP^? 9.45 S2 BME A 300 A 197 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 2 # 4 A 151 ASP A 44 ASP~? 11.03 S2 BME A 300 A 197 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 2 # 5 A 151 ASP A 48 ASP~? 19.85 S2 BME A 300 A 197 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 2 # 6 A 151 ASP A 82 ASP^? 20.57 S2 BME A 300 A 197 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 10.12 9.33 8.59 8.15 9.51 7.94 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 2 # 7 A 151 ASP A 82 ASP^? 20.57 S2 BME A 300 A 197 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 10.12 9.33 8.59 8.15 9.51 7.94 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 2 # 8 A 151 ASP A 82 ASP^? 20.57 S2 BME A 300 A 197 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 10.12 9.33 8.59 8.15 9.51 7.94 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 5.01 -1.60 7.62 5.37 -3.69 7.71 1vq1_c02 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 8 hits 1vq1_c02 naa= 2 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 B 151 ASP A 23 ASP^? 9.45 S2 BME A 300 B 197 ASN A 37 ASN.? 22.15 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 B 151 ASP A 23 ASP^? 9.45 S2 BME A 300 B 197 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 2 # 3 B 151 ASP A 23 ASP^? 9.45 S2 BME A 300 B 197 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 5.01 -1.60 7.62 5.37 -3.69 7.71 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 2 # 4 B 151 ASP A 44 ASP~? 11.03 S2 BME A 300 B 197 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 2 # 5 B 151 ASP A 48 ASP~? 19.85 S2 BME A 300 B 197 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 2 # 6 B 151 ASP A 82 ASP^? 20.57 S2 BME A 300 B 197 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 10.12 9.33 8.59 8.15 9.51 7.94 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 2 # 7 B 151 ASP A 82 ASP^? 20.57 S2 BME A 300 B 197 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 10.12 9.33 8.59 8.15 9.51 7.94 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 2 # 8 B 151 ASP A 82 ASP^? 20.57 S2 BME A 300 B 197 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 10.12 9.33 8.59 8.15 9.51 7.94 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 5.01 -1.60 7.62 5.37 -3.69 7.71 1vq1_c03 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 8 hits 1vq1_c03 naa= 2 ULMN 2 1wnw_c00 HEME OXYGENASE user 1 2 # 1 A 136 ASN A 79 ASN.? 19.89 S2 BME A 300 A 140 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 15.66 5.60 16.72 16.27 4.24 18.24 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1wnw_c00 HEME OXYGENASE user 2 2 # 2 A 136 ASN A 85 ASN^? 8.15 S2 BME A 300 A 140 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 5.61 -7.93 6.44 5.80 -8.57 6.93 1wnw_c00 source 1wnw HEME OXYGENASE : 2 hits 1wnw_c00 naa= 2 ULMN 2 1wnw_c01 HEME OXYGENASE user 1 2 # 1 B 136 ASN A 79 ASN.? 19.89 S2 BME A 300 B 140 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 10.41 13.55 22.30 12.49 13.88 22.44 15.66 5.60 16.72 16.27 4.24 18.24 coo 12.77 16.12 18.53 12.82 15.99 17.73 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1wnw_c01 HEME OXYGENASE user 2 2 # 2 B 136 ASN A 85 ASN^? 8.15 S2 BME A 300 B 140 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 10.41 13.55 22.30 12.49 13.88 22.44 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 12.77 16.12 18.53 12.82 15.99 17.73 5.61 -7.93 6.44 5.80 -8.57 6.93 1wnw_c01 source 1wnw HEME OXYGENASE : 2 hits 1wnw_c01 naa= 2 ULMN 2 1wnw_c02 HEME OXYGENASE user 1 2 # 1 C 136 ASN A 79 ASN.? 19.89 S2 BME A 300 C 140 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 26.63 1.54 53.35 24.49 1.91 53.34 15.66 5.60 16.72 16.27 4.24 18.24 coo 23.86 0.66 57.49 23.81 0.02 58.00 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1wnw_c02 HEME OXYGENASE user 2 2 # 2 C 136 ASN A 85 ASN^? 8.15 S2 BME A 300 C 140 GLY A 66 GLY.? -4.48 C1 BME A 300s coo 26.63 1.54 53.35 24.49 1.91 53.34 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 23.86 0.66 57.49 23.81 0.02 58.00 5.61 -7.93 6.44 5.80 -8.57 6.93 1wnw_c02 source 1wnw HEME OXYGENASE : 2 hits 1wnw_c02 naa= 2 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 1 2 # 1 A 56 GLU A 29 GLU~? 6.68 S2 BME A 300 A 228 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 27.49 35.40 20.60 28.62 36.02 22.28 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 33.88 38.22 25.20 34.46 38.14 23.17 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 2 2 # 2 A 56 GLU A 29 GLU~? 6.68 S2 BME A 300 A 228 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 27.49 35.40 20.60 28.62 36.02 22.28 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 33.88 38.22 25.20 34.46 38.14 23.17 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 3 2 # 3 A 56 GLU A 57 GLU.? 23.43 S2 BME A 300 A 228 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 27.49 35.40 20.60 28.62 36.02 22.28 16.30 10.78 3.24 16.87 9.97 1.36 coo 33.88 38.22 25.20 34.46 38.14 23.17 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 4 2 # 4 A 56 GLU A 77 GLU~? 17.67 S2 BME A 300 A 228 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 27.49 35.40 20.60 28.62 36.02 22.28 7.63 5.18 13.95 5.55 5.01 14.48 coo 33.88 38.22 25.20 34.46 38.14 23.17 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 5 2 # 5 A 56 GLU A 87 GLU.? 12.12 O1 BME A 300 A 228 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 27.49 35.40 20.60 28.62 36.02 22.28 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 33.88 38.22 25.20 34.46 38.14 23.17 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1x7d_c00 source 1x7d ORNITHINE CYCLODEAMINASE : 5 hits 1x7d_c00 naa= 2 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 1 2 # 1 B 56 GLU A 29 GLU~? 6.68 S2 BME A 300 B 228 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 8.97 35.22 21.27 7.95 33.38 21.10 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 2.71 29.91 19.58 2.03 31.89 19.36 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 2 2 # 2 B 56 GLU A 29 GLU~? 6.68 S2 BME A 300 B 228 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 8.97 35.22 21.27 7.95 33.38 21.10 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 2.71 29.91 19.58 2.03 31.89 19.36 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 3 2 # 3 B 56 GLU A 57 GLU.? 23.43 S2 BME A 300 B 228 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 8.97 35.22 21.27 7.95 33.38 21.10 16.30 10.78 3.24 16.87 9.97 1.36 coo 2.71 29.91 19.58 2.03 31.89 19.36 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 4 2 # 4 B 56 GLU A 77 GLU~? 17.67 S2 BME A 300 B 228 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 8.97 35.22 21.27 7.95 33.38 21.10 7.63 5.18 13.95 5.55 5.01 14.48 coo 2.71 29.91 19.58 2.03 31.89 19.36 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 5 2 # 5 B 56 GLU A 87 GLU.? 12.12 O1 BME A 300 B 228 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 8.97 35.22 21.27 7.95 33.38 21.10 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 2.71 29.91 19.58 2.03 31.89 19.36 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 1x7d_c01 source 1x7d ORNITHINE CYCLODEAMINASE : 5 hits 1x7d_c01 naa= 2 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 1 2 # 1 A 165 SER A 3 SER^? 13.09 C1 BME A 300 A 187 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 8.34 44.73 23.71 9.07 45.54 21.52 2.01 1.27 5.67 0.61 -0.61 5.33 coo 6.50 51.89 29.29 8.22 51.77 30.59 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 2 2 # 2 A 165 SER A 3 SER^? 13.09 C1 BME A 300 A 187 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 8.34 44.73 23.71 9.07 45.54 21.52 2.01 1.27 5.67 0.61 -0.61 5.33 coo 6.50 51.89 29.29 8.22 51.77 30.59 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 3 2 # 3 A 165 SER A 52 SER~? 19.64 S2 BME A 300 A 187 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 8.34 44.73 23.71 9.07 45.54 21.52 22.49 4.36 7.95 23.43 2.12 7.73 coo 6.50 51.89 29.29 8.22 51.77 30.59 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 4 2 # 4 A 165 SER A 69 SER~? 5.63 S2 BME A 300 A 187 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 8.34 44.73 23.71 9.07 45.54 21.52 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 6.50 51.89 29.29 8.22 51.77 30.59 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 5 2 # 5 A 165 SER A 69 SER~? 5.63 S2 BME A 300 A 187 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 8.34 44.73 23.71 9.07 45.54 21.52 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 6.50 51.89 29.29 8.22 51.77 30.59 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 6 2 # 6 A 165 SER A 102 SER.? -26.95 S2 BME A 300s A 187 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 8.34 44.73 23.71 9.07 45.54 21.52 28.10 -11.09 -8.44 28.33 -11.90 -10.72 coo 6.50 51.89 29.29 8.22 51.77 30.59 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1xgm_c00 source 1xgm METHIONINE AMINOPEPTIDASE : 6 hits 1xgm_c00 naa= 2 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 1 2 # 1 B 165 SER A 3 SER^? 13.09 C1 BME A 300 B 187 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 12.53 42.28 15.16 11.35 44.10 16.30 2.01 1.27 5.67 0.61 -0.61 5.33 coo 12.85 44.05 6.07 11.44 42.52 5.44 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 2 2 # 2 B 165 SER A 3 SER^? 13.09 C1 BME A 300 B 187 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 12.53 42.28 15.16 11.35 44.10 16.30 2.01 1.27 5.67 0.61 -0.61 5.33 coo 12.85 44.05 6.07 11.44 42.52 5.44 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 3 2 # 3 B 165 SER A 52 SER~? 19.64 S2 BME A 300 B 187 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 12.53 42.28 15.16 11.35 44.10 16.30 22.49 4.36 7.95 23.43 2.12 7.73 coo 12.85 44.05 6.07 11.44 42.52 5.44 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 4 2 # 4 B 165 SER A 69 SER~? 5.63 S2 BME A 300 B 187 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 12.53 42.28 15.16 11.35 44.10 16.30 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 12.85 44.05 6.07 11.44 42.52 5.44 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 5 2 # 5 B 165 SER A 69 SER~? 5.63 S2 BME A 300 B 187 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 12.53 42.28 15.16 11.35 44.10 16.30 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 12.85 44.05 6.07 11.44 42.52 5.44 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 6 2 # 6 B 165 SER A 102 SER.? -26.95 S2 BME A 300s B 187 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 12.53 42.28 15.16 11.35 44.10 16.30 28.10 -11.09 -8.44 28.33 -11.90 -10.72 coo 12.85 44.05 6.07 11.44 42.52 5.44 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1xgm_c01 source 1xgm METHIONINE AMINOPEPTIDASE : 6 hits 1xgm_c01 naa= 2 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 1 2 # 1 A 242 ALA A 31 ALA~? 16.01 S2 BME A 300 A 243 THR A 30 THR~? 11.99 S2 BME A 300 coo 7.23 22.00 24.48 6.68 23.42 24.57 21.12 -13.83 -1.18 21.96 -14.90 -0.48 coo 9.58 21.79 21.50 11.25 23.03 20.90 18.48 -11.65 0.55 19.28 -10.22 2.01 1xqd_c00 source 1xqd CYTOCHROME P450 55A1 : 1 hits 1xqd_c00 naa= 2 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 128 ASP A 82 ASP^? 20.57 S2 BME A 300 A 130 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -16.14 7.55 9.89 -16.27 5.86 11.13 10.12 9.33 8.59 8.15 9.51 7.94 coo -17.69 11.71 5.97 -16.98 11.70 6.47 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 128 ASP A 95 ASP.? 15.99 O1 BME A 300 A 130 GLY A 33 GLY.? 15.27 S2 BME A 300 coo -16.14 7.55 9.89 -16.27 5.86 11.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -17.69 11.71 5.97 -16.98 11.70 6.47 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 128 ASP A 95 ASP.? 15.99 O1 BME A 300 A 130 GLY A 94 GLY~? 13.27 O1 BME A 300 coo -16.14 7.55 9.89 -16.27 5.86 11.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -17.69 11.71 5.97 -16.98 11.70 6.47 7.18 -11.38 -5.94 7.80 -10.95 -5.54 1xs1_c00 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c00 naa= 2 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 128 ASP A 82 ASP^? 20.57 S2 BME A 300 B 130 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 8.08 5.58 9.89 6.73 6.58 11.12 10.12 9.33 8.59 8.15 9.51 7.94 coo 12.76 4.19 5.97 12.32 3.80 6.57 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 128 ASP A 95 ASP.? 15.99 O1 BME A 300 B 130 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 8.08 5.58 9.89 6.73 6.58 11.12 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 12.76 4.19 5.97 12.32 3.80 6.57 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 128 ASP A 95 ASP.? 15.99 O1 BME A 300 B 130 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 8.08 5.58 9.89 6.73 6.58 11.12 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 12.76 4.19 5.97 12.32 3.80 6.57 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 128 ASP A 95 ASP.? 15.99 O1 BME A 300 B 130 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 8.08 5.58 9.89 6.73 6.58 11.12 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 12.76 4.19 5.97 12.32 3.80 6.57 13.13 -8.12 -11.42 13.24 -8.65 -10.80 1xs1_c01 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c01 naa= 2 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 C 128 ASP A 82 ASP^? 20.57 S2 BME A 300 C 130 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 10.12 9.33 8.59 8.15 9.51 7.94 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 C 128 ASP A 95 ASP.? 15.99 O1 BME A 300 C 130 GLY A 33 GLY.? 15.27 S2 BME A 300 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 C 128 ASP A 95 ASP.? 15.99 O1 BME A 300 C 130 GLY A 94 GLY~? 13.27 O1 BME A 300 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 C 128 ASP A 95 ASP.? 15.99 O1 BME A 300 C 130 GLY A 97 GLY.? 20.00 S2 BME A 300 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 13.13 -8.12 -11.42 13.24 -8.65 -10.80 1xs1_c02 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c02 naa= 2 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 128 ASP A 82 ASP^? 20.57 S2 BME A 300 D 130 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 10.12 9.33 8.59 8.15 9.51 7.94 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 128 ASP A 95 ASP.? 15.99 O1 BME A 300 D 130 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 128 ASP A 95 ASP.? 15.99 O1 BME A 300 D 130 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 128 ASP A 95 ASP.? 15.99 O1 BME A 300 D 130 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 13.13 -8.12 -11.42 13.24 -8.65 -10.80 1xs1_c03 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c03 naa= 2 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 128 ASP A 82 ASP^? 20.57 S2 BME A 300 E 130 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -5.69 16.82 71.43 -4.17 15.98 70.17 10.12 9.33 8.59 8.15 9.51 7.94 coo -8.93 20.40 75.02 -9.14 19.76 74.49 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 128 ASP A 95 ASP.? 15.99 O1 BME A 300 E 130 GLY A 33 GLY.? 15.27 S2 BME A 300 coo -5.69 16.82 71.43 -4.17 15.98 70.17 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -8.93 20.40 75.02 -9.14 19.76 74.49 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 128 ASP A 95 ASP.? 15.99 O1 BME A 300 E 130 GLY A 94 GLY~? 13.27 O1 BME A 300 coo -5.69 16.82 71.43 -4.17 15.98 70.17 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -8.93 20.40 75.02 -9.14 19.76 74.49 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 128 ASP A 95 ASP.? 15.99 O1 BME A 300 E 130 GLY A 97 GLY.? 20.00 S2 BME A 300 coo -5.69 16.82 71.43 -4.17 15.98 70.17 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -8.93 20.40 75.02 -9.14 19.76 74.49 13.13 -8.12 -11.42 13.24 -8.65 -10.80 1xs1_c04 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c04 naa= 2 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 128 ASP A 82 ASP^? 20.57 S2 BME A 300 F 130 GLY A 80 GLY.? 22.31 S2 BME A 300 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 10.12 9.33 8.59 8.15 9.51 7.94 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 128 ASP A 95 ASP.? 15.99 O1 BME A 300 F 130 GLY A 33 GLY.? 15.27 S2 BME A 300 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 128 ASP A 95 ASP.? 15.99 O1 BME A 300 F 130 GLY A 94 GLY~? 13.27 O1 BME A 300 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 7.18 -11.38 -5.94 7.80 -10.95 -5.54 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 128 ASP A 95 ASP.? 15.99 O1 BME A 300 F 130 GLY A 97 GLY.? 20.00 S2 BME A 300 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 13.13 -8.12 -11.42 13.24 -8.65 -10.80 1xs1_c05 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c05 naa= 2 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 111 SER A 69 SER~? 5.63 S2 BME A 300 A 115 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 6.26 6.70 20.48 8.06 5.10 20.15 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 10.04 5.32 23.68 11.46 4.45 21.05 12.31 -11.28 10.33 12.92 -12.61 7.64 1xs1_c13 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c13 naa= 2 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 111 SER A 69 SER~? 5.63 S2 BME A 300 B 115 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 12.31 -11.28 10.33 12.92 -12.61 7.64 1xs1_c14 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c14 naa= 2 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 111 SER A 69 SER~? 5.63 S2 BME A 300 D 115 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -4.43 14.92 60.69 -6.72 15.54 61.22 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -7.63 17.31 57.53 -9.07 18.28 60.09 12.31 -11.28 10.33 12.92 -12.61 7.64 1xs1_c15 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c15 naa= 2 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 111 SER A 69 SER~? 5.63 S2 BME A 300 E 115 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 12.31 -11.28 10.33 12.92 -12.61 7.64 1xs1_c16 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c16 naa= 2 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 111 SER A 69 SER~? 5.63 S2 BME A 300 F 115 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 6.41 -4.25 61.68 8.03 -2.52 62.26 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 12.31 -11.28 10.33 12.92 -12.61 7.64 1xs1_c17 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c17 naa= 2 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 A 175 ARG A 25 ARG.? 9.68 S2 BME A 300 A 242 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 56.19 79.96 8.87 56.06 80.16 11.92 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 63.28 81.69 5.71 63.99 80.11 7.80 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1xva_c02 source 1xva GLYCINE N-METHYLTRANSFERASE : 1 hits 1xva_c02 naa= 2 ULMN 2 1y9m_c00 EXO-INULINASE user 1 2 # 1 A 41 ASP A 7 ASP~? 16.68 O1 BME A 300 A 241 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 24.90 6.62 22.11 24.45 8.58 22.70 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 19.12 12.64 24.04 21.16 13.15 23.94 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 1y9m_c00 EXO-INULINASE user 2 2 # 2 A 41 ASP A 23 ASP^? 9.45 S2 BME A 300 A 241 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 24.90 6.62 22.11 24.45 8.58 22.70 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 19.12 12.64 24.04 21.16 13.15 23.94 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1y9m_c00 EXO-INULINASE user 3 2 # 3 A 41 ASP A 27 ASP~? 15.09 S2 BME A 300 A 241 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 24.90 6.62 22.11 24.45 8.58 22.70 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 19.12 12.64 24.04 21.16 13.15 23.94 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 1y9m_c00 EXO-INULINASE user 4 2 # 4 A 41 ASP A 82 ASP^? 20.57 S2 BME A 300 A 241 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 24.90 6.62 22.11 24.45 8.58 22.70 10.12 9.33 8.59 8.15 9.51 7.94 coo 19.12 12.64 24.04 21.16 13.15 23.94 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 1y9m_c00 EXO-INULINASE user 5 2 # 5 A 41 ASP A 82 ASP^? 20.57 S2 BME A 300 A 241 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 24.90 6.62 22.11 24.45 8.58 22.70 10.12 9.33 8.59 8.15 9.51 7.94 coo 19.12 12.64 24.04 21.16 13.15 23.94 7.63 5.18 13.95 5.55 5.01 14.48 1y9m_c00 source 1y9m EXO-INULINASE : 5 hits 1y9m_c00 naa= 2 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 A 178 TYR A 34 TYR.? 16.37 S2 BME A 300 A 182 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 87.67 8.69 17.10 86.62 10.83 18.52 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 85.30 6.17 22.83 87.26 11.02 23.50 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 A 178 TYR A 34 TYR.? 16.37 S2 BME A 300 A 182 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 87.67 8.69 17.10 86.62 10.83 18.52 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 85.30 6.17 22.83 87.26 11.02 23.50 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 A 178 TYR A 59 TYR^? 18.50 S2 BME A 300 A 182 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 87.67 8.69 17.10 86.62 10.83 18.52 14.59 5.14 5.72 16.82 6.86 5.68 coo 85.30 6.17 22.83 87.26 11.02 23.50 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 A 178 TYR A 75 TYR~? 15.90 S2 BME A 300 A 182 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 87.67 8.69 17.10 86.62 10.83 18.52 14.46 -0.26 16.60 17.11 0.41 17.22 coo 85.30 6.17 22.83 87.26 11.02 23.50 8.82 -4.39 14.42 10.42 -10.04 16.23 1ybv_c06 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c06 naa= 2 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 B 178 TYR A 34 TYR.? 16.37 S2 BME A 300 B 182 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 54.99 -1.20 35.40 56.04 1.15 36.44 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 57.40 2.23 30.19 55.43 5.44 33.87 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 B 178 TYR A 34 TYR.? 16.37 S2 BME A 300 B 182 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 54.99 -1.20 35.40 56.04 1.15 36.44 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 57.40 2.23 30.19 55.43 5.44 33.87 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 B 178 TYR A 59 TYR^? 18.50 S2 BME A 300 B 182 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 54.99 -1.20 35.40 56.04 1.15 36.44 14.59 5.14 5.72 16.82 6.86 5.68 coo 57.40 2.23 30.19 55.43 5.44 33.87 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 B 178 TYR A 75 TYR~? 15.90 S2 BME A 300 B 182 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 54.99 -1.20 35.40 56.04 1.15 36.44 14.46 -0.26 16.60 17.11 0.41 17.22 coo 57.40 2.23 30.19 55.43 5.44 33.87 8.82 -4.39 14.42 10.42 -10.04 16.23 1ybv_c07 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c07 naa= 2 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 A 14 LYS A 10 LYS~? 16.18 O1 BME A 300 A 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 18.28 7.83 36.39 22.82 8.75 39.52 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 14.16 13.09 37.03 20.00 12.44 37.49 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 18.28 7.83 36.39 22.82 8.75 39.52 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 14.16 13.09 37.03 20.00 12.44 37.49 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 2 # 3 A 14 LYS A 12 LYS~? 21.81 S2 BME A 300 A 74 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 18.28 7.83 36.39 22.82 8.75 39.52 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 14.16 13.09 37.03 20.00 12.44 37.49 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 2 # 4 A 14 LYS A 17 LYS.? 25.68 S2 BME A 300 A 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 18.28 7.83 36.39 22.82 8.75 39.52 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 14.16 13.09 37.03 20.00 12.44 37.49 7.13 5.12 -6.84 5.25 7.73 -2.58 1ylu_c02 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c02 naa= 2 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 B 14 LYS A 10 LYS~? 16.18 O1 BME A 300 B 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 13.51 0.92 76.10 12.98 6.13 74.68 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 19.89 -0.55 76.51 17.10 4.32 77.43 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 B 14 LYS A 12 LYS~? 21.81 S2 BME A 300 B 74 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 13.51 0.92 76.10 12.98 6.13 74.68 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 19.89 -0.55 76.51 17.10 4.32 77.43 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 2 # 3 B 14 LYS A 12 LYS~? 21.81 S2 BME A 300 B 74 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 13.51 0.92 76.10 12.98 6.13 74.68 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 19.89 -0.55 76.51 17.10 4.32 77.43 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 2 # 4 B 14 LYS A 17 LYS.? 25.68 S2 BME A 300 B 74 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 13.51 0.92 76.10 12.98 6.13 74.68 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 19.89 -0.55 76.51 17.10 4.32 77.43 7.13 5.12 -6.84 5.25 7.73 -2.58 1ylu_c03 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c03 naa= 2 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 A 39 ASP A 23 ASP^? 9.45 S2 BME A 300 A 67 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 A 39 ASP A 23 ASP^? 9.45 S2 BME A 300 A 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 A 39 ASP A 27 ASP~? 15.09 S2 BME A 300 A 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 A 39 ASP A 44 ASP~? 11.03 S2 BME A 300 A 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 A 39 ASP A 48 ASP~? 19.85 S2 BME A 300 A 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 A 39 ASP A 82 ASP^? 20.57 S2 BME A 300 A 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 10.12 9.33 8.59 8.15 9.51 7.94 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 7 2 # 7 A 39 ASP A 95 ASP.? 15.99 O1 BME A 300 A 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ze1_c00 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 7 hits 1ze1_c00 naa= 2 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 B 39 ASP A 23 ASP^? 9.45 S2 BME A 300 B 67 TYR A 59 TYR^? 18.50 S2 BME A 300 coo -2.18 16.79 38.50 -4.08 16.27 37.73 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -3.28 26.12 34.97 -5.09 24.87 36.72 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 B 39 ASP A 23 ASP^? 9.45 S2 BME A 300 B 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -2.18 16.79 38.50 -4.08 16.27 37.73 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -3.28 26.12 34.97 -5.09 24.87 36.72 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 B 39 ASP A 27 ASP~? 15.09 S2 BME A 300 B 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo -2.18 16.79 38.50 -4.08 16.27 37.73 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -3.28 26.12 34.97 -5.09 24.87 36.72 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 B 39 ASP A 44 ASP~? 11.03 S2 BME A 300 B 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo -2.18 16.79 38.50 -4.08 16.27 37.73 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -3.28 26.12 34.97 -5.09 24.87 36.72 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 B 39 ASP A 48 ASP~? 19.85 S2 BME A 300 B 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo -2.18 16.79 38.50 -4.08 16.27 37.73 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -3.28 26.12 34.97 -5.09 24.87 36.72 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 B 39 ASP A 82 ASP^? 20.57 S2 BME A 300 B 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo -2.18 16.79 38.50 -4.08 16.27 37.73 10.12 9.33 8.59 8.15 9.51 7.94 coo -3.28 26.12 34.97 -5.09 24.87 36.72 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 7 2 # 7 B 39 ASP A 95 ASP.? 15.99 O1 BME A 300 B 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo -2.18 16.79 38.50 -4.08 16.27 37.73 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -3.28 26.12 34.97 -5.09 24.87 36.72 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ze1_c01 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 7 hits 1ze1_c01 naa= 2 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 C 39 ASP A 23 ASP^? 9.45 S2 BME A 300 C 67 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 C 39 ASP A 23 ASP^? 9.45 S2 BME A 300 C 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 C 39 ASP A 27 ASP~? 15.09 S2 BME A 300 C 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 C 39 ASP A 44 ASP~? 11.03 S2 BME A 300 C 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 C 39 ASP A 48 ASP~? 19.85 S2 BME A 300 C 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 C 39 ASP A 82 ASP^? 20.57 S2 BME A 300 C 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 10.12 9.33 8.59 8.15 9.51 7.94 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 7 2 # 7 C 39 ASP A 95 ASP.? 15.99 O1 BME A 300 C 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ze1_c02 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 7 hits 1ze1_c02 naa= 2 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 D 39 ASP A 23 ASP^? 9.45 S2 BME A 300 D 67 TYR A 59 TYR^? 18.50 S2 BME A 300 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 14.59 5.14 5.72 16.82 6.86 5.68 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 D 39 ASP A 23 ASP^? 9.45 S2 BME A 300 D 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 D 39 ASP A 27 ASP~? 15.09 S2 BME A 300 D 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 18.83 -7.61 -2.88 21.31 -7.06 -4.03 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 D 39 ASP A 44 ASP~? 11.03 S2 BME A 300 D 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 D 39 ASP A 48 ASP~? 19.85 S2 BME A 300 D 67 TYR A 75 TYR~? 15.90 S2 BME A 300 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 14.46 -0.26 16.60 17.11 0.41 17.22 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 D 39 ASP A 82 ASP^? 20.57 S2 BME A 300 D 67 TYR A 60 TYR^? 16.66 S2 BME A 300 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 10.12 9.33 8.59 8.15 9.51 7.94 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 9.00 3.02 1.57 7.75 5.45 1.00 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 7 2 # 7 D 39 ASP A 95 ASP.? 15.99 O1 BME A 300 D 67 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 18.83 -7.61 -2.88 21.31 -7.06 -4.03 1ze1_c03 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 7 hits 1ze1_c03 naa= 2 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 23 ASP^? 9.45 S2 BME A 300 A 373 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -8.85 26.59 24.55 -9.45 28.36 23.61 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP A 27 ASP~? 15.09 S2 BME A 300 A 373 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -8.85 26.59 24.55 -9.45 28.36 23.61 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 3 2 # 3 A 369 ASP A 27 ASP~? 15.09 S2 BME A 300 A 373 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -8.85 26.59 24.55 -9.45 28.36 23.61 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 4 2 # 4 A 369 ASP A 44 ASP~? 11.03 S2 BME A 300 A 373 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -8.85 26.59 24.55 -9.45 28.36 23.61 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 5 2 # 5 A 369 ASP A 44 ASP~? 11.03 S2 BME A 300 A 373 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -8.85 26.59 24.55 -9.45 28.36 23.61 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 6 2 # 6 A 369 ASP A 48 ASP~? 19.85 S2 BME A 300 A 373 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -8.85 26.59 24.55 -9.45 28.36 23.61 19.36 -9.90 14.44 17.51 -11.01 14.77 1zrz_c00 source 1zrz PROTEIN KINASE C, IOTA : 6 hits 1zrz_c00 naa= 2 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 7 ASP~? 16.68 O1 BME A 300 A 371 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -4.43 30.92 22.89 -6.61 31.91 19.71 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP A 23 ASP^? 9.45 S2 BME A 300 A 371 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -4.43 30.92 22.89 -6.61 31.91 19.71 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 3 2 # 3 A 369 ASP A 82 ASP^? 20.57 S2 BME A 300 A 371 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -5.17 31.09 15.73 -7.07 31.12 16.73 10.12 9.33 8.59 8.15 9.51 7.94 coo -4.43 30.92 22.89 -6.61 31.91 19.71 15.98 12.20 9.88 16.28 11.97 16.11 1zrz_c01 source 1zrz PROTEIN KINASE C, IOTA : 3 hits 1zrz_c01 naa= 2 ULMN 2 206l_c00 LYSOZYME user 1 2 # 1 A 11 GLU A 29 GLU~? 6.68 S2 BME A 300 A 20 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 40.46 12.70 11.55 39.54 14.42 10.81 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 39.78 21.54 11.61 37.90 22.43 11.16 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 206l_c00 LYSOZYME user 2 2 # 2 A 11 GLU A 29 GLU~? 6.68 S2 BME A 300 A 20 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 40.46 12.70 11.55 39.54 14.42 10.81 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 39.78 21.54 11.61 37.90 22.43 11.16 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 206l_c00 LYSOZYME user 3 2 # 3 A 11 GLU A 57 GLU.? 23.43 S2 BME A 300 A 20 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 40.46 12.70 11.55 39.54 14.42 10.81 16.30 10.78 3.24 16.87 9.97 1.36 coo 39.78 21.54 11.61 37.90 22.43 11.16 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 206l_c00 LYSOZYME user 4 2 # 4 A 11 GLU A 77 GLU~? 17.67 S2 BME A 300 A 20 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 40.46 12.70 11.55 39.54 14.42 10.81 7.63 5.18 13.95 5.55 5.01 14.48 coo 39.78 21.54 11.61 37.90 22.43 11.16 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 206l_c00 LYSOZYME user 5 2 # 5 A 11 GLU A 87 GLU.? 12.12 O1 BME A 300 A 20 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 40.46 12.70 11.55 39.54 14.42 10.81 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 39.78 21.54 11.61 37.90 22.43 11.16 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 206l_c00 source 206l LYSOZYME : 5 hits 206l_c00 naa= 2 ULMN 2 2a0n_c00 4.01.03.0000 user 1 2 # 1 A 11 ASP A 7 ASP~? 16.68 O1 BME A 300 A 130 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 22.18 80.79 26.12 23.22 81.35 27.91 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2a0n_c00 4.01.03.0000 user 2 2 # 2 A 11 ASP A 23 ASP^? 9.45 S2 BME A 300 A 130 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 22.18 80.79 26.12 23.22 81.35 27.91 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2a0n_c00 4.01.03.0000 user 3 2 # 3 A 11 ASP A 23 ASP^? 9.45 S2 BME A 300 A 130 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 22.18 80.79 26.12 23.22 81.35 27.91 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 2a0n_c00 4.01.03.0000 user 4 2 # 4 A 11 ASP A 23 ASP^? 9.45 S2 BME A 300 A 130 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 22.18 80.79 26.12 23.22 81.35 27.91 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2a0n_c00 4.01.03.0000 user 5 2 # 5 A 11 ASP A 27 ASP~? 15.09 S2 BME A 300 A 130 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 22.18 80.79 26.12 23.22 81.35 27.91 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 2a0n_c00 4.01.03.0000 user 6 2 # 6 A 11 ASP A 44 ASP~? 11.03 S2 BME A 300 A 130 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 22.18 80.79 26.12 23.22 81.35 27.91 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2a0n_c00 4.01.03.0000 user 7 2 # 7 A 11 ASP A 48 ASP~? 19.85 S2 BME A 300 A 130 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 22.18 80.79 26.12 23.22 81.35 27.91 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2a0n_c00 4.01.03.0000 user 8 2 # 8 A 11 ASP A 48 ASP~? 19.85 S2 BME A 300 A 130 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 22.18 80.79 26.12 23.22 81.35 27.91 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2a0n_c00 4.01.03.0000 user 9 2 # 9 A 11 ASP A 95 ASP.? 15.99 O1 BME A 300 A 130 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 22.18 80.79 26.12 23.22 81.35 27.91 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2a0n_c00 4.01.03.0000 user 10 2 # 10 A 11 ASP A 95 ASP.? 15.99 O1 BME A 300 A 130 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 25.89 89.29 37.40 24.53 87.99 36.37 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 22.18 80.79 26.12 23.22 81.35 27.91 15.97 -5.82 2.06 15.42 -7.84 1.89 2a0n_c00 source 2a0n 4.01.03.0000 : 10 hits 2a0n_c00 naa= 2 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 2 # 1 142 TRP A 93 TRP~? 14.44 S2 BME A 300 223 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 128.40 33.01 26.67 128.12 36.28 28.81 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 127.91 41.73 23.55 129.18 40.35 24.44 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2aat_c00 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 2 # 2 142 TRP A 93 TRP~? 14.44 S2 BME A 300 223 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 128.40 33.01 26.67 128.12 36.28 28.81 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 127.91 41.73 23.55 129.18 40.35 24.44 15.97 -5.82 2.06 15.42 -7.84 1.89 2aat_c00 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 2 hits 2aat_c00 naa= 2 ULMN 2 2abk_c00 ENDONUCLEASE III user 1 2 # 1 120 LYS A 2 LYS.? 20.18 S2 BME A 300 138 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 35.70 11.61 29.91 35.27 16.84 33.08 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.57 16.23 36.65 31.90 16.89 37.78 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2abk_c00 ENDONUCLEASE III user 2 2 # 2 120 LYS A 12 LYS~? 21.81 S2 BME A 300 138 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 35.70 11.61 29.91 35.27 16.84 33.08 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 33.57 16.23 36.65 31.90 16.89 37.78 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2abk_c00 ENDONUCLEASE III user 3 2 # 3 120 LYS A 55 LYS.? 25.54 S2 BME A 300 138 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 35.70 11.61 29.91 35.27 16.84 33.08 15.98 12.20 9.88 16.28 11.97 16.11 coo 33.57 16.23 36.65 31.90 16.89 37.78 10.12 9.33 8.59 8.15 9.51 7.94 2abk_c00 source 2abk ENDONUCLEASE III : 3 hits 2abk_c00 naa= 2 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 1 2 # 1 49 TYR A 34 TYR.? 16.37 S2 BME A 300 79 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 2 2 # 2 49 TYR A 34 TYR.? 16.37 S2 BME A 300 79 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 8.78 -8.94 37.04 9.01 -6.91 35.11 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 3 2 # 3 49 TYR A 59 TYR^? 18.50 S2 BME A 300 79 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 14.59 5.14 5.72 16.82 6.86 5.68 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 4 2 # 4 49 TYR A 59 TYR^? 18.50 S2 BME A 300 79 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 14.59 5.14 5.72 16.82 6.86 5.68 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 5 2 # 5 49 TYR A 60 TYR^? 16.66 S2 BME A 300 79 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 9.00 3.02 1.57 7.75 5.45 1.00 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 6 2 # 6 49 TYR A 60 TYR^? 16.66 S2 BME A 300 79 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 9.00 3.02 1.57 7.75 5.45 1.00 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 7 2 # 7 49 TYR A 60 TYR^? 16.66 S2 BME A 300 79 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 9.00 3.02 1.57 7.75 5.45 1.00 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 8 2 # 8 49 TYR A 75 TYR~? 15.90 S2 BME A 300 79 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 14.46 -0.26 16.60 17.11 0.41 17.22 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 8.82 -4.39 14.42 10.42 -10.04 16.23 2alr_c01 source 2alr ALDEHYDE REDUCTASE : 8 hits 2alr_c01 naa= 2 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 23 ASP^? 9.45 S2 BME A 300 218 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 21.10 106.02 13.04 21.16 106.76 12.59 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 23 ASP^? 9.45 S2 BME A 300 218 GLY A 89 GLY~? 6.94 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 21.10 106.02 13.04 21.16 106.76 12.59 6.75 -7.92 2.09 6.22 -8.11 1.54 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 82 ASP^? 20.57 S2 BME A 300 218 GLY A 80 GLY.? 22.31 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.12 9.33 8.59 8.15 9.51 7.94 coo 21.10 106.02 13.04 21.16 106.76 12.59 13.21 9.55 15.29 13.34 8.86 14.89 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP A 95 ASP.? 15.99 O1 BME A 300 218 GLY A 33 GLY.? 15.27 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 21.10 106.02 13.04 21.16 106.76 12.59 17.51 -11.85 -4.66 17.42 -11.88 -3.82 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP A 95 ASP.? 15.99 O1 BME A 300 218 GLY A 97 GLY.? 20.00 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 21.10 106.02 13.04 21.16 106.76 12.59 13.13 -8.12 -11.42 13.24 -8.65 -10.80 2amg_c00 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 5 hits 2amg_c00 naa= 2 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 7 ASP~? 16.68 O1 BME A 300 219 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 25.84 105.87 9.06 27.86 105.55 8.74 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 27 ASP~? 15.09 S2 BME A 300 219 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 25.84 105.87 9.06 27.86 105.55 8.74 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 27 ASP~? 15.09 S2 BME A 300 219 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 25.84 105.87 9.06 27.86 105.55 8.74 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP A 82 ASP^? 20.57 S2 BME A 300 219 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.12 9.33 8.59 8.15 9.51 7.94 coo 25.84 105.87 9.06 27.86 105.55 8.74 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP A 82 ASP^? 20.57 S2 BME A 300 219 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.12 9.33 8.59 8.15 9.51 7.94 coo 25.84 105.87 9.06 27.86 105.55 8.74 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 2 # 6 193 ASP A 95 ASP.? 15.99 O1 BME A 300 219 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 25.84 105.87 9.06 27.86 105.55 8.74 8.57 -11.88 -11.59 9.67 -13.45 -12.41 2amg_c03 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 6 hits 2amg_c03 naa= 2 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 1 2 # 1 A 86 ASP A 23 ASP^? 9.45 S2 BME A 300 A 176 ASN A 37 ASN.? 22.15 S2 BME A 300 coo 3.77 27.43 22.56 5.17 28.98 22.54 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 10.49 32.46 17.76 9.08 34.05 17.38 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 2 2 # 2 A 86 ASP A 44 ASP~? 11.03 S2 BME A 300 A 176 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 3.77 27.43 22.56 5.17 28.98 22.54 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 10.49 32.46 17.76 9.08 34.05 17.38 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 3 2 # 3 A 86 ASP A 48 ASP~? 19.85 S2 BME A 300 A 176 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 3.77 27.43 22.56 5.17 28.98 22.54 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 10.49 32.46 17.76 9.08 34.05 17.38 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 4 2 # 4 A 86 ASP A 82 ASP^? 20.57 S2 BME A 300 A 176 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 3.77 27.43 22.56 5.17 28.98 22.54 10.12 9.33 8.59 8.15 9.51 7.94 coo 10.49 32.46 17.76 9.08 34.05 17.38 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 5 2 # 5 A 86 ASP A 82 ASP^? 20.57 S2 BME A 300 A 176 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 3.77 27.43 22.56 5.17 28.98 22.54 10.12 9.33 8.59 8.15 9.51 7.94 coo 10.49 32.46 17.76 9.08 34.05 17.38 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 2bmi_c00 CLASS B BETA-LACTAMASE user 6 2 # 6 A 86 ASP A 82 ASP^? 20.57 S2 BME A 300 A 176 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 3.77 27.43 22.56 5.17 28.98 22.54 10.12 9.33 8.59 8.15 9.51 7.94 coo 10.49 32.46 17.76 9.08 34.05 17.38 15.66 5.60 16.72 16.27 4.24 18.24 2bmi_c00 source 2bmi CLASS B BETA-LACTAMASE : 6 hits 2bmi_c00 naa= 2 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 1 2 # 1 B 86 ASP A 23 ASP^? 9.45 S2 BME A 300 B 176 ASN A 37 ASN.? 22.15 S2 BME A 300 coo -11.22 46.67 61.63 -9.21 47.42 61.86 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -3.84 50.99 67.30 -2.89 49.10 67.47 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 2 2 # 2 B 86 ASP A 44 ASP~? 11.03 S2 BME A 300 B 176 ASN A 49 ASN~? 18.38 S2 BME A 300 coo -11.22 46.67 61.63 -9.21 47.42 61.86 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -3.84 50.99 67.30 -2.89 49.10 67.47 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 3 2 # 3 B 86 ASP A 48 ASP~? 19.85 S2 BME A 300 B 176 ASN A 51 ASN~? 25.08 S2 BME A 300 coo -11.22 46.67 61.63 -9.21 47.42 61.86 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -3.84 50.99 67.30 -2.89 49.10 67.47 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 4 2 # 4 B 86 ASP A 82 ASP^? 20.57 S2 BME A 300 B 176 ASN A 54 ASN.? 24.37 S2 BME A 300 coo -11.22 46.67 61.63 -9.21 47.42 61.86 10.12 9.33 8.59 8.15 9.51 7.94 coo -3.84 50.99 67.30 -2.89 49.10 67.47 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 5 2 # 5 B 86 ASP A 82 ASP^? 20.57 S2 BME A 300 B 176 ASN A 56 ASN.? 28.57 S2 BME A 300 coo -11.22 46.67 61.63 -9.21 47.42 61.86 10.12 9.33 8.59 8.15 9.51 7.94 coo -3.84 50.99 67.30 -2.89 49.10 67.47 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 6 2 # 6 B 86 ASP A 82 ASP^? 20.57 S2 BME A 300 B 176 ASN A 79 ASN.? 19.89 S2 BME A 300 coo -11.22 46.67 61.63 -9.21 47.42 61.86 10.12 9.33 8.59 8.15 9.51 7.94 coo -3.84 50.99 67.30 -2.89 49.10 67.47 15.66 5.60 16.72 16.27 4.24 18.24 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 7 2 # 7 B 86 ASP A 82 ASP^? 20.57 S2 BME A 300 B 176 ASN A 85 ASN^? 8.15 S2 BME A 300 coo -11.22 46.67 61.63 -9.21 47.42 61.86 10.12 9.33 8.59 8.15 9.51 7.94 coo -3.84 50.99 67.30 -2.89 49.10 67.47 5.01 -1.60 7.62 5.37 -3.69 7.71 2bmi_c01 source 2bmi CLASS B BETA-LACTAMASE : 7 hits 2bmi_c01 naa= 2 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 1 2 # 1 A 171 PHE A 53 PHE~? 16.58 S2 BME A 300 A 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 17.96 4.29 9.15 17.54 1.52 8.86 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 19.85 -1.20 1.64 21.03 4.07 2.80 2c7v_c00 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c00 naa= 2 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 1 2 # 1 B 171 PHE A 53 PHE~? 16.58 S2 BME A 300 B 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -21.65 17.34 10.98 -21.84 19.41 9.11 17.96 4.29 9.15 17.54 1.52 8.86 coo -19.24 6.75 9.26 -18.50 8.42 4.13 19.85 -1.20 1.64 21.03 4.07 2.80 2c7v_c01 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c01 naa= 2 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 1 2 # 1 C 171 PHE A 53 PHE~? 16.58 S2 BME A 300 C 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 6.32 17.53 24.32 6.46 19.72 26.09 17.96 4.29 9.15 17.54 1.52 8.86 coo 3.63 7.30 27.09 2.92 9.52 32.06 19.85 -1.20 1.64 21.03 4.07 2.80 2c7v_c02 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c02 naa= 2 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 1 2 # 1 D 171 PHE A 53 PHE~? 16.58 S2 BME A 300 D 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 17.96 4.29 9.15 17.54 1.52 8.86 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 19.85 -1.20 1.64 21.03 4.07 2.80 2c7v_c03 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c03 naa= 2 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 1 2 # 1 A 174 TYR A 34 TYR.? 16.37 S2 BME A 300 A 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 2 2 # 2 A 174 TYR A 34 TYR.? 16.37 S2 BME A 300 A 178 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 8.61 -7.11 20.41 7.51 -6.92 17.85 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 3 2 # 3 A 174 TYR A 59 TYR^? 18.50 S2 BME A 300 A 178 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 14.59 5.14 5.72 16.82 6.86 5.68 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 4 2 # 4 A 174 TYR A 75 TYR~? 15.90 S2 BME A 300 A 178 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 14.46 -0.26 16.60 17.11 0.41 17.22 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 8.82 -4.39 14.42 10.42 -10.04 16.23 2c7v_c04 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c04 naa= 2 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 1 2 # 1 B 174 TYR A 34 TYR.? 16.37 S2 BME A 300 B 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -21.46 12.70 8.53 -19.04 12.30 7.24 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -19.24 6.75 9.26 -18.50 8.42 4.13 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 2 2 # 2 B 174 TYR A 34 TYR.? 16.37 S2 BME A 300 B 178 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -21.46 12.70 8.53 -19.04 12.30 7.24 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -19.24 6.75 9.26 -18.50 8.42 4.13 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 3 2 # 3 B 174 TYR A 59 TYR^? 18.50 S2 BME A 300 B 178 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -21.46 12.70 8.53 -19.04 12.30 7.24 14.59 5.14 5.72 16.82 6.86 5.68 coo -19.24 6.75 9.26 -18.50 8.42 4.13 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 4 2 # 4 B 174 TYR A 75 TYR~? 15.90 S2 BME A 300 B 178 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -21.46 12.70 8.53 -19.04 12.30 7.24 14.46 -0.26 16.60 17.11 0.41 17.22 coo -19.24 6.75 9.26 -18.50 8.42 4.13 8.82 -4.39 14.42 10.42 -10.04 16.23 2c7v_c05 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c05 naa= 2 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 1 2 # 1 C 174 TYR A 34 TYR.? 16.37 S2 BME A 300 C 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 5.94 13.28 27.17 3.53 13.05 28.58 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 3.63 7.30 27.09 2.92 9.52 32.06 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 2 2 # 2 C 174 TYR A 34 TYR.? 16.37 S2 BME A 300 C 178 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 5.94 13.28 27.17 3.53 13.05 28.58 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 3.63 7.30 27.09 2.92 9.52 32.06 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 3 2 # 3 C 174 TYR A 59 TYR^? 18.50 S2 BME A 300 C 178 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 5.94 13.28 27.17 3.53 13.05 28.58 14.59 5.14 5.72 16.82 6.86 5.68 coo 3.63 7.30 27.09 2.92 9.52 32.06 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 4 2 # 4 C 174 TYR A 75 TYR~? 15.90 S2 BME A 300 C 178 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 5.94 13.28 27.17 3.53 13.05 28.58 14.46 -0.26 16.60 17.11 0.41 17.22 coo 3.63 7.30 27.09 2.92 9.52 32.06 8.82 -4.39 14.42 10.42 -10.04 16.23 2c7v_c06 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c06 naa= 2 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 1 2 # 1 D 174 TYR A 34 TYR.? 16.37 S2 BME A 300 D 178 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 2 2 # 2 D 174 TYR A 34 TYR.? 16.37 S2 BME A 300 D 178 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 3 2 # 3 D 174 TYR A 59 TYR^? 18.50 S2 BME A 300 D 178 LYS A 55 LYS.? 25.54 S2 BME A 300 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 14.59 5.14 5.72 16.82 6.86 5.68 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 4 2 # 4 D 174 TYR A 75 TYR~? 15.90 S2 BME A 300 D 178 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 14.46 -0.26 16.60 17.11 0.41 17.22 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 8.82 -4.39 14.42 10.42 -10.04 16.23 2c7v_c07 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c07 naa= 2 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 1 2 # 1 A 197 ASP A 7 ASP~? 16.68 O1 BME A 300 A 236 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -2.69 16.54 48.12 -4.57 15.63 48.33 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 2 2 # 2 A 197 ASP A 23 ASP^? 9.45 S2 BME A 300 A 236 ASP A 44 ASP~? 11.03 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -2.69 16.54 48.12 -4.57 15.63 48.33 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 3 2 # 3 A 197 ASP A 23 ASP^? 9.45 S2 BME A 300 A 236 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -2.69 16.54 48.12 -4.57 15.63 48.33 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 4 2 # 4 A 197 ASP A 23 ASP^? 9.45 S2 BME A 300 A 236 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -2.69 16.54 48.12 -4.57 15.63 48.33 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 5 2 # 5 A 197 ASP A 27 ASP~? 15.09 S2 BME A 300 A 236 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -2.69 16.54 48.12 -4.57 15.63 48.33 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 6 2 # 6 A 197 ASP A 27 ASP~? 15.09 S2 BME A 300 A 236 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -2.69 16.54 48.12 -4.57 15.63 48.33 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 7 2 # 7 A 197 ASP A 44 ASP~? 11.03 S2 BME A 300 A 236 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -2.69 16.54 48.12 -4.57 15.63 48.33 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 8 2 # 8 A 197 ASP A 48 ASP~? 19.85 S2 BME A 300 A 236 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -2.69 16.54 48.12 -4.57 15.63 48.33 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 9 2 # 9 A 197 ASP A 48 ASP~? 19.85 S2 BME A 300 A 236 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -2.69 16.54 48.12 -4.57 15.63 48.33 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 10 2 # 10 A 197 ASP A 95 ASP.? 15.99 O1 BME A 300 A 236 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -2.69 16.54 48.12 -4.57 15.63 48.33 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 11 2 # 11 A 197 ASP A 95 ASP.? 15.99 O1 BME A 300 A 236 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -2.69 16.54 48.12 -4.57 15.63 48.33 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 12 2 # 12 A 197 ASP A 95 ASP.? 15.99 O1 BME A 300 A 236 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 12.51 17.07 49.46 12.44 16.89 47.35 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo -2.69 16.54 48.12 -4.57 15.63 48.33 23.07 -12.79 5.06 23.81 -10.95 5.75 2cpu_c00 source 2cpu ALPHA-AMYLASE : 12 hits 2cpu_c00 naa= 2 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 1 2 # 1 22 GLU A 8 GLU~? 18.47 O1 BME A 300 100 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 41.76 43.63 69.91 46.12 48.11 71.43 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 2 2 # 2 22 GLU A 8 GLU~? 18.47 O1 BME A 300 100 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 -0.20 1.85 -3.14 -1.06 2.30 -1.20 coo 41.76 43.63 69.91 46.12 48.11 71.43 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 3 2 # 3 22 GLU A 15 GLU~? 24.22 S2 BME A 300 100 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 6.94 9.23 -7.95 6.28 8.57 -6.07 coo 41.76 43.63 69.91 46.12 48.11 71.43 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 4 2 # 4 22 GLU A 57 GLU.? 23.43 S2 BME A 300 100 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 16.30 10.78 3.24 16.87 9.97 1.36 coo 41.76 43.63 69.91 46.12 48.11 71.43 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 5 2 # 5 22 GLU A 74 GLU~? 13.09 S2 BME A 300 100 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 6.36 -0.87 15.92 5.32 -2.36 17.02 coo 41.76 43.63 69.91 46.12 48.11 71.43 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 6 2 # 6 22 GLU A 77 GLU~? 17.67 S2 BME A 300 100 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 7.63 5.18 13.95 5.55 5.01 14.48 coo 41.76 43.63 69.91 46.12 48.11 71.43 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 7 2 # 7 22 GLU A 77 GLU~? 17.67 S2 BME A 300 100 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 7.63 5.18 13.95 5.55 5.01 14.48 coo 41.76 43.63 69.91 46.12 48.11 71.43 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 8 2 # 8 22 GLU A 87 GLU.? 12.12 O1 BME A 300 100 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 41.76 43.63 69.91 46.12 48.11 71.43 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 9 2 # 9 22 GLU A 99 GLU.? 20.82 S2 BME A 300 100 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 48.89 50.87 68.09 48.88 49.14 69.31 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 41.76 43.63 69.91 46.12 48.11 71.43 19.85 -1.20 1.64 21.03 4.07 2.80 2dhn_c00 source 2dhn 7,8-DIHYDRONEOPTERIN ALDOLASE : 9 hits 2dhn_c00 naa= 2 ULMN 2 2dor_c00 DIHYDROOROTATE DEHYDROGENASE A user 1 2 # 1 A 43 LYS A 39 LYS^? 20.06 S2 BME A 300 A 130 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 3.62 55.50 16.52 4.39 51.53 12.77 19.85 -1.20 1.64 21.03 4.07 2.80 coo 9.77 45.38 15.71 9.55 46.94 13.47 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 2 2dor_c00 DIHYDROOROTATE DEHYDROGENASE A user 2 2 # 2 A 43 LYS A 71 LYS~? 8.54 S2 BME A 300 A 130 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 3.62 55.50 16.52 4.39 51.53 12.77 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 9.77 45.38 15.71 9.55 46.94 13.47 10.91 -8.39 4.98 11.88 -9.73 7.18 2dor_c00 source 2dor DIHYDROOROTATE DEHYDROGENASE A : 2 hits 2dor_c00 naa= 2 ULMN 2 2dor_c01 DIHYDROOROTATE DEHYDROGENASE A user 1 2 # 1 B 43 LYS A 39 LYS^? 20.06 S2 BME A 300 B 130 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 2.86 8.74 19.83 1.70 12.73 23.44 19.85 -1.20 1.64 21.03 4.07 2.80 coo 7.79 18.91 23.50 6.49 17.36 25.33 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 2 2dor_c01 DIHYDROOROTATE DEHYDROGENASE A user 2 2 # 2 B 43 LYS A 71 LYS~? 8.54 S2 BME A 300 B 130 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 2.86 8.74 19.83 1.70 12.73 23.44 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 7.79 18.91 23.50 6.49 17.36 25.33 10.91 -8.39 4.98 11.88 -9.73 7.18 2dor_c01 source 2dor DIHYDROOROTATE DEHYDROGENASE A : 2 hits 2dor_c01 naa= 2 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 1 2 # 1 130 ASP A 7 ASP~? 16.68 O1 BME A 300 132 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 25.19 32.92 18.85 27.07 32.05 18.66 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 30.29 33.92 17.74 30.60 31.83 17.87 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 2 2 # 2 130 ASP A 27 ASP~? 15.09 S2 BME A 300 132 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 25.19 32.92 18.85 27.07 32.05 18.66 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 30.29 33.92 17.74 30.60 31.83 17.87 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 3 2 # 3 130 ASP A 82 ASP^? 20.57 S2 BME A 300 132 GLU A 77 GLU~? 17.67 S2 BME A 300 coo 25.19 32.92 18.85 27.07 32.05 18.66 10.12 9.33 8.59 8.15 9.51 7.94 coo 30.29 33.92 17.74 30.60 31.83 17.87 7.63 5.18 13.95 5.55 5.01 14.48 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 4 2 # 4 130 ASP A 95 ASP.? 15.99 O1 BME A 300 132 GLU A 96 GLU.? 20.00 O1 BME A 300 coo 25.19 32.92 18.85 27.07 32.05 18.66 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 30.29 33.92 17.74 30.60 31.83 17.87 8.57 -11.88 -11.59 9.67 -13.45 -12.41 2ebn_c00 source 2ebn ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1 (E.C.3.2.: 4 hits 2ebn_c00 naa= 2 ULMN 2 2eng_c00 ENDOGLUCANASE V user 1 2 # 1 10 ASP A 23 ASP^? 9.45 S2 BME A 300 121 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -1.15 29.58 35.96 -2.72 28.77 37.06 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -7.97 24.78 30.86 -9.67 25.90 30.49 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2eng_c00 ENDOGLUCANASE V user 2 2 # 2 10 ASP A 27 ASP~? 15.09 S2 BME A 300 121 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -1.15 29.58 35.96 -2.72 28.77 37.06 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -7.97 24.78 30.86 -9.67 25.90 30.49 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2eng_c00 ENDOGLUCANASE V user 3 2 # 3 10 ASP A 27 ASP~? 15.09 S2 BME A 300 121 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -1.15 29.58 35.96 -2.72 28.77 37.06 23.07 -12.79 5.06 23.81 -10.95 5.75 coo -7.97 24.78 30.86 -9.67 25.90 30.49 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2eng_c00 ENDOGLUCANASE V user 4 2 # 4 10 ASP A 44 ASP~? 11.03 S2 BME A 300 121 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -1.15 29.58 35.96 -2.72 28.77 37.06 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -7.97 24.78 30.86 -9.67 25.90 30.49 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2eng_c00 ENDOGLUCANASE V user 5 2 # 5 10 ASP A 44 ASP~? 11.03 S2 BME A 300 121 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -1.15 29.58 35.96 -2.72 28.77 37.06 19.36 -9.90 14.44 17.51 -11.01 14.77 coo -7.97 24.78 30.86 -9.67 25.90 30.49 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 2eng_c00 ENDOGLUCANASE V user 6 2 # 6 10 ASP A 48 ASP~? 19.85 S2 BME A 300 121 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -1.15 29.58 35.96 -2.72 28.77 37.06 24.97 -2.58 14.97 24.99 -3.62 16.79 coo -7.97 24.78 30.86 -9.67 25.90 30.49 19.36 -9.90 14.44 17.51 -11.01 14.77 2eng_c00 source 2eng ENDOGLUCANASE V : 6 hits 2eng_c00 naa= 2 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 1 2 # 1 35 GLU A 29 GLU~? 6.68 S2 BME A 300 53 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 24.12 3.58 26.55 22.78 2.48 27.73 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 2 2 # 2 35 GLU A 29 GLU~? 6.68 S2 BME A 300 53 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 24.12 3.58 26.55 22.78 2.48 27.73 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 3 2 # 3 35 GLU A 57 GLU.? 23.43 S2 BME A 300 53 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 16.30 10.78 3.24 16.87 9.97 1.36 coo 24.12 3.58 26.55 22.78 2.48 27.73 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 4 2 # 4 35 GLU A 77 GLU~? 17.67 S2 BME A 300 53 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 7.63 5.18 13.95 5.55 5.01 14.48 coo 24.12 3.58 26.55 22.78 2.48 27.73 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 5 2 # 5 35 GLU A 87 GLU.? 12.12 O1 BME A 300 53 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 24.12 3.58 26.55 22.78 2.48 27.73 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 2eql_c00 source 2eql LYSOZYME (APO FORM) : 5 hits 2eql_c00 naa= 2 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 A 28 GLU A 15 GLU~? 24.22 S2 BME A 300 A 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 A 28 GLU A 28 GLU~? 14.38 S2 BME A 300 A 120 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 A 28 GLU A 28 GLU~? 14.38 S2 BME A 300 A 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 A 28 GLU A 29 GLU~? 6.68 S2 BME A 300 A 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 A 28 GLU A 29 GLU~? 6.68 S2 BME A 300 A 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 A 28 GLU A 74 GLU~? 13.09 S2 BME A 300 A 120 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 A 28 GLU A 96 GLU.? 20.00 O1 BME A 300 A 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 A 28 GLU A 99 GLU.? 20.82 S2 BME A 300 A 120 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 A 28 GLU A 99 GLU.? 20.82 S2 BME A 300 A 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 10.74 -14.23 -6.96 9.54 -15.53 -8.09 2fmn_c00 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 9 hits 2fmn_c00 naa= 2 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 B 28 GLU A 15 GLU~? 24.22 S2 BME A 300 B 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -4.96 18.58 65.50 -6.34 17.73 64.12 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 B 28 GLU A 28 GLU~? 14.38 S2 BME A 300 B 120 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -4.96 18.58 65.50 -6.34 17.73 64.12 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 B 28 GLU A 28 GLU~? 14.38 S2 BME A 300 B 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -4.96 18.58 65.50 -6.34 17.73 64.12 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 B 28 GLU A 29 GLU~? 6.68 S2 BME A 300 B 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -4.96 18.58 65.50 -6.34 17.73 64.12 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 B 28 GLU A 29 GLU~? 6.68 S2 BME A 300 B 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -4.96 18.58 65.50 -6.34 17.73 64.12 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 B 28 GLU A 74 GLU~? 13.09 S2 BME A 300 B 120 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -4.96 18.58 65.50 -6.34 17.73 64.12 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 B 28 GLU A 96 GLU.? 20.00 O1 BME A 300 B 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -4.96 18.58 65.50 -6.34 17.73 64.12 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 B 28 GLU A 99 GLU.? 20.82 S2 BME A 300 B 120 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -4.96 18.58 65.50 -6.34 17.73 64.12 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 B 28 GLU A 99 GLU.? 20.82 S2 BME A 300 B 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -18.25 19.28 62.84 -16.77 17.78 62.83 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -4.96 18.58 65.50 -6.34 17.73 64.12 10.74 -14.23 -6.96 9.54 -15.53 -8.09 2fmn_c01 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 9 hits 2fmn_c01 naa= 2 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 C 28 GLU A 15 GLU~? 24.22 S2 BME A 300 C 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 6.94 9.23 -7.95 6.28 8.57 -6.07 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 C 28 GLU A 28 GLU~? 14.38 S2 BME A 300 C 120 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 C 28 GLU A 28 GLU~? 14.38 S2 BME A 300 C 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 21.30 -17.97 5.16 20.86 -18.94 6.97 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 C 28 GLU A 29 GLU~? 6.68 S2 BME A 300 C 120 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 19.36 -9.90 14.44 17.51 -11.01 14.77 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 C 28 GLU A 29 GLU~? 6.68 S2 BME A 300 C 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 15.50 -15.19 4.21 14.37 -14.08 5.62 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 C 28 GLU A 74 GLU~? 13.09 S2 BME A 300 C 120 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 6.36 -0.87 15.92 5.32 -2.36 17.02 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 C 28 GLU A 96 GLU.? 20.00 O1 BME A 300 C 120 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 C 28 GLU A 99 GLU.? 20.82 S2 BME A 300 C 120 ASP A 27 ASP~? 15.09 S2 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 C 28 GLU A 99 GLU.? 20.82 S2 BME A 300 C 120 ASP A 95 ASP.? 15.99 O1 BME A 300 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 10.74 -14.23 -6.96 9.54 -15.53 -8.09 2fmn_c02 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 9 hits 2fmn_c02 naa= 2 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 A 150 TYR A 34 TYR.? 16.37 S2 BME A 300 A 245 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 A 150 TYR A 60 TYR^? 16.66 S2 BME A 300 A 245 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 9.00 3.02 1.57 7.75 5.45 1.00 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 A 150 TYR A 75 TYR~? 15.90 S2 BME A 300 A 245 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 14.46 -0.26 16.60 17.11 0.41 17.22 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 24.97 -2.58 14.97 24.99 -3.62 16.79 2gsa_c00 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c00 naa= 2 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 34 TYR.? 16.37 S2 BME A 300 B 245 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR A 59 TYR^? 18.50 S2 BME A 300 B 245 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 14.59 5.14 5.72 16.82 6.86 5.68 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 150 TYR A 60 TYR^? 16.66 S2 BME A 300 B 245 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 9.00 3.02 1.57 7.75 5.45 1.00 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 10.12 9.33 8.59 8.15 9.51 7.94 2gsa_c01 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c01 naa= 2 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 34 TYR.? 16.37 S2 BME A 300 B 245 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 18.83 -7.61 -2.88 21.31 -7.06 -4.03 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 23.07 -12.79 5.06 23.81 -10.95 5.75 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR A 59 TYR^? 18.50 S2 BME A 300 B 245 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 14.59 5.14 5.72 16.82 6.86 5.68 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 150 TYR A 60 TYR^? 16.66 S2 BME A 300 B 245 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 9.00 3.02 1.57 7.75 5.45 1.00 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 10.12 9.33 8.59 8.15 9.51 7.94 2gsa_c03 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c03 naa= 2 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 157 PHE A 53 PHE~? 16.58 S2 BME A 300 B 245 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 17.96 4.29 9.15 17.54 1.52 8.86 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 10.12 9.33 8.59 8.15 9.51 7.94 2gsa_c05 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c05 naa= 2 ULMN 2 2jcw_c00 CU/ZN SUPEROXIDE DISMUTASE user 1 2 # 1 63 HIS A 91 HIS~? 7.63 O1 BME A 300 143 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 7.37 21.96 20.34 6.83 20.29 19.19 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 2.05 15.79 24.54 1.75 18.84 24.36 13.39 -11.16 2.90 14.53 -11.26 0.04 2jcw_c00 source 2jcw CU/ZN SUPEROXIDE DISMUTASE : 1 hits 2jcw_c00 naa= 2 ULMN 2 2npx_c00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 1 2 # 1 37 ILE A 58 ILE^? 20.10 S2 BME A 300 42 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 23.96 38.25 125.15 23.87 37.68 123.87 9.94 8.39 3.74 8.69 8.76 3.47 coo 36.88 46.86 127.06 36.03 46.98 124.43 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 2 2npx_c00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 2 2 # 2 37 ILE A 81 ILE.? 18.92 S2 BME A 300 42 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 23.96 38.25 125.15 23.87 37.68 123.87 14.28 6.83 11.64 15.36 6.24 11.41 coo 36.88 46.86 127.06 36.03 46.98 124.43 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 2 2npx_c00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 3 2 # 3 37 ILE A 100 ILE.? 19.99 S2 BME A 300 42 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 23.96 38.25 125.15 23.87 37.68 123.87 21.53 -12.29 -7.18 21.37 -13.39 -7.89 coo 36.88 46.86 127.06 36.03 46.98 124.43 10.91 -8.39 4.98 11.88 -9.73 7.18 2npx_c00 source 2npx NADH PEROXIDASE (E.C.1.11.1.1) WITH CYS 42 OXI: 3 hits 2npx_c00 naa= 2 ULMN 2 2oat_c00 ORNITHINE AMINOTRANSFERASE user 1 2 # 1 A 178 TRP A 93 TRP~? 14.44 S2 BME A 300 A 263 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 48.96 45.07 19.49 48.62 41.39 18.16 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 54.43 44.82 23.74 55.21 45.06 21.80 10.74 -14.23 -6.96 9.54 -15.53 -8.09 2oat_c00 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c00 naa= 2 ULMN 2 2oat_c01 ORNITHINE AMINOTRANSFERASE user 1 2 # 1 B 178 TRP A 93 TRP~? 14.44 S2 BME A 300 B 263 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 45.83 31.15 4.65 45.88 34.74 6.24 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 10.74 -14.23 -6.96 9.54 -15.53 -8.09 2oat_c01 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c01 naa= 2 ULMN 2 2oat_c02 ORNITHINE AMINOTRANSFERASE user 1 2 # 1 C 178 TRP A 93 TRP~? 14.44 S2 BME A 300 C 263 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 20.52 16.65 4.15 17.32 18.91 4.39 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 19.84 12.02 9.33 18.68 11.23 7.75 10.74 -14.23 -6.96 9.54 -15.53 -8.09 2oat_c02 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c02 naa= 2 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 1 2 # 1 131 ASP A 23 ASP^? 9.45 S2 BME A 300 218 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 29.20 21.16 -9.67 28.83 20.92 -7.62 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 2 2 # 2 131 ASP A 27 ASP~? 15.09 S2 BME A 300 218 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 3 2 # 3 131 ASP A 27 ASP~? 15.09 S2 BME A 300 218 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 29.20 21.16 -9.67 28.83 20.92 -7.62 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 4 2 # 4 131 ASP A 44 ASP~? 11.03 S2 BME A 300 218 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 5 2 # 5 131 ASP A 95 ASP.? 15.99 O1 BME A 300 218 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 13.39 -11.16 2.90 14.53 -11.26 0.04 2pec_c00 source 2pec PECTATE LYASE C (PLC) (E.C.4.2.2.2) : 5 hits 2pec_c00 naa= 2 ULMN 2 2phk_c00 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 7 ASP~? 16.68 O1 BME A 300 A 153 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 51.07 15.29 42.97 50.55 17.18 42.21 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 2phk_c00 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 23 ASP^? 9.45 S2 BME A 300 A 153 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 51.07 15.29 42.97 50.55 17.18 42.21 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 2phk_c00 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 23 ASP^? 9.45 S2 BME A 300 A 153 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 51.07 15.29 42.97 50.55 17.18 42.21 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 2phk_c00 MC-PEPTIDE user 4 2 # 4 A 149 ASP A 44 ASP~? 11.03 S2 BME A 300 A 153 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 51.07 15.29 42.97 50.55 17.18 42.21 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 2phk_c00 MC-PEPTIDE user 5 2 # 5 A 149 ASP A 82 ASP^? 20.57 S2 BME A 300 A 153 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 10.12 9.33 8.59 8.15 9.51 7.94 coo 51.07 15.29 42.97 50.55 17.18 42.21 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 2 2phk_c00 MC-PEPTIDE user 6 2 # 6 A 149 ASP A 95 ASP.? 15.99 O1 BME A 300 A 153 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 51.07 15.29 42.97 50.55 17.18 42.21 15.50 -15.19 4.21 14.37 -14.08 5.62 2phk_c00 source 2phk MC-PEPTIDE : 6 hits 2phk_c00 naa= 2 ULMN 2 2phk_c01 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 7 ASP~? 16.68 O1 BME A 300 A 151 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 45.75 16.58 39.61 47.43 18.26 45.54 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 2phk_c01 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 23 ASP^? 9.45 S2 BME A 300 A 151 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 45.75 16.58 39.61 47.43 18.26 45.54 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 2phk_c01 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 82 ASP^? 20.57 S2 BME A 300 A 151 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 41.42 17.90 44.98 43.39 18.36 45.61 10.12 9.33 8.59 8.15 9.51 7.94 coo 45.75 16.58 39.61 47.43 18.26 45.54 15.98 12.20 9.88 16.28 11.97 16.11 2phk_c01 source 2phk MC-PEPTIDE : 3 hits 2phk_c01 naa= 2 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 A 549 ASP A 7 ASP~? 16.68 O1 BME A 300 A 655 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 A 549 ASP A 23 ASP^? 9.45 S2 BME A 300 A 655 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 A 549 ASP A 23 ASP^? 9.45 S2 BME A 300 A 655 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 A 549 ASP A 23 ASP^? 9.45 S2 BME A 300 A 655 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 A 549 ASP A 27 ASP~? 15.09 S2 BME A 300 A 655 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 A 549 ASP A 48 ASP~? 19.85 S2 BME A 300 A 655 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 A 549 ASP A 82 ASP^? 20.57 S2 BME A 300 A 655 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 10.12 9.33 8.59 8.15 9.51 7.94 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 A 549 ASP A 95 ASP.? 15.99 O1 BME A 300 A 655 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 23.07 -12.79 5.06 23.81 -10.95 5.75 2qf7_c00 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 8 hits 2qf7_c00 naa= 2 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 B 549 ASP A 7 ASP~? 16.68 O1 BME A 300 B 655 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 66.54 57.43 28.71 66.94 55.81 27.41 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 B 549 ASP A 7 ASP~? 16.68 O1 BME A 300 B 655 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 66.54 57.43 28.71 66.94 55.81 27.41 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 B 549 ASP A 23 ASP^? 9.45 S2 BME A 300 B 655 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 66.54 57.43 28.71 66.94 55.81 27.41 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 B 549 ASP A 23 ASP^? 9.45 S2 BME A 300 B 655 ASP A 48 ASP~? 19.85 S2 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 66.54 57.43 28.71 66.94 55.81 27.41 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 B 549 ASP A 23 ASP^? 9.45 S2 BME A 300 B 655 ASP A 82 ASP^? 20.57 S2 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 66.54 57.43 28.71 66.94 55.81 27.41 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 B 549 ASP A 27 ASP~? 15.09 S2 BME A 300 B 655 ASP A 95 ASP.? 15.99 O1 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 66.54 57.43 28.71 66.94 55.81 27.41 10.74 -14.23 -6.96 9.54 -15.53 -8.09 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 B 549 ASP A 48 ASP~? 19.85 S2 BME A 300 B 655 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 66.54 57.43 28.71 66.94 55.81 27.41 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 B 549 ASP A 82 ASP^? 20.57 S2 BME A 300 B 655 ASP A 23 ASP^? 9.45 S2 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 10.12 9.33 8.59 8.15 9.51 7.94 coo 66.54 57.43 28.71 66.94 55.81 27.41 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 9 2 # 9 B 549 ASP A 95 ASP.? 15.99 O1 BME A 300 B 655 ASP A 7 ASP~? 16.68 O1 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 66.54 57.43 28.71 66.94 55.81 27.41 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 10 2 # 10 B 549 ASP A 95 ASP.? 15.99 O1 BME A 300 B 655 ASP A 27 ASP~? 15.09 S2 BME A 300 coo 76.34 71.89 30.92 75.58 70.99 29.16 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 66.54 57.43 28.71 66.94 55.81 27.41 23.07 -12.79 5.06 23.81 -10.95 5.75 2qf7_c01 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 10 hits 2qf7_c01 naa= 2 ULMN 2 2thi_c00 THIAMINASE I user 1 2 # 1 A 113 CYH A 63 CYH.? -3.36 S2 BME A 300s A 241 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 34.48 86.17 8.89 35.98 87.52 6.88 10.91 -8.39 4.98 11.88 -9.73 7.18 coo 41.40 85.25 6.42 39.33 85.57 6.74 15.50 -15.19 4.21 14.37 -14.08 5.62 2thi_c00 source 2thi THIAMINASE I : 1 hits 2thi_c00 naa= 2 ULMN 2 2thi_c01 THIAMINASE I user 1 2 # 1 B 113 CYH A 63 CYH.? -3.36 S2 BME A 300s B 241 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 6.76 34.20 8.77 5.34 32.83 6.71 10.91 -8.39 4.98 11.88 -9.73 7.18 coo -0.20 35.10 6.38 1.89 34.79 6.65 15.50 -15.19 4.21 14.37 -14.08 5.62 2thi_c01 source 2thi THIAMINASE I : 1 hits 2thi_c01 naa= 2 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 A 158 ASP A 23 ASP^? 9.45 S2 BME A 300 A 185 ASN A 37 ASN.? 22.15 S2 BME A 300 coo 18.62 26.83 58.17 18.48 28.64 57.08 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 11.83 33.94 58.73 11.65 35.30 57.09 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 A 158 ASP A 44 ASP~? 11.03 S2 BME A 300 A 185 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 18.62 26.83 58.17 18.48 28.64 57.08 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 11.83 33.94 58.73 11.65 35.30 57.09 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 2 # 3 A 158 ASP A 48 ASP~? 19.85 S2 BME A 300 A 185 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 18.62 26.83 58.17 18.48 28.64 57.08 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 11.83 33.94 58.73 11.65 35.30 57.09 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 2 # 4 A 158 ASP A 82 ASP^? 20.57 S2 BME A 300 A 185 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 18.62 26.83 58.17 18.48 28.64 57.08 10.12 9.33 8.59 8.15 9.51 7.94 coo 11.83 33.94 58.73 11.65 35.30 57.09 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 2 # 5 A 158 ASP A 82 ASP^? 20.57 S2 BME A 300 A 185 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 18.62 26.83 58.17 18.48 28.64 57.08 10.12 9.33 8.59 8.15 9.51 7.94 coo 11.83 33.94 58.73 11.65 35.30 57.09 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 4mdh_c00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 2 # 6 A 158 ASP A 82 ASP^? 20.57 S2 BME A 300 A 185 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 18.62 26.83 58.17 18.48 28.64 57.08 10.12 9.33 8.59 8.15 9.51 7.94 coo 11.83 33.94 58.73 11.65 35.30 57.09 15.66 5.60 16.72 16.27 4.24 18.24 4mdh_c00 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 6 hits 4mdh_c00 naa= 2 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 B 158 ASP A 23 ASP^? 9.45 S2 BME A 300 B 185 ASN A 37 ASN.? 22.15 S2 BME A 300 coo 44.53 16.44 28.54 44.89 18.45 28.77 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 54.37 18.81 28.31 54.76 20.47 29.61 18.58 0.66 -5.47 19.39 1.00 -7.43 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 B 158 ASP A 44 ASP~? 11.03 S2 BME A 300 B 185 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 44.53 16.44 28.54 44.89 18.45 28.77 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 54.37 18.81 28.31 54.76 20.47 29.61 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 2 # 3 B 158 ASP A 48 ASP~? 19.85 S2 BME A 300 B 185 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 44.53 16.44 28.54 44.89 18.45 28.77 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 54.37 18.81 28.31 54.76 20.47 29.61 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 2 # 4 B 158 ASP A 82 ASP^? 20.57 S2 BME A 300 B 185 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 44.53 16.44 28.54 44.89 18.45 28.77 10.12 9.33 8.59 8.15 9.51 7.94 coo 54.37 18.81 28.31 54.76 20.47 29.61 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 2 # 5 B 158 ASP A 82 ASP^? 20.57 S2 BME A 300 B 185 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 44.53 16.44 28.54 44.89 18.45 28.77 10.12 9.33 8.59 8.15 9.51 7.94 coo 54.37 18.81 28.31 54.76 20.47 29.61 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 2 # 6 B 158 ASP A 82 ASP^? 20.57 S2 BME A 300 B 185 ASN A 79 ASN.? 19.89 S2 BME A 300 coo 44.53 16.44 28.54 44.89 18.45 28.77 10.12 9.33 8.59 8.15 9.51 7.94 coo 54.37 18.81 28.31 54.76 20.47 29.61 15.66 5.60 16.72 16.27 4.24 18.24 4mdh_c01 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 6 hits 4mdh_c01 naa= 2 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 2 # 1 127 ARG A 25 ARG.? 9.68 S2 BME A 300 270 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 2 # 2 127 ARG A 25 ARG.? 9.68 S2 BME A 300 270 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 2 # 3 127 ARG A 68 ARG~? -4.35 S2 BME A 300s 270 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 2 # 4 127 ARG A 68 ARG~? -4.35 S2 BME A 300s 270 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 6.36 -0.87 15.92 5.32 -2.36 17.02 5cpa_c00 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 4 hits 5cpa_c00 naa= 2 ULMN 2 5eat_c00 5-EPI-ARISTOLOCHENE SYNTHASE user 1 2 # 1 273 TRP A 93 TRP~? 14.44 S2 BME A 300 527 TYR A 34 TYR.? 16.37 S2 BME A 300 coo 117.04 37.52 43.58 116.69 37.55 47.50 9.46 -7.28 -5.55 9.24 -3.36 -5.14 coo 115.56 42.29 49.60 115.28 44.39 47.77 18.83 -7.61 -2.88 21.31 -7.06 -4.03 5eat_c00 source 5eat 5-EPI-ARISTOLOCHENE SYNTHASE : 1 hits 5eat_c00 naa= 2 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 191 HIS A 91 HIS~? 7.63 O1 BME A 300 345 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 87.81 42.65 46.75 88.49 40.86 45.92 3.84 -13.89 0.30 2.26 -15.26 0.08 coo 103.66 43.57 23.68 98.86 47.65 23.32 13.04 11.19 -6.33 8.80 12.60 -2.10 5enl_c02 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 1 hits 5enl_c02 naa= 2 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 242 LYS A 10 LYS~? 16.18 O1 BME A 300 345 LYS A 55 LYS.? 25.54 S2 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 103.66 43.57 23.68 98.86 47.65 23.32 15.98 12.20 9.88 16.28 11.97 16.11 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 2 # 2 242 LYS A 10 LYS~? 16.18 O1 BME A 300 345 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 103.66 43.57 23.68 98.86 47.65 23.32 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 3 2 # 3 242 LYS A 12 LYS~? 21.81 S2 BME A 300 345 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 103.66 43.57 23.68 98.86 47.65 23.32 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 4 2 # 4 242 LYS A 12 LYS~? 21.81 S2 BME A 300 345 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 99.51 55.26 43.28 102.26 58.28 46.19 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 103.66 43.57 23.68 98.86 47.65 23.32 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 5 2 # 5 242 LYS A 17 LYS.? 25.68 S2 BME A 300 345 LYS A 101 LYS.? -19.93 S2 BME A 300s coo 99.51 55.26 43.28 102.26 58.28 46.19 13.04 11.19 -6.33 8.80 12.60 -2.10 coo 103.66 43.57 23.68 98.86 47.65 23.32 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 6 2 # 6 242 LYS A 55 LYS.? 25.54 S2 BME A 300 345 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 15.98 12.20 9.88 16.28 11.97 16.11 coo 103.66 43.57 23.68 98.86 47.65 23.32 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 7 2 # 7 242 LYS A 71 LYS~? 8.54 S2 BME A 300 345 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 8 2 # 8 242 LYS A 71 LYS~? 8.54 S2 BME A 300 345 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 9 2 # 9 242 LYS A 101 LYS.? -19.93 S2 BME A 300s 345 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 10 2 # 10 242 LYS A 101 LYS.? -19.93 S2 BME A 300s 345 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 99.51 55.26 43.28 102.26 58.28 46.19 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo 103.66 43.57 23.68 98.86 47.65 23.32 13.04 11.19 -6.33 8.80 12.60 -2.10 5enl_c03 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 10 hits 5enl_c03 naa= 2 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 1 2 # 1 151 ASP A 7 ASP~? 16.68 O1 BME A 300 277 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 25.08 13.39 65.77 24.68 15.22 66.73 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 24.99 20.41 57.94 24.48 20.83 59.94 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 2 2 # 2 151 ASP A 23 ASP^? 9.45 S2 BME A 300 277 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 25.08 13.39 65.77 24.68 15.22 66.73 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 24.99 20.41 57.94 24.48 20.83 59.94 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 3 2 # 3 151 ASP A 23 ASP^? 9.45 S2 BME A 300 277 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 25.08 13.39 65.77 24.68 15.22 66.73 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 24.99 20.41 57.94 24.48 20.83 59.94 20.94 -6.78 -7.87 21.43 -4.80 -7.49 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 4 2 # 4 151 ASP A 44 ASP~? 11.03 S2 BME A 300 277 GLU A 28 GLU~? 14.38 S2 BME A 300 coo 25.08 13.39 65.77 24.68 15.22 66.73 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 24.99 20.41 57.94 24.48 20.83 59.94 21.30 -17.97 5.16 20.86 -18.94 6.97 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 5 2 # 5 151 ASP A 44 ASP~? 11.03 S2 BME A 300 277 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 25.08 13.39 65.77 24.68 15.22 66.73 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 24.99 20.41 57.94 24.48 20.83 59.94 15.50 -15.19 4.21 14.37 -14.08 5.62 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 6 2 # 6 151 ASP A 95 ASP.? 15.99 O1 BME A 300 277 GLU A 29 GLU~? 6.68 S2 BME A 300 coo 25.08 13.39 65.77 24.68 15.22 66.73 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 24.99 20.41 57.94 24.48 20.83 59.94 15.50 -15.19 4.21 14.37 -14.08 5.62 7nn9_c00 source 7nn9 NEURAMINIDASE N9 : 6 hits 7nn9_c00 naa= 2 ULMN 2 8tln_c00 VAL-LYS DIPEPTIDE user 1 2 # 1 E 143 GLU A 29 GLU~? 6.68 S2 BME A 300 E 231 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 32.08 45.78 -2.96 33.40 44.57 -4.14 15.50 -15.19 4.21 14.37 -14.08 5.62 coo 41.22 40.67 -7.44 39.17 40.76 -7.88 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 8tln_c00 VAL-LYS DIPEPTIDE user 2 2 # 2 E 143 GLU A 87 GLU.? 12.12 O1 BME A 300 E 231 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 32.08 45.78 -2.96 33.40 44.57 -4.14 0.17 -4.11 3.03 -1.78 -3.73 3.87 coo 41.22 40.67 -7.44 39.17 40.76 -7.88 3.84 -13.89 0.30 2.26 -15.26 0.08 ULMN 2 8tln_c00 VAL-LYS DIPEPTIDE user 3 2 # 3 E 143 GLU A 96 GLU.? 20.00 O1 BME A 300 E 231 HIS A 91 HIS~? 7.63 O1 BME A 300 coo 32.08 45.78 -2.96 33.40 44.57 -4.14 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo 41.22 40.67 -7.44 39.17 40.76 -7.88 3.84 -13.89 0.30 2.26 -15.26 0.08 8tln_c00 source 8tln VAL-LYS DIPEPTIDE : 3 hits 8tln_c00 naa= 2 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 75 TYR~? 15.90 S2 BME A 300 A 112 PHE A 53 PHE~? 16.58 S2 BME A 300 A 140 ASN A 49 ASN~? 18.38 S2 BME A 300 coo -6.29 44.15 17.65 -9.00 44.92 17.68 14.46 -0.26 16.60 17.11 0.41 17.22 coo -7.38 52.77 16.75 -5.54 52.71 18.82 17.96 4.29 9.15 17.54 1.52 8.86 coo -4.46 50.64 12.29 -5.69 49.89 13.85 22.96 -0.28 10.82 24.47 -1.69 10.46 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 1 hits 1o8s_p00 naa= 3 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 1 2 # 1 A 86 ASP A 95 ASP.? 15.99 O1 BME A 300 A 104 GLY A 94 GLY~? 13.27 O1 BME A 300 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 10.74 -14.23 -6.96 9.54 -15.53 -8.09 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 7.18 -11.38 -5.94 7.80 -10.95 -5.54 1qmo_p00 source 1qmo MANNOSE BINDING LECTIN, FRIL : 1 hits 1qmo_p00 naa= 2 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 59 TYR^? 18.50 S2 BME A 300 A 108 ASN A 51 ASN~? 25.08 S2 BME A 300 A 135 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 17.59 4.66 17.88 15.38 5.96 18.97 14.59 5.14 5.72 16.82 6.86 5.68 coo 12.36 16.24 15.27 12.06 14.29 16.05 25.44 5.20 11.13 26.70 5.92 12.70 coo 18.05 11.56 12.71 17.57 10.75 14.60 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 75 TYR~? 15.90 S2 BME A 300 A 108 ASN A 51 ASN~? 25.08 S2 BME A 300 A 135 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 17.59 4.66 17.88 15.38 5.96 18.97 14.46 -0.26 16.60 17.11 0.41 17.22 coo 12.36 16.24 15.27 12.06 14.29 16.05 25.44 5.20 11.13 26.70 5.92 12.70 coo 18.05 11.56 12.71 17.57 10.75 14.60 22.96 -0.28 10.82 24.47 -1.69 10.46 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 2 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 59 TYR^? 18.50 S2 BME A 300 A 108 ASN A 51 ASN~? 25.08 S2 BME A 300 A 135 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 17.50 4.57 17.85 15.28 5.88 18.97 14.59 5.14 5.72 16.82 6.86 5.68 coo 12.22 15.98 15.24 11.94 14.05 16.09 25.44 5.20 11.13 26.70 5.92 12.70 coo 17.94 11.43 12.65 17.42 10.61 14.53 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 75 TYR~? 15.90 S2 BME A 300 A 108 ASN A 51 ASN~? 25.08 S2 BME A 300 A 135 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 17.50 4.57 17.85 15.28 5.88 18.97 14.46 -0.26 16.60 17.11 0.41 17.22 coo 12.22 15.98 15.24 11.94 14.05 16.09 25.44 5.20 11.13 26.70 5.92 12.70 coo 17.94 11.43 12.65 17.42 10.61 14.53 22.96 -0.28 10.82 24.47 -1.69 10.46 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 2 hits 1uy4_p00 naa= 3 ULMN 2 1xx9_p00 COAGULATION FACTOR XI user 1 2 # 1 A 105 LEU A 9 LEU~? 15.34 S2 BME A 300 A 107 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 14.74 34.20 45.57 16.90 34.20 45.46 6.39 0.21 -2.66 8.38 0.58 -1.75 coo 12.62 34.46 51.51 14.85 38.84 54.29 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1xx9_p00 COAGULATION FACTOR XI user 2 2 # 2 A 105 LEU A 9 LEU~? 15.34 S2 BME A 300 A 107 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 14.74 34.20 45.57 16.90 34.20 45.46 6.39 0.21 -2.66 8.38 0.58 -1.75 coo 12.62 34.46 51.51 14.85 38.84 54.29 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1xx9_p00 COAGULATION FACTOR XI user 3 2 # 3 A 105 LEU A 13 LEU~? 21.24 S2 BME A 300 A 107 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 14.74 34.20 45.57 16.90 34.20 45.46 9.86 2.24 -9.76 10.77 0.60 -8.70 coo 12.62 34.46 51.51 14.85 38.84 54.29 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1xx9_p00 COAGULATION FACTOR XI user 4 2 # 4 A 105 LEU A 13 LEU~? 21.24 S2 BME A 300 A 107 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 14.74 34.20 45.57 16.90 34.20 45.46 9.86 2.24 -9.76 10.77 0.60 -8.70 coo 12.62 34.46 51.51 14.85 38.84 54.29 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1xx9_p00 COAGULATION FACTOR XI user 5 2 # 5 A 105 LEU A 14 LEU~? 26.41 S2 BME A 300 A 107 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 14.74 34.20 45.57 16.90 34.20 45.46 6.47 5.89 -12.18 5.84 4.27 -13.50 coo 12.62 34.46 51.51 14.85 38.84 54.29 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1xx9_p00 COAGULATION FACTOR XI user 6 2 # 6 A 105 LEU A 14 LEU~? 26.41 S2 BME A 300 A 107 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 14.74 34.20 45.57 16.90 34.20 45.46 6.47 5.89 -12.18 5.84 4.27 -13.50 coo 12.62 34.46 51.51 14.85 38.84 54.29 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1xx9_p00 COAGULATION FACTOR XI user 7 2 # 7 A 105 LEU A 40 LEU^? 14.51 S2 BME A 300 A 107 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 14.74 34.20 45.57 16.90 34.20 45.46 21.19 -5.80 2.30 20.52 -6.59 0.34 coo 12.62 34.46 51.51 14.85 38.84 54.29 19.85 -1.20 1.64 21.03 4.07 2.80 1xx9_p00 source 1xx9 COAGULATION FACTOR XI : 7 hits 1xx9_p00 naa= 2 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 25 ARG.? 9.68 S2 BME A 300 A 148 SER A 69 SER~? 5.63 S2 BME A 300 A 152 ALA A 70 ALA~? 8.30 S2 BME A 300 A 194 GLU A 87 GLU.? 12.12 O1 BME A 300 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 6.63 -3.94 11.35 5.27 -4.56 11.61 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 0.17 -4.11 3.03 -1.78 -3.73 3.87 2cl8_p00 source 2cl8 DECTIN-1 : 1 hits 2cl8_p00 naa= 4 ULMN 2 2p3j_p00 VP4 user 1 2 # 1 A 188 TYR A 59 TYR^? 18.50 S2 BME A 300 A 190 SER A 52 SER~? 19.64 S2 BME A 300 coo 47.26 12.29 13.69 48.76 12.40 16.04 14.59 5.14 5.72 16.82 6.86 5.68 coo 43.90 7.13 15.43 45.58 7.50 17.10 22.49 4.36 7.95 23.43 2.12 7.73 ULMN 2 2p3j_p00 VP4 user 2 2 # 2 A 188 TYR A 60 TYR^? 16.66 S2 BME A 300 A 190 SER A 3 SER^? 13.09 C1 BME A 300 coo 47.26 12.29 13.69 48.76 12.40 16.04 9.00 3.02 1.57 7.75 5.45 1.00 coo 43.90 7.13 15.43 45.58 7.50 17.10 2.01 1.27 5.67 0.61 -0.61 5.33 2p3j_p00 source 2p3j VP4 : 2 hits 2p3j_p00 naa= 2 ULMN 2 2qmk_p00 PANCREATIC ALPHA-AMYLASE user 1 2 # 1 A 459 ASN A 49 ASN~? 18.38 S2 BME A 300 A 461 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 10.54 -60.80 7.09 12.67 -60.59 7.14 22.96 -0.28 10.82 24.47 -1.69 10.46 coo 5.69 -61.52 9.40 4.99 -63.37 8.82 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 2qmk_p00 PANCREATIC ALPHA-AMYLASE user 2 2 # 2 A 459 ASN A 51 ASN~? 25.08 S2 BME A 300 A 461 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 10.54 -60.80 7.09 12.67 -60.59 7.14 25.44 5.20 11.13 26.70 5.92 12.70 coo 5.69 -61.52 9.40 4.99 -63.37 8.82 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 2qmk_p00 PANCREATIC ALPHA-AMYLASE user 3 2 # 3 A 459 ASN A 54 ASN.? 24.37 S2 BME A 300 A 461 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 10.54 -60.80 7.09 12.67 -60.59 7.14 19.57 10.98 7.57 19.01 10.99 5.54 coo 5.69 -61.52 9.40 4.99 -63.37 8.82 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 2qmk_p00 PANCREATIC ALPHA-AMYLASE user 4 2 # 4 A 459 ASN A 56 ASN.? 28.57 S2 BME A 300 A 461 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 10.54 -60.80 7.09 12.67 -60.59 7.14 15.96 14.72 5.79 16.70 16.41 6.88 coo 5.69 -61.52 9.40 4.99 -63.37 8.82 19.57 10.98 7.57 19.01 10.99 5.54 2qmk_p00 source 2qmk PANCREATIC ALPHA-AMYLASE : 4 hits 2qmk_p00 naa= 2 ULMN 2 2v3i_p00 EXOGLUCANASE 1 user 1 2 # 1 A 270 ASN A 37 ASN.? 22.15 S2 BME A 300 A 314 PRO A 36 PRO.? 18.77 S2 BME A 300 coo 22.31 63.29 110.86 22.44 65.19 111.73 18.58 0.66 -5.47 19.39 1.00 -7.43 coo 26.96 64.75 109.97 28.68 63.64 110.86 16.36 -4.28 -8.75 16.89 -3.72 -6.60 2v3i_p00 source 2v3i EXOGLUCANASE 1 : 1 hits 2v3i_p00 naa= 2 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 11 ASN~? 22.08 O1 BME A 300 A 384 ASN A 54 ASN.? 24.37 S2 BME A 300 A 385 GLU A 57 GLU.? 23.43 S2 BME A 300 coo 22.28 63.17 110.61 22.47 65.06 111.53 3.09 3.41 -8.04 1.54 2.11 -8.64 coo 7.06 50.07 96.17 8.50 48.54 96.31 19.57 10.98 7.57 19.01 10.99 5.54 coo 11.59 49.83 99.41 10.92 47.97 100.16 16.30 10.78 3.24 16.87 9.97 1.36 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 54 ASN.? 24.37 S2 BME A 300 A 384 ASN A 11 ASN~? 22.08 O1 BME A 300 A 385 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 22.28 63.17 110.61 22.47 65.06 111.53 19.57 10.98 7.57 19.01 10.99 5.54 coo 7.06 50.07 96.17 8.50 48.54 96.31 3.09 3.41 -8.04 1.54 2.11 -8.64 coo 11.59 49.83 99.41 10.92 47.97 100.16 6.94 9.23 -7.95 6.28 8.57 -6.07 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 2 hits 2v3r_p00 naa= 3 ULMN 2 3bai_p00 PANCREATIC ALPHA-AMYLASE user 1 2 # 1 A 459 ASN A 49 ASN~? 18.38 S2 BME A 300 A 461 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 10.94 60.60 59.95 11.55 61.32 58.01 22.96 -0.28 10.82 24.47 -1.69 10.46 coo 5.55 62.82 55.95 5.28 64.78 56.80 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 3bai_p00 PANCREATIC ALPHA-AMYLASE user 2 2 # 2 A 459 ASN A 51 ASN~? 25.08 S2 BME A 300 A 461 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 10.94 60.60 59.95 11.55 61.32 58.01 25.44 5.20 11.13 26.70 5.92 12.70 coo 5.55 62.82 55.95 5.28 64.78 56.80 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 3bai_p00 PANCREATIC ALPHA-AMYLASE user 3 2 # 3 A 459 ASN A 51 ASN~? 25.08 S2 BME A 300 A 461 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 10.94 60.60 59.95 11.55 61.32 58.01 25.44 5.20 11.13 26.70 5.92 12.70 coo 5.55 62.82 55.95 5.28 64.78 56.80 19.57 10.98 7.57 19.01 10.99 5.54 ULMN 2 3bai_p00 PANCREATIC ALPHA-AMYLASE user 4 2 # 4 A 459 ASN A 54 ASN.? 24.37 S2 BME A 300 A 461 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 10.94 60.60 59.95 11.55 61.32 58.01 19.57 10.98 7.57 19.01 10.99 5.54 coo 5.55 62.82 55.95 5.28 64.78 56.80 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 3bai_p00 PANCREATIC ALPHA-AMYLASE user 5 2 # 5 A 459 ASN A 54 ASN.? 24.37 S2 BME A 300 A 461 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 10.94 60.60 59.95 11.55 61.32 58.01 19.57 10.98 7.57 19.01 10.99 5.54 coo 5.55 62.82 55.95 5.28 64.78 56.80 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 3bai_p00 PANCREATIC ALPHA-AMYLASE user 6 2 # 6 A 459 ASN A 56 ASN.? 28.57 S2 BME A 300 A 461 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 10.94 60.60 59.95 11.55 61.32 58.01 15.96 14.72 5.79 16.70 16.41 6.88 coo 5.55 62.82 55.95 5.28 64.78 56.80 19.57 10.98 7.57 19.01 10.99 5.54 3bai_p00 source 3bai PANCREATIC ALPHA-AMYLASE : 6 hits 3bai_p00 naa= 2 ULMN 2 3baw_p00 PANCREATIC ALPHA-AMYLASE user 1 2 # 1 A 459 ASN A 49 ASN~? 18.38 S2 BME A 300 A 461 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 11.20 26.59 -7.00 13.14 25.75 -7.34 22.96 -0.28 10.82 24.47 -1.69 10.46 coo 5.76 27.78 -9.43 5.23 29.61 -8.50 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 3baw_p00 PANCREATIC ALPHA-AMYLASE user 2 2 # 2 A 459 ASN A 51 ASN~? 25.08 S2 BME A 300 A 461 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 11.20 26.59 -7.00 13.14 25.75 -7.34 25.44 5.20 11.13 26.70 5.92 12.70 coo 5.76 27.78 -9.43 5.23 29.61 -8.50 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 3baw_p00 PANCREATIC ALPHA-AMYLASE user 3 2 # 3 A 459 ASN A 54 ASN.? 24.37 S2 BME A 300 A 461 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 11.20 26.59 -7.00 13.14 25.75 -7.34 19.57 10.98 7.57 19.01 10.99 5.54 coo 5.76 27.78 -9.43 5.23 29.61 -8.50 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 3baw_p00 PANCREATIC ALPHA-AMYLASE user 4 2 # 4 A 459 ASN A 56 ASN.? 28.57 S2 BME A 300 A 461 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 11.20 26.59 -7.00 13.14 25.75 -7.34 15.96 14.72 5.79 16.70 16.41 6.88 coo 5.76 27.78 -9.43 5.23 29.61 -8.50 19.57 10.98 7.57 19.01 10.99 5.54 3baw_p00 source 3baw PANCREATIC ALPHA-AMYLASE : 4 hits 3baw_p00 naa= 2 ULMN 2 3bax_p00 PANCREATIC ALPHA-AMYLASE user 1 2 # 1 A 459 ASN A 49 ASN~? 18.38 S2 BME A 300 A 461 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 10.93 26.61 -6.41 12.76 25.58 -6.83 22.96 -0.28 10.82 24.47 -1.69 10.46 coo 5.81 28.00 -9.56 5.25 29.91 -8.91 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 3bax_p00 PANCREATIC ALPHA-AMYLASE user 2 2 # 2 A 459 ASN A 51 ASN~? 25.08 S2 BME A 300 A 461 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 10.93 26.61 -6.41 12.76 25.58 -6.83 25.44 5.20 11.13 26.70 5.92 12.70 coo 5.81 28.00 -9.56 5.25 29.91 -8.91 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 3bax_p00 PANCREATIC ALPHA-AMYLASE user 3 2 # 3 A 459 ASN A 54 ASN.? 24.37 S2 BME A 300 A 461 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 10.93 26.61 -6.41 12.76 25.58 -6.83 19.57 10.98 7.57 19.01 10.99 5.54 coo 5.81 28.00 -9.56 5.25 29.91 -8.91 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 3bax_p00 PANCREATIC ALPHA-AMYLASE user 4 2 # 4 A 459 ASN A 56 ASN.? 28.57 S2 BME A 300 A 461 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 10.93 26.61 -6.41 12.76 25.58 -6.83 15.96 14.72 5.79 16.70 16.41 6.88 coo 5.81 28.00 -9.56 5.25 29.91 -8.91 19.57 10.98 7.57 19.01 10.99 5.54 3bax_p00 source 3bax PANCREATIC ALPHA-AMYLASE : 4 hits 3bax_p00 naa= 2 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 59 TYR^? 18.50 S2 BME A 300 I 306 VAL A 22 VAL^? 12.97 S2 BME A 300 I 308 VAL A 24 VAL.? 8.05 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.59 5.14 5.72 16.82 6.86 5.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.49 -1.26 3.46 16.36 -0.26 5.24 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.68 -6.47 6.85 14.25 -5.17 7.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 59 TYR^? 18.50 S2 BME A 300 I 306 VAL A 22 VAL^? 12.97 S2 BME A 300 I 308 VAL A 62 VAL^? 8.11 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.59 5.14 5.72 16.82 6.86 5.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.49 -1.26 3.46 16.36 -0.26 5.24 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.52 -4.83 3.69 10.95 -5.47 1.63 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 59 TYR^? 18.50 S2 BME A 300 I 306 VAL A 84 VAL^? 14.84 S2 BME A 300 I 308 VAL A 62 VAL^? 8.11 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.59 5.14 5.72 16.82 6.86 5.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 6.77 2.80 6.54 5.77 4.01 5.02 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.52 -4.83 3.69 10.95 -5.47 1.63 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 59 TYR^? 18.50 S2 BME A 300 I 306 VAL A 84 VAL^? 14.84 S2 BME A 300 I 308 VAL A 73 VAL~? 12.09 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.59 5.14 5.72 16.82 6.86 5.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 6.77 2.80 6.54 5.77 4.01 5.02 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.22 0.35 11.81 7.68 0.85 10.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 59 TYR^? 18.50 S2 BME A 300 I 306 VAL A 84 VAL^? 14.84 S2 BME A 300 I 308 VAL A 86 VAL^? 10.46 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.59 5.14 5.72 16.82 6.86 5.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 6.77 2.80 6.54 5.77 4.01 5.02 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.69 -2.55 3.15 7.10 -2.56 1.49 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 60 TYR^? 16.66 S2 BME A 300 I 306 VAL A 22 VAL^? 12.97 S2 BME A 300 I 308 VAL A 24 VAL.? 8.05 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 9.00 3.02 1.57 7.75 5.45 1.00 coo 23.55 29.53 9.81 23.15 27.39 10.24 15.49 -1.26 3.46 16.36 -0.26 5.24 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.68 -6.47 6.85 14.25 -5.17 7.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 60 TYR^? 16.66 S2 BME A 300 I 306 VAL A 62 VAL^? 8.11 S2 BME A 300 I 308 VAL A 24 VAL.? 8.05 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 9.00 3.02 1.57 7.75 5.45 1.00 coo 23.55 29.53 9.81 23.15 27.39 10.24 10.52 -4.83 3.69 10.95 -5.47 1.63 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.68 -6.47 6.85 14.25 -5.17 7.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 60 TYR^? 16.66 S2 BME A 300 I 306 VAL A 84 VAL^? 14.84 S2 BME A 300 I 308 VAL A 73 VAL~? 12.09 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 9.00 3.02 1.57 7.75 5.45 1.00 coo 23.55 29.53 9.81 23.15 27.39 10.24 6.77 2.80 6.54 5.77 4.01 5.02 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.22 0.35 11.81 7.68 0.85 10.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 75 TYR~? 15.90 S2 BME A 300 I 306 VAL A 72 VAL~? 9.85 S2 BME A 300 I 308 VAL A 24 VAL.? 8.05 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.46 -0.26 16.60 17.11 0.41 17.22 coo 23.55 29.53 9.81 23.15 27.39 10.24 11.63 -2.55 12.61 13.22 -3.01 11.19 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.68 -6.47 6.85 14.25 -5.17 7.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 75 TYR~? 15.90 S2 BME A 300 I 306 VAL A 73 VAL~? 12.09 S2 BME A 300 I 308 VAL A 84 VAL^? 14.84 S2 BME A 300 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.46 -0.26 16.60 17.11 0.41 17.22 coo 23.55 29.53 9.81 23.15 27.39 10.24 9.22 0.35 11.81 7.68 0.85 10.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 6.77 2.80 6.54 5.77 4.01 5.02 1cqt_d00 source 1cqt GENE REGULATION/DNA : 10 hits 1cqt_d00 naa= 3 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 1 2 # 1 B 3 ARG A 25 ARG.? 9.68 S2 BME A 300 B 23 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -4.82 6.94 7.68 -7.31 2.71 11.39 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 2 2 # 2 B 3 ARG A 25 ARG.? 9.68 S2 BME A 300 B 23 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -4.82 6.94 7.68 -7.31 2.71 11.39 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 3 2 # 3 B 3 ARG A 25 ARG.? 9.68 S2 BME A 300 B 23 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 13.39 -11.16 2.90 14.53 -11.26 0.04 coo -4.82 6.94 7.68 -7.31 2.71 11.39 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 1egw_d00 TRANSCRIPTION/DNA user 4 2 # 4 B 3 ARG A 68 ARG~? -4.35 S2 BME A 300s B 23 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -9.35 -6.75 13.18 -8.87 -6.96 16.20 12.31 -11.28 10.33 12.92 -12.61 7.64 coo -4.82 6.94 7.68 -7.31 2.71 11.39 19.85 -1.20 1.64 21.03 4.07 2.80 1egw_d00 source 1egw TRANSCRIPTION/DNA : 4 hits 1egw_d00 naa= 2 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 10 LYS~? 16.18 O1 BME A 300 D 25 THR A 5 THR~? 15.55 O1 BME A 300 D 27 SER A 3 SER^? 13.09 C1 BME A 300 coo 86.60 33.38 44.00 87.05 39.52 42.71 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 81.20 31.58 48.03 79.23 32.24 47.54 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 coo 79.09 29.82 54.20 77.17 28.90 53.05 2.01 1.27 5.67 0.61 -0.61 5.33 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 1 hits 1mjo_d00 naa= 3 ULMN 2 1oup_d00 HYDROLASE/DNA user 1 2 # 1 A 72 ARG A 25 ARG.? 9.68 S2 BME A 300 A 100 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 19.97 27.85 31.70 17.85 26.95 29.64 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 15.66 34.43 15.50 18.97 32.01 19.25 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 1oup_d00 HYDROLASE/DNA user 2 2 # 2 A 72 ARG A 25 ARG.? 9.68 S2 BME A 300 A 100 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 19.97 27.85 31.70 17.85 26.95 29.64 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 15.66 34.43 15.50 18.97 32.01 19.25 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 1oup_d00 HYDROLASE/DNA user 3 2 # 3 A 72 ARG A 25 ARG.? 9.68 S2 BME A 300 A 100 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 19.97 27.85 31.70 17.85 26.95 29.64 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 15.66 34.43 15.50 18.97 32.01 19.25 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 1oup_d00 HYDROLASE/DNA user 4 2 # 4 A 72 ARG A 68 ARG~? -4.35 S2 BME A 300s A 100 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 19.97 27.85 31.70 17.85 26.95 29.64 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 15.66 34.43 15.50 18.97 32.01 19.25 2.39 3.95 8.25 5.67 8.88 7.74 1oup_d00 source 1oup HYDROLASE/DNA : 4 hits 1oup_d00 naa= 2 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 2 LYS.? 20.18 S2 BME A 300 A1294 ASN A 85 ASN^? 8.15 S2 BME A 300 A1297 GLU A 74 GLU~? 13.09 S2 BME A 300 coo 39.24 18.84-161.99 36.62 21.47-165.99 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.53 17.37-161.81 34.31 17.81-163.76 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 29.78 23.31-161.30 31.23 23.66-162.84 6.36 -0.87 15.92 5.32 -2.36 17.02 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 2 LYS.? 20.18 S2 BME A 300 A1294 ASN A 85 ASN^? 8.15 S2 BME A 300 A1297 GLU A 87 GLU.? 12.12 O1 BME A 300 coo 39.24 18.84-161.99 36.62 21.47-165.99 2.39 3.95 8.25 5.67 8.88 7.74 coo 33.53 17.37-161.81 34.31 17.81-163.76 5.01 -1.60 7.62 5.37 -3.69 7.71 coo 29.78 23.31-161.30 31.23 23.66-162.84 0.17 -4.11 3.03 -1.78 -3.73 3.87 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS A 10 LYS~? 16.18 O1 BME A 300 A1294 ASN A 11 ASN~? 22.08 O1 BME A 300 A1297 GLU A 15 GLU~? 24.22 S2 BME A 300 coo 39.24 18.84-161.99 36.62 21.47-165.99 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 33.53 17.37-161.81 34.31 17.81-163.76 3.09 3.41 -8.04 1.54 2.11 -8.64 coo 29.78 23.31-161.30 31.23 23.66-162.84 6.94 9.23 -7.95 6.28 8.57 -6.07 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS A 12 LYS~? 21.81 S2 BME A 300 A1294 ASN A 11 ASN~? 22.08 O1 BME A 300 A1297 GLU A 8 GLU~? 18.47 O1 BME A 300 coo 39.24 18.84-161.99 36.62 21.47-165.99 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 33.53 17.37-161.81 34.31 17.81-163.76 3.09 3.41 -8.04 1.54 2.11 -8.64 coo 29.78 23.31-161.30 31.23 23.66-162.84 -0.20 1.85 -3.14 -1.06 2.30 -1.20 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS A 39 LYS^? 20.06 S2 BME A 300 A1294 ASN A 37 ASN.? 22.15 S2 BME A 300 A1297 GLU A 99 GLU.? 20.82 S2 BME A 300 coo 39.24 18.84-161.99 36.62 21.47-165.99 19.85 -1.20 1.64 21.03 4.07 2.80 coo 33.53 17.37-161.81 34.31 17.81-163.76 18.58 0.66 -5.47 19.39 1.00 -7.43 coo 29.78 23.31-161.30 31.23 23.66-162.84 20.94 -6.78 -7.87 21.43 -4.80 -7.49 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 5 hits 1xpx_d00 naa= 3 ULMN 2 2bnw_d00 DNA-BINDING/REGULATORY PROTEIN user 1 2 # 1 C 29 THR A 26 THR~? 9.55 S2 BME A 300 C 31 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 34.25 12.25 21.93 34.58 12.95 19.89 18.56 -12.42 6.87 17.83 -14.33 7.60 coo 26.40 15.79 19.69 26.97 16.79 16.86 12.31 -11.28 10.33 12.92 -12.61 7.64 2bnw_d00 source 2bnw DNA-BINDING/REGULATORY PROTEIN : 1 hits 2bnw_d00 naa= 2 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 1 2 # 1 G1014 LYS A 12 LYS~? 21.81 S2 BME A 300 G1042 ARG A 68 ARG~? -4.35 S2 BME A 300s coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 7.13 5.12 -6.84 5.25 7.73 -2.58 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 2 2 # 2 G1014 LYS A 17 LYS.? 25.68 S2 BME A 300 G1042 ARG A 25 ARG.? 9.68 S2 BME A 300 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 13.04 11.19 -6.33 8.80 12.60 -2.10 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 13.39 -11.16 2.90 14.53 -11.26 0.04 ULMN 2 2f8n_d00 STRUCTURAL PROTEIN/DNA user 3 2 # 3 G1014 LYS A 55 LYS.? 25.54 S2 BME A 300 G1042 ARG A 25 ARG.? 9.68 S2 BME A 300 coo -84.33 -13.90 85.53 -85.53 -20.01 86.48 15.98 12.20 9.88 16.28 11.97 16.11 coo -63.29 -26.20 76.78 -63.72 -25.66 79.76 13.39 -11.16 2.90 14.53 -11.26 0.04 2f8n_d00 source 2f8n STRUCTURAL PROTEIN/DNA : 3 hits 2f8n_d00 naa= 2 ULMN 2 2jxi_d00 DNA BINDING PROTEIN, DNA user 1 2 # 1 B 50 THR A 6 THR~? 12.27 O1 BME A 300 B 75 HIS A 91 HIS~? 7.63 O1 BME A 300 coo -0.41 4.77 5.26 -2.32 5.64 4.71 3.82 -3.37 -2.85 3.90 -5.51 -2.59 coo -8.73 -0.98 4.47 -7.89 0.86 5.05 3.84 -13.89 0.30 2.26 -15.26 0.08 2jxi_d00 source 2jxi DNA BINDING PROTEIN, DNA : 1 hits 2jxi_d00 naa= 2 ULMN 2 2w36_d00 HYDROLASE user 1 2 # 1 A 81 ILE A 35 ILE.? 14.29 S2 BME A 300 A 82 PRO A 36 PRO.? 18.77 S2 BME A 300 coo 16.70 36.15 9.74 15.48 35.45 9.87 13.89 -4.42 -3.92 12.58 -3.84 -3.70 coo 18.14 40.55 6.78 18.13 39.84 8.91 16.36 -4.28 -8.75 16.89 -3.72 -6.60 ULMN 2 2w36_d00 HYDROLASE user 2 2 # 2 A 81 ILE A 41 ILE.? 14.39 S2 BME A 300 A 82 PRO A 42 PRO~? 11.96 S2 BME A 300 coo 16.70 36.15 9.74 15.48 35.45 9.87 20.13 -3.02 7.42 20.56 -1.72 7.86 coo 18.14 40.55 6.78 18.13 39.84 8.91 21.20 -8.68 7.66 19.62 -7.16 8.23 ULMN 2 2w36_d00 HYDROLASE user 3 2 # 3 A 81 ILE A 46 ILE~? 13.14 S2 BME A 300 A 82 PRO A 47 PRO~? 16.35 S2 BME A 300 coo 16.70 36.15 9.74 15.48 35.45 9.87 17.99 -2.79 12.64 17.34 -1.74 11.64 coo 18.14 40.55 6.78 18.13 39.84 8.91 19.20 -3.02 17.30 20.25 -1.76 15.75 2w36_d00 source 2w36 HYDROLASE : 3 hits 2w36_d00 naa= 2 ULMN 2 2y9z_d00 TRANSCRIPTION user 1 2 # 1 A 987 ASN A 49 ASN~? 18.38 S2 BME A 300 A 988 ASN A 51 ASN~? 25.08 S2 BME A 300 coo 106.56 11.35 44.90 105.45 13.05 44.25 22.96 -0.28 10.82 24.47 -1.69 10.46 coo 106.91 11.19 50.72 106.77 9.24 49.89 25.44 5.20 11.13 26.70 5.92 12.70 ULMN 2 2y9z_d00 TRANSCRIPTION user 2 2 # 2 A 987 ASN A 51 ASN~? 25.08 S2 BME A 300 A 988 ASN A 49 ASN~? 18.38 S2 BME A 300 coo 106.56 11.35 44.90 105.45 13.05 44.25 25.44 5.20 11.13 26.70 5.92 12.70 coo 106.91 11.19 50.72 106.77 9.24 49.89 22.96 -0.28 10.82 24.47 -1.69 10.46 ULMN 2 2y9z_d00 TRANSCRIPTION user 3 2 # 3 A 987 ASN A 54 ASN.? 24.37 S2 BME A 300 A 988 ASN A 56 ASN.? 28.57 S2 BME A 300 coo 106.56 11.35 44.90 105.45 13.05 44.25 19.57 10.98 7.57 19.01 10.99 5.54 coo 106.91 11.19 50.72 106.77 9.24 49.89 15.96 14.72 5.79 16.70 16.41 6.88 ULMN 2 2y9z_d00 TRANSCRIPTION user 4 2 # 4 A 987 ASN A 56 ASN.? 28.57 S2 BME A 300 A 988 ASN A 54 ASN.? 24.37 S2 BME A 300 coo 106.56 11.35 44.90 105.45 13.05 44.25 15.96 14.72 5.79 16.70 16.41 6.88 coo 106.91 11.19 50.72 106.77 9.24 49.89 19.57 10.98 7.57 19.01 10.99 5.54 2y9z_d00 source 2y9z TRANSCRIPTION : 4 hits 2y9z_d00 naa= 2 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 52 SER~? 19.64 S2 BME A 300 B 37 ASN A 49 ASN~? 18.38 S2 BME A 300 B 45 THR A 26 THR~? 9.55 S2 BME A 300 coo -19.49 41.97 71.08 -17.37 40.80 71.17 22.49 4.36 7.95 23.43 2.12 7.73 coo -23.05 39.62 69.74 -22.86 39.59 67.61 22.96 -0.28 10.82 24.47 -1.69 10.46 coo -30.87 34.84 80.57 -28.94 34.51 81.49 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 52 SER~? 19.64 S2 BME A 300 B 37 ASN A 49 ASN~? 18.38 S2 BME A 300 B 45 THR A 30 THR~? 11.99 S2 BME A 300 coo -19.49 41.97 71.08 -17.37 40.80 71.17 22.49 4.36 7.95 23.43 2.12 7.73 coo -23.05 39.62 69.74 -22.86 39.59 67.61 22.96 -0.28 10.82 24.47 -1.69 10.46 coo -30.87 34.84 80.57 -28.94 34.51 81.49 18.48 -11.65 0.55 19.28 -10.22 2.01 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 5 3cmy_d00 TRANSCRIPTION REGULATOR/DNA user 1 5 # 1 A 2 ARG A 25 ARG.? 9.68 S2 BME A 300 A 5 ARG A 68 ARG~? -4.35 S2 BME A 300s A 47 VAL A 86 VAL^? 10.46 S2 BME A 300 A 50 SER A 3 SER^? 13.09 C1 BME A 300 A 51 ASN A 85 ASN^? 8.15 S2 BME A 300 coo 2.06 -6.55 10.80 -0.58 -5.46 9.64 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 3.72 -1.62 16.17 1.92 0.85 15.88 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 3.74 4.59 4.82 3.83 2.47 5.42 5.69 -2.55 3.15 7.10 -2.56 1.49 coo -0.41 7.75 4.78 -1.71 5.76 4.41 2.01 1.27 5.67 0.61 -0.61 5.33 coo 0.28 6.32 9.33 0.05 4.25 8.83 5.01 -1.60 7.62 5.37 -3.69 7.71 3cmy_d00 source 3cmy TRANSCRIPTION REGULATOR/DNA : 1 hits 3cmy_d00 naa= 5 ULMN 2 3coq_d00 TRANSCRIPTION/DNA user 1 2 # 1 A 18 LYS A 10 LYS~? 16.18 O1 BME A 300 A 19 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 38.38 8.27 102.28 37.90 13.50 105.58 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 40.20 5.61 98.62 41.76 5.18 99.93 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 2 3coq_d00 TRANSCRIPTION/DNA user 2 2 # 2 A 18 LYS A 10 LYS~? 16.18 O1 BME A 300 A 19 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 38.38 8.27 102.28 37.90 13.50 105.58 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 40.20 5.61 98.62 41.76 5.18 99.93 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 2 3coq_d00 TRANSCRIPTION/DNA user 3 2 # 3 A 18 LYS A 12 LYS~? 21.81 S2 BME A 300 A 19 LEU A 9 LEU~? 15.34 S2 BME A 300 coo 38.38 8.27 102.28 37.90 13.50 105.58 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 40.20 5.61 98.62 41.76 5.18 99.93 6.39 0.21 -2.66 8.38 0.58 -1.75 ULMN 2 3coq_d00 TRANSCRIPTION/DNA user 4 2 # 4 A 18 LYS A 12 LYS~? 21.81 S2 BME A 300 A 19 LEU A 13 LEU~? 21.24 S2 BME A 300 coo 38.38 8.27 102.28 37.90 13.50 105.58 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 40.20 5.61 98.62 41.76 5.18 99.93 9.86 2.24 -9.76 10.77 0.60 -8.70 ULMN 2 3coq_d00 TRANSCRIPTION/DNA user 5 2 # 5 A 18 LYS A 12 LYS~? 21.81 S2 BME A 300 A 19 LEU A 14 LEU~? 26.41 S2 BME A 300 coo 38.38 8.27 102.28 37.90 13.50 105.58 7.13 5.12 -6.84 5.25 7.73 -2.58 coo 40.20 5.61 98.62 41.76 5.18 99.93 6.47 5.89 -12.18 5.84 4.27 -13.50 ULMN 2 3coq_d00 TRANSCRIPTION/DNA user 6 2 # 6 A 18 LYS A 39 LYS^? 20.06 S2 BME A 300 A 19 LEU A 40 LEU^? 14.51 S2 BME A 300 coo 38.38 8.27 102.28 37.90 13.50 105.58 19.85 -1.20 1.64 21.03 4.07 2.80 coo 40.20 5.61 98.62 41.76 5.18 99.93 21.19 -5.80 2.30 20.52 -6.59 0.34 3coq_d00 source 3coq TRANSCRIPTION/DNA : 6 hits 3coq_d00 naa= 2 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 1 2 # 1 A 86 ARG A 25 ARG.? 9.68 S2 BME A 300 A 92 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 75.64 41.38 9.40 75.07 44.20 10.47 13.39 -11.16 2.90 14.53 -11.26 0.04 coo 68.74 46.63 6.45 66.12 46.59 4.85 12.31 -11.28 10.33 12.92 -12.61 7.64 ULMN 2 3gfi_d00 TRANSCRIPTION/DNA user 2 2 # 2 A 86 ARG A 68 ARG~? -4.35 S2 BME A 300s A 92 ARG A 25 ARG.? 9.68 S2 BME A 300 coo 75.64 41.38 9.40 75.07 44.20 10.47 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 68.74 46.63 6.45 66.12 46.59 4.85 13.39 -11.16 2.90 14.53 -11.26 0.04 3gfi_d00 source 3gfi TRANSCRIPTION/DNA : 2 hits 3gfi_d00 naa= 2 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG A 68 ARG~? -4.35 S2 BME A 300s B 148 LYS A 10 LYS~? 16.18 O1 BME A 300 B 151 LEU A 9 LEU~? 15.34 S2 BME A 300 B 154 ILE A 21 ILE^? 14.46 S2 BME A 300 coo 13.00 32.05 60.31 16.02 31.73 59.80 12.31 -11.28 10.33 12.92 -12.61 7.64 coo 11.05 44.13 44.68 12.77 44.45 49.56 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo 11.72 38.91 44.77 13.11 39.67 46.23 6.39 0.21 -2.66 8.38 0.58 -1.75 coo 7.03 36.97 46.99 7.83 37.90 47.52 13.55 -0.12 -0.64 12.56 -0.86 -1.45 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 1 hits 3odc_d00 naa= 4 ULMN 2 3qex_d00 TRANSFERASE/DNA user 1 2 # 1 A 706 LYS A 2 LYS.? 20.18 S2 BME A 300 A 734 LYS A 71 LYS~? 8.54 S2 BME A 300 coo -12.90 -10.53 -46.75 -8.78 -6.74 -46.21 2.39 3.95 8.25 5.67 8.88 7.74 coo -12.11 -16.91 -35.98 -15.80 -12.15 -36.51 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 3qex_d00 TRANSFERASE/DNA user 2 2 # 2 A 706 LYS A 10 LYS~? 16.18 O1 BME A 300 A 734 LYS A 17 LYS.? 25.68 S2 BME A 300 coo -12.90 -10.53 -46.75 -8.78 -6.74 -46.21 6.34 -0.11 -7.21 5.79 -6.41 -7.72 coo -12.11 -16.91 -35.98 -15.80 -12.15 -36.51 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 3qex_d00 TRANSFERASE/DNA user 3 2 # 3 A 706 LYS A 17 LYS.? 25.68 S2 BME A 300 A 734 LYS A 10 LYS~? 16.18 O1 BME A 300 coo -12.90 -10.53 -46.75 -8.78 -6.74 -46.21 13.04 11.19 -6.33 8.80 12.60 -2.10 coo -12.11 -16.91 -35.98 -15.80 -12.15 -36.51 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 3qex_d00 TRANSFERASE/DNA user 4 2 # 4 A 706 LYS A 39 LYS^? 20.06 S2 BME A 300 A 734 LYS A 101 LYS.? -19.93 S2 BME A 300s coo -12.90 -10.53 -46.75 -8.78 -6.74 -46.21 19.85 -1.20 1.64 21.03 4.07 2.80 coo -12.11 -16.91 -35.98 -15.80 -12.15 -36.51 25.21 -9.57 -6.43 25.99 -6.47 -1.23 ULMN 2 3qex_d00 TRANSFERASE/DNA user 5 2 # 5 A 706 LYS A 71 LYS~? 8.54 S2 BME A 300 A 734 LYS A 2 LYS.? 20.18 S2 BME A 300 coo -12.90 -10.53 -46.75 -8.78 -6.74 -46.21 8.82 -4.39 14.42 10.42 -10.04 16.23 coo -12.11 -16.91 -35.98 -15.80 -12.15 -36.51 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 3qex_d00 TRANSFERASE/DNA user 6 2 # 6 A 706 LYS A 101 LYS.? -19.93 S2 BME A 300s A 734 LYS A 39 LYS^? 20.06 S2 BME A 300 coo -12.90 -10.53 -46.75 -8.78 -6.74 -46.21 25.21 -9.57 -6.43 25.99 -6.47 -1.23 coo -12.11 -16.91 -35.98 -15.80 -12.15 -36.51 19.85 -1.20 1.64 21.03 4.07 2.80 3qex_d00 source 3qex TRANSFERASE/DNA : 6 hits 3qex_d00 naa= 2 ULMN 2 4av1_d00 TRANSFERASE user 1 2 # 1 A 16 SER A 69 SER~? 5.63 S2 BME A 300 A 18 ARG A 68 ARG~? -4.35 S2 BME A 300s coo 11.59 -11.82 19.62 13.22 -10.05 19.96 9.36 -5.27 9.06 7.58 -5.59 7.43 coo 17.80 -8.92 20.54 20.05 -8.13 22.58 12.31 -11.28 10.33 12.92 -12.61 7.64 4av1_d00 source 4av1 TRANSFERASE : 1 hits 4av1_d00 naa= 2 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 1 2 # 1 B 51 ALA A 31 ALA~? 16.01 S2 BME A 300 B 66 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 21.12 -13.83 -1.18 21.96 -14.90 -0.48 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 2 2 # 2 B 51 ALA A 38 ALA.? 14.54 S2 BME A 300 B 66 LYS A 10 LYS~? 16.18 O1 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 17.61 -1.66 -1.41 16.80 -2.91 -1.17 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 6.34 -0.11 -7.21 5.79 -6.41 -7.72 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 3 2 # 3 B 51 ALA A 38 ALA.? 14.54 S2 BME A 300 B 66 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 17.61 -1.66 -1.41 16.80 -2.91 -1.17 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 4 2 # 4 B 51 ALA A 38 ALA.? 14.54 S2 BME A 300 B 66 LYS A 17 LYS.? 25.68 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 17.61 -1.66 -1.41 16.80 -2.91 -1.17 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 13.04 11.19 -6.33 8.80 12.60 -2.10 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 5 2 # 5 B 51 ALA A 64 ALA.? -4.27 S2 BME A 300s B 66 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 9.64 -11.83 3.81 9.95 -13.24 4.40 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 6 2 # 6 B 51 ALA A 64 ALA.? -4.27 S2 BME A 300s B 66 LYS A 71 LYS~? 8.54 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 9.64 -11.83 3.81 9.95 -13.24 4.40 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 8.82 -4.39 14.42 10.42 -10.04 16.23 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 7 2 # 7 B 51 ALA A 78 ALA~? 19.15 S2 BME A 300 B 66 LYS A 2 LYS.? 20.18 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 11.30 5.32 18.63 11.37 4.04 19.42 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 2.39 3.95 8.25 5.67 8.88 7.74 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 8 2 # 8 B 51 ALA A 83 ALA^? 14.63 S2 BME A 300 B 66 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 9.58 4.45 8.44 10.26 3.43 9.36 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 7.13 5.12 -6.84 5.25 7.73 -2.58 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 9 2 # 9 B 51 ALA A 83 ALA^? 14.63 S2 BME A 300 B 66 LYS A 39 LYS^? 20.06 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 9.58 4.45 8.44 10.26 3.43 9.36 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 19.85 -1.20 1.64 21.03 4.07 2.80 ULMN 2 4g92_d01 TRANSCRIPTION/DNA user 10 2 # 10 B 51 ALA A 92 ALA~? 9.87 O1 BME A 300 B 66 LYS A 12 LYS~? 21.81 S2 BME A 300 coo 39.86 -30.00 -40.76 38.60 -29.19 -40.47 3.61 -9.63 -2.13 2.90 -8.54 -1.35 coo 48.71 -26.46 -51.44 46.36 -23.54 -56.56 7.13 5.12 -6.84 5.25 7.73 -2.58 4g92_d01 source 4g92 TRANSCRIPTION/DNA : 10 hits 4g92_d01 naa= 2 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 99 GLU.? 20.82 S2 BME A 300 A 44 ASP A 23 ASP^? 9.45 S2 BME A 300 A 50 THR A 30 THR~? 11.99 S2 BME A 300 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 18.48 -11.65 0.55 19.28 -10.22 2.01 3hde_o00 source 3HDE LYSOZYME : 1 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 96 GLU.? 20.00 O1 BME A 300 B 44 ASP A 7 ASP~? 16.68 O1 BME A 300 B 50 THR A 6 THR~? 12.27 O1 BME A 300 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 8.57 -11.88 -11.59 9.67 -13.45 -12.41 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 99 GLU.? 20.82 S2 BME A 300 B 44 ASP A 23 ASP^? 9.45 S2 BME A 300 B 50 THR A 30 THR~? 11.99 S2 BME A 300 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 15.97 -5.82 2.06 15.42 -7.84 1.89 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 18.48 -11.65 0.55 19.28 -10.22 2.01 3hde_o01 source 3HDE LYSOZYME : 2 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 99 GLU.? 20.82 S2 BME A 300 C 44 ASP A 23 ASP^? 9.45 S2 BME A 300 C 50 THR A 30 THR~? 11.99 S2 BME A 300 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 20.94 -6.78 -7.87 21.43 -4.80 -7.49 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 25.48 4.87 1.60 23.90 4.95 0.15 18.48 -11.65 0.55 19.28 -10.22 2.01 3hde_o02 source 3HDE LYSOZYME : 1 hits 3hde_o02 naa= 3 ULMN 2 3hde_o03 LYSOZYME user 1 2 # 1 D 44 ASP A 7 ASP~? 16.68 O1 BME A 300 D 50 THR A 5 THR~? 15.55 O1 BME A 300 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 1.20 -1.92 -0.51 -0.74 -1.43 -1.41 ULMN 2 3hde_o03 LYSOZYME user 2 2 # 2 D 44 ASP A 7 ASP~? 16.68 O1 BME A 300 D 50 THR A 6 THR~? 12.27 O1 BME A 300 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 3.82 -3.37 -2.85 3.90 -5.51 -2.59 ULMN 2 3hde_o03 LYSOZYME user 3 2 # 3 D 44 ASP A 23 ASP^? 9.45 S2 BME A 300 D 50 THR A 30 THR~? 11.99 S2 BME A 300 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 15.97 -5.82 2.06 15.42 -7.84 1.89 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 3hde_o03 LYSOZYME user 4 2 # 4 D 44 ASP A 27 ASP~? 15.09 S2 BME A 300 D 50 THR A 26 THR~? 9.55 S2 BME A 300 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 18.56 -12.42 6.87 17.83 -14.33 7.60 ULMN 2 3hde_o03 LYSOZYME user 5 2 # 5 D 44 ASP A 27 ASP~? 15.09 S2 BME A 300 D 50 THR A 30 THR~? 11.99 S2 BME A 300 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 23.07 -12.79 5.06 23.81 -10.95 5.75 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 18.48 -11.65 0.55 19.28 -10.22 2.01 ULMN 2 3hde_o03 LYSOZYME user 6 2 # 6 D 44 ASP A 44 ASP~? 11.03 S2 BME A 300 D 50 THR A 45 THR~? 14.85 S2 BME A 300 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 19.36 -9.90 14.44 17.51 -11.01 14.77 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 21.81 -5.88 13.03 22.64 -6.51 11.11 ULMN 2 3hde_o03 LYSOZYME user 7 2 # 7 D 44 ASP A 48 ASP~? 19.85 S2 BME A 300 D 50 THR A 45 THR~? 14.85 S2 BME A 300 coo 21.14 2.63 -8.02 19.80 2.68 -9.68 24.97 -2.58 14.97 24.99 -3.62 16.79 coo 25.02 -1.03 -10.60 24.75 1.10 -10.80 21.81 -5.88 13.03 22.64 -6.51 11.11 3hde_o03 source 3HDE LYSOZYME : 7 hits 3hde_o03 naa= 2 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 1 2 # 1 B 445 SER A 3 SER^? 13.09 C1 BME A 300 B 524 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 2.01 1.27 5.67 0.61 -0.61 5.33 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 2 2 # 2 B 445 SER A 3 SER^? 13.09 C1 BME A 300 B 524 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 2.01 1.27 5.67 0.61 -0.61 5.33 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 3 2 # 3 B 445 SER A 52 SER~? 19.64 S2 BME A 300 B 524 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 22.49 4.36 7.95 23.43 2.12 7.73 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 4 2 # 4 B 445 SER A 69 SER~? 5.63 S2 BME A 300 B 524 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 3o4g_o01 ACYLAMINO-ACID-RELEASING ENZYME user 5 2 # 5 B 445 SER A 69 SER~? 5.63 S2 BME A 300 B 524 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -12.54 -12.66 -2.73 -13.74 -14.77 -2.32 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -2.46 -15.93 -4.29 -3.78 -17.32 -3.34 19.36 -9.90 14.44 17.51 -11.01 14.77 3o4g_o01 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 5 hits 3o4g_o01 naa= 2 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 1 2 # 1 D 445 SER A 3 SER^? 13.09 C1 BME A 300 D 524 ASP A 7 ASP~? 16.68 O1 BME A 300 coo -21.22 29.97 46.24 -19.61 31.88 46.01 2.01 1.27 5.67 0.61 -0.61 5.33 coo -18.89 26.14 55.97 -17.47 27.48 55.08 0.43 -2.32 -6.15 -0.04 -4.41 -6.14 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 2 2 # 2 D 445 SER A 3 SER^? 13.09 C1 BME A 300 D 524 ASP A 82 ASP^? 20.57 S2 BME A 300 coo -21.22 29.97 46.24 -19.61 31.88 46.01 2.01 1.27 5.67 0.61 -0.61 5.33 coo -18.89 26.14 55.97 -17.47 27.48 55.08 10.12 9.33 8.59 8.15 9.51 7.94 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 3 2 # 3 D 445 SER A 52 SER~? 19.64 S2 BME A 300 D 524 ASP A 48 ASP~? 19.85 S2 BME A 300 coo -21.22 29.97 46.24 -19.61 31.88 46.01 22.49 4.36 7.95 23.43 2.12 7.73 coo -18.89 26.14 55.97 -17.47 27.48 55.08 24.97 -2.58 14.97 24.99 -3.62 16.79 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 4 2 # 4 D 445 SER A 69 SER~? 5.63 S2 BME A 300 D 524 ASP A 23 ASP^? 9.45 S2 BME A 300 coo -21.22 29.97 46.24 -19.61 31.88 46.01 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -18.89 26.14 55.97 -17.47 27.48 55.08 15.97 -5.82 2.06 15.42 -7.84 1.89 ULMN 2 3o4g_o03 ACYLAMINO-ACID-RELEASING ENZYME user 5 2 # 5 D 445 SER A 69 SER~? 5.63 S2 BME A 300 D 524 ASP A 44 ASP~? 11.03 S2 BME A 300 coo -21.22 29.97 46.24 -19.61 31.88 46.01 9.36 -5.27 9.06 7.58 -5.59 7.43 coo -18.89 26.14 55.97 -17.47 27.48 55.08 19.36 -9.90 14.44 17.51 -11.01 14.77 3o4g_o03 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 5 hits 3o4g_o03 naa= 2 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 24 VAL.? 8.05 S2 BME A 300 H 117 LYS A 39 LYS^? 20.06 S2 BME A 300 H 150 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 45.82 27.58 23.40 45.30 28.87 21.66 15.68 -6.47 6.85 14.25 -5.17 7.91 coo 38.01 32.08 28.20 39.46 29.85 23.57 19.85 -1.20 1.64 21.03 4.07 2.80 coo 41.19 29.62 18.76 39.21 28.51 20.32 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 2 3 # 2 H 28 VAL A 24 VAL.? 8.05 S2 BME A 300 H 117 LYS A 71 LYS~? 8.54 S2 BME A 300 H 150 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 45.82 27.58 23.40 45.30 28.87 21.66 15.68 -6.47 6.85 14.25 -5.17 7.91 coo 38.01 32.08 28.20 39.46 29.85 23.57 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 41.19 29.62 18.76 39.21 28.51 20.32 10.91 -8.39 4.98 11.88 -9.73 7.18 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 3 3 # 3 H 28 VAL A 86 VAL^? 10.46 S2 BME A 300 H 117 LYS A 71 LYS~? 8.54 S2 BME A 300 H 150 CYH A 63 CYH.? -3.36 S2 BME A 300s coo 45.82 27.58 23.40 45.30 28.87 21.66 5.69 -2.55 3.15 7.10 -2.56 1.49 coo 38.01 32.08 28.20 39.46 29.85 23.57 8.82 -4.39 14.42 10.42 -10.04 16.23 coo 41.19 29.62 18.76 39.21 28.51 20.32 10.91 -8.39 4.98 11.88 -9.73 7.18 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 3 hits 3uao_o07 naa= 3